Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
GFAP	FLJ45472	ENSG00000131095	"Glial fibrillary acidic protein"	P14136	17	44903161-44916937	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"brain: 595.5"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 9.5"	"Cancer enriched"	"Detected in some"	368	"glioma: 2468.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 9.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.8;NK-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000039, HPA056030, HPA063513"	Enhanced	Supported	Supported	"Intermediate filaments"			220000000	"Intermediate filaments"		"CAB000039: AB_10013382, HPA056030: , HPA063513: "	"unprognostic (1.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.12e-5)"	"unprognostic (4.08e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.57e-3)"	"unprognostic (7.35e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.75e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	3.0	2.9	122.2	3.2	105.4	5.8	3.0	33.9	595.5	2.7	3.0	171.0	0.0	2.8	2.9	3.0	3.6	3.2	3.1	4.0	143.0	175.1	3.0	2.8	3.0	3.1	227.0	67.3	3.0	3.0	3.4	1.3	2.8	212.7	3.0	2.9	0.0	3.1	2.9	3.2	3.3	2.8	2.9	482.0	3.0	3.0	2.9	119.0	0.0	3.0	0.0	2.9	3.4	0.0	1.1	0.8	9.8	1.2	2.9	0.8	0.3	1.7	1.1	2.0	3.8	0.0	0.8	0.5	1.7	2.0	2.4	2.0	2.1	2.4	3.5	3.1	0.9	4.3	2.2	0.7	3.0	4.3	1.9	2.8	2.9	1.4	0.1	0.8	4.2	0.2	1.3	1.7	0.0	0.0	1.3	8.3	0.6	2.2	2.9	4.1	2.7	5.2	1.2	1.2	2.8	1.1	1.5	2.7	2.9	0.5	3.4	0.3	2.2	2.2	1.2	2.1	1.6	1.9	2.5	1.2	2.3	2.7	9.5	3.4	3.3	1.9	1.2	0.5	0.5	1.1	0.4	0.4	0.5	0.7	0.3	1.1	0.6	0.8	9.8	2.9	0.7	0.8	0.4	0.3	122.2	105.4	33.9	69.4	143.0	175.1	227.0	67.3	212.7	119.0
TLX3	"HOX11L2, RNX"	ENSG00000164438	"T cell leukemia homeobox 3"	O43711	5	171309284-171312134	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"brain: 46.6"	"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 24.0"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.7"	"Region enriched"	"Detected in some"	22	"cerebellum: 46.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 2.5"	"Region enriched"	"Detected in some"	11	"cerebellum: 48.1"	"HPA030504, HPA060957, HPA069359"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA030504: , HPA060957: , HPA069359: "		"unprognostic (3.52e-2)"		"unprognostic (2.43e-2)"					"unprognostic (2.09e-1)"	"unprognostic (3.11e-1)"				"unprognostic (9.80e-2)"	"unprognostic (2.76e-2)"		"unprognostic (4.48e-2)"	0.4	0.5	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	24.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0
NEUROD2	"bHLHa1, NDRF"	ENSG00000171532	"Neuronal differentiation 2"	Q15784	17	39603536-39609777	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	54	"brain: 51.4"	"Cell line enriched"	"Detected in single"	239	"SCLC-21H: 23.9"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"amygdala: 28.0;cerebellum: 127.9;cerebral cortex: 45.1;hippocampal formation: 107.5"												"unprognostic (5.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.51e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.69e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.96e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.21e-6)"	"unprognostic (4.20e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.57e-3)"	0.7	0.7	10.9	0.7	8.3	0.7	0.7	51.4	22.1	0.7	0.7	0.2	0.0	0.7	0.7	0.7	0.7	0.7	0.7	0.7	18.8	0.6	0.7	0.7	0.7	0.7	1.1	18.3	0.7	0.7	0.7	0.2	0.7	12.3	0.7	0.7	0.0	0.7	0.7	0.7	0.8	0.7	0.7	1.1	0.7	0.9	0.7	0.0	0.0	0.7	0.0	0.7	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	8.3	51.4	18.8	18.8	0.6	1.1	18.3	12.3	0.0
NEUROD6	"Atoh2, bHLHa2, Math-2, Nex1, NEX1M"	ENSG00000164600	"Neuronal differentiation 6"	Q96NK8	7	31337461-31340894	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"brain: 30.6"	"Cell line enriched"	"Detected in single"	116	"SCLC-21H: 11.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 8.3;basal ganglia: 10.7;cerebral cortex: 25.5;hippocampal formation: 30.6;olfactory region: 17.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"cerebral cortex: 99.2;hippocampal formation: 246.6"	"Group enriched"	"Detected in some"	10	"cerebral cortex: 26.0;hippocampal formation: 108.7"	HPA074530	Enhanced									"HPA074530: "					"unprognostic (3.68e-2)"													0.5	0.5	8.3	0.5	10.7	0.5	0.5	3.9	25.5	0.5	0.5	0.7	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.5	30.6	0.5	0.5	0.5	0.5	0.5	1.3	17.4	0.5	0.5	0.5	0.1	0.5	0.4	0.5	0.5	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.4	0.5	0.5	0.5	0.0	0.0	0.5	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	10.7	3.9	25.5	30.6	0.5	1.3	17.4	0.4	0.0
NCAN	CSPG3	ENSG00000130287	Neurocan	O14594	19	19211973-19252233	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"brain: 88.4"	"Cell line enhanced"	"Detected in some"		"AF22: 2.9;SCLC-21H: 6.3;SH-SY5Y: 4.4"	"Cancer enriched"	"Detected in some"	57	"glioma: 71.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036814	Enhanced				"Secreted in brain"		340000			"HPA036814: AB_10673666"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.09e-6)"	"unprognostic (1.10e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.58e-2)"	1.1	1.2	21.2	1.1	23.2	1.1	1.1	5.4	88.4	1.1	1.1	12.9	0.0	1.1	1.1	1.1	1.1	1.1	1.1	1.1	16.8	8.3	1.1	1.2	1.1	1.1	7.8	15.2	1.1	1.1	1.1	0.1	1.1	12.3	1.1	1.1	0.0	1.2	1.1	1.1	1.1	1.1	1.1	4.0	1.1	1.1	1.8	5.6	0.0	1.1	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	6.3	4.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	23.2	5.4	22.8	16.8	8.3	7.8	15.2	12.3	5.6
MOG	"BTN6, BTNL11"	ENSG00000204655	"Myelin oligodendrocyte glycoprotein"	Q16653	6	29656981-29672372	"Disease related genes, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	47	"brain: 106.4"	"Group enriched"	"Detected in some"	7	"BEWO: 3.4;HEK 293: 2.1"	"Cancer enriched"	"Detected in single"	45	"glioma: 15.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021873	Enhanced									"HPA021873: AB_1854055"	"unprognostic (1.33e-1)"				"unprognostic (1.32e-1)"				"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"		"unprognostic (7.87e-2)"	"unprognostic (3.00e-4)"	"unprognostic (4.89e-2)"	"unprognostic (4.90e-2)"			1.9	1.7	22.1	1.7	35.1	1.7	1.7	3.1	30.0	1.7	1.9	79.5	0.0	1.7	1.7	1.7	1.7	1.7	1.7	1.7	40.2	19.6	2.0	1.7	1.8	1.7	49.2	17.1	2.0	1.7	1.7	0.0	1.8	39.8	1.8	2.1	0.0	1.7	2.2	1.7	1.7	2.0	1.7	106.4	1.7	1.7	2.0	46.4	0.0	1.7	0.0	1.8	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	22.1	35.1	3.1	30.0	40.2	19.6	49.2	17.1	39.8	46.4
HPCA		ENSG00000121905	Hippocalcin	P84074	1	32885994-32898441	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	46	"brain: 118.9"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 10.0"	"Cancer enriched"	"Detected in many"	9	"glioma: 8.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 118.9;cerebral cortex: 40.4;hippocampal formation: 42.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 1321.6;hippocampal formation: 1344.5"	"CAB012340, HPA043245"	Enhanced									"CAB012340: AB_2120209, HPA043245: "	"unprognostic (4.60e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.72e-3)"	"unprognostic (5.18e-2)"	"unprognostic (9.08e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.85e-3)"	1.2	1.5	13.5	1.2	118.9	1.1	1.2	4.8	82.2	1.4	1.5	2.2	0.0	1.2	1.4	1.2	1.1	1.4	1.3	1.2	42.5	2.8	1.3	1.1	1.1	1.2	3.7	14.5	1.5	1.2	1.1	0.0	1.2	0.0	1.3	1.5	0.6	1.3	1.3	1.1	1.2	1.4	1.3	0.8	1.2	1.2	2.5	12.2	0.0	1.3	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.6	1.4	0.3	0.4	0.0	0.1	0.1	0.3	0.8	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.6	0.0	0.0	10.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	1.0	0.8	0.0	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	13.5	118.9	4.8	40.4	42.5	2.8	3.7	14.5	0.0	12.2
AVP	"ADH, ARVP"	ENSG00000101200	"Arginine vasopressin"	P01185	20	3082556-3084724	"Disease related genes, Predicted secreted proteins"		"Hormone, Vasoactive, Vasoconstrictor"	"Diabetes insipidus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"brain: 270.1"	"Cell line enriched"	"Detected in single"	13	"NB-4: 6.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	18	"hypothalamus: 270.1"	"Cell type enriched"	"Detected in some"	6	"eosinophil: 6.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.1"	"Region enriched"	"Detected in some"	10	"hypothalamus: 273.6"	"Group enriched"	"Detected in some"	645	"basal ganglia: 1065.4;hypothalamus: 1058.2"	"CAB025318, HPA071892"	Enhanced	Supported			"Secreted to blood"	19255				"CAB025318: , HPA071892: "										"unprognostic (1.15e-1)"					"unprognostic (2.61e-1)"			0.7	0.9	11.7	0.4	15.0	4.2	0.0	0.0	0.9	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	270.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	1.0	0.1	11.7	15.0	0.0	0.9	3.4	270.1	0.0	0.0	0.8	0.0
BARHL1		ENSG00000125492	"BarH like homeobox 1"	Q9BZE3	9	132582185-132590266	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	44	"brain: 40.1"	"Cell line enriched"	"Detected in single"	105	"SCLC-21H: 19.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"cerebellum: 23.8;pons and medulla: 40.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebellum: 3.6;midbrain: 2.9;pons and medulla: 1.1"	"Region enhanced"	"Detected in many"		"cerebellum: 16.3"	HPA004809	Enhanced									"HPA004809: AB_1078266"					"unprognostic (2.29e-1)"					"unprognostic (6.42e-2)"	"unprognostic (8.07e-2)"			"unprognostic (9.31e-2)"				0.3	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.5	0.3	0.0	0.0	0.0	2.2	0.0	0.2	0.9	0.0	0.0	0.0	40.1	0.1	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.9	0.0	0.5	2.2	0.0	40.1	0.0
FGF3	"HBGF-3, INT2"	ENSG00000186895	"Fibroblast growth factor 3"	P11487	11	69809969-69819024	"Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins"	Differentiation	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	43	"brain: 16.6"	"Cell line enriched"	"Detected in single"	48	"CAPAN-2: 4.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	38	"cerebellum: 16.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.7"	"Not detected"	"Not detected"			HPA012692	Enhanced				"Secreted in brain"					"HPA012692: AB_1848526"				"unprognostic (6.42e-3)"						"unprognostic (7.82e-2)"	"unprognostic (1.89e-1)"			"unprognostic (3.61e-1)"	"unprognostic (7.75e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0
MBP		ENSG00000197971	"Myelin basic protein"	P02686	18	76978827-77133683	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autoimmune encephalomyelitis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	43	"brain: 1297.7"	"Cell line enhanced"	"Detected in many"		"HL-60: 28.4;SK-MEL-30: 59.1"	"Group enriched"	"Detected in all"	9	"glioma: 47.5;melanoma: 20.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002300, HPA049222, HPA064368"	Enhanced	Supported	Approved	"Plasma membrane"				"Plasma membrane"		"CAB002300: AB_563893, HPA049222: , HPA064368: "	"unprognostic (9.36e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.95e-1)"	"prognostic favourable (4.48e-12)"	"unprognostic (2.90e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.03e-2)"	4.0	3.4	271.6	6.1	244.9	10.1	4.5	28.7	418.9	5.6	5.5	487.7	0.0	5.9	4.4	3.6	6.4	9.0	5.7	6.8	355.0	247.6	6.2	5.9	6.2	7.1	645.5	43.4	3.7	6.8	16.4	0.7	2.7	242.9	4.5	5.6	0.4	5.0	4.9	29.9	7.9	6.2	3.8	1297.7	7.6	5.1	2.9	224.3	0.0	6.8	0.0	7.7	6.0	0.6	3.4	6.8	23.7	4.7	15.4	17.1	5.6	7.4	6.5	0.0	0.2	11.0	16.4	2.6	0.1	0.2	0.2	0.1	0.9	11.5	4.6	1.3	0.5	14.7	1.1	6.5	0.2	17.8	1.6	2.9	1.1	1.5	6.9	28.4	19.8	2.3	5.5	5.9	9.1	1.9	0.0	1.0	0.0	0.9	1.1	14.6	0.6	5.2	0.4	0.1	10.2	10.4	10.1	0.5	0.1	0.9	0.0	59.1	0.2	17.4	0.0	0.0	0.1	0.0	0.8	0.0	0.1	4.9	1.7	18.0	0.7	11.0	4.7	17.8	13.2	4.6	8.0	3.4	9.4	17.1	5.3	3.3	5.7	10.5	23.7	15.4	4.4	6.8	7.9	5.6	271.6	244.9	28.7	127.7	355.0	247.6	645.5	43.4	242.9	224.3
MEPE		ENSG00000152595	"Matrix extracellular phosphoglycoprotein"	Q9NQ76	4	87821411-87846817	"Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	43	"brain: 34.2"	"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"amygdala: 34.2;cerebral cortex: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enhanced"	"Detected in single"		"amygdala: 1.3"	"HPA038003, HPA038004"	Uncertain				"Secreted to extracellular matrix"		24000000			"HPA038003: , HPA038004: AB_10670537"	"unprognostic (2.88e-1)"				"unprognostic (8.15e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.61e-1)"		"unprognostic (4.76e-2)"	"unprognostic (1.11e-1)"		"unprognostic (3.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.41e-1)"		"unprognostic (5.64e-4)"	0.2	0.2	34.2	0.2	5.2	0.3	0.5	0.0	10.0	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.2	2.4	1.7	0.3	0.2	0.3	0.2	0.5	5.4	0.2	0.2	0.2	0.1	0.3	0.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.2	5.2	0.0	10.0	2.4	1.7	0.5	5.4	0.0	0.0
OPALIN	"HTMP10, TMEM10, TMP10"	ENSG00000197430	"Oligodendrocytic myelin paranodal and inner loop protein"	Q96PE5	10	96343216-96359365	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	43	"brain: 69.7"	"Group enriched"	"Detected in some"	11	"MOLT-4: 2.2;REH: 4.5"	"Cancer enriched"	"Detected in single"	36	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014372	Supported									"HPA014372: AB_2158172"					"unprognostic (1.18e-1)"													1.5	1.5	35.0	1.5	42.1	1.6	1.5	2.8	69.7	1.5	1.5	52.5	0.0	1.5	1.5	1.5	1.5	1.5	1.5	1.5	40.1	15.1	1.5	1.5	1.5	1.5	19.9	17.8	1.5	1.5	1.5	0.0	1.5	13.8	1.5	1.5	0.0	1.5	1.5	1.5	1.5	1.5	1.5	17.8	1.5	1.5	1.5	29.5	0.0	1.5	0.0	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.0	42.1	2.8	33.4	40.1	15.1	19.9	17.8	13.8	29.5
OMG	OMGP	ENSG00000126861	"Oligodendrocyte myelin glycoprotein"	P23515	17	31272013-31297539	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	40	"brain: 89.6"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;U-87 MG: 1.4"	"Group enriched"	"Detected in some"	7	"endometrial cancer: 3.5;glioma: 9.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008206, HPA012693"	Enhanced				"Intracellular and membrane"					"HPA008206: AB_1854240, HPA012693: AB_1854239"	"unprognostic (8.05e-4)"	"unprognostic (2.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.54e-2)"	"unprognostic (8.60e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.96e-13)"	"unprognostic (7.80e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.42e-2)"	1.6	1.8	25.2	1.6	25.4	2.2	1.6	10.2	89.6	1.6	1.7	20.3	0.0	1.7	1.6	1.6	1.6	1.6	1.6	1.6	26.8	20.6	1.6	1.6	1.6	1.6	30.8	23.2	1.6	1.6	1.6	0.1	1.6	36.8	1.6	1.7	1.4	1.6	1.6	1.7	1.6	1.7	1.6	23.0	1.7	1.6	1.6	39.6	0.0	1.6	0.0	1.6	1.6	0.0	0.0	0.1	1.6	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.2	0.2	3.5	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.6	1.4	0.0	0.7	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	25.2	25.4	10.2	34.1	26.8	20.6	30.8	23.2	36.8	39.6
HAPLN2	BRAL1	ENSG00000132702	"Hyaluronan and proteoglycan link protein 2"	Q9GZV7	1	156619294-156625725	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	39	"brain: 108.1"	"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 1.1;U-266/70: 4.5;U-87 MG: 1.3"	"Cancer enriched"	"Detected in some"	10	"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045765	Enhanced				"Secreted in brain"					"HPA045765: AB_10964781"	"unprognostic (3.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-3)"	"unprognostic (1.31e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.72e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-3)"	1.5	1.5	11.0	1.3	21.1	1.3	1.3	4.4	45.3	1.3	1.3	43.6	0.0	2.7	1.6	1.3	1.3	1.4	1.3	1.3	21.2	13.9	1.4	1.3	1.4	1.3	49.3	9.3	1.3	1.3	1.6	0.0	1.3	43.1	1.9	1.3	0.0	1.4	1.5	1.9	1.6	1.7	1.3	108.1	1.3	1.3	1.7	31.5	0.0	1.3	0.0	1.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	4.5	0.1	0.2	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	21.1	4.4	15.1	21.2	13.9	49.3	9.3	43.1	31.5
GRIN1	"GluN1, NMDAR1"	ENSG00000176884	"Glutamate ionotropic receptor NMDA type subunit 1"	Q05586	9	137138390-137168762	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	38	"brain: 97.5"	"Cell line enhanced"	"Detected in some"		"REH: 3.0;RPMI-8226: 4.3;SCLC-21H: 9.8;SH-SY5Y: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067773	Enhanced									"HPA067773: "	"unprognostic (3.58e-2)"	"unprognostic (4.51e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.48e-4)"	"unprognostic (5.20e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.72e-2)"	1.7	2.0	23.6	2.0	47.5	1.7	1.8	28.1	97.5	1.8	2.0	3.2	0.0	2.2	1.7	1.8	1.7	1.7	1.7	1.7	29.1	26.4	1.8	1.7	1.8	1.8	15.4	37.9	1.7	1.8	1.8	0.0	1.7	22.0	2.2	1.8	0.7	2.5	1.8	1.7	1.8	2.2	1.8	4.7	1.8	1.8	1.9	6.3	0.0	1.7	0.0	1.8	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.4	1.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	1.5	0.1	0.0	0.2	0.2	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.0	0.1	0.0	3.0	0.0	4.3	0.0	0.0	9.8	6.8	0.1	0.5	0.0	2.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	23.6	47.5	28.1	87.9	29.1	26.4	15.4	37.9	22.0	6.3
CAMKV	"MGC8407, VACAMKL"	ENSG00000164076	"CaM kinase like vesicle associated"	Q8NCB2	3	49857988-49870222	"Enzymes, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	36	"brain: 77.2"	"Cell line enhanced"	"Detected in some"		"AF22: 5.2;HAP1: 6.9;NTERA-2: 24.6;RPMI-8226: 4.7;SCLC-21H: 8.4;SH-SY5Y: 5.4"	"Group enriched"	"Detected in some"	11	"glioma: 4.0;testis cancer: 5.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007656, CAB034931"	Enhanced	Supported	Approved	"Nucleoplasm,Cytokinetic bridge"				Nucleoplasm	"Cytokinetic bridge"	"CAB034931: AB_2068550, HPA007656: AB_1078391"	"unprognostic (9.47e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-7)"	"unprognostic (2.76e-1)"	"unprognostic (7.95e-4)"		"unprognostic (3.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.61e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.67e-3)"	1.2	2.1	20.7	1.2	77.2	1.2	1.2	0.5	62.8	1.2	1.2	1.7	0.0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	33.4	11.7	1.2	1.2	1.2	1.2	3.3	23.5	1.2	1.2	1.2	1.8	1.2	2.1	1.2	1.2	0.0	1.2	1.2	1.2	1.3	1.2	1.2	1.9	1.2	1.3	2.1	6.0	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	5.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.7	0.1	24.6	0.1	0.7	0.0	4.7	0.0	0.0	8.4	5.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	20.7	77.2	0.5	34.0	33.4	11.7	3.3	23.5	2.1	6.0
MOBP		ENSG00000168314	"Myelin-associated oligodendrocyte basic protein"	Q13875	3	39467198-39529479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	32	"brain: 194.3"	"Cell line enriched"	"Detected in single"	52	"HAP1: 20.2"	"Cancer enriched"	"Detected in single"	63	"glioma: 4.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA035152	Supported		Supported	"Cytoplasmic bodies"				"Cytoplasmic bodies"		"HPA035152: AB_10603020"	"unprognostic (1.76e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.53e-2)"	"unprognostic (7.35e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.60e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.04e-5)"	"unprognostic (2.28e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	1.7	1.8	35.0	1.7	58.5	1.7	1.7	3.8	101.8	1.7	2.3	102.1	0.0	1.6	1.8	1.7	1.7	2.7	1.7	1.7	51.4	33.4	1.7	1.6	2.3	1.6	84.8	14.7	2.1	1.6	6.0	0.0	1.6	68.2	1.6	1.8	0.0	1.6	1.7	1.8	1.7	1.7	1.8	194.3	1.6	1.7	5.0	64.2	0.0	1.7	0.0	1.6	1.7	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	35.0	58.5	3.8	29.1	51.4	33.4	84.8	14.7	68.2	64.2
HCRT	"OX, PPOX"	ENSG00000161610	"Hypocretin neuropeptide precursor"	O43612	17	42184060-42185452	"Disease related genes, Predicted secreted proteins"		Neuropeptide	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	31	"brain: 84.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.9;Karpas-707: 1.0;RPMI-8226: 3.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"					"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.7;granulocytes: 2.3;T-cells: 2.2"	"Region enriched"	"Detected in some"	5	"hypothalamus: 110.5"	"Region enriched"	"Detected in single"	56	"hypothalamus: 152.0"	"HPA064801, CAB079778"	Enhanced	Supported			"Secreted to blood"					"CAB079778: , HPA064801: "			"unprognostic (3.34e-2)"		"unprognostic (7.76e-5)"					"unprognostic (3.21e-2)"	"unprognostic (3.01e-2)"		"unprognostic (2.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"			0.9	0.0	0.0	1.1	0.2	0.9	0.0	0.0	0.7	0.0	0.5			1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	84.3	0.4	0.0	0.0	0.4	0.1		0.3	0.0	0.0	0.0	0.3		0.0	0.1		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.3			0.0		0.0	0.0	0.0	2.7	0.4	2.3	0.5	0.4	2.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.8	0.8	0.4	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.2	0.7	0.8	0.2	0.0	0.1	0.0	2.3	0.5	0.0	1.2	0.4	2.2	1.5	0.9	1.6	0.4	2.7	1.4	1.3	0.1	0.4	0.2	0.3	0.5	0.1										
SPHAR		ENSG00000213029	"S-phase response (cyclin related)"	Q15513	1	229304857-229305504	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	31	"brain: 3.1"	"Cell line enriched"	"Detected in single"	20	"Daudi: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.2		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PMP2	"FABP8, M-FABP, MP2"	ENSG00000147588	"Peripheral myelin protein 2"	P02689	8	81440326-81447523	"Predicted intracellular proteins"	Transport		"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	30	"brain: 124.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.0;Karpas-707: 1.3;U-87 MG: 1.6;WM-115: 5.3"	"Cancer enriched"	"Detected in some"	59	"glioma: 239.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	26	"midbrain: 78.0;pons and medulla: 111.5"													"unprognostic (5.87e-2)"			"unprognostic (5.81e-2)"	"unprognostic (1.12e-2)"		"unprognostic (1.95e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.45e-2)"	"unprognostic (4.43e-2)"		"unprognostic (7.21e-2)"	"unprognostic (4.41e-1)"		"unprognostic (3.27e-3)"	2.7	2.5	39.2	2.4	36.9	1.5	1.6	13.4	124.8	2.5	2.2	14.5	0.0	1.8	1.6	2.8	2.0	1.7	2.2	2.4	30.4	31.2	1.6	1.6	1.5	1.5	48.3	18.3	1.7	1.8	1.5	0.0	1.5	66.6	2.0	2.0	0.0	2.2	4.2	1.7	1.7	1.9	1.7	106.3	1.5	1.6	1.6	45.8	0.0	1.5	0.0	1.5	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	36.9	13.4	27.8	30.4	31.2	48.3	18.3	66.6	45.8
C1orf61	CROC4	ENSG00000125462	"Chromosome 1 open reading frame 61"	Q13536	1	156404250-156430701	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	29	"brain: 184.8"	"Cell line enriched"	"Detected in some"	9	"BEWO: 16.9"	"Cancer enriched"	"Detected in some"	116	"glioma: 77.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 6.3;MAIT T-cell: 5.2"	"Lineage enriched"	"Detected in single"	34	"T-cells: 6.3"																				"unprognostic (6.20e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.35e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.16e-7)"	"unprognostic (5.87e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.88e-2)"	2.0	1.9	71.9	1.9	69.5	2.1	2.0	20.2	184.8	1.9	2.0	19.3	0.0	2.0	2.0	2.0	2.0	2.0	1.9	1.9	48.9	45.2	1.9	2.0	1.9	2.1	65.3	23.6	1.9	1.9	2.0	0.0	1.9	27.4	1.9	2.0	1.4	2.0	1.9	1.9	1.9	2.0	2.0	22.7	2.1	1.9	3.1	14.8	0.0	1.9	0.0	2.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	6.3	0.5	0.0	0.8	0.0	0.3	0.0	0.0	16.9	0.0	0.0	0.0	0.1	0.3	0.3	1.2	0.0	0.0	0.2	0.6	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	1.3	0.8	0.0	0.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.3	0.4	0.0	0.0	0.0	6.3	0.0	5.2	0.0	1.5	3.3	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.6	0.5	71.9	69.5	20.2	43.5	48.9	45.2	65.3	23.6	27.4	14.8
CACNG7		ENSG00000105605	"Calcium voltage-gated channel auxiliary subunit gamma 7"	P62955	19	53909335-53943941	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"brain: 54.4"	"Cell line enhanced"	"Detected in some"		"AF22: 28.8;HMC-1: 22.4;NTERA-2: 7.6;SH-SY5Y: 17.7;U-2 OS: 6.1"	"Cancer enriched"	"Detected in some"	16	"glioma: 29.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																	"unprognostic (3.11e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.24e-2)"				"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"		"unprognostic (1.01e-5)"	"unprognostic (1.51e-1)"	"unprognostic (7.36e-2)"			1.2	1.8	22.2	1.3	15.6	1.2	1.2	22.7	54.4	1.2	1.3	8.3	0.0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	21.4	13.7	1.2	1.2	1.3	1.2	16.5	10.3	1.2	1.3	1.2	1.8	1.2	9.9	1.2	1.2	0.3	1.2	1.3	1.2	1.2	1.4	1.3	13.5	1.2	1.3	1.5	4.5	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	28.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	22.4	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.1	0.0	0.0	0.0	1.7	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.2	15.6	22.7	25.9	21.4	13.7	16.5	10.3	9.9	4.5
GRM4	"GPRC1D, mGlu4, MGLUR4"	ENSG00000124493	"Glutamate metabotropic receptor 4"	Q14833	6	34018645-34155622	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"brain: 101.6"	"Group enriched"	"Detected in some"	8	"BEWO: 6.4;SCLC-21H: 25.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Region enriched"	"Detected in many"	21	"cerebellum: 101.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"cerebellum: 83.5"	"Region enriched"	"Detected in many"	4	"cerebellum: 252.6"	CAB022096	Enhanced									"CAB022096: "	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.56e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.15e-11)"	"unprognostic (5.32e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.07e-1)"	0.2	0.1	0.4	0.3	4.9	0.2	0.2	101.6	7.2	0.6	0.1	0.3	0.1	0.5	0.5	0.1	0.1	0.3	0.1	0.1	0.5	0.9	0.2	0.3	0.3	0.2	0.3	0.4	0.2	3.5	0.1	0.0	0.3	4.3	0.3	0.2	0.1	0.1	0.2	0.3	0.6	0.8	0.7	1.1	0.1	0.2	1.6	0.5	0.0	0.3	0.0	0.7	0.4	0.0	0.2	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	4.9	101.6	1.0	0.5	0.9	0.3	0.4	4.3	0.5
KCNJ9	"GIRK3, Kir3.3"	ENSG00000162728	"Potassium voltage-gated channel subfamily J member 9"	Q92806	1	160081570-160090563	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	27	"brain: 52.0"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 2.3;SH-SY5Y: 2.7;U-266/70: 2.8"	"Cancer enriched"	"Detected in single"	35	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070478	Enhanced									"HPA070478: "	"unprognostic (2.35e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-2)"	1.4	1.9	15.6	1.4	15.3	1.4	1.4	32.1	52.0	1.4	1.4	11.9	0.0	1.4	1.4	1.4	1.4	1.4	1.4	1.4	18.4	11.1	1.5	1.4	1.4	1.4	18.3	20.6	1.4	1.4	1.4	0.7	1.4	7.4	1.4	1.4	0.0	1.4	1.4	1.4	1.4	1.5	1.4	11.4	1.4	1.5	1.7	11.6	0.0	1.4	0.0	1.4	1.4	0.0	0.8	0.0	0.0	0.3	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	2.3	2.7	0.0	0.1	0.3	0.0	0.1	0.3	0.0	0.0	0.5	0.0	2.8	0.2	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.5	0.3	1.1	0.4	0.2	1.1	0.0	0.8	0.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	15.6	15.3	32.1	27.2	18.4	11.1	18.3	20.6	7.4	11.6
AMER2	"FAM123A, FLJ25477"	ENSG00000165566	"APC membrane recruitment protein 2"	Q8N7J2	13	25161684-25172288	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"brain: 57.0"	"Group enriched"	"Detected in some"	6	"AF22: 5.9;SCLC-21H: 5.0;U-266/70: 11.3"	"Cancer enriched"	"Detected in single"	24	"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039458	Enhanced									"HPA039458: AB_10795677"	"unprognostic (1.69e-2)"	"unprognostic (4.13e-2)"		"unprognostic (7.43e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.00e-3)"		"unprognostic (5.00e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.90e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.34e-1)"		1.2	1.4	15.5	1.2	33.5	1.2	1.2	11.7	57.0	1.2	1.2	24.7	0.0	1.2	1.2	1.2	1.2	2.2	1.2	1.2	19.9	9.7	1.2	1.2	1.2	1.2	41.9	9.2	1.2	1.2	1.1	1.6	1.2	15.8	1.4	1.2	0.0	1.2	1.5	1.4	1.3	1.2	1.2	15.9	1.2	1.2	2.0	47.8	0.0	1.2	0.0	1.2	1.2	0.0	0.4	0.4	1.1	0.4	0.7	0.3	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.4	0.0	0.2	0.0	0.1	1.1	0.3	0.2	0.2	0.3	0.3	0.3	0.2	0.2	0.1	0.4	0.3	0.3	0.9	0.7	0.4	0.4	0.3	0.0	15.5	33.5	11.7	20.9	19.9	9.7	41.9	9.2	15.8	47.8
PLP1	"GPM6C, PLP, SPG2"	ENSG00000123560	"Proteolipid protein 1"	P60201	X	103773718-103792619	"Cancer-related genes, Disease related genes, Predicted membrane proteins"			"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"brain: 463.6"	"Group enriched"	"Detected in some"	5	"SK-MEL-30: 66.3;WM-115: 39.6"	"Group enriched"	"Detected in many"	22	"glioma: 160.5;melanoma: 75.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"plasmacytoid DC: 2.3"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004128	Enhanced									"HPA004128: AB_1079635"	"unprognostic (5.72e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.95e-2)"		"unprognostic (2.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.62e-5)"	"unprognostic (4.91e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.16e-2)"	3.6	5.6	90.6	2.8	109.9	1.9	3.1	8.9	463.6	3.9	5.7	208.1	0.0	3.3	3.6	3.5	4.2	2.5	4.0	5.0	143.8	73.8	2.1	2.1	2.1	2.0	174.8	42.2	3.0	2.2	17.9	0.3	1.9	124.4	3.6	5.4	0.0	3.4	9.3	2.2	7.3	5.1	7.0	453.8	2.0	2.8	9.2	145.2	0.0	2.0	0.0	2.0	2.7	0.8	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	39.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	90.6	109.9	8.9	68.1	143.8	73.8	174.8	42.2	124.4	145.2
TBR1		ENSG00000136535	"T-box, brain 1"	Q16650	2	161416094-161425870	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"brain: 34.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.6;HMC-1: 1.3;Karpas-707: 1.0;SCLC-21H: 1.7;U-266/84: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"amygdala: 45.6;basal ganglia: 28.5;cerebral cortex: 70.3;hippocampal formation: 50.1"	"Region enhanced"	"Detected in many"		"cerebral cortex: 63.6"	"HPA051256, HPA078644, HPA078657"	Enhanced	Supported								"HPA051256: , HPA078644: AB_2732387, HPA078657: AB_2732388"	"unprognostic (3.08e-2)"	"unprognostic (5.45e-2)"		"unprognostic (1.13e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.43e-3)"		"unprognostic (1.95e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.14e-1)"			"unprognostic (1.39e-9)"	"unprognostic (5.72e-2)"	"unprognostic (1.72e-1)"		"unprognostic (5.37e-2)"	0.6	0.5	11.2	0.5	13.7	0.5	0.5	0.3	34.9	0.6	0.5	0.0	0.0	0.5	0.5	0.6	0.5	0.6	0.5	0.5	6.1	1.3	0.5	0.5	0.5	0.5	0.8	21.0	0.5	0.6	0.6	0.3	0.5	0.0	0.5	0.6	0.0	0.5	0.7	0.5	0.5	0.5	0.5	0.4	0.5	0.5	1.3	0.0	0.0	0.5	0.0	0.5	0.5	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.6	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.2	0.2	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.2	0.5	1.5	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	11.2	13.7	0.3	34.9	6.1	1.3	0.8	21.0	0.0	0.0
TMEM235		ENSG00000204278	"Transmembrane protein 235"	A6NFC5	17	78231310-78240987	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	26	"brain: 33.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;HUVEC TERT2: 1.2"	"Cancer enriched"	"Detected in single"	15	"glioma: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA053939	Uncertain									"HPA053939: "					"unprognostic (1.47e-1)"	"unprognostic (6.91e-3)"								"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"			1.0	1.0	12.2	1.0	17.4	1.0	1.0	2.0	25.6	1.0	1.0	33.0	0.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	20.9	9.7	1.0	1.0	1.0	1.1	18.3	8.6	1.1	1.0	1.0	0.0	1.2	10.3	1.0	1.0	0.0	1.0	1.0	1.0	1.0	1.0	1.0	20.7	1.0	1.0	1.2	18.0	0.0	1.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	17.4	2.0	10.2	20.9	9.7	18.3	8.6	10.3	18.0
GABRD		ENSG00000187730	"Gamma-aminobutyric acid type A receptor delta subunit"	O14764	1	2019298-2030758	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	25	"brain: 87.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.8;HMC-1: 2.5;MCF7: 8.2;NB-4: 5.2;SH-SY5Y: 3.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 87.0"	"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA044371	Enhanced		Uncertain	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA044371: "	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-8)"	"unprognostic (6.34e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (4.12e-8)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.16e-2)"	1.2	3.4	8.8	0.9	16.8	1.0	1.0	87.0	40.0	1.0	1.2	1.7	0.0	0.9	1.3	1.2	1.3	1.0	1.5	1.7	6.0	1.7	1.1	0.9	1.4	1.3	3.3	11.1	0.9	0.9	1.4	0.7	1.2	17.1	1.0	1.0	0.0	1.1	0.9	1.3	1.4	1.0	1.4	1.4	1.0	1.0	3.3	1.5	0.0	1.6	0.0	1.0	1.2	0.1	0.0	1.2	0.2	0.1	0.0	0.0	0.8	0.0	0.7	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	5.2	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.1	0.1	0.0	0.0	1.1	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.8	8.8	16.8	87.0	40.0	6.0	1.7	3.3	11.1	17.1	1.5
GAP43	"B-50, PP46"	ENSG00000172020	"Growth associated protein 43"	P17677	3	115623324-115721490	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Differentiation, Growth regulation, Neurogenesis"	"Calmodulin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"brain: 132.7"	"Cell line enhanced"	"Detected in some"		"AF22: 16.4;NTERA-2: 34.8;SCLC-21H: 22.4;SH-SY5Y: 16.8;U-87 MG: 7.8"	"Cancer enriched"	"Detected in many"	43	"glioma: 245.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"naive CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004417, HPA013392, HPA015600, CAB078783"	Enhanced	Supported	Enhanced	"Plasma membrane"				"Plasma membrane"		"CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.72e-5)"	"unprognostic (7.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.08e-4)"	"unprognostic (3.33e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.35e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.29e-3)"	1.8	5.0	48.8	5.2	38.3	1.4	1.9	31.2	132.7	1.6	4.1	4.3	0.0	2.7	1.5	1.5	1.9	1.5	3.8	3.6	29.0	56.6	1.4	1.4	1.5	1.5	30.6	42.2	1.4	1.8	1.4	1.5	2.2	25.7	1.7	4.0	0.8	2.2	1.5	1.4	1.4	4.3	3.6	6.1	1.4	1.5	1.6	5.7	0.0	1.5	0.0	1.6	1.7	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	22.4	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	48.8	38.3	31.2	75.7	29.0	56.6	30.6	42.2	25.7	5.7
TTC9B	FLJ30373	ENSG00000174521	"Tetratricopeptide repeat domain 9B"	Q8N6N2	19	40216058-40218399	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"brain: 47.9"	"Cell line enriched"	"Detected in some"	19	"SCLC-21H: 24.5"	"Cancer enriched"	"Detected in single"	15	"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042496	Approved				"Secreted in brain"					"HPA042496: AB_10795506"	"unprognostic (2.31e-1)"	"unprognostic (1.39e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.24e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.69e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.39e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.24e-2)"	1.0	1.8	45.5	1.4	10.3	1.0	1.0	24.6	47.9	1.0	1.2	1.2	0.0	1.1	1.0	1.0	1.0	1.0	1.0	1.0	22.3	14.0	1.0	1.0	1.0	1.0	7.5	9.9	1.0	1.0	1.0	0.0	1.0	7.1	1.0	1.0	0.3	1.0	1.0	1.0	1.0	1.2	1.1	2.5	1.0	1.1	1.1	1.0	0.0	1.0	0.0	1.0	1.0	0.0	0.1	0.5	0.0	1.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	24.5	1.3	0.1	0.0	0.9	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.3	0.0	45.5	10.3	24.6	31.3	22.3	14.0	7.5	9.9	7.1	1.0
GRM3	"GPRC1C, mGlu3, MGLUR3"	ENSG00000198822	"Glutamate metabotropic receptor 3"	Q14832	7	86643914-86864884	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	24	"brain: 53.3"	"Cell line enriched"	"Detected in some"	6	"AF22: 28.0"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"						"unprognostic (2.05e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.07e-3)"	"unprognostic (6.99e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.00e-2)"	"unprognostic (9.34e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.12e-2)"	1.2	2.2	10.6	1.2	22.5	1.2	1.2	4.6	53.3	1.3	1.3	23.9	0.0	1.3	1.3	1.2	1.2	1.2	1.3	1.3	12.6	5.6	1.4	1.2	1.3	1.2	18.9	13.0	1.2	1.2	1.2	0.2	1.2	11.5	1.7	1.2	0.0	1.3	1.3	2.1	1.2	1.2	1.2	12.0	1.8	1.3	2.2	22.1	0.0	1.2	0.0	1.2	1.4	0.1	0.5	0.1	0.5	0.0	0.1	0.3	0.1	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	10.6	22.5	4.6	20.2	12.6	5.6	18.9	13.0	11.5	22.1
SNCB		ENSG00000074317	"Synuclein beta"	Q16143	5	176620084-176630556	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	24	"brain: 134.8"	"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 36.1"	"Cancer enriched"	"Detected in some"	8	"glioma: 11.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"naive B-cell: 3.1"	"Lineage enriched"	"Detected in single"	12	"B-cells: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002681, HPA035876"	Enhanced	Supported								"CAB002681: , HPA035876: AB_10670592"	"unprognostic (3.55e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.95e-2)"		"unprognostic (6.07e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.31e-1)"	"unprognostic (5.41e-5)"	"unprognostic (1.31e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.42e-3)"	1.6	3.9	53.7	1.6	24.9	1.5	1.6	64.1	134.8	1.5	1.7	2.2	0.0	1.6	1.6	1.5	1.5	1.6	1.6	1.8	39.4	31.0	1.6	1.5	1.5	1.7	27.5	30.0	1.5	2.1	1.5	1.9	1.6	31.5	1.6	1.6	5.6	1.5	1.5	2.7	1.6	1.6	1.6	7.4	1.6	1.6	1.7	1.5	0.0	1.5	0.0	1.6	1.6	0.0	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.5	0.0	0.1	1.6	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	1.1	0.6	0.0	0.0	2.7	1.6	0.0	0.0	0.1	0.0	0.0	36.1	1.3	0.0	0.1	3.4	1.6	0.1	0.0	0.0	1.4	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	53.7	24.9	64.1	87.6	39.4	31.0	27.5	30.0	31.5	1.5
GABRA6		ENSG00000145863	"Gamma-aminobutyric acid type A receptor alpha6 subunit"	Q16445	5	161547063-161702593	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	23	"brain: 96.4"	"Group enriched"	"Detected in some"	9	"AF22: 1.0;PC-3: 1.4;TIME: 1.0;U-266/70: 2.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	36	"cerebellum: 96.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	40	"cerebellum: 1204.9"	"Region enriched"	"Detected in single"	44	"cerebellum: 189.6"	CAB022462	Approved									"CAB022462: "																"unprognostic (3.79e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.4	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.4	0.1	0.0	0.0	0.0	0.0	2.6	0.0
POU3F2	"BRN2, OCT7, OTF7, POUF3"	ENSG00000184486	"POU class 3 homeobox 2"	P20265	6	98834592-98839470	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"brain: 28.0"	"Cell line enhanced"	"Detected in some"		"AF22: 51.0;SK-MEL-30: 7.0;U-251 MG: 15.6;WM-115: 13.5"	"Cancer enriched"	"Detected in some"	11	"glioma: 16.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047081, HPA056261"		Approved	Supported	Nucleoplasm				Nucleoplasm		"HPA047081: , HPA056261: "	"unprognostic (5.94e-4)"	"unprognostic (7.80e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-3)"	"unprognostic (4.77e-1)"	"unprognostic (9.38e-11)"	"unprognostic (4.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.04e-1)"	0.9	1.0	9.0	0.9	10.8	0.9	0.9	3.4	28.0	0.9	0.9	10.3	0.0	0.9	0.9	0.9	0.9	0.9	0.9	0.9	9.8	7.1	0.9	0.9	0.9	0.9	10.7	6.8	0.9	0.9	0.9	0.0	0.9	9.7	0.9	0.9	0.0	0.9	0.9	0.9	1.0	0.9	0.9	8.4	0.9	0.9	1.2	9.0	0.0	0.9	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	51.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.0	0.2	2.2	1.6	0.4	0.0	0.0	0.0	2.8	1.4	0.0	0.0	7.0	0.4	0.0	0.0	0.3	0.0	0.1	15.6	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.0	10.8	3.4	12.5	9.8	7.1	10.7	6.8	9.7	9.0
GABRA1	EJM5	ENSG00000022355	"Gamma-aminobutyric acid type A receptor alpha1 subunit"	P14867	5	161847063-161899981	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"brain: 58.6"	"Cell line enhanced"	"Detected in some"		"HEL: 3.6;SCLC-21H: 1.1;U-2 OS: 1.5;U-87 MG: 2.3;WM-115: 1.2"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022502, HPA055746"	Enhanced	Supported								"CAB022502: , HPA055746: "					"unprognostic (2.58e-2)"						"unprognostic (4.78e-3)"	"unprognostic (1.84e-1)"		"unprognostic (3.31e-1)"		"unprognostic (2.43e-1)"		1.0	2.6	8.5	1.0	21.9	1.0	1.0	35.2	58.6	1.0	1.0	1.8	0.0	1.1	1.0	1.0	1.0	1.0	1.0	1.0	10.5	8.8	1.0	1.0	1.0	1.0	6.7	22.0	1.0	1.0	1.0	0.1	1.0	7.4	1.2	1.0	0.2	1.0	1.1	1.0	1.0	1.0	1.0	1.3	1.1	1.5	1.1	0.0	0.0	1.0	0.0	1.3	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.6	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	2.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	21.9	35.2	49.8	10.5	8.8	6.7	22.0	7.4	0.0
HRH3	GPCR97	ENSG00000101180	"Histamine receptor H3"	Q9Y5N1	20	62214970-62220267	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	22	"brain: 50.1"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 18.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.56e-1)"	"unprognostic (3.22e-1)"		"unprognostic (4.15e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.77e-2)"			"unprognostic (1.62e-2)"	"unprognostic (7.30e-2)"	"unprognostic (3.17e-4)"	"unprognostic (2.40e-1)"		"unprognostic (3.66e-3)"	"unprognostic (3.30e-1)"		"unprognostic (3.59e-2)"	1.0	2.3	5.7	0.8	50.1	0.9	0.9	16.7	20.6	0.8	0.9	2.8	0.0	1.0	0.8	0.8	0.9	0.8	0.8	0.8	5.1	16.5	0.9	0.9	0.9	0.9	2.7	8.7	0.8	0.8	0.8	0.7	0.8	2.6	1.4	0.9	0.0	1.1	0.8	0.8	1.6	0.9	0.9	1.0	0.8	0.9	1.6	10.5	0.0	0.8	0.0	0.9	2.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.9	0.0	0.0	0.0	1.2	0.0	0.1	18.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.7	50.1	16.7	15.1	5.1	16.5	2.7	8.7	2.6	10.5
SNAP25	"bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25"	ENSG00000132639	"Synaptosome associated protein 25"	P60880	20	10218830-10307418	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"			"Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"brain: 356.9"	"Group enriched"	"Detected in some"	4	"Karpas-707: 10.8;SCLC-21H: 35.7;SH-SY5Y: 21.3;U-87 MG: 25.7"	"Group enriched"	"Detected in many"	6	"glioma: 28.9;pancreatic cancer: 6.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000360, HPA001830, HPA071013"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Vesicles	"CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: "	"unprognostic (1.64e-3)"	"unprognostic (7.26e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-7)"	"unprognostic (6.86e-3)"	"unprognostic (5.87e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.02e-2)"	2.2	16.4	81.0	3.3	60.0	2.1	3.4	202.9	356.9	2.2	2.8	3.4	3.7	3.2	4.6	6.4	2.2	4.0	2.8	2.4	86.5	37.1	2.5	2.3	2.6	2.2	46.7	65.2	3.7	4.1	2.1	5.5	2.3	97.7	3.1	2.8	4.0	2.2	11.9	2.1	2.2	3.3	4.7	13.9	2.1	4.3	3.2	7.4	0.0	2.3	0.0	2.2	2.6	0.1	0.0	1.6	0.7	0.0	0.0	0.6	0.3	0.0	2.1	1.7	0.0	0.2	0.0	0.0	0.9	0.0	2.2	0.6	0.0	0.0	0.0	1.9	0.0	0.4	0.2	0.0	4.4	0.2	0.1	0.0	2.9	0.3	1.6	0.0	0.2	2.0	0.0	1.8	0.0	0.0	0.0	10.8	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	35.7	21.3	0.3	0.0	0.0	0.0	2.9	0.0	2.3	3.1	0.0	1.0	0.0	5.5	0.0	25.7	0.0	2.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.6	0.3	81.0	60.0	202.9	163.5	86.5	37.1	46.7	65.2	97.7	7.4
CREG2		ENSG00000175874	"Cellular repressor of E1A stimulated genes 2"	Q8IUH2	2	101345551-101387595	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"brain: 56.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.1;CAPAN-2: 2.4;HaCaT: 10.7;HeLa: 4.1;PC-3: 4.3;RT4: 2.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"T-reg: 2.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038224	Enhanced				"Secreted in brain"					"HPA038224: AB_10673167"	"unprognostic (5.09e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.10e-3)"	"unprognostic (8.15e-3)"	"unprognostic (5.63e-3)"	"unprognostic (9.68e-3)"	"unprognostic (4.52e-8)"	"unprognostic (3.86e-4)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.90e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.26e-3)"	"unprognostic (7.77e-2)"	0.8	0.9	12.6	0.8	13.8	0.9	0.8	0.2	56.0	0.9	0.8	1.0	0.0	0.9	0.8	0.8	0.8	1.1	0.9	0.9	17.2	4.4	0.9	0.8	0.8	0.8	3.3	16.6	0.9	0.8	0.8	0.2	0.9	7.2	0.8	0.9	0.0	0.8	0.8	0.8	0.8	0.9	0.8	1.2	0.8	0.8	0.9	0.5	0.0	0.8	0.0	0.8	0.8	0.6	0.2	0.3	0.5	0.0	0.0	2.6	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	2.4	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.2	0.0	0.4	0.1	0.0	0.0	0.1	0.1	4.3	0.0	0.0	0.0	0.0	2.9	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.3	2.6	0.0	12.6	13.8	0.2	29.7	17.2	4.4	3.3	16.6	7.2	0.5
GABRA5		ENSG00000186297	"Gamma-aminobutyric acid type A receptor alpha5 subunit"	P31644	15	26866363-26949207	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"brain: 52.6"	"Group enriched"	"Detected in some"	12	"A549: 25.8;HAP1: 8.9;NTERA-2: 10.7;U-2 OS: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA077031, CAB079022"		Supported	Supported	"Plasma membrane"				"Plasma membrane"		"CAB079022: , HPA077031: "	"unprognostic (6.33e-2)"			"unprognostic (8.94e-3)"	"unprognostic (1.04e-1)"			"unprognostic (2.50e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (9.50e-3)"	"unprognostic (2.57e-1)"		"unprognostic (7.63e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.44e-2)"		0.8	0.8	12.0	0.8	48.2	0.8	0.8	0.1	52.6	0.8	0.8	0.8	0.0	0.8	0.8	0.7	2.5	0.8	1.5	0.9	20.9	6.0	0.9	0.8	0.8	0.8	2.3	15.2	0.7	0.7	0.7	0.1	0.8	1.0	1.0	0.7	0.0	0.7	0.9	0.7	0.8	0.7	1.4	0.3	0.8	1.1	1.4	2.0	1.3	0.9	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	8.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	48.2	0.1	26.0	20.9	6.0	2.3	15.2	1.0	2.0
HTR2C	"5-HT2C, 5HTR2C, HTR1C"	ENSG00000147246	"5-hydroxytryptamine receptor 2C"	P28335	X	114584078-114910061	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	20	"brain: 45.3"	"Group enriched"	"Detected in some"	4	"EFO-21: 4.9;RPMI-8226: 2.4;U-266/70: 8.7;U-266/84: 7.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 45.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"																		"unprognostic (2.14e-1)"	"unprognostic (6.09e-3)"		"unprognostic (9.54e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-2)"		"unprognostic (3.42e-2)"		"unprognostic (9.22e-4)"	"unprognostic (1.37e-1)"		"unprognostic (6.84e-2)"	0.5	0.5	2.4	0.4	45.3	0.5	0.5	0.0	9.4	2.3	0.4	8.5	0.0	0.4	0.5	0.6	0.4	0.4	0.5	0.4	2.4	9.8	0.5	0.5	0.5	0.4	2.0	1.2	0.4	0.4	0.4	0.3	1.0	29.7	0.9	0.4	0.8	0.4	1.1	0.4	0.4	0.4	0.4	1.7	0.4	0.4	0.6	2.4	0.0	0.4	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	2.4	0.0	1.3	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.9	0.0	0.0	8.7	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.4	45.3	0.0	4.6	2.4	9.8	2.0	1.2	29.7	2.4
SULT4A1	"hBR-STL-1, SULTX3"	ENSG00000130540	"Sulfotransferase family 4A member 1"	Q9BR01	22	43824509-43862503	"Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"brain: 80.3"	"Group enriched"	"Detected in some"	4	"HEK 293: 2.5;THP-1: 3.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003129	Enhanced									"HPA003129: AB_1080130"	"unprognostic (2.61e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.59e-4)"	"unprognostic (7.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.20e-3)"	"unprognostic (8.34e-3)"	1.2	4.0	12.1	1.5	17.2	1.2	1.2	27.8	80.3	1.2	1.7	1.1	0.0	1.3	1.2	1.2	1.2	1.2	1.3	1.2	15.7	19.3	1.2	1.2	1.2	1.2	13.1	18.9	1.2	1.4	1.2	0.8	1.2	18.0	1.2	1.4	0.6	1.3	1.2	1.2	1.2	1.6	1.5	3.1	1.3	1.3	1.9	1.3	0.0	1.2	0.0	1.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	17.2	27.8	44.4	15.7	19.3	13.1	18.9	18.0	1.3
SYN2	"SYNII, SYNIIa, SYNIIb"	ENSG00000157152	"Synapsin II"		3	12004402-12191400	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	20	"brain: 72.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.4;HEK 293: 3.3;HMC-1: 6.1;NTERA-2: 5.1;SCLC-21H: 4.1;SH-SY5Y: 16.2"	"Cancer enhanced"	"Detected in many"		"glioma: 4.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037012, CAB079005"		Supported	Approved	Nucleoplasm				Nucleoplasm		"CAB079005: , HPA037012: "	"unprognostic (1.62e-3)"	"unprognostic (1.60e-2)"	"unprognostic (7.54e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.89e-4)"	"unprognostic (9.94e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.78e-2)"	3.7	2.7	28.2	0.7	23.3	0.5	1.4	9.2	72.5	1.0	0.8	0.2	0.0	0.8	1.2	1.2	0.5	0.8	0.7	0.7	15.4		1.4	0.4	0.8	0.5	0.0	33.4	1.5	0.5	1.8	0.0	2.3	15.3	0.7	0.9	0.0	0.9	0.6	0.9	0.9	1.2	1.9	2.2	0.8	1.2	2.4	1.6	0.0	0.5	0.0	0.5	0.5	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	0.7	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	3.4	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	6.1	0.1	0.0	0.1	0.4	0.5	0.0	0.3	0.0	0.0	0.0	0.0	5.1	0.4	0.0	0.0	0.0	0.0	0.2	4.1	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0										
ATP6V1G2	"ATP6G, ATP6G2, Em:AC004181.3, NG38, Vma10"	ENSG00000213760	"ATPase H+ transporting V1 subunit G2"	O95670	6	31544462-31548427	"Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"brain: 91.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.4;Karpas-707: 7.1"	"Cancer enriched"	"Detected in many"	11	"glioma: 15.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"CAB004616, HPA068667"	Enhanced									"CAB004616: AB_667829, HPA068667: "	"unprognostic (9.95e-2)"	"unprognostic (8.75e-2)"	"unprognostic (9.21e-3)"	"unprognostic (2.11e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.41e-5)"	"unprognostic (1.36e-1)"	"unprognostic (7.22e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.02e-1)"	2.8	3.3	41.8	3.5	25.7	1.8	1.6	91.9	53.3	1.8	2.3	8.1	0.0	1.5	2.5	2.4	2.2	1.8	1.9	2.9	39.4	27.1	2.6	1.6	2.0	4.7	26.6	29.5	3.1	2.1	2.9	1.2	1.7	43.7	2.6	2.0	2.0	2.0	3.3	4.3	2.0	2.7	2.1	16.3	3.4	1.9	2.7	6.4	0.0	2.3	0.0	4.8	1.7	0.2	0.7	0.7	0.0	0.1	0.8	1.5	0.1	0.2	1.7	3.1	1.5	1.3	1.7	0.0	0.6	0.0	0.0	0.2	0.0	0.9	1.7	0.7	0.6	1.4	0.1	0.6	0.1	6.4	0.0	0.5	0.0	0.9	0.2	0.7	0.6	1.3	0.8	0.5	0.3	0.5	0.7	7.1	0.8	0.2	3.3	1.2	0.0	0.5	0.8	0.0	0.7	0.0	0.0	2.8	3.9	0.0	0.0	0.0	2.1	0.3	1.6	2.0	0.3	0.1	0.0	0.7	1.5	2.4	0.7	0.7	1.4	0.0	0.1	0.0	0.1	0.0	1.5	0.1	0.0	0.8	0.7	0.7	1.2	1.5	0.0	0.8	0.0	0.0	1.1	0.1	41.8	25.7	91.9	53.3	39.4	27.1	26.6	29.5	43.7	6.4
GPR6		ENSG00000146360	"G protein-coupled receptor 6"	P46095	6	109978256-109980718	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	19	"brain: 42.5"	"Cell line enriched"	"Detected in single"	22	"SCLC-21H: 4.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"basal ganglia: 42.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	11	"basal ganglia: 81.5"																				"unprognostic (1.14e-2)"						"unprognostic (1.59e-2)"				"unprognostic (7.10e-3)"			0.4	0.5	3.5	0.4	42.5	0.5	0.4	0.0	6.5	0.4	0.4	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	1.3	1.8	0.4	0.4	0.4	0.4	0.1	0.8	0.4	0.4	0.4	2.2	0.4	0.0	0.4	0.4	0.0	0.5	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.8	0.5	4.6	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	42.5	0.0	4.0	1.3	1.8	0.1	0.8	0.0	4.6
GRIN2B	"GluN2B, NMDAR2B"	ENSG00000273079	"Glutamate ionotropic receptor NMDA type subunit 2B"	Q13224	12	13437942-13981957	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"brain: 36.5"	"Cell line enhanced"	"Detected in some"		"A549: 1.4;AF22: 3.3;CACO-2: 3.8;Daudi: 1.5;NTERA-2: 4.8;RPTEC TERT1: 4.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"amygdala: 19.5;basal ganglia: 26.0;cerebral cortex: 36.5;hippocampal formation: 19.6;olfactory region: 15.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA069762	Approved									"HPA069762: "	"unprognostic (2.01e-2)"	"unprognostic (4.07e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.77e-3)"	"unprognostic (3.39e-3)"	"unprognostic (9.36e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.77e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.68e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.48e-5)"	"unprognostic (2.43e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-1)"	1.9	0.9	19.5	0.8	26.0	0.8	0.9	0.9	36.5	0.8	1.9	1.9	0.0	0.8	0.8	0.8	0.9	0.8	0.8	0.8	19.6	3.5	1.0	1.6	0.8	1.4	1.8	15.0	0.9	0.8	0.8	0.4	0.9	2.6	0.8	1.2	0.0	0.8	0.8	0.8	0.8	1.8	0.8	0.8	0.9	1.0	1.5	3.6	0.0	0.8	0.0	1.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	26.0	0.9	36.5	19.6	3.5	1.8	15.0	2.6	3.6
LRTM2		ENSG00000166159	"Leucine rich repeats and transmembrane domains 2"	Q8N967	12	1820267-1836752	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"brain: 18.7"	"Group enriched"	"Detected in some"	8	"HEL: 9.0;SCLC-21H: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA055094, HPA062745"	Uncertain		Approved	Cytosol				Cytosol		"HPA055094: , HPA062745: "	"unprognostic (1.84e-3)"			"unprognostic (4.83e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"		"unprognostic (5.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.24e-1)"		"unprognostic (6.20e-4)"	"unprognostic (2.21e-1)"	"unprognostic (8.02e-2)"		0.7	0.7	5.1	0.7	12.3	0.7	0.7	0.8	18.7	0.7	0.7	1.7	0.0	0.7	0.7	0.7	0.7	0.7	0.7	0.7	3.3	5.0	0.7	0.7	0.7	0.7	1.7	10.5	0.7	0.7	0.7	0.1	0.7	4.7	0.7	0.7	0.1	0.7	0.8	0.7	0.7	0.7	0.7	1.7	0.7	0.8	0.9	4.3	0.0	0.7	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	12.3	0.8	18.7	3.3	5.0	1.7	10.5	4.7	4.3
TNR		ENSG00000116147	"Tenascin R"	Q92752	1	175315194-175743770	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"brain: 56.4"	"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 5.7;THP-1: 2.3;U-937: 4.2"	"Cancer enriched"	"Detected in single"	46	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022343, HPA027134, HPA027150, HPA029859"	Enhanced				"Secreted in brain"		230000			"CAB022343: , HPA027134: AB_1851983, HPA027150: AB_1851985, HPA029859: AB_10600916"	"unprognostic (1.04e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.79e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.03e-3)"	"unprognostic (7.26e-4)"	"unprognostic (4.48e-4)"	"unprognostic (3.26e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	1.2	3.0	21.8	1.4	14.2	1.3	1.2	9.1	56.4	1.2	1.2	17.2	0.0	1.2	1.3	1.4	1.3	1.2	1.3	1.2	18.1	14.4	1.2	1.7	1.7	1.4	16.5	13.3	1.2	1.7	1.2	2.0	1.2	16.1	1.2	1.3	0.1	1.2	1.2	1.2	1.2	1.3	1.3	8.2	1.4	1.6	1.6	14.3	0.0	1.3	0.0	1.6	1.3	0.1	0.4	0.1	0.6	0.0	1.9	0.1	0.0	0.0	0.2	1.2	0.2	0.1	0.1	0.7	0.3	0.2	0.3	0.1	0.7	0.2	0.4	0.6	1.1	0.7	0.0	0.6	0.2	0.3	0.0	0.1	0.5	0.4	0.0	0.4	0.1	0.4	0.8	0.1	0.4	0.2	0.2	0.4	0.0	0.6	0.2	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.3	5.7	0.6	0.3	0.2	0.4	2.3	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.5	4.2	0.3	0.6	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.4	0.1	0.1	0.4	1.9	0.0	0.1	0.0	0.0	21.8	14.2	9.1	23.7	18.1	14.4	16.5	13.3	16.1	14.3
CACNG3		ENSG00000006116	"Calcium voltage-gated channel auxiliary subunit gamma 3"	O60359	16	24255553-24362801	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"brain: 32.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.3;Karpas-707: 1.0;U-266/70: 1.0"	"Cancer enriched"	"Detected in single"	15	"glioma: 0.7"	"Group enriched"	"Detected in many"	6	"amygdala: 12.8;basal ganglia: 13.1;cerebral cortex: 20.0;hippocampal formation: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077238	Enhanced									"HPA077238: "					"unprognostic (5.61e-2)"						"unprognostic (3.09e-1)"			"unprognostic (2.12e-1)"	"unprognostic (1.17e-1)"			0.4	1.8	12.8	0.4	13.1	0.5	0.3	0.2	32.2	0.3	0.4	0.1	0.0	0.3	0.3	0.4	0.3	0.4	0.3	0.3	12.7	2.2	0.3	0.4	0.3	0.4	1.8	2.3	0.4	0.3	0.3	0.0	0.4	0.3	0.4	0.4	0.1	0.3	0.4	0.3	0.4	0.3	0.4	0.3	0.4	0.4	0.6	0.0	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.0	0.2	0.9	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	12.8	13.1	0.2	20.0	12.7	2.2	1.8	2.3	0.3	0.0
FBXL16	"C16orf22, Fbl16, MGC33974"	ENSG00000127585	"F-box and leucine rich repeat protein 16"	Q8N461	16	692498-705829	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"brain: 102.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 12.8;MCF7: 10.4;SCLC-21H: 21.5;SH-SY5Y: 16.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.3"	"Lineage enriched"	"Detected in single"	9	"T-cells: 3.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 279.3;basal ganglia: 710.3;cerebral cortex: 403.7;hippocampal formation: 376.0"	"HPA039504, HPA056354"	Enhanced									"HPA039504: AB_10794197, HPA056354: AB_2683105"	"unprognostic (5.51e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (6.24e-5)"	"unprognostic (2.58e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.75e-1)"	"prognostic favourable (7.34e-5)"	"unprognostic (1.62e-3)"	"prognostic favourable (1.87e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.36e-2)"	1.7	5.7	53.5	2.0	75.8	1.6	1.8	17.7	102.2	1.6	1.8	2.5	0.1	2.2	1.6	1.6	1.7	1.8	1.6	1.6	44.9	10.2	2.1	1.6	1.7	1.8	10.2	25.8	1.6	3.6	2.6	3.8	1.6	5.1	1.9	1.6	0.0	5.5	2.4	1.6	2.2	1.9	1.5	2.5	2.0	2.8	5.0	11.9	0.0	2.0	0.0	1.7	1.6	0.0	0.3	0.0	0.0	0.0	0.0	3.3	0.3	0.4	0.6	0.2	12.8	0.1	0.1	0.4	0.4	0.1	2.3	0.1	1.2	0.1	0.2	3.5	0.0	2.3	1.0	1.3	0.1	6.4	0.3	0.0	3.0	0.5	0.0	1.3	0.2	0.0	2.0	0.0	1.2	0.0	0.6	3.2	0.0	10.4	0.3	0.0	0.6	4.1	0.0	0.0	7.2	0.1	0.0	21.5	16.0	2.2	0.4	0.2	1.1	0.0	0.0	0.1	4.4	0.0	1.6	0.6	3.7	1.6	1.8	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.3	1.5	0.2	0.0	0.0	3.3	0.7	0.0	0.0	0.0	0.0	1.2	0.3	53.5	75.8	17.7	56.5	44.9	10.2	10.2	25.8	5.1	11.9
GPR37L1	ETBR-LP-2	ENSG00000170075	"G protein-coupled receptor 37 like 1"	O60883	1	202122858-202133592	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"brain: 44.0"	"Group enriched"	"Detected in some"	4	"HaCaT: 2.8;MCF7: 3.2;T-47d: 8.7"	"Cancer enriched"	"Detected in some"	57	"glioma: 36.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064454	Enhanced									"HPA064454: "	"unprognostic (2.12e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.61e-3)"	"unprognostic (4.52e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.26e-4)"	"unprognostic (5.83e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.49e-1)"	1.6	2.0	20.5	1.6	25.2	1.9	1.6	13.2	44.0	2.0	2.4	33.4	0.0	1.9	1.8	1.8	1.7	1.8	1.7	1.6	22.3	12.6	1.5	1.6	1.6	1.5	17.7	22.1	1.7	1.5	1.5	0.4	1.6	23.8	1.7	1.9	0.9	1.9	2.3	1.7	1.8	2.1	1.7	11.1	1.6	1.6	1.9	15.7	0.0	1.8	0.0	1.5	1.6	0.2	0.9	0.9	1.8	0.9	0.6	1.4	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.2	0.6	0.0	0.1	0.0	2.8	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.1	1.2	0.0	8.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.0	0.8	0.7	0.5	0.9	0.7	0.6	0.3	0.2	0.6	0.9	0.7	0.5	1.8	0.6	0.4	0.9	1.4	0.2	20.5	25.2	13.2	39.3	22.3	12.6	17.7	22.1	23.8	15.7
KIF5A	"D12S1889, MY050, NKHC, SPG10"	ENSG00000155980	"Kinesin family member 5A"	Q12840	12	57549998-57586632	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Amyotrophic lateral sclerosis, Disease mutation, Epilepsy, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"brain: 138.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 20.0;K-562: 8.4;NTERA-2: 10.3;SCLC-21H: 21.3;U-87 MG: 7.9"	"Cancer enriched"	"Detected in some"	5	"glioma: 26.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.4;naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004469, HPA073448"	Enhanced		Approved	"Nucleoplasm,Mitotic spindle,Cytosol"				"Nucleoplasm, Cytosol"	"Mitotic spindle"	"HPA004469: AB_1079212, HPA073448: "	"unprognostic (7.94e-2)"	"unprognostic (4.95e-3)"	"unprognostic (3.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (7.12e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.22e-5)"	"unprognostic (2.82e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.52e-2)"	"prognostic favourable (5.23e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.26e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	1.8	7.6	85.4	3.0	47.6	1.9	1.9	15.2	138.6	2.1	2.8	4.0	0.0	2.4	3.4	2.1	1.9	2.0	1.9	1.7	52.4	18.3	2.0	1.7	1.8	1.8	12.9	43.6	1.8	2.3	6.0	2.5	1.7	21.6	1.9	2.8	0.6	2.0	2.0	1.7	1.7	3.0	2.8	9.0	1.8	2.1	4.4	12.9	0.0	2.8	0.0	1.8	1.8	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	3.7	3.2	0.0	0.0	0.1	0.2	0.7	1.3	1.7	0.0	0.0	1.6	0.0	0.6	0.1	2.0	0.0	1.0	20.0	1.4	0.1	0.1	1.6	0.6	0.0	0.1	0.2	0.1	1.0	0.0	0.2	8.4	4.4	0.0	0.0	0.3	0.0	10.3	0.0	0.0	0.0	0.0	0.2	0.0	21.3	4.8	0.0	0.2	0.0	0.4	0.0	0.0	0.0	2.4	0.0	0.9	2.8	3.4	0.3	7.9	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.4	0.8	0.0	0.0	0.8	2.0	0.0	0.0	0.0	0.0	0.3	0.0	85.4	47.6	15.2	112.0	52.4	18.3	12.9	43.6	21.6	12.9
RTP5	"C2orf85, CXXC11, FLJ33590, Z3CXXC5"	ENSG00000188011	"Receptor transporter protein 5 (putative)"	Q14D33	2	241869600-241873823	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	18	"brain: 44.8"	"Group enriched"	"Detected in some"	29	"MOLT-4: 3.6;SCLC-21H: 7.2"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA050902	Enhanced									"HPA050902: "	"unprognostic (3.26e-2)"	"unprognostic (5.38e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.40e-4)"	"unprognostic (8.68e-3)"	"unprognostic (2.04e-1)"	"unprognostic (6.34e-4)"	"unprognostic (3.30e-1)"	"unprognostic (9.01e-3)"	"unprognostic (3.91e-1)"	"unprognostic (9.08e-8)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.72e-2)"	0.8	0.8	27.9	1.1	44.8	1.9	0.7	0.2	13.5	0.7	0.7	2.1	0.0	0.9	0.7	0.7	0.7	0.7	0.8	0.8	32.9	24.9	0.7	0.7	0.8	2.4	3.1	4.8	0.7	0.9	0.7	0.0	0.7	7.3	0.7	0.7	0.0	0.9	0.7	0.7	0.7	0.7	0.7	2.1	1.1	0.8	0.7	1.5	0.0	0.7	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	44.8	0.2	12.7	32.9	24.9	3.1	4.8	7.3	1.5
ANKRD63		ENSG00000230778	"Ankyrin repeat domain 63"	C9JTQ0	15	40281444-40282586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 22.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.1;HEK 293: 5.4;HEL: 2.6;NB-4: 1.9;SCLC-21H: 2.0;THP-1: 3.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	8	"basal ganglia: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 50.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.3"																"unprognostic (9.36e-2)"					"unprognostic (7.45e-2)"				"unprognostic (8.32e-2)"	"unprognostic (4.42e-1)"			0.2	0.2	1.8	0.4	22.4	0.2	0.2	0.3	4.7	0.2	0.2	0.0	0.0	0.2	0.3	0.2	0.2	0.7	0.3	0.5	0.3	0.4	1.3	0.2	0.2	0.3	0.3	1.1	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.5	0.2	0.0	0.7	0.3	0.7	1.8	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.1	0.0	0.0	0.4	0.0	0.0	0.0	5.4	2.6	1.1	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.2	1.9	0.2	0.4	1.4	0.0	0.4	0.0	0.1	2.0	0.2	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	22.4	0.3	2.8	0.3	0.4	0.3	1.1	0.0	1.8
KCNF1	"IK8, KCNF, kH1, Kv5.1"	ENSG00000162975	"Potassium voltage-gated channel modifier subfamily F member 1"	Q9H3M0	2	10911937-10914225	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"brain: 36.9"	"Cell line enhanced"	"Detected in some"		"A549: 16.5;MCF7: 5.8;T-47d: 7.2"	"Cancer enriched"	"Detected in many"	7	"glioma: 27.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"amygdala: 70.7;basal ganglia: 55.9;cerebral cortex: 78.2;hippocampal formation: 69.5;olfactory region: 141.1"	"Low region specificity"	"Detected in all"			"HPA014738, HPA062278"	Enhanced		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA014738: AB_1852114, HPA062278: "	"unprognostic (2.54e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.41e-4)"	"unprognostic (1.54e-3)"	"unprognostic (4.83e-5)"	"unprognostic (1.57e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.10e-4)"	"unprognostic (2.37e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.08e-2)"	0.9	0.9	11.5	1.0	25.5	0.8	1.2	0.8	36.9	0.9	1.2	2.4	0.0	1.2	1.9	0.8	1.6	1.1	1.0	1.1	13.1	4.7	1.1	0.9	1.0	1.0	3.1	10.5	0.9	2.2	0.8	0.2	0.9	3.6	1.0	1.2	0.0	0.8	1.4	0.8	0.8	1.1	1.0	1.0	1.5	1.1	1.0	3.1	0.5	0.8	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	16.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.8	0.0	0.0	2.5	1.7	0.0	0.1	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	7.2	0.8	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.5	25.5	0.8	28.5	13.1	4.7	3.1	10.5	3.6	3.1
PDYN	"ADCA, PENKB, SCA23"	ENSG00000101327	Prodynorphin	P01213	20	1978757-1994285	"Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Neurotransmitter, Opioid peptide"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 55.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.5;NTERA-2: 2.8;THP-1: 2.6"	"Group enriched"	"Detected in some"	29	"glioma: 2.6;ovarian cancer: 1.6"	"Region enriched"	"Detected in many"	4	"basal ganglia: 55.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 150.7;hypothalamus: 70.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 131.1"	"HPA053342, CAB079777"	Enhanced	Supported			"Secreted in brain"					"CAB079777: , HPA053342: "					"unprognostic (7.00e-2)"				"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"					"unprognostic (3.73e-2)"			0.4	0.4	13.2	0.4	55.9	0.4	0.4	0.0	40.3	0.4	0.4	1.2	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	5.0	3.9	0.4	0.4	0.4	0.4	0.7	3.7	0.4	0.4	0.4	0.0	0.4	0.2	0.4	0.4	0.0	0.4	0.4	0.4	0.6	0.4	0.4	2.2	0.4	0.4	3.2	1.1	0.0	0.5	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	55.9	0.0	3.8	5.0	3.9	0.7	3.7	0.2	1.1
STMN4	RB3	ENSG00000015592	"Stathmin 4"	Q9H169	8	27235323-27258420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"brain: 132.2"	"Cell line enriched"	"Detected in some"	26	"SCLC-21H: 44.0"	"Cancer enriched"	"Detected in some"	27	"glioma: 14.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027765			Uncertain	"Golgi apparatus,Vesicles"				"Golgi apparatus"	Vesicles	"HPA027765: AB_1857607"	"unprognostic (1.52e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.19e-6)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.31e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.37e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.63e-2)"	1.5	7.9	30.8	1.5	23.4	1.5	1.5	22.2	132.2	1.5	2.3	37.3	0.0	1.8	1.5	2.0	1.5	1.5	1.6	1.4	36.3	27.9	1.5	1.4	1.5	1.5	34.9	37.2	1.4	1.4	1.5	0.0	1.4	21.4	1.5	2.3	0.0	1.5	1.5	1.4	1.5	2.2	1.8	71.8	1.4	1.5	1.6	6.6	0.0	1.4	0.0	1.4	1.5	0.0	1.0	0.9	0.3	0.2	0.1	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.7	0.0	0.1	0.3	0.2	0.4	0.1	1.0	0.7	0.2	0.3	0.1	0.2	0.9	0.4	0.0	30.8	23.4	22.2	34.4	36.3	27.9	34.9	37.2	21.4	6.6
SYN1		ENSG00000008056	"Synapsin I"	P17600	X	47571898-47619943	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"brain: 127.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.9;HHSteC: 6.4;NTERA-2: 13.5;SCLC-21H: 23.6;SH-SY5Y: 6.1"	"Cancer enhanced"	"Detected in many"		"glioma: 11.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000397, CAB021929"	Enhanced									"CAB021929: , HPA000397: AB_1080146"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.05e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.31e-1)"	"unprognostic (3.49e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-4)"	"unprognostic (2.73e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.95e-3)"	"unprognostic (5.27e-2)"	1.7	7.1	31.8	2.9	33.3	2.0	1.3	34.4	127.0	1.7	1.9	2.1	0.0	1.4	1.6	1.9	1.5	2.1	2.5	7.6	33.6	24.9	1.4	1.8	1.7	1.3	13.3	27.1	2.5	2.0	2.1	6.1	3.4	24.0	2.0	2.1	0.9	1.3	2.0	1.5	1.7	2.0	2.0	3.7	1.3	1.9	2.4	2.1	0.0	1.2	0.0	1.5	1.9	0.1	0.0	0.8	0.0	0.6	0.0	0.9	0.0	0.0	0.0	3.8	0.5	0.1	0.8	0.0	0.6	0.1	1.1	0.3	0.0	0.0	0.0	1.2	0.1	6.9	0.3	0.0	0.3	0.5	0.1	0.3	0.0	0.0	6.4	0.0	1.7	1.5	0.0	1.1	0.3	0.0	0.4	0.2	0.2	0.2	0.2	0.2	13.5	0.1	0.0	0.0	0.2	0.0	0.0	23.6	6.1	0.0	0.0	0.1	1.7	0.0	0.2	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.9	0.0	0.0	0.6	0.8	0.0	0.0	31.8	33.3	34.4	56.9	33.6	24.9	13.3	27.1	24.0	2.1
ZDHHC22	C14orf59	ENSG00000177108	"Zinc finger DHHC-type containing 22"	Q8N966	14	77131270-77142734	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"brain: 52.3"	"Group enriched"	"Detected in some"	4	"AF22: 5.2;NTERA-2: 5.5;RH-30: 9.2;SCLC-21H: 10.2"	"Cancer enriched"	"Detected in single"	40	"glioma: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049471, HPA072213"			Enhanced	"Plasma membrane"				"Plasma membrane"		"HPA049471: , HPA072213: "	"unprognostic (1.02e-1)"	"unprognostic (3.42e-1)"		"unprognostic (1.22e-4)"	"unprognostic (1.66e-1)"	"unprognostic (8.86e-2)"		"unprognostic (2.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.94e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.79e-1)"	1.1	1.5	11.2	1.1	12.6	1.1	1.1	8.4	52.3	1.1	1.2	6.7	0.0	1.1	1.1	1.4	1.3	1.2	1.1	1.2	14.5	18.4	1.1	1.1	1.1	1.1	10.7	19.5	1.1	1.1	1.1	3.1	1.1	9.2	1.1	1.3	0.5	1.1	1.1	1.3	1.1	1.1	1.2	3.6	1.1	1.3	1.4	5.1	0.0	1.3	0.0	1.1	1.4	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	5.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	5.5	0.7	0.0	9.2	0.0	0.0	0.0	10.2	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	11.2	12.6	8.4	29.5	14.5	18.4	10.7	19.5	9.2	5.1
ZIC1	"ZIC, ZNF201"	ENSG00000152977	"Zic family member 1"	Q15915	3	147393422-147510293	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 124.7"	"Cell line enriched"	"Detected in many"	4	"AF22: 60.8"	"Cancer enhanced"	"Detected in many"		"glioma: 9.5"	"Region enriched"	"Detected in all"	8	"cerebellum: 124.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 232.6"	"Region enriched"	"Detected in many"	9	"cerebellum: 491.0"	HPA004098	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA004098: AB_1859065"	"unprognostic (1.33e-2)"			"unprognostic (1.82e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.19e-1)"		"unprognostic (5.01e-1)"	"unprognostic (2.61e-7)"	"unprognostic (2.95e-3)"	"unprognostic (1.67e-2)"		"unprognostic (3.01e-1)"	0.7	0.6	1.5	0.5	8.6	0.5	0.8	124.7	25.5	0.5	0.7	12.3	0.0	0.9	0.6	3.8	1.0	0.5	0.8	0.5	6.2	5.2	0.5	7.3	0.7	0.7	5.2	8.0	0.9	0.5	0.6	0.6	0.5	15.3	0.5	0.7	3.0	0.5	0.6	7.4	4.1	1.9	0.5	10.0	0.5	0.5	1.0	4.5	0.0	0.5	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.8	0.0	6.4	7.0	3.4	3.9	4.7	4.2	3.5	0.0	0.0	0.0	3.2	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	1.0	0.0	3.7	14.7	0.0	0.0	0.1	0.0	0.0	6.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	3.5	0.0	0.0	0.0	6.3	0.0	9.9	3.7	0.0	0.0	0.0	4.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	8.6	124.7	5.2	6.2	5.2	5.2	8.0	15.3	4.5
GPR101		ENSG00000165370	"G protein-coupled receptor 101"	Q96P66	X	137030148-137031674	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	16	"brain: 11.1"	"Cell line enriched"	"Detected in single"	4	"HEK 293: 2.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hypothalamus: 44.7"	"Low region specificity"	"Detected in many"			HPA001084	Uncertain									"HPA001084: AB_1078920"																		0.0	0.0	0.0	0.0	11.1	0.1	0.0	0.0	1.7	0.0	0.0			0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1			0.0		0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PTPN5	"PTPSTEP, STEP, STEP61"	ENSG00000110786	"Protein tyrosine phosphatase, non-receptor type 5"	P54829	11	18727928-18792721	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"brain: 70.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HMC-1: 3.6;NTERA-2: 5.7"	"Group enriched"	"Detected in some"	6	"glioma: 1.6;testis cancer: 2.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 70.0"	"Cell type enriched"	"Detected in single"	9	"basophil: 1.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031014, HPA072091"	Supported		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA031014: AB_10669550, HPA072091: "	"unprognostic (1.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.83e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.58e-1)"	"unprognostic (8.44e-4)"	"unprognostic (4.21e-3)"	"unprognostic (3.90e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.49e-2)"	2.5	1.6	16.3	1.1	70.0	1.1	1.2	0.9	47.5	1.5	1.1	0.4	0.0	1.1	1.2	1.0	1.3	1.7	1.4	4.3	9.1	8.6	1.1	0.9	2.7	1.1	3.5	16.0	2.5	1.2	1.5	0.5	0.9	6.1	1.6	1.4	0.0	1.3	1.7	1.8	1.0	1.4	1.4	2.1	1.3	1.3	3.4	9.3	0.0	1.2	0.0	1.0	1.5	0.3	0.1	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.0	3.6	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	5.7	0.3	0.0	0.1	0.1	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.3	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	70.0	0.9	25.1	9.1	8.6	3.5	16.0	6.1	9.3
SLC17A7	"BNPI, VGLUT1"	ENSG00000104888	"Solute carrier family 17 member 7"	Q9P2U7	19	49429401-49442360	"Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"brain: 150.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 20.7;K-562: 6.5;REH: 3.8;SCLC-21H: 4.8"	"Cancer enriched"	"Detected in some"	6	"glioma: 7.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 281.0;cerebellum: 378.0;cerebral cortex: 391.3;hippocampal formation: 626.6"	"CAB037183, HPA050458, HPA063679"	Enhanced	Supported								"CAB037183: AB_261840, HPA050458: , HPA063679: "	"unprognostic (1.79e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.32e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.26e-12)"	"unprognostic (8.36e-4)"	"unprognostic (4.27e-1)"	"unprognostic (1.35e-2)"	"unprognostic (6.17e-3)"	2.1	1.2	58.3	1.0	27.6	1.0	1.7	52.7	150.0	1.3	1.3	1.5	0.0	1.1	1.2	1.2	1.4	1.3	1.3	1.4	74.3	1.7	1.1	1.0	1.1	1.3	6.0	36.4	1.0	1.0	1.0	0.1	1.0	20.0	1.0	1.2	9.1	1.1	1.1	1.4	1.6	1.3	1.2	0.9	1.0	1.1	1.5	0.0	0.0	1.2	0.0	1.2	1.2	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.4	1.6	0.3	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.3	0.5	0.1	1.8	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.1	0.3	0.0	0.0	6.5	0.9	0.0	0.2	0.0	0.1	0.0	0.3	3.8	0.1	0.1	0.0	0.0	4.8	0.4	0.0	0.1	0.1	0.1	0.1	0.1	0.3	2.3	0.8	0.0	0.4	0.3	0.3	0.6	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.3	27.6	52.7	76.0	74.3	1.7	6.0	36.4	20.0	0.0
ZIC2	HPE5	ENSG00000043355	"Zic family member 2"	O95409	13	99981772-99986773	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease mutation, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"brain: 63.0"	"Cell line enhanced"	"Detected in many"		"AF22: 27.0;HDLM-2: 13.0;HEK 293: 20.5;NTERA-2: 25.2;SCLC-21H: 56.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 63.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 214.5"	HPA055031			Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA055031: "	"unprognostic (6.43e-6)"	"prognostic favourable (2.64e-4)"	"unprognostic (5.73e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.39e-1)"	"unprognostic (3.12e-2)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (4.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.42e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.26e-1)"	"unprognostic (2.11e-1)"		"unprognostic (5.36e-3)"	0.6	0.5	3.9	0.5	2.9	0.5	0.7	63.0	14.7	0.5	0.8	7.7	0.0	0.6	0.8	0.5	0.8	0.5	0.5	0.5	6.1	2.1	0.6	0.5	0.7	0.6	1.7	7.4	0.5	0.6	0.5	0.5	0.5	13.4	0.6	0.6	3.8	0.5	0.5	0.5	0.8	0.5	0.6	2.2	0.5	0.6	2.5	1.0	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.5	27.0	1.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	1.7	0.0	2.3	0.0	0.0	1.2	0.0	0.0	13.0	20.5	1.9	1.2	1.3	0.0	0.0	1.3	0.0	1.9	0.0	1.2	0.0	1.9	0.0	0.0	0.8	0.1	10.3	25.2	0.6	5.9	1.0	0.0	0.1	0.6	56.7	0.0	0.8	0.1	0.0	1.3	10.1	0.0	6.4	0.0	1.1	1.7	0.2	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	2.9	63.0	7.1	6.1	2.1	1.7	7.4	13.4	1.0
BCAN	"BEHAB, CSPG7, MGC13038"	ENSG00000132692	Brevican	Q96GW7	1	156641390-156659532	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 144.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 24.2;K-562: 34.1;U-266/70: 20.5;U-266/84: 39.4"	"Group enriched"	"Detected in many"	77	"glioma: 348.5;melanoma: 75.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"basophil: 8.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007865, CAB025862"	Enhanced	Supported			"Secreted in brain"		98000			"CAB025862: , HPA007865: AB_1078299"	"unprognostic (7.14e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (9.47e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.54e-2)"	"unprognostic (5.40e-1)"	"unprognostic (1.90e-1)"	1.4	5.8	51.8	1.6	35.9	1.3	1.4	10.4	144.2	2.3	2.4	30.5	1.3	4.6	2.7	9.5	1.6	2.4	3.1	1.5	40.8	22.9	1.4	1.3	1.5	1.5	26.6	21.5	1.4	1.3	1.3	0.7	1.7	15.1	1.4	1.3	4.3	2.0	2.4	1.6	9.0	5.0	2.4	13.0	1.6	2.4	2.0	26.7	0.0	1.4	0.0	1.3	2.3	0.3	0.6	0.0	8.2	0.4	0.0	0.0	0.0	13.7	9.5	0.0	2.6	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.3	6.8	0.0	14.7	0.0	9.7	0.1	0.0	0.0	24.2	0.8	2.4	6.3	7.8	0.0	0.9	2.4	0.0	0.0	0.0	0.0	0.0	34.1	6.7	0.0	4.0	0.0	0.0	0.7	1.4	0.0	15.8	0.0	0.0	1.7	0.0	0.2	0.0	0.0	14.3	0.0	0.9	2.9	0.0	7.8	2.8	3.7	20.5	39.4	0.0	2.9	6.4	1.1	8.2	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.8	35.9	10.4	33.3	40.8	22.9	26.6	21.5	15.1	26.7
CNTNAP4	"CASPR4, KIAA1763"	ENSG00000152910	"Contactin associated protein like 4"	Q9C0A0	16	76277278-76559238	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"brain: 36.9"	"Group enriched"	"Detected in some"	6	"Daudi: 13.7;HSkMC: 5.5;Karpas-707: 4.7;RPMI-8226: 8.7"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031859	Enhanced						73000			"HPA031859: AB_10601360"	"unprognostic (7.88e-2)"	"unprognostic (7.19e-2)"			"unprognostic (6.58e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.50e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.26e-4)"	"unprognostic (1.83e-2)"		"unprognostic (2.00e-2)"	"unprognostic (4.56e-1)"		"unprognostic (1.09e-1)"	0.9	2.4	10.2	0.9	19.1	0.9	0.9	13.2	36.9	1.3	0.9	27.6	0.0	1.2	0.9	0.9	0.9	0.9	0.9	0.9	9.9	2.2	1.0	0.9	0.9	1.0	23.1	15.1	1.0	0.9	0.9	0.8	0.9	25.0	1.3	0.9	0.0	0.9	1.4	0.9	0.9	1.1	1.0	30.9	0.9	0.9	2.2	21.4	0.0	0.9	0.0	1.0	0.9	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.3	1.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.2	19.1	13.2	14.4	9.9	2.2	23.1	15.1	25.0	21.4
NRGN	RC3	ENSG00000154146	Neurogranin	Q92686	11	124739846-124747210	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 223.3"	"Cell line enhanced"	"Detected in many"		"HEL: 48.3;PC-3: 39.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"amygdala: 79.5;basal ganglia: 172.6;cerebral cortex: 220.7;hippocampal formation: 63.6;olfactory region: 71.9"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"dendritic cells: 2.5;granulocytes: 3.8;monocytes: 5.0"	"Group enriched"	"Detected in many"	9	"amygdala: 797.3;basal ganglia: 614.3;cerebral cortex: 1197.5;hippocampal formation: 705.6"	"Group enriched"	"Detected in all"	5	"basal ganglia: 2514.3;cerebral cortex: 5912.4;hippocampal formation: 3143.5"	"CAB006908, HPA038171"	Enhanced						10000000			"CAB006908: , HPA038171: "	"unprognostic (1.37e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.72e-3)"	"unprognostic (4.14e-3)"	"unprognostic (5.20e-2)"	"prognostic unfavourable (1.52e-5)"	"unprognostic (8.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.03e-2)"	4.3	2.8	79.5	4.0	172.6	11.8	1.7	0.3	223.3	2.8	2.7	3.2	0.0	2.1	3.5	2.5	2.5	4.6	3.3	3.8	63.6	13.3	3.7	1.8	14.9	2.6	9.5	71.9	2.8	1.9	1.5	0.5	3.5	4.6	2.0	2.0	0.0	1.9	2.4	2.5	1.9	2.6	3.2	1.8	8.5	2.6	2.3	17.5	0.0	2.5	0.0	2.0	2.9	0.7	0.6	2.5	3.8	5.0	0.2	0.3	9.4	4.1	3.5	14.9	16.6	0.2	0.0	0.5	2.0	1.2	1.9	1.2	2.4	6.5	11.8	7.2	0.4	1.3	2.9	5.0	0.8	1.9	7.9	48.3	1.6	1.4	0.0	1.2	15.3	0.1	0.0	1.5	0.3	9.5	2.6	4.8	1.5	15.9	0.0	0.6	5.1	39.1	6.7	7.0	1.1	1.0	2.9	2.6	5.3	2.7	9.0	0.5	8.3	12.9	9.8	7.1	5.2	2.9	5.2	1.1	0.1	0.1	5.0	12.5	8.7	1.6	5.0	1.1	0.2	2.8	0.3	0.4	0.3	0.1	2.5	0.6	0.3	0.2	3.8	0.2	1.7	0.7	0.1	9.4	79.5	172.6	0.3	220.7	63.6	13.3	9.5	71.9	4.6	17.5
PCDHGC5	PCDH-GAMMA-C5	ENSG00000240764	"Protocadherin gamma subfamily C, 5"	Q9Y5F6	5	141489121-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 43.7"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 16.3;U-251 MG: 7.0;U-87 MG: 10.0"	"Group enriched"	"Detected in some"	13	"glioma: 3.1;head and neck cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4"					"HPA008755, HPA010580, HPA076140"	Supported		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA076140: "	"unprognostic (2.86e-3)"	"unprognostic (7.63e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.52e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-9)"	"unprognostic (6.87e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.77e-3)"	1.0	1.1	7.4	1.1	34.5	0.9	1.1	3.0	43.7	1.1	1.0	2.8	0.0	0.9	1.4	1.3	1.0	1.2	1.2	2.8	11.8	2.8	0.9	0.9	1.1	0.9	2.2	10.0	1.1	1.0	1.0	1.1	1.0	2.3	1.3	1.0	0.0	0.9	1.6	1.6	1.5	0.9	2.0	0.8	1.0	1.0	1.3	1.1	0.0	1.0	0.0	1.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	1.7	0.2	0.8	0.6	0.5	0.6	0.0	0.0	0.5	1.6	2.4	0.1	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.9	0.8	0.3	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.2	0.1	16.3	0.2	0.2	7.0	0.0	0.0	0.0	10.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	34.5	3.0	39.2	11.8	2.8	2.2	10.0	2.3	1.1
POU3F4	"BRN4, DFN3, DFNX2, OTF9"	ENSG00000196767	"POU class 3 homeobox 4"	P49335	X	83508261-83512127	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"brain: 39.0"	"Cell line enriched"	"Detected in single"	145	"AF22: 14.7"	"Cancer enriched"	"Detected in single"	21	"glioma: 5.6"	"Region enriched"	"Detected in all"	6	"basal ganglia: 39.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062295			Supported	Nucleoplasm				Nucleoplasm		"HPA062295: "					"unprognostic (5.73e-2)"										"unprognostic (2.00e-1)"			0.5	0.5	3.3	0.5	39.0	0.6	0.5	5.0	15.2	0.5	0.7	2.4	0.0	0.5	0.5	0.5	0.5	0.5	1.3	0.5	2.8	1.6	2.5	0.5	0.5	0.5	2.4	3.7	1.1	0.5	0.5	0.1	0.5	2.4	0.5	0.6	0.0	0.5	0.5	0.5	0.5	0.5	0.6	1.7	0.5	0.5	0.5	6.6	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	39.0	5.0	4.2	2.8	1.6	2.4	3.7	2.4	6.6
STX1B	"STX1B1, STX1B2"	ENSG00000099365	"Syntaxin 1B"	P61266	16	30989256-31010661	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter transport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 64.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 9.7;hTEC/SVTERT24-B: 11.8"	"Cancer enriched"	"Detected in some"	7	"glioma: 5.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069176, CAB079008"	Supported	Approved								"CAB079008: , HPA069176: "	"unprognostic (1.43e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.40e-4)"	"unprognostic (3.90e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.57e-2)"	1.6	1.9	12.7	1.9	31.8	1.3	1.8	45.8	64.9	1.2	1.4	2.9	0.0	1.4	2.7	4.2	1.9	1.4	1.3	2.1	10.5	10.0	1.4	2.5	1.2	2.4	6.8	26.2	1.3	1.3	1.3	2.2	1.2	39.3	1.8	1.4	1.0	1.9	2.8	1.3	4.0	1.8	2.5	3.8	2.2	1.3	3.2	4.5	0.0	1.3	0.0	2.3	1.3	0.7	0.6	0.3	1.3	0.4	0.5	1.7	0.1	0.1	3.2	5.0	0.8	0.5	0.2	0.2	4.4	6.7	5.5	9.7	0.0	3.6	0.8	0.2	5.8	0.8	2.2	0.6	6.6	2.6	0.4	0.4	2.6	2.5	0.4	0.2	3.1	1.8	0.2	11.8	1.1	0.0	0.5	0.2	5.8	1.3	2.0	0.2	2.5	0.3	7.2	0.2	0.2	0.5	0.0	6.8	4.3	0.5	0.2	0.0	0.8	0.1	0.9	3.2	2.6	0.4	0.2	0.3	0.2	0.3	3.5	0.3	0.1	0.9	0.4	0.7	0.3	0.2	0.1	0.5	1.7	0.3	0.1	0.6	0.3	0.4	1.3	0.5	0.1	0.3	0.2	0.1	12.7	31.8	45.8	60.5	10.5	10.0	6.8	26.2	39.3	4.5
TMEM88B		ENSG00000205116	"Transmembrane protein 88B"	A6NKF7	1	1426128-1427787	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 36.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;Hep G2: 9.0;SCLC-21H: 3.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065743	Enhanced									"HPA065743: "	"unprognostic (3.17e-2)"	"unprognostic (1.42e-2)"		"unprognostic (1.63e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.30e-5)"	"unprognostic (2.00e-1)"	"unprognostic (2.64e-1)"			"unprognostic (3.53e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.95e-2)"	1.1	1.1	10.2	1.4	24.7	1.2	1.1	1.0	23.3	1.1	1.1	34.0	0.0	1.1	1.1	1.1	1.1	1.4	1.3	1.2	19.6	8.3	1.5	1.1	1.4	1.2	30.8	11.2	1.1	1.1	1.1	0.0	1.2	16.1	1.3	1.1	0.0	1.1	1.1	1.1	1.7	1.1	1.1	36.9	1.1	1.3	2.4	28.5	0.0	1.1	0.0	1.1	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	3.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	24.7	1.0	20.6	19.6	8.3	30.8	11.2	16.1	28.5
AC079341.3		ENSG00000284849			4	121758930-121765185	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	14	"brain: 16.4"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 6.7"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA077585	Approved									"HPA077585: "																		0.3	0.3	1.1	0.3	7.1	0.3	0.3	0.0	16.4	0.3	0.3	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	6.8		0.3	0.3	0.3	0.4	0.0	7.6	0.3	0.3	0.3	0.0	1.1	0.4	0.3	0.3	0.5	0.3	0.4	0.3	0.3	0.5	0.3	0.0	0.3	0.3	0.3	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2										
C11orf87	"LOC399947, LOH11CR1A, NEURIM1"	ENSG00000185742	"Chromosome 11 open reading frame 87"	Q6NUJ2	11	109422120-109429114	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 32.3"	"Group enriched"	"Detected in some"	4	"BJ hTERT+ SV40 Large T+: 3.9;fHDF/TERT166: 15.4;SCLC-21H: 4.0"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA034656	Approved									"HPA034656: AB_10600788"	"unprognostic (5.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.85e-1)"		"unprognostic (1.63e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.28e-5)"	"unprognostic (8.38e-2)"	"unprognostic (9.65e-2)"		"unprognostic (2.72e-6)"	0.7	1.0	5.8	0.7	18.1	0.7	0.8	2.7	32.3	2.3	0.8	1.5	0.0	0.8	2.2	1.2	0.8	1.1	0.7	0.7	8.3	3.8	0.8	0.7	0.7	0.7	2.5	12.0	0.7	0.7	0.7	0.3	0.8	11.1	0.9	0.7	0.0	0.8	0.8	0.7	0.8	0.7	0.8	1.2	2.2	0.8	0.8	0.1	0.0	0.7	0.0	0.7	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.5	0.0	0.1	0.2	3.9	1.9	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	18.1	2.7	27.7	8.3	3.8	2.5	12.0	11.1	0.1
PSD2	"DKFZp761B0514, EFA6C"	ENSG00000146005	"Pleckstrin and Sec7 domain containing 2"	Q9BQI7	5	139795821-139844466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"brain: 52.4"	"Cell line enhanced"	"Detected in some"		"HEL: 3.5;SCLC-21H: 2.1;SH-SY5Y: 3.6;U-2 OS: 1.7"	"Cancer enriched"	"Detected in single"	43	"glioma: 19.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.76e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.34e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.16e-3)"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.12e-3)"	1.3	1.7	21.1	1.3	28.9	1.3	1.7	12.6	52.4	1.9	1.3	15.2	0.0	1.4	1.4	3.6	1.3	1.6	1.3	1.4	16.1	15.2	1.3	1.3	1.3	1.3	18.9	14.4	1.3	1.6	1.3	0.2	1.3	24.7	1.4	1.3	0.0	3.5	1.7	1.4	1.3	1.3	1.4	12.8	1.4	1.3	2.2	17.0	0.0	1.3	0.0	1.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.2	0.9	0.1	0.2	0.0	0.0	0.2	0.3	0.9	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.2	0.1	0.4	0.1	0.0	0.4	0.0	0.1	0.0	0.1	2.1	3.6	0.0	0.7	0.1	0.0	0.2	0.0	0.2	1.7	0.0	0.0	1.0	0.0	1.5	1.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	28.9	12.6	17.5	16.1	15.2	18.9	14.4	24.7	17.0
SLC17A6	"DNPI, VGLUT2"	ENSG00000091664	"Solute carrier family 17 member 6"	Q9P2U8	11	22338097-22379503	"Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 75.2"	"Cell line enriched"	"Detected in single"	222	"SCLC-21H: 26.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"hypothalamus: 20.2;pons and medulla: 75.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 54.1;hypothalamus: 163.2;midbrain: 206.4;pons and medulla: 90.5;thalamus: 180.7"	"Low region specificity"	"Detected in many"			"CAB037130, HPA039226, CAB078204"	Supported	Supported								"CAB037130: AB_477611, CAB078204: , HPA039226: "					"unprognostic (1.39e-1)"						"unprognostic (1.93e-1)"							0.5	0.5	7.6	0.5	1.1	0.5	0.5	0.2	13.8	0.5	0.5	1.3	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.5	1.1	20.2	0.5	0.5	0.5	0.5	7.1	2.1	0.5	1.5	0.5	5.3	0.5	75.2	0.5	0.5	1.4	0.5	0.5	0.5	0.5	0.5	0.5	5.9	0.5	0.5	0.5	0.0	0.0	0.5	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	1.1	0.2	8.4	1.1	20.2	7.1	2.1	75.2	0.0
SLC6A3	"DAT, DAT1"	ENSG00000142319	"Solute carrier family 6 member 3"	Q01959	5	1392790-1445430	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 48.4"	"Group enriched"	"Detected in some"	5	"NTERA-2: 1.2;RPMI-8226: 2.0;SCLC-21H: 3.7"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 25.7"	"Region enriched"	"Detected in some"	47	"midbrain: 48.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"midbrain: 96.4;thalamus: 31.8"	"Region enriched"	"Detected in single"	139	"midbrain: 362.2"	"HPA012763, HPA013602, CAB016249, CAB078172"	Enhanced	Supported	Approved	Vesicles				Vesicles		"CAB016249: AB_627402, CAB078172: , HPA012763: , HPA013602: AB_1847484"	"unprognostic (2.25e-4)"	"unprognostic (2.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.24e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.64e-5)"	"unprognostic (9.31e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavourable (3.40e-7)"	"unprognostic (6.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.74e-2)"	0.2	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.3	0.7	0.0	0.0	0.0	0.3	1.1	0.8	0.1	0.8	0.6	0.1	0.0	0.6	0.3	0.0	3.4	0.0	48.4	0.0	1.5	0.0	0.0	0.0	0.1	1.0	0.7	0.0	1.7	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.8	0.0	2.4	2.2	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	2.0	0.0	0.1	3.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.6	48.4	0.0	1.0	0.0
TPH2	"FLJ37295, NTPH"	ENSG00000139287	"Tryptophan hydroxylase 2"	Q8IWU9	12	71938846-72186618	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Serotonin biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 46.2"	"Group enriched"	"Detected in some"	9	"EFO-21: 2.8;NTERA-2: 3.1;SCLC-21H: 1.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	15	"pons and medulla: 46.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"midbrain: 127.6;pons and medulla: 36.3"	"Group enriched"	"Detected in some"	10	"midbrain: 95.6;pons and medulla: 91.5"	CAB078198	Enhanced									"CAB078198: "	"unprognostic (1.19e-1)"	"unprognostic (6.01e-1)"		"unprognostic (3.46e-2)"	"unprognostic (2.31e-1)"				"unprognostic (5.91e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.01e-2)"			"unprognostic (7.32e-2)"	"unprognostic (1.34e-1)"			0.1	0.2	0.4	0.3	0.5	0.1	0.1	0.3	4.4	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.2	3.0	1.5	0.1	0.3	0.1	0.1	0.9	0.0	0.1	1.7	0.1	3.2	0.1	46.2	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.2	0.3	0.1	0.1	1.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.3	1.4	3.0	1.5	0.9	0.0	46.2	0.0
ZIC4		ENSG00000174963	"Zic family member 4"	Q8N9L1	3	147386046-147406860	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 52.2"	"Cell line enhanced"	"Detected in some"		"AF22: 18.2;ASC diff: 5.2;MCF7: 5.2;SH-SY5Y: 5.5;U-2197: 4.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	18	"cerebellum: 52.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 118.4"	HPA030194	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA030194: "	"unprognostic (1.12e-1)"			"unprognostic (9.95e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.13e-2)"			"unprognostic (1.10e-10)"	"unprognostic (3.50e-2)"	"unprognostic (8.69e-2)"			0.2	0.0	0.2	0.0	0.4	0.0	0.0	52.2	7.9	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.8	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1.0	0.0	0.0	3.7	3.5	0.5	0.0	1.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	18.2	0.0	5.2	2.1	3.9	1.9	0.4	0.2	0.5	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.2	0.0	0.4	5.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.5	0.0	0.0	2.5	0.0	0.0	0.0	1.3	0.0	4.3	1.9	0.0	0.0	0.0	1.7	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	52.2	0.4	0.3	0.8	0.3	0.4	2.9	0.3
CBLN3		ENSG00000139899	"Cerebellin 3 precursor"	Q6UW01	14	24426532-24430954	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 105.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.8;HDLM-2: 12.5;HSkMC: 18.6;Karpas-707: 14.0;U-266/70: 9.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	23	"cerebellum: 105.2"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.5;naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in some"	25	"cerebellum: 481.8"	"Region enriched"	"Detected in some"	48	"cerebellum: 583.0"	HPA041266	Enhanced	Supported	Approved	Nucleoplasm	"Secreted in brain"			Nucleoplasm		"HPA041266: AB_10674430"	"unprognostic (5.02e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.43e-3)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (4.39e-4)"	"unprognostic (5.39e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavourable (6.20e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.02e-2)"	2.1	7.7	1.2	4.5	1.3	0.0	1.2	105.2	1.7	1.8	1.1	1.9	1.0	0.6	1.3	4.8	1.0	1.2	3.1	1.6	1.0	1.1	1.2	1.4	1.3	7.9	1.3	1.4	3.3	1.0	1.0	1.3	1.7	4.6	1.2	0.7	1.7	1.6	1.6	1.4	1.6	1.3	1.3	2.0	7.4	1.4	1.6	1.1	1.1	1.2	1.5	5.3	1.9	1.3	2.3	0.3	0.1	0.8	0.0	0.3	0.0	1.1	1.0	0.5	1.9	4.9	10.8	0.3	4.1	8.5	1.6	2.1	0.5	2.0	1.8	0.9	2.6	0.3	0.6	2.2	1.1	12.5	0.4	0.0	3.4	0.8	2.7	0.3	0.7	18.6	1.0	2.1	1.7	1.4	0.5	14.0	2.1	0.6	0.0	0.5	0.1	1.1	0.0	0.0	1.3	1.0	0.4	0.7	0.4	0.3	0.1	0.5	0.6	0.4	6.5	6.0	1.2	2.4	0.2	9.8	2.3	1.9	0.3	0.8	1.0	0.0	0.0	0.1	0.0	0.8	0.3	1.5	0.1	0.1	0.0	2.3	0.2	0.0	0.1	0.0	0.1	0.3	0.0	0.0	1.2	1.3	105.2	1.7	1.0	1.1	1.3	1.4	4.6	1.1
CPLX1	CPX-I	ENSG00000168993	"Complexin 1"	O14810	4	784957-826198	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 98.8"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles				Vesicles		"HPA071191: , HPA074390: "	"unprognostic (9.21e-3)"	"prognostic unfavourable (4.20e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.26e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.01e-2)"	"prognostic favourable (5.05e-4)"	"unprognostic (1.10e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.77e-2)"	7.8	6.5	13.1	2.9	40.7	1.5	2.4	26.3	98.8	2.2	2.5	3.9	0.0	2.8	4.2	1.5	1.6	2.3	1.9	3.0	16.9	7.6	2.4	2.4	2.8	2.4	16.3	18.3	2.4	3.0	3.4	1.7	1.8	52.8	4.4	1.7	3.8	4.4	2.5	4.5	3.0	2.8	2.0	5.4	5.6	3.2	4.9	4.2	0.0	1.8	0.0	1.6	1.7	1.7	0.2	2.3	0.1	0.0	0.0	0.8	0.0	2.7	0.2	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	8.0	0.8	2.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.2	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.9	0.1	0.0	1.1	1.1	0.0	1.3	1.3	0.0	0.0	0.7	0.0	0.2	42.0	5.8	0.2	2.7	0.0	4.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	2.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	13.1	40.7	26.3	98.8	16.9	7.6	16.3	18.3	52.8	4.2
ELAVL3	"DKFZp547J036, HUC, HUCL, MGC20653, PLE21"	ENSG00000196361	"ELAV like RNA binding protein 3"	Q14576	19	11451326-11481046	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 53.8"	"Group enriched"	"Detected in some"	8	"SCLC-21H: 39.6;SH-SY5Y: 22.8"	"Cancer enriched"	"Detected in some"	10	"glioma: 11.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.9;naive B-cell: 1.9"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013066	Enhanced									"CAB013066: AB_221448"	"unprognostic (1.47e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.78e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.60e-3)"	1.0	2.4	14.0	1.5	13.2	1.0	1.0	45.2	53.8	1.0	1.3	12.2	0.0	1.2	1.1	1.6	1.2	1.0	1.0	1.1	17.3	13.0	1.1	1.1	1.1	1.0	14.3	18.3	1.0	1.0	1.0	1.3	1.0	9.5	1.6	1.2	0.1	1.0	1.2	4.0	1.0	1.2	1.2	21.9	1.1	1.2	1.5	5.1	0.0	1.0	0.0	1.0	1.0	0.0	1.9	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	39.6	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	1.9	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	14.0	13.2	45.2	35.2	17.3	13.0	14.3	18.3	9.5	5.1
RIMS1	"CORD7, KIAA0340, RAB3IP2, RIM, RIM1"	ENSG00000079841	"Regulating synaptic membrane exocytosis 1"	Q86UR5	6	71886703-72403143	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision"		"Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 83.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.8;EFO-21: 8.7;LHCN-M2: 9.6;RPTEC TERT1: 14.8;SH-SY5Y: 10.4;TIME: 5.1;U-138 MG: 5.0"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"	"Region enriched"	"Detected in all"	6	"cerebellum: 83.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076565	Enhanced									"HPA076565: "	"unprognostic (1.34e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.57e-2)"		"unprognostic (2.85e-1)"	"unprognostic (7.76e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.07e-2)"	0.5	2.3	10.5	1.5	9.8	0.4	1.2	83.1	27.7	0.9	0.6	0.5	0.0	1.5	0.8	0.5	3.7	0.5	6.2	0.6	9.3	3.6	0.5	0.4	0.7	0.5	2.8	11.7	0.5	0.8	5.0	4.6	0.4	7.2	4.9	0.6	0.2	1.9	0.9	0.6	0.4	0.8	1.4	1.5	0.4	1.4	5.9	2.7	0.0	0.5	0.0	0.4	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.2	1.3	0.0	0.1	0.0	0.0	4.8	8.7	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.4	14.8	0.0	0.4	10.4	0.0	0.0	0.0	0.6	0.0	5.1	5.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	9.8	83.1	12.9	9.3	3.6	2.8	11.7	7.2	2.7
SHANK1	"SPANK-1, SSTRIP, synamon"	ENSG00000161681	"SH3 and multiple ankyrin repeat domains 1"	Q9Y566	19	50661827-50719450	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 35.7"	"Cell line enhanced"	"Detected in some"		"REH: 7.3;SH-SY5Y: 3.5;U-138 MG: 4.1;U-2 OS: 10.4;U-87 MG: 3.9;U-937: 4.3"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA032129, HPA032130"	Uncertain		Supported	"Plasma membrane"				"Plasma membrane"		"HPA032129: AB_10602796, HPA032130: "	"unprognostic (1.62e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.14e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.29e-3)"	0.9	2.6	27.9	0.9	10.0	1.2	0.9	13.6	35.7	1.3	0.9	1.1	0.0	0.9	1.3	1.0	0.9	2.2	1.1	0.9	25.6	12.3	0.9	0.8	0.8	0.9	6.0	11.1	0.9	0.9	2.1	2.8	1.0	4.1	1.0	0.8	0.2	0.9	1.0	1.0	1.2	0.9	1.1	2.2	0.9	0.8	1.4	3.5	0.4	0.9	0.0	0.9	0.9	0.0	0.0	0.7	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.5	0.0	1.2	1.2	0.1	0.1	0.0	0.0	0.0	1.9	0.7	0.0	0.2	0.0	0.1	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.1	0.6	0.0	0.0	0.7	0.1	0.1	0.8	1.2	0.1	7.3	0.0	0.7	0.0	0.0	0.0	3.5	0.0	0.0	1.1	0.0	3.1	2.2	4.1	10.4	0.0	0.0	0.0	0.0	0.0	3.9	4.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	27.9	10.0	13.6	23.0	25.6	12.3	6.0	11.1	4.1	3.5
UNCX	Uncx4.1	ENSG00000164853	"UNC homeobox"	A6NJT0	7	1232907-1237318	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 44.8"	"Cell line enriched"	"Detected in some"	20	"NB-4: 46.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	20	"cerebellum: 44.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 3.6"	"Region enriched"	"Detected in many"	9	"cerebellum: 19.3"	HPA063294			Approved	Nucleoplasm				Nucleoplasm		"HPA063294: "					"unprognostic (1.15e-1)"										"unprognostic (9.71e-2)"			0.1	0.1	0.0	0.2	0.0	0.1	0.1	44.8	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.1	3.5	0.1	0.1	0.1	0.9	0.0	0.1	0.1	0.1	0.3	0.1	2.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.8	0.0	0.0	1.1	0.9	0.0	2.2	0.5
VSTM2B		ENSG00000187135	"V-set and transmembrane domain containing 2B"	A6NLU5	19	29526499-29564479	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 40.8"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 13.1"	"Cancer enhanced"	"Detected in some"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.8;naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"																		"unprognostic (1.74e-1)"				"unprognostic (1.87e-3)"	"unprognostic (6.64e-2)"				"unprognostic (1.08e-2)"	"unprognostic (5.35e-2)"			1.0	1.2	16.2	1.0	17.0	0.9	1.0	13.4	40.8	3.1	1.0	8.6	0.0	1.0	1.0	1.6	0.9	1.0	1.0	1.0	14.2	9.4	1.0	0.9	0.9	1.1	12.5	9.2	1.0	0.9	0.9	0.0	0.9	4.5	0.9	1.0	0.3	0.9	1.0	0.9	1.0	1.0	1.3	11.7	1.0	1.0	1.0	2.2	0.0	0.9	0.0	1.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	17.0	13.4	16.6	14.2	9.4	12.5	9.2	4.5	2.2
ZIC3	"HTX, HTX1, ZNF203"	ENSG00000156925	"Zic family member 3"	O60481	X	137566142-137577691	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Heterotaxy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 50.6"	"Group enriched"	"Detected in some"	40	"AF22: 24.4;NTERA-2: 27.3"	"Cancer enriched"	"Detected in single"	14	"testis cancer: 5.0"	"Region enriched"	"Detected in all"	8	"cerebellum: 50.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052936, HPA069523"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA052936: , HPA069523: "					"unprognostic (3.55e-5)"					"unprognostic (3.82e-1)"		"unprognostic (1.95e-1)"			"unprognostic (3.31e-1)"			0.3	0.2	1.4	0.4	2.5	1.1	0.4	50.6	5.8	0.3	0.4	2.7	0.0	0.5	0.5	0.2	0.3	0.3	0.4	0.3	1.9	2.2	0.3	0.3	0.4	0.4	2.4	1.2	0.4	0.5	0.4	1.1	0.4	6.1	0.5	0.3	3.9	0.7	0.3	0.5	0.8	0.5	0.2	1.9	0.5	0.4	3.9	2.2	0.0	0.5	0.0	0.4	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	2.5	50.6	2.6	1.9	2.2	2.4	1.2	6.1	2.2
APC2	APCL	ENSG00000115266	"APC2, WNT signaling pathway regulator"	O95996	19	1446302-1473244	"Disease related genes, Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 59.4"	"Cell line enhanced"	"Detected in some"		"AF22: 6.3;SCLC-21H: 7.6;SH-SY5Y: 25.9"	"Cancer enriched"	"Detected in some"	27	"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078002			Supported	"Cytokinetic bridge,Midbody,Cytosol"				"Cytokinetic bridge, Midbody"	Cytosol	"HPA078002: "	"unprognostic (1.78e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.88e-5)"	"unprognostic (3.64e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.45e-2)"	"unprognostic (9.49e-3)"	"unprognostic (7.39e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.98e-3)"	1.5	4.7	17.3	1.4	16.4	1.5	1.3	21.7	59.4	1.4	1.6	20.7	0.0	2.1	1.4	1.4	1.4	1.5	1.6	1.4	16.8	13.9	1.3	1.3	1.4	1.4	15.0	14.0	1.3	2.0	1.3	3.0	1.4	17.1	1.4	1.4	0.8	1.7	1.4	1.6	1.4	1.8	1.5	13.9	1.4	1.4	1.8	14.5	0.0	1.5	0.0	1.3	1.6	0.0	1.1	0.2	0.4	0.0	0.0	0.1	0.1	0.2	0.5	6.3	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.7	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.9	0.3	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.1	0.2	0.1	0.1	0.4	0.1	0.0	0.7	0.0	0.0	7.6	25.9	0.9	0.0	0.4	0.1	0.0	0.0	0.5	0.5	0.2	0.2	1.9	0.4	0.3	0.7	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.1	17.3	16.4	21.7	21.3	16.8	13.9	15.0	14.0	17.1	14.5
BTBD17	"BTBD17A, LGALS3BPL, TANGO10A"	ENSG00000204347	"BTB domain containing 17"	A6NE02	17	74356416-74361946	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 18.2"	"Group enriched"	"Detected in some"	20	"AF22: 3.8;NTERA-2: 5.0;SCLC-21H: 15.0"	"Group enriched"	"Detected in some"	11	"glioma: 9.5;testis cancer: 1.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025022	Approved				"Secreted in brain"					"HPA025022: AB_2067352"					"unprognostic (2.63e-1)"					"unprognostic (2.77e-1)"	"unprognostic (4.82e-5)"			"unprognostic (3.89e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.89e-3)"		0.4	1.5	5.4	0.4	5.1	0.4	0.4	5.6	18.2	0.4	0.4	2.7	0.0	1.2	0.4	0.4	0.4	0.4	0.4	0.4	3.7	5.7	0.4	0.4	0.4	0.4	3.8	1.8	0.4	0.4	0.4	0.2	0.4	6.1	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.5	0.4	3.7	0.6	1.4	0.5	2.2	0.0	0.6	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	0.3	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.4	5.1	5.6	8.2	3.7	5.7	3.8	1.8	6.1	2.2
C1QL3	"C1ql, C1QTNF13, CTRP13, K100"	ENSG00000165985	"Complement C1q like 3"	Q5VWW1	10	16513743-16522005	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 33.8"	"Group enriched"	"Detected in some"	7	"HDLM-2: 24.3;SCLC-21H: 15.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 99.4;cerebral cortex: 74.9;hippocampal formation: 78.6"						"Secreted in brain"						"unprognostic (7.24e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.19e-3)"	"unprognostic (6.31e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"prognostic favourable (6.29e-5)"	"unprognostic (3.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.59e-2)"	"unprognostic (6.12e-2)"	1.2	1.5	24.8	1.0	14.6	0.5	0.5	7.4	33.8	0.5	0.6	0.1	0.0	2.6	0.7	0.4	0.7	0.5	0.6	1.4	22.8	4.3	1.9	0.8	0.9	1.3	1.4	23.4	0.4	0.9	0.4	0.3	0.6	2.3	1.0	0.4	0.2	1.0	0.5	1.7	1.6	1.2	0.4	0.9	1.0	0.9	0.5	0.0	0.0	1.6	0.0	0.5	1.2	0.4	1.0	0.9	0.8	2.0	0.7	2.8	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	1.6	0.8	2.7	0.0	0.0	0.3	0.0	0.0	0.0	24.3	0.2	1.3	0.9	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.1	0.1	0.9	0.1	0.9	0.2	1.3	0.1	0.5	15.0	1.2	1.3	0.2	0.8	0.1	0.2	0.0	0.0	0.1	0.7	0.0	0.5	0.7	0.7	0.1	1.4	0.6	0.0	1.1	0.8	2.1	2.0	1.3	1.0	1.6	1.8	0.5	0.8	1.7	2.8	0.2	0.7	1.4	0.9	1.7	0.6	24.8	14.6	7.4	29.5	22.8	4.3	1.4	23.4	2.3	0.0
C4orf50	FLJ46481	ENSG00000181215	"Chromosome 4 open reading frame 50"	Q6ZRC1	4	5897373-6018507	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	12	"brain: 6.0"	"Cell line enriched"	"Detected in some"	4	"RPMI-8226: 4.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (7.02e-3)"	"unprognostic (6.55e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.35e-2)"	"unprognostic (9.94e-5)"	"unprognostic (4.31e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.88e-6)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.68e-2)"	0.0	0.5	1.0	0.2	6.0	0.2	0.0	0.0	4.1	0.1	0.1			0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.2	1.7	0.0	0.1	0.1	0.1	0.5		0.1	0.0	0.0	0.1	0.0		0.5	0.1		0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.3			0.1		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.9	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0										
CASKIN1	"ANKS5A, KIAA1306"	ENSG00000167971	"CASK interacting protein 1"	Q8WXD9	16	2177180-2196525	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 30.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.5;HDLM-2: 16.6;HEK 293: 3.7;SCLC-21H: 7.7;SH-SY5Y: 3.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055990, CAB079050"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB079050: , HPA055990: "	"unprognostic (4.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.02e-2)"	"unprognostic (6.58e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.21e-4)"	"unprognostic (2.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.34e-3)"	"unprognostic (3.39e-1)"	1.1	1.8	17.7	1.2	18.1	1.1	1.4	15.0	30.4	1.5	1.2	2.3	0.0	1.2	1.5	1.3	1.2	1.4	1.2	2.5	16.4	12.8	1.3	1.1	1.1	1.1	12.4	11.7	1.2	1.5	1.9	1.4	1.2	11.1	1.8	1.2	1.8	2.5	1.4	1.3	2.2	1.3	1.2	2.8	1.1	1.3	1.8	4.0	0.0	1.6	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	4.5	0.0	0.0	2.2	0.0	0.0	0.1	0.0	1.5	0.1	0.0	0.9	0.0	0.0	1.2	0.3	0.0	16.6	3.7	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	1.3	0.0	0.9	0.7	0.0	0.9	0.0	0.4	0.2	0.0	7.7	3.7	0.1	0.2	0.2	1.0	0.5	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	18.1	15.0	21.7	16.4	12.8	12.4	11.7	11.1	4.0
DPF1	"BAF45b, NEUD4, neuro-d4"	ENSG00000011332	"Double PHD fingers 1"	Q92782	19	38211006-38229714	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 31.6"	"Cell line enhanced"	"Detected in many"		"HAP1: 15.4;SCLC-21H: 18.2"	"Cancer enhanced"	"Detected in some"		"glioma: 5.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049148	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	Mitochondria	"HPA049148: "	"unprognostic (7.72e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.11e-3)"	"unprognostic (8.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.11e-16)"	"unprognostic (2.56e-1)"	"unprognostic (3.75e-1)"	"unprognostic (6.96e-2)"	"unprognostic (8.20e-4)"	1.1	1.5	11.8	1.5	15.7	1.0	0.9	6.4	31.6	0.8	1.0	0.9	0.0	0.9	1.0	0.8	0.8	1.0	1.0	1.0	12.4	7.7	0.8	0.8	1.0	1.1	4.5	11.3	0.9	0.9	0.9	1.3	1.1	2.0	0.9	0.9	0.0	1.2	0.8	1.1	1.2	1.0	1.3	2.1	1.1	0.8	2.5	1.2	0.0	0.8	0.0	1.1	0.9	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	3.4	2.9	12.5	9.1	0.9	0.6	1.2	3.7	2.1	6.3	5.4	2.1	0.3	5.7	2.5	2.8	2.2	15.4	2.1	2.8	5.4	3.0	1.9	1.4	0.8	0.3	1.4	1.6	0.7	0.0	3.8	1.2	1.1	4.2	0.3	6.0	4.8	3.0	0.3	2.2	3.5	5.7	6.3	1.2	0.6	1.0	18.2	6.3	4.2	0.4	0.8	1.9	0.3	1.4	9.2	2.9	2.2	3.3	2.3	7.5	7.6	4.8	2.0	3.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	11.8	15.7	6.4	19.6	12.4	7.7	4.5	11.3	2.0	1.2
DRD1		ENSG00000184845	"Dopamine receptor D1"	P21728	5	175440039-175444208	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"brain: 34.5"	"Cell line enriched"	"Detected in some"	5	"RT4: 23.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"basal ganglia: 34.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"basal ganglia: 147.4"	"Region enriched"	"Detected in many"	13	"basal ganglia: 95.6"	HPA013393		Supported								"HPA013393: AB_1847833"	"unprognostic (2.74e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.15e-6)"	"unprognostic (6.69e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-2)"	"unprognostic (8.60e-4)"	"unprognostic (5.86e-2)"	"unprognostic (5.43e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-2)"	0.7	1.5	1.9	0.2	34.5	0.0	0.1	0.1	12.0	0.7	0.7	0.4	0.0	0.5	0.4	0.7	0.7	0.6	1.1	0.3	1.0	0.6	0.7	2.6	1.8	0.1	0.5	1.6	0.3	0.0	0.0	0.1	2.5	0.3	2.7	0.9	2.1	0.1	1.2	0.1	0.1	0.3	0.4	0.1	0.4	0.4	0.1	6.8	0.1	0.1	0.0	0.4	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	34.5	0.1	5.3	1.0	0.6	0.5	1.6	0.3	6.8
GABBR2	"GABABR2, GPR51, GPRC3B, HG20"	ENSG00000136928	"Gamma-aminobutyric acid type B receptor subunit 2"	O75899	9	98288082-98709197	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 52.7"	"Cell line enhanced"	"Detected in some"		"BJ: 10.9;fHDF/TERT166: 5.4;HUVEC TERT2: 22.5;U-138 MG: 8.8"	"Group enriched"	"Detected in many"	10	"glioma: 7.2;thyroid cancer: 11.6;urothelial cancer: 3.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013820, HPA031684, CAB079065"	Enhanced	Approved								"CAB079065: , HPA013820: AB_1849364, HPA031684: "	"unprognostic (2.00e-1)"	"unprognostic (7.56e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.09e-5)"	"unprognostic (2.52e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.45e-2)"	0.9	4.4	13.6	1.0	14.6	0.8	0.9	19.7	52.7	0.8	0.9	2.1	0.0	0.8	1.1	1.1	0.9	0.8	0.9	0.9	14.6	11.1	0.9	0.9	1.0	0.9	7.6	17.6	0.8	0.8	0.9	0.3	0.9	10.3	0.9	0.8	0.6	0.9	0.9	3.2	0.9	0.8	1.0	2.2	0.9	1.0	1.3	0.2	0.0	2.3	0.0	1.1	1.5	0.1	0.7	0.7	1.7	1.1	1.7	1.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	1.0	10.9	2.2	2.3	4.2	0.0	0.1	0.0	0.7	5.4	0.0	0.1	0.2	0.8	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.8	0.2	22.5	0.2	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.6	3.1	0.0	0.0	2.8	0.0	0.0	0.1	1.0	8.8	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.7	0.4	0.8	0.6	0.7	1.0	0.7	0.7	0.7	0.4	0.6	0.8	0.9	1.2	1.7	1.1	0.7	1.0	0.4	13.6	14.6	19.7	35.0	14.6	11.1	7.6	17.6	10.3	0.2
GPR52		ENSG00000203737	"G protein-coupled receptor 52"	Q9Y2T5	1	174448111-174449198	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"brain: 28.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.0;Daudi: 1.4;Karpas-707: 2.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"basal ganglia: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"														"unprognostic (1.93e-1)"	"unprognostic (1.15e-1)"				"unprognostic (8.60e-2)"		"unprognostic (2.61e-2)"			"unprognostic (3.65e-1)"			"unprognostic (2.27e-1)"			"unprognostic (4.49e-1)"	0.3	0.3	0.8	0.2	28.0	2.2	0.1	0.2	7.4	0.1	0.2	0.1	0.0	0.1	0.4	0.4	0.2	0.2	0.2	0.3	0.2	0.7	0.2	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.1	0.9	0.4	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.6	0.2	0.6	0.0	0.2	0.3	0.4	5.0	0.0	0.1	0.0	0.8	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.2	0.0	0.0	0.2	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.5	0.0	0.0	0.4	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.4	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.7	0.0	0.0	0.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	28.0	0.2	3.2	0.2	0.7	0.2	0.1	0.0	5.0
KCNC1	Kv3.1	ENSG00000129159	"Potassium voltage-gated channel subfamily C member 1"	P48547	11	17734774-17856804	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 67.5"	"Cell line enhanced"	"Detected in some"		"RH-30: 7.4;SCLC-21H: 7.0;SH-SY5Y: 4.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Region enhanced"	"Detected in all"		"cerebellum: 67.5"	"Cell type enhanced"	"Detected in some"		"basophil: 5.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047634, HPA048249"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"				"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA047634: , HPA048249: "	"unprognostic (1.79e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.04e-5)"	"unprognostic (5.89e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.83e-2)"	0.7	2.3	8.2	1.0	10.0	2.9	0.9	67.5	33.3	3.0	1.0	1.0	0.0	1.4	1.5	0.6	1.1	0.9	1.3	0.6	5.6	4.9	0.9	1.1	1.0	1.2	3.3	12.6	1.1	0.9	0.6	1.4	0.7	19.5	1.2	0.8	0.7	1.2	0.7	1.7	1.8	1.2	0.8	1.9	1.0	1.3	2.9	2.0	0.0	1.5	0.0	0.8	2.4	0.5	1.7	0.8	5.8	0.8	0.7	1.1	0.3	0.4	0.1	3.0	1.2	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.2	0.0	1.1	1.8	0.0	0.3	0.3	2.1	0.6	2.9	0.2	0.3	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.5	1.4	0.0	0.5	0.5	1.1	1.5	0.0	0.7	7.4	0.9	0.0	0.4	7.0	4.3	0.4	0.4	0.0	0.6	0.5	0.1	0.2	2.3	0.3	0.3	0.5	0.6	1.0	0.5	0.3	0.9	5.8	0.7	1.1	1.1	0.7	0.7	0.7	0.9	0.5	0.2	1.7	0.7	0.8	3.8	0.7	0.8	0.8	0.4	0.3	8.2	10.0	67.5	33.3	5.6	4.9	3.3	12.6	19.5	2.0
KCNN1	"hSK1, KCa2.1"	ENSG00000105642	"Potassium calcium-activated channel subfamily N member 1"	Q92952	19	17951293-18000080	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	12	"brain: 32.5"	"Cell line enriched"	"Detected in some"	12	"REH: 57.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"basophil: 2.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065938			Approved	"Actin filaments,Cytosol"				"Actin filaments, Cytosol"		"HPA065938: "	"unprognostic (7.55e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.94e-5)"	"unprognostic (3.92e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.71e-3)"	"unprognostic (3.38e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.24e-3)"	"unprognostic (3.24e-1)"	0.8	0.9	25.8	1.5	11.3	0.9	0.8	3.3	27.0	1.6	1.0	0.5	0.1	1.0	1.7	1.0	1.0	0.9	1.0	1.3	32.5	3.3	0.9	0.8	0.8	1.0	5.0	8.7	2.6	0.9	0.7	0.2	0.8	4.1	1.2	0.8	0.0	1.5	1.3	1.0	0.9	1.2	0.9	1.2	0.9	0.9	2.8	1.6	0.0	0.9	0.0	1.0	0.9	0.0	0.2	0.2	2.3	0.1	0.1	0.2	0.0	0.0	0.2	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.0	0.0	0.1	0.1	0.9	1.8	0.1	0.0	0.0	0.0	4.9	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.7	0.0	57.4	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.5	0.1	0.0	0.2	0.0	0.0	25.8	11.3	3.3	22.4	32.5	3.3	5.0	8.7	4.1	1.6
MGAT5B	"FLJ25132, GnT-IX, GnT-VB"	ENSG00000167889	"Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B"	Q3V5L5	17	76868456-76950393	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 28.1"	"Cell line enhanced"	"Detected in many"		"A549: 21.6;SCLC-21H: 11.1;U-138 MG: 13.1;U-2 OS: 14.2"	"Group enriched"	"Detected in many"	5	"glioma: 2.6;melanoma: 7.1;testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011082			Approved	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"				"Nucleoplasm, Mitotic spindle"	"Cytokinetic bridge"	"HPA011082: "	"unprognostic (6.37e-2)"	"unprognostic (9.16e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.68e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.52e-3)"	"unprognostic (5.30e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.01e-1)"	1.1	1.2	9.3	1.1	13.4	1.0	0.9	4.4	28.1	1.0	0.9	1.1	0.0	0.8	1.1	0.7	0.9	1.0	0.9	0.8	5.5	2.8	0.9	0.7	1.0	0.9	2.3	8.1	1.2	0.8	1.0	0.6	1.1	2.6	0.8	0.8	1.1	0.8	0.8	0.7	0.9	0.9	0.8	0.7	1.4	1.0	2.3	1.7	0.0	0.8	0.0	0.9	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	21.6	4.4	2.2	0.0	0.0	2.3	0.3	0.9	7.9	4.7	0.0	0.5	0.0	1.7	1.0	0.1	1.0	0.2	2.1	0.0	0.3	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	1.2	1.4	0.1	0.0	0.0	1.0	0.0	0.0	1.2	2.2	3.0	3.8	4.5	6.2	0.0	11.1	4.2	3.8	1.7	3.4	0.1	0.1	4.0	13.1	14.2	0.2	4.1	0.0	0.0	0.5	0.4	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	13.4	4.4	27.4	5.5	2.8	2.3	8.1	2.6	1.7
MT3	GIF	ENSG00000087250	"Metallothionein 3"	P25713	16	56589074-56591088	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 243.8"	"Group enriched"	"Detected in some"	5	"RPMI-8226: 5.2;SCLC-21H: 9.0;U-87 MG: 15.2"	"Cancer enriched"	"Detected in many"	58	"glioma: 392.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"naive CD8 T-cell: 8.0"	"Lineage enriched"	"Detected in single"	81	"T-cells: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004011, CAB017779"	Enhanced									"CAB017779: , HPA004011: AB_1854158"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.26e-2)"	2.7	19.8	168.7	2.6	140.5	2.3	2.4	42.2	243.8	2.5	3.6	20.2	0.0	2.4	2.4	2.3	3.2	2.5	2.4	3.8	107.2	80.5	3.1	2.3	2.5	2.5	129.1	53.2	2.6	2.3	2.3	1.1	2.7	37.0	2.6	3.1	0.0	17.4	2.5	2.8	2.5	2.8	2.4	53.7	2.4	2.4	5.9	48.6	0.0	2.4	0.0	5.9	2.4	0.2	0.0	0.0	0.0	0.0	0.0	8.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	5.2	0.0	0.0	9.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	1.7	8.0	0.0	0.0	0.0	0.0	0.0	0.9	168.7	140.5	42.2	102.1	107.2	80.5	129.1	53.2	37.0	48.6
NCDN	"NCDN-1, NCDN-2"	ENSG00000020129	Neurochondrin	Q9UBB6	1	35557473-35567274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 144.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023676	Enhanced	Supported	Supported	Cytosol				Cytosol		"HPA023676: AB_1854325"	"unprognostic (1.15e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.05e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (1.91e-5)"	"unprognostic (4.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.36e-2)"	"prognostic favourable (3.73e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.34e-3)"	"unprognostic (5.88e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-2)"	5.2	11.3	33.4	6.0	144.3	3.4	3.6	28.7	104.9	9.9	3.5	8.7	1.2	3.9	6.2	4.8	4.5	8.1	6.5	12.0	45.4	25.0	4.0	2.5	4.5	5.9	15.8	32.3	9.2	6.1	6.2	5.5	4.7	26.4	7.1	2.9	3.6	6.7	8.0	5.3	5.6	3.2	6.5	10.7	5.0	4.7	5.8	15.6	0.8	6.5	0.6	4.6	6.0	2.4	5.9	2.7	0.8	4.5	3.0	6.5	5.5	8.7	10.6	8.9	14.0	12.9	16.0	6.1	11.6	12.1	12.2	9.8	10.6	13.0	10.0	11.3	10.7	13.5	8.7	14.1	4.5	9.7	18.0	12.4	15.6	5.4	17.9	11.2	14.3	15.3	11.8	21.6	8.7	6.5	13.4	16.0	9.9	15.7	10.2	7.2	39.9	18.7	8.4	4.9	12.9	8.2	9.8	11.1	16.0	13.2	12.2	16.3	11.7	7.4	8.8	15.6	11.2	11.4	15.8	22.6	15.9	7.4	19.4	18.0	14.2	0.0	4.5	0.8	3.1	2.6	3.8	5.9	4.8	4.8	2.7	2.7	6.5	5.3	0.7	3.0	4.2	1.6	2.7	5.5	33.4	144.3	28.7	61.4	45.4	25.0	15.8	32.3	26.4	15.6
NETO1	"BCTL1, BTCL1"	ENSG00000166342	"Neuropilin and tolloid like 1"	Q8TDF5	18	72742314-72868146	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 47.9"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 14.8;REH: 14.5;RPMI-8226: 23.2;RT4: 15.4;SCLC-21H: 20.5;U-2 OS: 7.5"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	27	"memory B-cell: 1.6;naive B-cell: 3.7"	"Lineage enriched"	"Detected in single"	38	"B-cells: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA064630			Approved	"Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"		"HPA064630: "	"unprognostic (4.02e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.35e-5)"	"unprognostic (4.05e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.13e-3)"	2.0	0.8	9.1	1.3	18.3	1.0	1.7	0.4	47.9	0.9	0.9	0.7	0.0	0.8	0.9	0.9	1.0	0.8	0.9	1.4	15.9	3.9	1.0	0.8	0.9	3.8	3.0	15.1	0.8	0.8	1.0	0.3	0.8	5.0	0.9	1.1	3.9	1.1	0.8	0.8	1.2	0.8	0.8	1.1	4.0	0.9	2.0	2.8	0.8	2.3	0.0	2.7	1.2	0.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.8	0.0	6.7	0.0	14.5	0.0	23.2	3.6	15.4	20.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	18.3	0.4	22.8	15.9	3.9	3.0	15.1	5.0	2.8
NTSR2	NTR2	ENSG00000169006	"Neurotensin receptor 2"	O95665	2	11658178-11670164	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	12	"brain: 33.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.0;NTERA-2: 1.8"	"Cancer enriched"	"Detected in single"	15	"glioma: 6.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (5.40e-2)"	"unprognostic (2.30e-2)"			"unprognostic (2.36e-2)"	"unprognostic (5.32e-2)"			"unprognostic (2.23e-1)"	"unprognostic (1.80e-1)"		"unprognostic (2.75e-1)"		"unprognostic (4.98e-1)"	"unprognostic (1.64e-1)"			1.3	1.8	22.3	1.1	30.7	1.1	1.1	2.1	33.4	1.1	1.1	11.9	0.0	1.1	1.1	1.2	1.1	1.1	1.1	1.1	13.4	15.6	1.1	1.1	1.1	1.1	26.8	13.8	2.8	1.7	1.1	0.0	1.1	10.6	1.1	1.1	0.0	1.1	1.1	1.2	1.1	1.1	1.1	4.3	1.1	1.1	1.5	8.7	0.0	1.1	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	30.7	2.1	14.5	13.4	15.6	26.8	13.8	10.6	8.7
PAQR6	"FLJ22672, PRdelta"	ENSG00000160781	"Progestin and adipoQ receptor family member 6"	Q6TCH4	1	156243321-156248117	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	12	"brain: 138.1"	"Cell line enhanced"	"Detected in many"		"U-266/70: 20.7"	"Cancer enriched"	"Detected in all"	6	"glioma: 34.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"NK-cell: 10.5"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 10.5"									HPA073505			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA073505: "	"unprognostic (1.64e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (1.60e-5)"	"unprognostic (7.42e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.50e-3)"	"unprognostic (4.75e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.25e-3)"	"prognostic unfavourable (1.99e-4)"	"prognostic unfavourable (1.58e-8)"	"unprognostic (1.26e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.82e-2)"	"prognostic favourable (1.86e-4)"	2.1	3.6	42.5	2.2	38.0	7.6	2.2	8.7	71.6	2.0	2.7	102.9	0.0	2.8	2.3	2.9	2.5	2.2	2.9	2.0	48.1	37.6	2.0	2.1	2.1	2.1	82.7	16.1	1.6	1.6	2.4	1.2	2.2	72.5	3.5	2.3	0.0	3.2	3.0	2.1	11.5	3.0	2.0	138.1	2.3	3.1	2.5	46.0	0.0	2.0	0.0	2.0	2.5	0.3	0.8	1.6	0.0	0.0	10.5	1.2	0.1	1.7	2.0	3.3	3.4	0.6	0.5	8.1	0.2	0.5	0.0	0.2	0.9	6.3	3.2	1.5	0.5	5.7	0.0	0.7	0.4	1.9	2.7	2.0	1.7	0.9	0.3	0.6	5.3	1.6	2.6	2.4	2.4	0.2	1.5	9.4	0.5	6.7	0.2	1.0	3.7	0.9	1.4	0.7	1.5	2.3	10.6	2.8	5.7	0.7	0.7	3.8	10.7	1.1	0.5	1.0	5.3	1.7	0.5	20.7	4.5	2.0	0.2	7.4	0.9	0.0	0.0	0.0	0.4	0.0	1.2	0.8	0.6	0.2	0.0	0.1	0.0	0.0	0.0	10.5	0.0	1.6	0.1	0.1	42.5	38.0	8.7	34.4	48.1	37.6	82.7	16.1	72.5	46.0
RESP18		ENSG00000182698	"Regulated endocrine specific protein 18"	Q5W5W9	2	219327409-219333177	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"brain: 28.7"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"basal ganglia: 28.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																										"unprognostic (2.57e-2)"										"unprognostic (2.12e-1)"			0.4	0.4	2.6	0.4	28.7	0.4	0.5	0.1	7.5	0.4	0.4	0.3	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	3.1	4.0	0.4	0.4	0.4	0.4	3.6	1.0	0.4	0.4	0.4	0.0	0.4	2.3	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.6	2.4	2.5	0.0	0.5	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	28.7	0.1	1.8	3.1	4.0	3.6	1.0	2.3	2.5
SEZ6		ENSG00000063015	"Seizure related 6 homolog"	Q53EL9	17	28954901-29006440	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 67.3"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 36.1"	"Cancer enriched"	"Detected in many"	11	"glioma: 16.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 2.8;neutrophil: 5.7"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011777	Enhanced									"HPA011777: AB_1856758"	"unprognostic (3.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.75e-3)"	"unprognostic (5.33e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.15e-3)"	"unprognostic (3.63e-6)"	"unprognostic (1.94e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.15e-3)"	1.2	2.0	18.8	1.4	67.3	1.6	1.1	43.5	48.2	1.1	1.6	3.1	0.0	2.4	1.1	1.5	1.2	1.2	1.1	1.2	10.5	10.0	1.2	1.1	1.3	1.2	4.9	9.4	1.1	1.9	1.1	4.9	1.2	9.1	1.3	1.8	3.3	1.2	1.2	1.4	1.4	1.4	1.3	2.7	1.2	1.7	1.6	5.4	0.0	1.2	0.0	1.1	1.3	0.0	0.8	0.9	5.7	0.5	0.5	0.9	0.4	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	36.1	6.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	2.8	0.5	0.9	0.2	0.5	0.9	0.8	0.4	0.5	0.6	0.5	0.6	0.7	5.7	0.5	0.5	0.9	0.2	0.4	18.8	67.3	43.5	18.8	10.5	10.0	4.9	9.4	9.1	5.4
TMEM151A	"MGC33486, TMEM151"	ENSG00000179292	"Transmembrane protein 151A"	Q8N4L1	11	66291870-66296664	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 48.5"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 18.2"	"Cancer enhanced"	"Detected in some"		"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041035	Uncertain		Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA041035: AB_10794404"	"unprognostic (1.20e-1)"	"unprognostic (8.24e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.48e-3)"	"unprognostic (8.57e-2)"	"unprognostic (8.73e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.02e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.80e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.67e-2)"	1.4	3.8	12.4	1.5	16.8	1.4	1.4	5.9	48.5	1.4	1.5	41.8	0.0	1.5	1.4	1.4	1.4	1.4	2.8	1.6	22.7	14.3	1.4	1.4	1.4	1.4	21.2	13.1	1.5	2.4	1.8	3.3	1.4	22.2	1.4	1.4	1.0	1.5	1.4	1.4	1.4	1.5	1.4	43.2	1.4	3.9	1.6	13.6	0.0	1.4	0.0	1.4	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.6	0.0	1.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	18.2	4.1	0.5	0.0	0.3	0.1	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.4	16.8	5.9	31.1	22.7	14.3	21.2	13.1	22.2	13.6
AL590132.1		ENSG00000284299			1	210858125-211134146	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	11	"brain: 17.5"	"Cell line enhanced"	"Detected in some"		"RH-30: 2.1;SH-SY5Y: 4.7;SK-MEL-30: 3.0;T-47d: 2.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.8	1.3	5.3	1.3	11.4	0.6	0.6	16.5	17.5	0.6	0.7	2.6	0.0	0.7	0.7	0.6	0.6	0.6	0.6	0.6	3.1		0.7	0.6	0.6	0.7	0.0	6.3	0.6	0.6	0.8	0.2	0.6	1.2	0.7	0.7	0.0	0.8	0.6	1.5	0.6	0.6	0.6	0.0	0.7	0.7	0.7	1.1	0.0	0.6	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.1	0.3	0.0	0.4	0.1	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.2	0.0	0.2	2.1	0.1	0.1	0.0	0.2	4.7	0.0	0.2	3.0	2.0	0.0	0.0	0.7	0.2	1.1	0.6	0.0	0.0	0.0	0.6	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
BAALC		ENSG00000164929	"BAALC, MAP3K1 and KLF4 binding"	Q8WXS3	8	103140710-103230305	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 121.3"	"Cell line enhanced"	"Detected in some"		"AF22: 24.4;BJ hTERT+: 8.5;SCLC-21H: 13.3;SH-SY5Y: 9.8;U-87 MG: 36.2"	"Cancer enriched"	"Detected in many"	8	"glioma: 139.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"NK-cell: 6.9"	"Lineage enriched"	"Detected in single"	25	"NK-cells: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027132, HPA068307"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA027132: AB_10600985, HPA068307: "	"unprognostic (1.68e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.40e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.27e-3)"	7.8	11.1	42.3	3.2	51.9	3.9	3.0	12.5	121.3	2.8	2.9	18.9	0.0	2.3	3.0	2.0	2.2	4.6	2.9	3.2	38.1	34.5	2.8	3.4	4.9	2.6	48.3	25.1	2.7	2.6	1.9	5.2	5.7	41.4	2.0	2.9	0.0	2.1	2.4	3.0	2.7	2.8	3.1	51.2	8.8	2.4	2.6	24.6	0.0	2.8	0.0	2.2	2.8	0.3	0.2	0.1	0.0	0.0	6.9	0.1	0.4	0.2	1.4	24.4	0.2	0.2	7.3	0.0	1.2	8.5	0.0	0.1	0.2	0.0	0.1	0.2	4.6	0.4	0.4	0.0	0.0	0.0	1.4	0.2	0.3	0.0	0.5	0.0	0.5	1.4	1.4	0.3	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.6	0.4	0.1	0.1	0.5	0.0	0.0	13.3	9.8	0.2	0.0	0.0	0.1	0.1	1.4	7.7	0.5	0.2	0.5	0.0	0.1	0.1	36.2	0.1	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.9	0.0	0.1	0.0	0.4	42.3	51.9	12.5	43.6	38.1	34.5	48.3	25.1	41.4	24.6
BHLHA9	"bHLHa9, BHLHF42"	ENSG00000205899	"Basic helix-loop-helix family member a9"	Q7RTU4	17	1270559-1271460	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	11	"brain: 4.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.1;HDLM-2: 1.6"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"																"unprognostic (9.27e-2)"							"unprognostic (2.63e-1)"				"unprognostic (2.99e-1)"	"unprognostic (7.74e-2)"			0.1	0.0	1.4	0.0	0.3	0.0	0.0	0.4	4.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.9	1.6	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.4	3.2	0.9	1.6	0.5	0.0	1.6	0.0
CACNG2	"MGC138502, MGC138504, stargazin"	ENSG00000166862	"Calcium voltage-gated channel auxiliary subunit gamma 2"	Q9Y698	22	36563921-36703558	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 30.7"	"Group enriched"	"Detected in some"	8	"SCLC-21H: 7.6;SH-SY5Y: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																		"unprognostic (7.54e-2)"					"unprognostic (3.06e-1)"	"unprognostic (8.80e-3)"			"unprognostic (2.34e-2)"	"unprognostic (3.07e-2)"			0.7	2.7	5.6	0.8	6.4	0.9	0.7	30.7	21.9	0.6	0.7	0.3	0.0	0.8	0.6	0.6	0.7	0.6	0.6	0.6	3.8	4.7	0.7	0.7	0.7	0.7	2.9	7.8	0.6	1.1	0.6	2.7	0.7	6.9	0.7	0.7	0.1	0.6	0.6	1.0	0.8	0.8	0.7	1.7	0.7	0.7	1.0	0.8	0.0	0.7	0.0	0.6	0.7	0.1	0.3	1.0	1.0	0.3	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.2	7.6	3.4	0.0	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.4	0.4	0.3	0.1	0.3	0.3	0.2	0.0	0.3	0.4	0.4	1.0	0.3	0.2	1.0	0.2	0.1	5.6	6.4	30.7	12.3	3.8	4.7	2.9	7.8	6.9	0.8
CPNE9	KIAA4217	ENSG00000144550	"Copine family member 9"	Q8IYJ1	3	9703807-9729908	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 46.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.8;U-937: 5.2"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.6"	"Group enriched"	"Detected in all"	4	"cerebellum: 26.6;cerebral cortex: 17.0;pons and medulla: 46.9"	"Group enriched"	"Detected in some"	7	"classical monocyte: 1.2;intermediate monocyte: 3.5;non-classical monocyte: 2.4;plasmacytoid DC: 1.4"	"Group enriched"	"Detected in many"	25	"dendritic cells: 1.4;monocytes: 3.5"	"Low region specificity"	"Detected in many"																		"unprognostic (2.96e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.67e-2)"	"unprognostic (5.44e-4)"	"unprognostic (1.47e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.48e-2)"	0.7	1.4	1.7	0.8	3.1	2.8	0.6	26.6	18.2	0.7	0.8	2.3	0.0	1.1	0.7	0.5	0.6	0.6	0.8	0.4	1.9	7.2	0.8	0.6	1.1	1.0	7.0	5.1	0.6	0.5	0.4	3.4	0.7	46.9	0.5	0.8	0.3	0.8	1.0	0.4	4.2	1.1	0.8	2.3	0.9	0.7	3.0	1.4	0.0	0.4	0.0	0.7	0.8	0.1	0.0	1.4	0.0	3.5	0.0	0.0	0.4	0.1	0.9	0.2	0.0	0.8	0.2	0.9	0.3	0.3	0.1	0.0	0.1	0.3	5.8	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.6	0.1	0.0	0.6	0.7	0.9	0.0	0.7	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.6	0.1	0.1	0.0	0.5	0.0	0.7	1.6	1.3	0.1	0.0	0.5	1.9	2.4	0.0	0.0	0.2	0.7	0.1	0.3	1.7	1.1	0.8	5.2	0.4	0.0	1.2	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.4	1.4	0.0	0.4	1.7	3.1	26.6	17.0	1.9	7.2	7.0	5.1	46.9	1.4
DNM1	DNM	ENSG00000106976	"Dynamin 1"	Q05193	9	128191655-128255248	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 133.5"	"Cell line enhanced"	"Detected in many"		"A549: 48.8;U-87 MG: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005920, HPA049910, HPA061801"	Enhanced		Supported	Nucleoplasm			440000	Nucleoplasm		"CAB005920: , HPA049910: , HPA061801: "	"unprognostic (3.25e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.95e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.62e-3)"	"unprognostic (6.30e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-3)"	5.9	6.1	31.5	3.3	36.9	2.3	4.6	57.7	133.5	11.7	3.0	2.5	0.0	2.4	4.6	2.7	3.3	6.3	9.0	2.7	33.4	24.0	2.9	1.8	2.5	2.5	18.3	33.0	1.6	4.7	3.2	5.5	2.7	33.0	2.9	2.9	4.3	2.6	3.1	2.3	4.6	3.3	4.4	5.1	1.6	2.6	4.0	1.8	0.0	1.9	0.4	2.3	3.6	3.7	0.3	0.4	0.5	0.3	0.0	0.3	0.7	3.2	48.8	4.4	1.0	1.4	14.9	0.2	3.0	7.3	6.2	2.6	0.6	1.0	0.0	4.2	6.3	5.8	0.7	0.3	3.4	0.0	4.7	3.1	7.0	0.2	1.0	0.4	2.2	3.9	0.1	4.8	0.0	0.0	1.1	0.2	0.0	1.3	0.2	1.0	4.7	8.9	5.8	0.1	1.5	0.9	0.0	6.3	10.6	10.4	0.3	0.4	0.1	4.2	0.2	0.2	14.1	14.2	6.2	0.4	0.1	0.3	18.6	0.1	1.0	0.0	0.3	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.4	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.7	31.5	36.9	57.7	71.8	33.4	24.0	18.3	33.0	33.0	1.8
ERMN	"ERMIN, JN, KIAA1189"	ENSG00000136541	Ermin	Q8TAM6	2	157318625-157327713	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 106.7"	"Cell line enriched"	"Detected in some"	6	"HAP1: 20.8"	"Group enriched"	"Detected in some"	12	"endometrial cancer: 2.2;glioma: 9.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038295, HPA038296"	Enhanced		Approved	"Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"		"HPA038295: AB_10805353, HPA038296: AB_10796217"	"unprognostic (7.89e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.71e-2)"	"prognostic favourable (6.93e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.02e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.84e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.97e-3)"	"unprognostic (5.76e-2)"	1.6	1.4	29.1	2.9	50.5	9.7	1.6	2.7	106.7	1.4	1.8	52.4	0.0	1.8	1.6	1.5	1.7	1.4	1.9	1.6	40.9	21.4	1.5	1.5	2.0	3.1	75.1	18.4	1.5	1.6	1.4	0.1	1.4	54.5	1.5	1.9	4.3	2.4	1.5	1.7	1.9	1.9	1.6	100.9	2.5	2.2	1.7	69.5	0.0	1.6	0.0	2.7	1.7	0.1	1.7	1.3	3.9	1.6	2.4	2.1	0.7	0.1	0.3	0.3	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.2	1.2	0.0	1.9	0.3	20.8	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.0	0.2	2.8	0.4	0.2	0.7	2.3	0.3	0.5	0.0	0.4	0.5	0.0	1.0	0.4	0.6	0.0	0.1	0.0	0.7	1.2	0.0	0.2	0.1	0.2	0.6	3.4	1.9	0.5	1.8	0.9	1.0	2.6	1.6	1.1	2.1	1.2	1.0	0.7	0.8	0.6	0.6	1.7	1.5	1.6	3.9	2.4	1.0	1.3	0.9	0.7	29.1	50.5	2.7	27.9	40.9	21.4	75.1	18.4	54.5	69.5
GPM6A	GPM6	ENSG00000150625	"Glycoprotein M6A"	P51674	4	175632934-176002664	"Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 249.7"	"Group enriched"	"Detected in some"	10	"AF22: 26.2;Daudi: 21.8;HAP1: 9.0;U-251 MG: 25.9"	"Cancer enriched"	"Detected in many"	107	"glioma: 110.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 22.2;naive B-cell: 9.1"	"Lineage enriched"	"Detected in many"	12	"B-cells: 22.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017338	Supported									"HPA017338: AB_1849933"	"unprognostic (1.36e-4)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.82e-5)"	"unprognostic (2.24e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.60e-3)"	2.4	3.1	81.8	2.0	51.1	1.8	2.5	83.3	249.7	4.1	4.1	15.9	0.0	2.2	4.3	2.7	2.3	4.4	3.1	2.3	54.4	31.2	4.3	6.2	8.8	2.4	23.5	39.4	6.5	2.2	2.0	1.0	1.7	13.1	3.7	3.8	6.3	1.9	4.2	1.8	1.9	2.3	5.5	9.6	6.9	2.0	2.1	17.0	0.0	5.9	0.0	2.0	2.4	0.5	22.2	1.7	0.3	0.1	0.0	0.0	0.4	0.1	0.4	26.2	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.5	0.3	21.8	0.1	0.1	0.4	9.0	0.7	0.0	0.1	2.1	0.2	1.7	0.7	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.5	0.8	0.3	0.6	0.3	0.1	0.1	0.1	0.0	1.1	0.2	0.2	0.1	0.4	0.1	0.3	0.0	0.1	0.5	0.3	0.3	25.9	0.8	0.0	1.3	0.9	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.1	9.1	0.0	0.0	0.1	0.0	0.1	1.7	0.0	0.4	81.8	51.1	83.3	79.7	54.4	31.2	23.5	39.4	13.1	17.0
GPR62		ENSG00000180929	"G protein-coupled receptor 62"	Q9BZJ7	3	51955314-51957504	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	11	"brain: 24.2"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 6.4"	"Cancer enhanced"	"Detected in single"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"																		"unprognostic (9.56e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-5)"	"unprognostic (3.64e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-2)"	1.0	1.3	5.6	0.6	12.5	0.6	0.8	1.4	16.2	0.8	0.7	24.2	0.0	0.7	1.1	1.4	0.8	1.1	1.0	1.3	9.7	5.3	1.2	1.0	0.7	0.7	17.8	5.4	2.1	0.8	1.3	0.4	0.7	10.6	0.9	0.7	0.0	1.1	1.0	1.3	0.8	0.7	0.8	18.6	0.8	1.0	0.8	14.5	0.0	0.9	0.0	0.7	0.8	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.2	0.2	0.2	0.0	0.0	0.1	6.4	1.2	1.0	0.0	1.1	0.0	0.0	0.0	0.1	1.0	0.2	0.1	0.6	0.2	0.0	0.4	0.9	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	12.5	1.4	8.5	9.7	5.3	17.8	5.4	10.6	14.5
MDGA1	"GPIM, MAMDC3"	ENSG00000112139	"MAM domain containing glycosylphosphatidylinositol anchor 1"	Q8NFP4	6	37630679-37699306	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 94.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 13.8;HaCaT: 8.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	17	"cerebellum: 94.7"	"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 3.1"	"Group enriched"	"Detected in many"	22	"B-cells: 1.1;T-cells: 3.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031235, HPA050382"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"		490000	"Plasma membrane"	"Golgi apparatus"	"HPA031235: AB_10603017, HPA050382: "	"unprognostic (4.67e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.69e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-5)"	"unprognostic (9.19e-3)"	"unprognostic (5.28e-3)"	"unprognostic (3.80e-3)"	"unprognostic (4.60e-2)"	1.5	3.7	3.4	3.1	2.4	0.0	1.0	94.7	5.1	3.0	1.3	1.5	1.0	0.0	3.0	1.5	1.8	2.1	3.4	1.2	5.0	2.0	0.8	0.5	3.5	3.4	1.7	2.4	8.4	2.6	6.6	2.6	0.5	5.4	1.5	1.1	3.4	0.7	1.2	0.9	6.7	1.5	2.6	4.1	3.9	1.2	1.4	1.3	0.6	1.1	1.7	2.7	1.1	3.1	1.1	0.0	0.0	0.0	0.0	3.1	0.4	0.1	3.8	6.9	2.6	13.8	5.6	3.0	2.7	2.7	3.5	3.9	0.7	0.0	0.9	0.6	1.7	8.9	0.5	0.0	1.1	6.9	4.0	0.0	0.5	0.0	0.6	0.0	0.9	1.0	0.1	1.4	0.0	0.0	0.1	0.0	1.2	0.1	0.0	0.5	0.0	0.4	7.4	2.4	0.0	0.8	4.2	6.3	0.0	1.5	0.4	3.3	3.2	0.6	0.5	3.7	1.2	1.3	5.0	0.0	0.1	0.0	5.9	1.1	2.4	0.0	0.0	0.0	1.4	0.0	0.4	1.1	1.2	0.8	0.0	1.0	3.1	0.8	0.0	0.0	0.0	0.0	1.8	0.4	3.4	2.4	94.7	2.7	5.0	2.0	1.7	2.4	5.4	1.3
PMCH	MCH	ENSG00000183395	"Pro-melanin concentrating hormone"	P20382	12	102196459-102197845	"Predicted secreted proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Hormone, Neuropeptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 124.8"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 30.6"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.8"	"Region enriched"	"Detected in some"	27	"hypothalamus: 124.8"	"Cell type enriched"	"Detected in some"	8	"T-reg: 11.3"	"Lineage enriched"	"Detected in single"	81	"T-cells: 11.3"	"Group enriched"	"Detected in some"	131	"hypothalamus: 737.6;thalamus: 373.6"	"Region enriched"	"Detected in single"	30	"hypothalamus: 98.6"	"HPA046055, HPA061884"	Enhanced	Supported			"Secreted to blood"	274240				"HPA046055: AB_2679517, HPA061884: AB_2684632"	"unprognostic (3.23e-3)"	"unprognostic (8.04e-2)"	"unprognostic (3.96e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.73e-2)"		"unprognostic (4.31e-3)"	"unprognostic (1.43e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.16e-6)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.10e-2)"	"unprognostic (3.53e-2)"	0.1	0.0	0.3	2.1	2.0	2.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	1.1	1.0	0.0	0.2	0.6	0.8	124.8	0.1	0.1	0.2	6.4	0.4	0.1	0.1	0.1	0.0	1.4	0.2	4.5	0.2	0.0	0.1	0.2	0.1	0.1	0.9	0.1	0.1	0.9	1.1	2.0	0.2	0.7	1.0	0.1	0.1	1.7	0.2	0.1	0.0	0.0	0.0	0.0	0.1	11.3	0.0	0.3	0.1	0.3	0.3	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.0	0.0	30.6	0.1	0.5	0.6	0.3	0.0	1.0	0.4	0.0	0.0	0.0	0.0	3.7	0.7	0.1	0.0	0.0	0.6	1.0	0.5	1.2	0.3	0.6	1.2	0.0	0.2	0.3	0.4	0.4	0.6	0.1	0.2	0.1	0.4	0.4	0.4	0.1	0.5	0.1	0.5	0.4	0.4	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.3	0.0	0.3	2.0	0.1	0.1	0.8	124.8	0.4	0.1	4.5	0.7
PRKCG	"MGC57564, PKCC, PKCG, SCA14"	ENSG00000126583	"Protein kinase C gamma"	P05129	19	53879190-53907652	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 49.9"	"Cell line enhanced"	"Detected in some"		"A549: 5.8;HAP1: 2.7;SH-SY5Y: 4.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB013051, HPA047870, HPA054560"	Enhanced									"CAB013051: AB_2533015, HPA047870: , HPA054560: "	"unprognostic (7.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.38e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.22e-7)"	"unprognostic (2.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	1.0	0.9	28.0	1.1	49.9	2.2	0.9	12.1	39.2	0.9	1.3	1.6	0.0	1.5	1.0	0.9	1.0	1.4	1.0	0.9	49.7	4.4	0.9	0.9	1.0	0.9	2.9	20.8	0.9	3.5	2.1	0.2	0.9	0.7	0.9	1.2	0.0	0.9	1.0	1.0	0.9	1.3	1.1	1.4	0.9	1.8	4.4	2.1	1.3	0.9	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.3	5.8	1.3	0.0	0.0	0.2	0.1	0.7	0.4	0.1	0.0	1.5	1.5	0.3	1.7	0.0	0.5	2.7	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.1	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.6	0.5	0.1	1.0	0.5	1.0	0.6	0.1	1.1	0.0	0.0	4.0	1.6	0.2	0.0	1.9	0.0	1.0	0.0	2.0	0.0	0.0	1.7	0.4	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	49.9	12.1	28.5	49.7	4.4	2.9	20.8	0.7	2.1
RIT2	"RIBA, RIN"	ENSG00000152214	"Ras like without CAAX 2"	Q99578	18	42743227-43115691	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 55.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.1;NTERA-2: 1.4;SH-SY5Y: 1.9"	"Cancer enriched"	"Detected in single"	49	"glioma: 4.7"	"Region enhanced"	"Detected in many"		"cerebellum: 55.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA072174	Enhanced									"HPA072174: "					"unprognostic (1.37e-2)"							"unprognostic (4.15e-1)"			"unprognostic (2.14e-1)"			0.7	5.2	3.7	0.9	15.0	0.6	0.8	55.9	24.1	1.0	0.7	0.1	0.0	0.8	0.6	0.6	0.6	0.7	0.7	0.6	5.1	11.7	0.6	0.7	0.6	0.7	3.6	5.9	0.8	0.6	0.6	0.4	0.8	6.1	0.7	0.9	0.0	0.6	0.8	0.6	0.6	0.7	0.8	2.1	0.6	0.6	1.1	0.8	0.0	0.7	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.4	1.9	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	15.0	55.9	11.0	5.1	11.7	3.6	5.9	6.1	0.8
SLC1A3	"EA6, EAAT1, GLAST"	ENSG00000079215	"Solute carrier family 1 member 3"	P43003	5	36606355-36688334	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 188.6"	"Cell line enhanced"	"Detected in many"		"AF22: 21.2;CACO-2: 34.1;HaCaT: 25.8"	"Cancer enriched"	"Detected in all"	21	"glioma: 168.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4"	"Group enriched"	"Detected in many"	39	"dendritic cells: 3.4;monocytes: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002573, HPA037467, HPA037468"	Enhanced	Supported	Approved	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.17e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	17.3	10.3	76.1	5.9	70.6	3.1	6.3	45.8	188.6	6.9	3.2	26.3	0.0	2.1	2.8	2.3	7.2	5.4	5.9	12.0	57.9	27.3	3.1	3.6	4.7	8.6	32.7	39.6	8.6	4.0	2.6	3.7	12.7	28.5	3.3	2.6	1.9	3.0	4.4	7.6	5.5	2.3	4.1	29.4	5.8	2.9	2.7	33.6	0.0	2.6	0.7	4.5	4.8	1.2	0.0	3.4	0.0	4.3	0.0	0.0	0.8	0.4	0.1	21.2	1.8	2.1	5.9	13.5	0.0	0.0	0.8	1.8	34.1	1.7	0.0	10.3	0.3	25.8	6.2	2.8	0.9	0.3	12.7	0.0	0.1	0.0	0.4	0.4	0.1	10.9	12.8	5.2	2.1	0.0	0.0	0.1	3.6	0.0	0.0	0.0	2.5	2.1	0.0	0.1	0.0	0.0	1.3	1.8	0.0	2.1	6.2	0.3	0.0	1.0	0.0	1.9	3.1	0.0	7.5	0.0	0.0	0.0	8.6	14.3	4.8	0.0	4.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.8	76.1	70.6	45.8	57.8	57.9	27.3	32.7	39.6	28.5	33.6
SYT1	"P65, SVP65, SYT"	ENSG00000067715	"Synaptotagmin 1"	P21579	12	78863993-79452008	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 141.7"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.5;LHCN-M2: 18.0;SH-SY5Y: 17.4;WM-115: 16.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.3;memory B-cell: 3.3;naive B-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008394, HPA064788"	Enhanced	Supported								"HPA008394: AB_1857696, HPA064788: AB_2685351"	"unprognostic (1.02e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.77e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.68e-5)"	"unprognostic (2.78e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.05e-8)"	"unprognostic (2.89e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	1.3	11.5	23.9	2.1	31.8	1.3	1.4	44.3	141.7	1.8	2.3	1.8	0.0	1.8	5.6	1.4	1.4	1.4	1.7	1.1	32.4	22.9	2.0	2.0	1.5	1.2	23.1	38.6	3.6	1.2	1.1	1.4	2.3	28.9	4.3	2.5	2.7	1.2	3.8	1.1	1.2	2.6	12.9	2.5	2.2	1.8	1.4	3.6	0.0	1.2	0.0	1.2	1.3	0.7	3.4	0.9	0.0	2.3	0.0	0.0	0.1	0.0	10.5	7.9	0.0	0.8	2.3	0.0	0.7	0.9	0.6	0.6	0.5	0.3	0.0	1.6	0.1	0.3	0.1	1.2	0.9	0.1	0.4	0.6	0.2	0.0	2.0	0.0	0.1	0.6	0.8	2.9	22.5	7.5	0.4	1.2	18.0	1.6	1.0	0.0	5.8	3.0	0.0	8.2	0.0	0.0	3.0	10.5	17.4	0.0	1.3	0.2	3.9	0.0	3.0	1.1	0.4	0.0	3.3	1.9	4.2	0.0	2.6	0.0	16.2	0.0	2.3	0.0	0.0	0.2	0.0	3.3	0.0	0.0	0.9	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.9	31.8	44.3	74.8	32.4	22.9	23.1	38.6	28.9	3.6
TMEM132D	"KIAA1944, MOLT, PPP1R153"	ENSG00000151952	"Transmembrane protein 132D"	Q14C87	12	129071725-129903666	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 18.0"	"Cell line enhanced"	"Detected in some"		"AF22: 5.4;Karpas-707: 1.7;MOLT-4: 9.1;NTERA-2: 3.5;U-266/84: 1.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 19.1;cerebral cortex: 57.9;hippocampal formation: 46.6"	HPA010739	Approved						150000			"HPA010739: AB_2204753"			"unprognostic (1.69e-1)"		"unprognostic (1.21e-1)"		"unprognostic (1.19e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.39e-1)"		"unprognostic (1.47e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.31e-4)"		0.4	0.9	4.5	0.7	6.6	0.7	0.4	0.4	18.0	0.4	0.8	0.6	0.0	0.8	0.5	0.4	0.4	0.4	0.4	0.4	2.9	4.2	0.6	0.7	0.8	0.4	1.7	6.2	0.5	1.1	0.4	0.7	0.4	0.8	1.1	0.7	1.2	0.4	0.4	0.4	0.5	0.9	0.5	0.6	0.4	1.0	1.6	0.8	0.0	0.5	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	0.0	9.1	0.0	3.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	6.6	0.4	11.7	2.9	4.2	1.7	6.2	0.8	0.8
TMEM59L	"BSMAP, C19orf4"	ENSG00000105696	"Transmembrane protein 59 like"	Q9UK28	19	18607430-18621039	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 148.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 20.3;ASC diff: 24.7;EFO-21: 14.6;Hep G2: 14.8;HSkMC: 9.1;SH-SY5Y: 12.0"	"Cancer enriched"	"Detected in many"	8	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010661, HPA070701"	Approved		Approved	"Nucleoplasm,Actin filaments"				"Actin filaments"	Nucleoplasm	"HPA010661: AB_1078338, HPA070701: "	"unprognostic (3.24e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.24e-4)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.40e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-3)"	"prognostic favourable (8.80e-4)"	"unprognostic (4.65e-2)"	"unprognostic (9.17e-7)"	"unprognostic (1.47e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-5)"	2.6	12.8	36.9	2.5	39.4	1.7	1.9	41.9	148.3	2.2	2.9	7.5	0.0	2.0	2.5	2.0	2.5	2.1	2.9	3.5	39.9	49.6	1.9	1.8	1.9	1.8	17.7	32.8	1.8	2.8	4.9	13.2	2.3	24.1	2.2	2.2	1.9	2.3	2.6	2.5	1.8	3.0	3.1	7.3	1.7	2.0	2.4	5.2	0.0	1.8	0.0	1.7	2.0	0.1	0.5	0.7	0.0	0.0	0.0	0.5	0.4	0.0	0.6	0.2	20.3	24.7	1.2	0.0	2.1	0.4	0.8	0.4	0.0	1.0	0.1	14.6	1.3	0.3	6.0	0.0	0.7	0.1	0.9	0.0	0.3	14.8	3.8	0.0	0.3	9.1	0.0	0.2	0.7	0.0	0.0	0.1	0.5	0.8	0.1	0.0	1.8	0.6	0.1	0.0	0.2	0.0	0.0	0.3	12.0	1.4	0.0	0.0	0.2	0.0	0.2	0.4	4.9	0.1	1.3	3.0	1.1	0.1	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.4	36.9	39.4	41.9	70.3	39.9	49.6	17.7	32.8	24.1	5.2
ZP2	ZPA	ENSG00000103310	"Zona pellucida glycoprotein 2"	Q05996	16	21197450-21214510	"Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 35.2"	"Cell line enriched"	"Detected in single"	35	"HDLM-2: 8.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	22	"cerebellum: 35.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA011296	Approved				"Secreted in female reproductive system"					"HPA011296: AB_1859485"	"unprognostic (2.35e-2)"		"unprognostic (3.12e-2)"			"unprognostic (6.60e-2)"		"unprognostic (9.83e-2)"			"unprognostic (3.44e-3)"	"unprognostic (3.12e-1)"		"unprognostic (1.66e-1)"	"unprognostic (4.41e-2)"			0.0	0.1	0.0	0.0	0.0	0.0	1.1	35.2	0.1	0.8	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.9	1.6	0.0	0.1	0.0	3.1	0.0	0.0	0.1	1.5	0.1	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.1	0.0	0.0	0.0	0.0	1.6	0.0
ADGRB2	BAI2	ENSG00000121753	"Adhesion G protein-coupled receptor B2"	O60241	1	31727117-31764893	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 52.0"	"Cell line enhanced"	"Detected in many"		"HeLa: 20.5;SH-SY5Y: 15.0;T-47d: 17.3;U-2 OS: 16.9"	"Cancer enhanced"	"Detected in many"		"glioma: 20.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052612, HPA054617"			Enhanced	Centrosome			49000	Centrosome		"HPA052612: , HPA054617: "	"prognostic favourable (6.46e-4)"	"unprognostic (1.74e-1)"	"unprognostic (7.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.17e-4)"	"prognostic unfavourable (4.02e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.75e-3)"	"unprognostic (7.98e-2)"	2.2	5.4	15.9	1.3	26.8	1.1	1.4	7.9	52.0	2.4	1.4	7.3	0.0	5.2	2.4	1.2	1.6	2.2	2.1	2.8	18.9	8.0	1.4	0.9	1.3	1.3	7.4	16.5	1.8	1.4	1.3	2.7	3.8	8.4	2.4	1.1	1.3	1.4	3.1	1.1	1.5	5.0	2.4	2.9	1.8	1.8	3.2	6.3	1.5	3.2	0.0	1.1	2.0	0.5	0.4	0.0	0.0	0.0	0.0	0.9	0.3	0.5	4.4	4.1	11.9	1.2	0.7	2.0	2.8	4.5	2.7	4.9	0.2	1.3	0.0	2.8	1.2	0.4	1.8	0.2	0.4	3.1	1.8	0.0	20.5	0.0	0.1	0.0	1.5	0.7	0.3	3.8	0.0	0.4	0.4	0.1	3.0	0.4	7.8	0.1	5.1	1.3	11.9	0.4	0.4	0.0	5.6	3.1	15.0	6.4	0.4	0.5	17.3	0.0	0.1	2.1	16.9	0.3	0.7	0.0	0.0	0.4	6.6	0.0	5.0	0.0	0.0	0.0	0.9	0.0	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	15.9	26.8	7.9	37.6	18.9	8.0	7.4	16.5	8.4	6.3
B3GAT1	"CD57, GlcAT-P, HNK-1, LEU7, NK-1"	ENSG00000109956	"Beta-1,3-glucuronyltransferase 1"	Q9P2W7	11	134378504-134411918	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 76.0"	"Cell line enhanced"	"Detected in some"		"AF22: 17.0;HMC-1: 18.8;NTERA-2: 16.3;SH-SY5Y: 6.2"	"Group enriched"	"Detected in some"	11	"glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.8;naive CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	39	"T-cells: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002500, CAB010893, HPA069468"	Enhanced		Supported	Vesicles	"Secreted in brain"			Vesicles		"CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: "	"unprognostic (6.72e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.60e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.87e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.26e-2)"	1.5	5.8	38.9	1.7	23.7	2.1	5.6	9.2	76.0	1.7	1.5	25.8	0.0	1.8	1.6	1.7	1.4	1.6	1.7	1.5	43.4	14.9	2.1	6.0	1.8	3.3	30.3	19.5	1.5	1.7	1.4	0.9	1.4	19.7	4.2	1.5	2.1	2.2	1.8	1.4	1.8	1.6	1.5	45.1	2.1	6.0	1.8	25.2	0.0	7.7	0.0	1.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.4	0.0	0.0	17.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	2.9	0.0	0.8	1.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	16.3	0.0	0.3	0.0	1.2	0.0	0.1	2.3	6.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.2	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.8	1.9	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.4	38.9	23.7	9.2	33.7	43.4	14.9	30.3	19.5	19.7	25.2
C8orf46	MGC33510	ENSG00000169085	"Chromosome 8 open reading frame 46"	Q8TAG6	8	66460003-66518524	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 51.7"	"Cell line enhanced"	"Detected in some"		"A-431: 3.2;CAPAN-2: 3.2;fHDF/TERT166: 3.2;LHCN-M2: 4.2;SK-MEL-30: 4.6;T-47d: 5.9;WM-115: 5.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 16.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"amygdala: 164.2;basal ganglia: 80.3;cerebral cortex: 305.1;hippocampal formation: 240.3"	"Low region specificity"	"Detected in all"			HPA075134			Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA075134: "	"unprognostic (6.87e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-4)"	"unprognostic (7.87e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.36e-3)"	"unprognostic (3.53e-4)"	"unprognostic (1.86e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.91e-2)"	1.2	1.4	14.9	1.2	16.6	1.2	1.2	1.8	51.7	1.6	1.2	16.3	0.0	1.0	1.6	1.3	1.5	1.2	1.7	2.2	39.1	8.3	1.3	1.2	1.4	1.4	13.8	19.4	1.1	1.8	1.1	0.2	1.1	10.9	2.2	1.3	0.0	1.7	5.3	3.1	1.4	1.4	2.0	17.9	1.2	1.1	1.4	10.0	0.0	1.3	0.0	1.1	1.5	0.2	0.0	0.7	0.0	0.0	0.0	0.7	0.1	3.2	0.2	0.5	2.1	0.0	0.1	0.0	0.3	0.4	0.5	0.1	0.0	3.2	0.0	0.3	3.2	0.1	0.0	0.0	2.3	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.2	4.2	0.5	0.0	0.0	0.2	0.2	0.0	0.5	0.0	1.3	0.1	0.5	0.0	0.0	0.0	4.6	5.9	0.0	0.0	0.4	0.7	0.2	2.8	0.1	1.2	0.0	1.2	0.1	5.8	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.9	16.6	1.8	26.7	39.1	8.3	13.8	19.4	10.9	10.0
CABP1		ENSG00000157782	"Calcium binding protein 1"	Q9NZU7	12	120640552-120667324	"Predicted intracellular proteins"	"Sensory transduction, Vision"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 90.6"	"Cell line enhanced"	"Detected in some"		"AF22: 3.9;NTERA-2: 9.1;RPTEC TERT1: 3.6;RT4: 5.2;SCLC-21H: 4.3;U-87 MG: 11.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.2"	"Region enhanced"	"Detected in many"		"cerebral cortex: 90.6"	"Cell type enhanced"	"Detected in single"		"myeloid DC: 3.1"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 3.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 177.9"	HPA051438	Uncertain				"Intracellular and membrane"					"HPA051438: "	"unprognostic (2.57e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.92e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.13e-3)"	"unprognostic (6.28e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.12e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.04e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.85e-1)"	9.0	2.0	26.2	1.0	18.1	0.4	1.1	13.1	90.6	1.8	2.0	0.3	0.2	1.1	2.6	3.6	1.7	2.0	1.3	3.7	29.3	5.7	8.9	0.5	0.9	0.6	6.7	18.4	1.2	0.9	3.7	1.0	1.4	3.5	1.9	1.9	1.0	0.8	3.9	2.6	0.8	1.4	2.5	2.5	1.0	1.6	0.9	0.0	0.0	0.6	0.0	0.6	2.1	0.6	0.0	3.1	0.5	0.4	0.0	0.0	0.2	0.2	0.7	3.9	1.2	0.0	0.1	0.0	0.1	0.4	0.2	0.2	0.3	0.0	0.0	0.6	0.0	0.3	3.4	0.0	0.2	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.1	9.1	0.6	2.2	0.0	0.0	3.6	5.2	4.3	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	11.7	0.0	0.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.5	0.0	0.1	0.9	0.0	0.2	26.2	18.1	13.1	90.6	29.3	5.7	6.7	18.4	3.5	0.0
CACNA1A	"APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6"	ENSG00000141837	"Calcium voltage-gated channel subunit alpha1 A"	O00555	19	13206442-13633025	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 77.9"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 30.5;U-87 MG: 17.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	4	"cerebellum: 77.9"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064258, HPA071902"	Enhanced	Supported	Uncertain	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA064258: , HPA071902: "	"unprognostic (1.09e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.78e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.47e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-2)"	"prognostic favourable (4.32e-4)"	"unprognostic (5.31e-3)"	"unprognostic (5.03e-6)"	"unprognostic (6.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (6.25e-2)"	2.2	5.3	7.6	1.0	12.2	0.7	0.9	77.9	19.7	0.8	1.5	1.8	0.0	3.9	1.2	2.8	0.7	2.2	0.8	1.1	5.7	5.1	0.7	0.5	0.7	1.3	3.9	7.3	1.1	3.0	0.7	1.5	0.6	7.2	0.8	1.7	1.2	0.9	0.8	1.3	0.7	2.8	0.9	3.3	1.3	7.7	1.9	2.8	0.0	0.7	0.0	1.0	0.8	0.3	2.8	0.8	1.9	1.1	0.8	0.8	0.4	0.0	0.1	0.0	3.8	0.1	0.3	0.0	1.6	1.5	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	2.0	0.0	1.2	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.1	0.9	0.2	0.4	0.0	0.1	0.0	0.1	30.5	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	17.2	0.0	0.4	1.9	0.4	0.7	0.5	0.5	0.8	2.8	0.5	0.3	0.4	1.7	0.6	0.7	1.6	0.8	1.1	0.8	0.6	0.4	7.6	12.2	77.9	17.4	5.7	5.1	3.9	7.3	7.2	2.8
CEND1	"BM88, FLJ90066"	ENSG00000184524	"Cell cycle exit and neuronal differentiation 1"	Q8N111	11	787104-790123	"Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 85.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 16.7;SCLC-21H: 30.0;SH-SY5Y: 11.2;U-266/70: 11.7;U-87 MG: 15.6"	"Cancer enriched"	"Detected in many"	13	"glioma: 24.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042527	Enhanced		Approved	Mitochondria				Mitochondria		"HPA042527: AB_2678038"	"unprognostic (4.62e-3)"	"unprognostic (1.34e-4)"	"unprognostic (9.66e-3)"	"unprognostic (1.27e-2)"	"prognostic unfavourable (4.38e-5)"	"unprognostic (2.20e-3)"	"unprognostic (4.11e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.00e-3)"	"unprognostic (4.24e-3)"	"unprognostic (1.94e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-1)"	1.9	8.2	28.5	2.9	34.7	1.8	1.8	46.5	85.2	1.8	2.3	8.3	1.3	2.5	1.9	2.0	2.2	1.8	1.9	2.1	34.2	25.3	2.1	1.8	1.8	2.1	32.0	30.7	1.8	1.9	1.9	5.1	1.8	42.4	3.2	1.9	2.1	1.8	3.6	1.8	1.9	2.7	2.3	10.2	1.8	1.9	1.9	5.9	0.0	1.8	0.0	2.0	2.1	0.1	3.6	0.2	0.0	0.7	0.0	1.9	0.3	0.0	0.4	0.4	0.7	0.1	0.1	0.1	0.7	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.0	0.1	0.0	2.9	0.3	0.0	0.4	0.0	0.1	0.0	16.7	0.2	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	30.0	11.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.4	11.7	3.2	0.7	15.6	0.1	0.2	0.0	0.0	0.0	0.9	0.7	0.3	3.6	1.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.3	28.5	34.7	46.5	65.2	34.2	25.3	32.0	30.7	42.4	5.9
CSPG5	NGC	ENSG00000114646	"Chondroitin sulfate proteoglycan 5"	O95196	3	47562239-47580792	"Predicted membrane proteins"	"Differentiation, Growth regulation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 81.1"	"Cell line enhanced"	"Detected in many"		"AF22: 26.2;HEK 293: 7.2"	"Cancer enriched"	"Detected in many"	19	"glioma: 48.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049529, HPA067818, HPA071779"	Enhanced		Approved	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA049529: , HPA067818: , HPA071779: "	"unprognostic (2.68e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.05e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.82e-1)"	"prognostic favourable (2.14e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.41e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	1.8	1.8	30.6	1.3	25.8	1.1	1.6	7.2	81.1	1.3	1.4	6.7	0.0	1.1	1.3	1.2	1.3	1.4	1.2	1.3	20.2	17.1	1.2	1.2	1.7	1.3	12.9	12.6	1.1	1.4	1.1	0.2	1.8	5.6	1.5	1.3	8.0	1.1	1.1	1.5	1.6	1.3	1.4	6.2	1.1	1.2	2.2	4.1	0.0	1.3	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	26.2	4.6	0.5	0.0	0.7	0.5	0.1	1.0	0.3	0.2	1.6	0.1	2.0	0.0	0.4	2.2	0.2	0.2	0.0	7.2	0.4	1.1	0.0	0.0	0.3	1.2	0.0	0.9	0.1	0.0	0.0	5.1	0.2	0.1	1.2	0.2	0.3	2.5	2.7	0.4	0.2	0.5	1.1	0.9	2.8	1.3	1.6	3.3	0.1	1.2	2.4	0.2	0.0	5.4	0.0	1.5	0.6	0.6	0.0	0.4	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	25.8	7.2	22.4	20.2	17.1	12.9	12.6	5.6	4.1
GLRA1	STHE	ENSG00000145888	"Glycine receptor alpha 1"	P23415	5	151822513-151924842	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"brain: 31.7"	"Cell line enhanced"	"Detected in single"		"HeLa: 1.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	10	"pons and medulla: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"hypothalamus: 11.0;midbrain: 18.1;pons and medulla: 27.6"	"Region enhanced"	"Detected in many"		"pons and medulla: 54.9"	"HPA016502, CAB079042"	Uncertain	Supported								"CAB079042: , HPA016502: AB_1849819"					"unprognostic (3.17e-1)"						"unprognostic (2.47e-1)"		"unprognostic (3.85e-7)"	"unprognostic (8.24e-2)"		"unprognostic (9.45e-3)"		0.3	3.2	1.2	0.1	0.7	0.2	0.1	3.2	0.9	0.1	0.2	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.3	0.1	2.7	0.2	0.1	0.1	0.1	2.7	0.0	0.1	2.2	0.1	0.1	0.2	31.7	0.1	0.1	1.6	0.1	0.1	0.6	0.1	0.1	0.1	12.6	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	3.2	0.9	0.1	2.7	2.7	0.0	31.7	0.0
GNG3		ENSG00000162188	"G protein subunit gamma 3"	P63215	11	62707658-62709201	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 136.6"	"Group enriched"	"Detected in some"	7	"Karpas-707: 38.2;SCLC-21H: 75.6"	"Cancer enriched"	"Detected in some"	14	"glioma: 12.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	30	"memory B-cell: 13.4;naive B-cell: 11.8"	"Lineage enriched"	"Detected in single"	32	"B-cells: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.43e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.68e-4)"	"unprognostic (2.73e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.37e-5)"	"unprognostic (3.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.00e-1)"	1.7	11.8	51.6	2.9	47.6	2.3	1.7	41.0	136.6	1.7	3.5	6.0	0.0	2.5	1.8	2.3	1.8	1.8	1.9	1.8	45.3	39.6	1.9	1.9	1.7	1.9	39.8	36.0	1.9	2.0	2.2	6.7	1.8	43.7	1.8	3.5	1.5	2.0	2.2	2.0	1.9	3.2	2.5	7.4	1.8	2.0	5.7	4.8	0.0	2.0	0.0	1.8	1.6	0.0	13.4	0.0	0.4	0.2	0.2	0.1	0.3	0.1	0.2	1.8	0.1	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.6	0.3	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.2	0.1	0.5	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	38.2	0.0	0.3	0.0	1.0	8.4	0.0	0.4	0.3	0.2	0.1	0.6	75.6	0.6	0.2	0.2	0.0	0.4	0.1	0.1	0.4	0.7	0.2	0.1	0.2	0.5	0.2	0.4	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	13.4	0.1	0.1	0.0	11.8	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.3	51.6	47.6	41.0	83.2	45.3	39.6	39.8	36.0	43.7	4.8
GPR26		ENSG00000154478	"G protein-coupled receptor 26"	Q8NDV2	10	123666355-123694607	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	10	"brain: 8.6"	"Cell line enriched"	"Detected in single"	16	"SCLC-21H: 5.3"	"Cancer enriched"	"Detected in single"	13	"breast cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062736	Enhanced									"HPA062736: "	"unprognostic (4.15e-2)"				"unprognostic (5.75e-2)"	"unprognostic (3.42e-1)"		"unprognostic (2.12e-1)"			"unprognostic (9.09e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.12e-1)"			0.0	0.0	1.0	0.1	0.2	0.1	0.0	0.0	8.6	0.0	0.4			0.0	0.0	0.0	0.1	0.0	0.1	0.1	2.6	2.4	0.0	0.3	0.0	0.1	4.8		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0										
IL1RAPL1	"IL1R8, IL1RAPL, MRX10, MRX21, MRX34, OPHN4, TIGIRR-2"	ENSG00000169306	"Interleukin 1 receptor accessory protein like 1"	Q9NZN1	X	28587399-29956723	"Disease related genes, Plasma proteins, Predicted membrane proteins"		Receptor	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 26.7"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 1.5;SK-MEL-30: 2.0;U-2 OS: 1.9;WM-115: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"																		"unprognostic (2.51e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.25e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.95e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.74e-4)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.58e-3)"	1.5	1.0	12.9	1.0	21.8	0.9	1.5	6.9	17.2	1.2	1.5	15.0	0.0	1.1	1.2	1.5	1.7	1.0	1.5	2.7	10.9	3.3	1.1	1.8	1.1	1.1	21.7	10.1	2.3	1.2	1.0	1.5	1.6	12.3	2.1	1.5	0.0	1.2	2.1	2.2	0.9	1.7	1.2	9.9	0.9	1.4	1.6	26.7	0.0	1.7	0.0	1.0	2.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.6	0.4	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.3	0.0	1.1	0.1	0.0	1.5	0.0	0.0	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	7.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	21.8	6.9	17.2	10.9	3.3	21.7	10.1	12.3	26.7
JPH3	"CAGL237, HDL2, JP-3, JP3, TNRC22"	ENSG00000154118	"Junctophilin 3"	Q8WXH2	16	87601835-87698156	"Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 44.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 6.4;NTERA-2: 5.7;SH-SY5Y: 7.3;SiHa: 4.7;U-2 OS: 23.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076304			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA076304: "	"unprognostic (8.97e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.82e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.28e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	1.3	3.6	27.2	1.6	24.1	1.1	1.2	18.9	44.2	1.5	1.4	1.2	0.0	1.4	1.3	1.2	2.4	1.4	1.2	1.2	30.9	14.6	1.2	1.2	1.2	1.2	8.3	12.2	1.1	1.5	1.2	4.4	1.2	6.4	1.3	1.3	0.8	1.2	1.7	1.1	1.2	1.7	1.3	3.3	1.2	1.5	1.8	3.5	0.0	1.2	0.0	1.2	1.1	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.8	0.0	0.0	1.5	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.4	0.0	0.0	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.5	7.3	4.7	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	27.2	24.1	18.9	30.3	30.9	14.6	8.3	12.2	6.4	3.5
KIF3C		ENSG00000084731	"Kinesin family member 3C"	O14782	2	25926596-25982749	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 72.9"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035755			Approved	"Nuclear membrane,Nuclear bodies,Intermediate filaments"				"Nuclear bodies, Intermediate filaments"	"Nuclear membrane"	"HPA035755: AB_10602242"	"unprognostic (3.95e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.96e-4)"	"unprognostic (1.53e-2)"	"prognostic favourable (1.22e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (3.90e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	3.0	7.3	22.8	2.9	21.2	2.2	2.6	22.7	72.9	3.6	2.4	3.8	0.0	2.1	3.9	2.6	3.0	3.3	4.1	3.0	21.6	18.9	2.0	1.6	2.6	2.0	17.5	20.3	7.3	2.3	4.5	4.8	2.8	22.8	3.3	2.6	1.9	1.9	4.6	2.4	2.3	2.7	4.8	6.2	2.2	2.0	3.0	5.2	0.5	2.5	0.0	2.0	3.5	1.5	0.1	0.3	2.4	0.2	0.7	2.0	1.3	13.0	19.8	10.6	8.1	6.2	7.2	8.5	6.8	3.4	4.1	4.7	3.5	2.0	0.0	5.7	6.2	1.4	8.0	4.1	2.8	2.2	3.8	4.7	1.5	7.1	3.7	1.2	4.1	5.2	1.2	12.9	2.6	13.6	1.7	1.7	4.3	0.9	3.3	1.6	10.8	5.8	5.3	5.2	0.8	9.4	3.2	12.9	29.1	2.7	1.2	14.3	0.4	1.6	10.7	7.2	7.4	3.2	6.6	0.4	2.3	1.5	16.3	6.4	6.1	0.0	0.2	0.0	0.4	0.0	1.1	0.0	1.6	1.5	0.3	0.1	0.5	0.6	2.4	0.7	0.0	0.2	2.0	1.3	22.8	21.2	22.7	40.0	21.6	18.9	17.5	20.3	22.8	5.2
OTP		ENSG00000171540	"Orthopedia homeobox"	Q5XKR4	5	77628712-77639688	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"brain: 16.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.2;SCLC-21H: 1.5;THP-1: 1.5"	"Cancer enriched"	"Detected in single"	6	"glioma: 1.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	7	"hypothalamus: 23.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 24.0"	HPA059342	Enhanced	Supported								"HPA059342: "	"unprognostic (1.00e-1)"	"unprognostic (2.40e-2)"		"unprognostic (6.25e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.16e-1)"		"unprognostic (7.77e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.39e-2)"	"unprognostic (9.66e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.76e-14)"	"unprognostic (3.38e-2)"	"unprognostic (1.84e-1)"		"unprognostic (9.49e-3)"	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.2	0.0	0.0	1.5	0.0	0.0		0.0	0.3	0.0	0.0	0.0		0.1	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OXT	"OT, OT-NPI, OXT-NPI"	ENSG00000101405	"Oxytocin/neurophysin I prepropeptide"	P01178	20	3071620-3072517	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 232.0"	"Group enriched"	"Detected in some"	4	"CACO-2: 5.1;HL-60: 1.3;HMC-1: 3.7;PC-3: 2.6"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 12.1"	"Region enriched"	"Detected in some"	59	"hypothalamus: 232.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"hypothalamus: 210.0"	"Group enriched"	"Detected in some"	878	"basal ganglia: 840.1;hypothalamus: 2453.1"	HPA071892	Supported	Supported			"Secreted to blood"	1501000				"HPA071892: "	"unprognostic (7.45e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.22e-2)"	"unprognostic (8.36e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.18e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.10e-1)"	5.0	0.2	0.0	0.1	3.9	0.2	0.2	0.0	0.3	0.1	0.0	0.4	0.0	2.6	0.0	3.8	0.0	0.0	0.0	0.0	0.1	232.0	1.6	24.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	1.8	0.6	0.2	0.2	0.0	0.0	0.4	0.2	0.2	0.2	2.4	0.0	0.0	0.2	0.2	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	1.5	6.3	0.4	0.4	3.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	6.3	0.8	0.4	1.0	3.7	1.7	1.1	0.9	3.6	3.2	3.6	1.1	0.4	0.0	1.5	2.4	0.9	0.0	3.9	0.0	0.3	0.1	232.0	0.0	0.0	0.2	0.0
SLITRK1	"KIAA1910, LRRC12"	ENSG00000178235	"SLIT and NTRK like family member 1"	Q96PX8	13	83877205-83882393	"Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 30.6"	"Group enriched"	"Detected in some"	4	"A-431: 7.4;AF22: 3.1;LHCN-M2: 2.7"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012414	Enhanced				"Secreted in brain"		270000			"HPA012414: AB_1857229"	"unprognostic (2.29e-1)"				"unprognostic (4.32e-1)"					"unprognostic (4.71e-2)"	"unprognostic (1.01e-1)"			"unprognostic (1.65e-2)"	"unprognostic (7.95e-2)"			0.9	1.3	16.7	0.9	9.5	0.9	1.0	2.0	30.6	1.2	1.0	6.3	0.0	1.0	1.0	1.0	0.9	0.9	1.0	0.9	16.9	7.3	1.0	0.9	0.9	0.9	7.3	14.9	0.9	3.1	0.9	3.1	0.9	5.8	0.9	1.0	0.1	1.0	1.4	1.0	0.9	0.9	0.9	3.7	0.9	1.0	1.0	8.5	0.0	0.9	0.0	0.9	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	3.1	0.0	0.1	0.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	2.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	9.5	2.0	21.5	16.9	7.3	7.3	14.9	5.8	8.5
SRRM4	"KIAA1853, nSR100"	ENSG00000139767	"Serine/arginine repetitive matrix 4"	A7MD48	12	118981495-119163051	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 62.1"	"Group enriched"	"Detected in some"	6	"HeLa: 6.5;SCLC-21H: 7.6;SH-SY5Y: 6.1"	"Cancer enriched"	"Detected in single"	7	"glioma: 1.3"	"Region enhanced"	"Detected in many"		"cerebellum: 62.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052783	Uncertain									"HPA052783: "	"unprognostic (2.44e-2)"	"unprognostic (2.66e-1)"		"unprognostic (2.40e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"		"unprognostic (1.37e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.61e-5)"	"unprognostic (1.10e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.70e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.61e-1)"	0.8	3.6	11.0	0.9	11.6	1.0	0.8	62.1	21.5	0.8	0.8	0.4	0.0	0.9	1.1	1.0	0.8	0.8	0.8	2.0	6.6	4.7	1.1	0.8	1.0	0.8	2.0	18.2	0.8	0.7	0.9	1.4	0.9	3.8	0.9	0.9	5.9	0.8	1.1	1.4	0.9	0.9	0.9	1.3	0.8	1.3	1.4	0.8	0.0	0.9	0.0	0.8	0.7	0.3	0.0	0.1	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	7.6	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	11.0	11.6	62.1	20.5	6.6	4.7	2.0	18.2	3.8	0.8
SYT11	"DKFZp781D015, KIAA0080, MGC10881, MGC17226"	ENSG00000132718	"Synaptotagmin 11"	Q9BT88	1	155859509-155885199	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 148.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 56.5;SCLC-21H: 22.5;SH-SY5Y: 24.6;U-87 MG: 27.2"	"Cancer enriched"	"Detected in all"	12	"glioma: 117.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064091	Enhanced									"HPA064091: "	"unprognostic (1.83e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (2.93e-5)"	"unprognostic (2.14e-1)"	"unprognostic (8.02e-3)"	"unprognostic (7.90e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-3)"	6.0	13.3	34.4	6.2	52.0	3.3	2.7	35.4	148.3	9.3	5.1	44.5	0.0	3.4	11.5	8.6	4.7	5.2	7.9	8.9	32.9	32.3	4.5	2.4	6.0	7.2	35.9	32.2	9.6	3.2	2.4	11.8	7.0	48.3	8.7	5.4	4.4	2.6	11.3	2.8	2.3	4.3	12.7	42.0	6.9	3.8	4.7	29.0	0.0	2.8	0.0	6.5	7.3	3.3	1.6	5.6	4.1	6.1	5.8	14.4	5.7	0.0	0.2	14.5	0.3	10.6	5.7	0.0	2.7	7.3	2.8	5.2	0.0	0.3	2.8	1.2	9.6	0.2	1.2	0.0	4.3	13.5	0.2	2.7	0.4	0.0	3.0	1.5	8.4	3.5	0.0	10.4	0.2	9.2	0.0	56.5	3.9	0.0	0.1	0.7	9.4	0.0	0.5	1.4	0.0	0.4	0.0	22.5	24.6	0.4	0.0	3.2	0.0	0.3	6.8	5.4	3.4	3.6	3.4	15.1	7.3	5.7	27.2	0.0	4.1	4.1	3.8	0.1	14.4	4.8	4.0	1.6	7.6	9.9	5.6	1.4	0.8	7.8	2.1	5.8	6.1	0.3	13.3	5.7	34.4	52.0	35.4	59.4	32.9	32.3	35.9	32.2	48.3	29.0
VAX1		ENSG00000148704	"Ventral anterior homeobox 1"	Q5SQQ9	10	117128521-117138301	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"brain: 21.8"	"Group enriched"	"Detected in some"	7	"A-431: 7.5;WM-115: 5.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 21.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 5.8;hypothalamus: 3.8;olfactory region: 1.8"	"Low region specificity"	"Detected in many"			HPA028946	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA028946: AB_10602679"		"unprognostic (1.08e-2)"		"unprognostic (1.92e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.96e-2)"		"unprognostic (5.77e-3)"	"unprognostic (2.19e-1)"			"unprognostic (1.17e-1)"		"unprognostic (5.72e-2)"	"unprognostic (2.09e-1)"		"unprognostic (2.99e-1)"	0.4	0.4	1.4	0.4	21.8	0.4	0.4	0.0	7.0	0.5	0.5	9.5	0.0	0.4	0.4	0.4	0.5	0.4	0.5	0.4	1.5	5.2	0.4	0.4	0.4	0.4	0.7	4.3	0.4	0.4	0.7	0.5	0.4	1.2	0.4	0.5	0.0	0.4	0.5	0.7	0.4	0.5	0.4	1.3	0.4	0.4	2.1	2.9	0.0	0.4	0.0	0.4	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.5	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.4	21.8	0.0	7.0	1.5	5.2	0.7	4.3	1.2	2.9
ABCA2	ABC2	ENSG00000107331	"ATP binding cassette subfamily A member 2"	Q9BZC7	9	137007227-137028922	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 84.3"	"Cell line enhanced"	"Detected in many"		"T-47d: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.7;NK-cells: 1.2;T-cells: 2.2"	"Low region specificity"	"Detected in all"							HPA042886	Approved									"HPA042886: "	"unprognostic (1.01e-2)"	"unprognostic (9.21e-3)"	"unprognostic (9.59e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.36e-1)"	7.8	6.1	20.0	3.9	42.4	5.7	2.6	16.7	54.2	4.0	4.5	84.3	0.9	3.2	2.8	4.7	3.5	6.3	5.7	7.1	32.2	17.6	4.8	3.8	4.1	4.1	57.5	21.9	2.5	8.6	8.1	7.8	3.3	31.1	5.2	2.5	3.8	8.0	5.1	5.7	6.3	4.1	2.7	70.5	8.3	6.1	3.0	47.7	0.2	9.5	0.1	2.2	3.3	1.8	0.4	2.7	0.4	0.3	1.2	2.2	1.1	4.3	4.8	2.4	9.5	6.0	6.4	4.1	4.8	1.9	2.2	0.8	1.4	5.3	0.2	13.8	5.2	7.4	1.5	3.6	0.4	3.2	3.0	0.4	13.7	1.7	2.9	6.8	7.6	2.7	3.3	1.5	0.4	1.2	1.1	0.8	2.7	13.0	0.0	14.7	1.2	4.8	6.7	2.4	6.4	1.5	1.0	9.1	10.5	5.2	10.2	3.7	34.6	8.9	6.2	6.0	3.3	8.5	2.0	0.1	0.1	0.0	10.1	1.3	3.0	0.0	0.3	0.0	2.2	0.2	1.3	0.4	0.2	0.7	0.3	0.2	0.0	0.9	0.4	1.2	0.0	2.7	1.0	1.1	20.0	42.4	16.7	30.7	32.2	17.6	57.5	21.9	31.1	47.7
AMBN		ENSG00000178522	Ameloblastin	Q9NP70	4	70592256-70607288	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"brain: 10.6"	"Cell line enriched"	"Detected in some"	8	"HEK 293: 12.1"	"Group enriched"	"Detected in some"	7	"cervical cancer: 2.6;endometrial cancer: 2.9"	"Region enriched"	"Detected in some"	5	"basal ganglia: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036099			Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"			Vesicles	Nucleoplasm	"HPA036099: "															"unprognostic (3.22e-1)"			0.2	0.0	0.0	0.0	10.6	0.0	0.0	0.0	2.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.1	0.0	1.2	0.2	1.2	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	10.6	0.0	2.0	0.0	0.4	0.1	0.0	0.4	2.0
AMER3	"FAM123C, FLJ38377"	ENSG00000178171	"APC membrane recruitment protein 3"	Q8N944	2	130755435-130768134	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 30.1"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 15.0"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Region enhanced"	"Detected in many"		"cerebellum: 30.1"	"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045593, HPA054230"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA045593: AB_10965021, HPA054230: "	"unprognostic (6.68e-2)"		"unprognostic (3.73e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.83e-1)"					"unprognostic (2.71e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.46e-3)"		0.5	2.4	4.8	0.7	6.0	0.8	0.5	30.1	13.9	0.5	0.8	0.0	0.0	2.0	0.6	0.5	0.5	0.5	0.5	0.5	2.7	4.3	0.5	0.5	0.5	0.6	1.8	5.6	0.6	3.3	0.4	3.4	0.5	3.0	0.6	0.8	0.7	0.5	0.5	0.5	0.7	1.2	0.5	0.8	0.6	2.5	1.6	0.7	0.0	0.6	0.0	0.5	0.5	0.1	0.3	0.3	1.5	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	15.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.1	0.2	1.5	0.2	0.1	0.3	0.1	0.0	4.8	6.0	30.1	10.3	2.7	4.3	1.8	5.6	3.0	0.7
B3GAT2	GlcAT-S	ENSG00000112309	"Beta-1,3-glucuronyltransferase 2"	Q9NPZ5	6	70856679-70957038	"Enzymes, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	9	"brain: 27.2"	"Cell line enriched"	"Detected in some"	20	"SCLC-21H: 22.2"	"Group enriched"	"Detected in some"	20	"glioma: 4.7;testis cancer: 1.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012059	Uncertain									"HPA012059: AB_2061050"	"unprognostic (7.10e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.16e-4)"	"unprognostic (8.09e-2)"	"unprognostic (7.43e-3)"	"unprognostic (6.88e-7)"	"unprognostic (2.72e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.45e-3)"	1.8	1.5	9.5	1.9	7.8	1.6	1.1	3.2	27.2	0.8	1.1	26.2	0.0	2.3	1.4	1.1	1.4	1.1	1.4	1.5	19.2	11.5	1.0	1.3	1.2	2.0	9.7	13.6	1.1	2.2	0.8	0.5	1.2	21.0	1.3	0.9	0.4	1.5	0.9	1.5	1.9	2.4	1.1	17.3	2.0	1.5	2.9	16.3	0.0	1.5	0.0	0.9	1.3	0.9	1.2	1.0	2.0	1.2	1.1	2.2	0.2	0.3	0.0	0.6	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.2	1.1	0.1	0.3	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.0	0.5	0.7	0.1	0.1	0.2	0.2	0.0	0.2	22.2	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.5	0.0	0.1	0.1	0.1	0.1	1.3	1.2	1.2	1.0	1.0	0.9	1.0	1.5	2.1	0.4	1.2	1.7	1.8	2.0	1.1	1.1	1.0	2.2	0.2	9.5	7.8	3.2	11.2	19.2	11.5	9.7	13.6	21.0	16.3
CDH18	"CDH14, EY-CADHERIN"	ENSG00000145526	"Cadherin 18"	Q13634	5	19472951-20575873	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 105.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.1;BEWO: 3.7;EFO-21: 6.3;U-2 OS: 9.9;U-2197: 8.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	7	"cerebellum: 105.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014416	Uncertain				"Intracellular and membrane"					"HPA014416: "	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"		"unprognostic (5.26e-7)"	"unprognostic (6.36e-2)"	"unprognostic (1.10e-1)"		"unprognostic (1.44e-2)"		"unprognostic (1.20e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.30e-2)"		"unprognostic (1.51e-2)"	"unprognostic (8.69e-2)"		"unprognostic (1.76e-2)"	0.7	9.3	6.9	0.7	7.1	0.7	0.6	105.4	23.2	1.0	0.6	0.0	0.0	0.7	0.6	0.6	0.7	0.7	0.7	0.6	4.6	8.1	0.9	0.6	0.7	0.8	1.8	8.3	0.7	1.2	2.1	11.3	0.6	7.1	0.8	0.7	2.2	0.6	0.8	0.9	0.8	0.7	0.6	2.2	0.7	0.6	3.7	1.3	0.0	0.6	0.0	0.6	0.6	0.3	0.7	0.3	1.2	0.5	0.6	0.4	0.5	1.6	0.0	0.3	0.0	1.0	4.1	3.7	0.2	2.3	0.1	0.7	0.0	0.0	0.0	6.3	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.1	2.5	0.0	0.2	0.7	0.4	0.2	0.0	0.2	0.3	0.2	0.0	0.1	1.2	0.0	0.0	0.8	0.2	0.1	0.1	0.0	0.1	0.0	0.0	1.9	9.9	8.7	0.0	2.4	0.0	0.0	2.8	0.0	0.0	1.1	0.5	0.3	0.4	0.1	0.2	0.3	0.2	0.2	0.2	0.7	0.4	0.4	1.2	0.6	0.4	0.3	0.2	0.5	6.9	7.1	105.4	14.1	4.6	8.1	1.8	8.3	7.1	1.3
CNTN2	"AXT, TAG-1, TAX, TAX1"	ENSG00000184144	"Contactin 2"	Q02246	1	205042937-205078284	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"		Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 78.5"	"Group enriched"	"Detected in some"	7	"NTERA-2: 5.6;SCLC-21H: 14.0"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001397, HPA012497"	Approved				"Secreted in brain"		13000			"HPA001397: AB_1847146, HPA012497: AB_1847147"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.44e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.73e-7)"	"unprognostic (9.82e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.07e-2)"	2.0	2.4	15.6	2.1	52.5	1.6	1.6	11.0	68.8	1.8	2.3	78.5	0.0	1.7	1.6	1.7	1.9	1.7	1.8	1.7	27.4	15.9	1.6	1.6	1.6	1.7	59.8	22.0	1.6	1.6	1.6	2.7	1.6	41.9	1.8	2.3	0.0	2.2	2.4	1.6	2.3	2.2	1.8	55.4	1.7	1.7	9.1	48.3	0.0	1.6	0.0	2.0	1.6	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	15.6	52.5	11.0	28.4	27.4	15.9	59.8	22.0	41.9	48.3
CORT	MGC32686	ENSG00000241563	Cortistatin	O00230	1	10449719-10451902	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 28.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	33	"amygdala: 13.7;basal ganglia: 5.1;cerebral cortex: 16.9;hippocampal formation: 11.6;olfactory region: 6.1"	"Low region specificity"	"Detected in many"								"Secreted in brain"						"unprognostic (1.25e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.94e-3)"	"unprognostic (7.08e-7)"	"unprognostic (2.01e-1)"	"unprognostic (9.01e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.14e-4)"	1.0	0.7	3.3	0.9	28.8	0.9	0.6	3.2	26.6	0.7	1.0	0.1	0.0	1.3	0.8	1.0	0.5	0.7	1.0	0.6	2.3	2.5	1.2	0.8	0.7	0.7	1.0	6.2	1.0	0.9	1.0	3.2	1.7	0.0	1.1	0.8	0.0	0.7	0.8	0.8	1.1	1.2	0.7	0.7	0.8	0.9	2.1	20.3	0.0	1.1	0.0	0.5	0.8	0.5	0.2	0.4	0.0	0.1	1.2	0.3	0.3	1.2	3.7	1.8	2.3	0.2	0.2	0.8	1.1	0.2	0.4	0.4	3.1	0.5	1.2	0.8	0.0	1.0	1.1	0.0	0.0	2.0	3.1	1.7	2.7	3.0	0.4	2.4	1.1	0.0	0.3	0.5	0.0	0.0	1.0	1.0	0.3	2.5	0.5	2.2	0.3	4.4	0.9	1.6	0.5	0.2	0.9	1.5	0.8	0.9	1.1	0.7	0.7	0.0	1.7	0.3	1.8	2.2	0.6	0.9	2.7	1.0	0.7	1.8	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.4	0.2	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.3	3.3	28.8	3.2	21.5	2.3	2.5	1.0	6.2	0.0	20.3
DISP2	"C15orf36, DISPB, HsT16908, KIAA1742, LINC00594"	ENSG00000140323	"Dispatched RND transporter family member 2"	A7MBM2	15	40358235-40378639	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 37.2"	"Group enriched"	"Detected in some"	5	"HaCaT: 8.0;SCLC-21H: 16.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059903	Uncertain		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA059903: "	"unprognostic (3.43e-4)"	"unprognostic (7.65e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.47e-8)"	"unprognostic (1.96e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-1)"	0.8	2.5	9.0	1.5	7.6	1.3	0.6	37.2	14.5	0.7	4.0	1.0	0.0	3.4	0.9	0.9	0.7	1.1	1.1	0.8	9.0	7.0	0.5	0.7	0.9	1.5	2.9	14.0	1.3	1.4	0.6	2.8	1.0	11.4	0.8	3.9	0.3	1.2	1.8	0.8	1.3	3.0	1.4	2.0	1.1	3.9	2.4	1.8	0.0	3.4	0.0	0.6	1.2	0.4	0.9	1.1	2.9	0.4	1.1	0.6	0.2	1.5	0.6	0.4	2.5	0.1	0.1	0.9	0.2	0.1	1.0	1.5	2.3	0.7	0.2	1.7	0.9	8.0	0.3	1.3	0.6	0.2	0.5	0.4	0.5	0.1	0.0	0.5	1.5	1.8	0.0	0.3	0.2	0.5	0.6	1.0	1.3	0.3	0.2	0.4	0.4	1.1	0.2	0.4	0.5	0.3	2.1	16.6	2.4	0.3	0.2	0.2	0.4	0.2	0.5	1.1	0.9	0.2	0.2	0.3	0.2	0.3	0.4	0.7	2.3	2.1	0.4	0.5	0.6	0.3	0.4	0.5	0.4	0.4	0.2	0.9	0.5	0.6	2.9	1.1	0.4	1.1	0.4	0.2	9.0	7.6	37.2	14.5	9.0	7.0	2.9	14.0	11.4	1.8
ENC1	"ENC-1, KLHL37, NRPB, PIG10, TP53I10"	ENSG00000171617	"Ectodermal-neural cortex 1"	O14682	5	74627406-74641424	"Cancer-related genes, Predicted intracellular proteins"		"Actin-binding, Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 106.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"amygdala: 39.7;basal ganglia: 42.7;cerebral cortex: 86.4;hippocampal formation: 44.1;olfactory region: 43.9"	"Group enriched"	"Detected in many"	6	"classical monocyte: 5.4;eosinophil: 3.4;gdT-cell: 2.3;intermediate monocyte: 4.8;memory CD8 T-cell: 3.0;myeloid DC: 2.4;naive CD8 T-cell: 2.5;neutrophil: 1.4;NK-cell: 2.8;non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA078061			Uncertain	"Plasma membrane"				"Plasma membrane"		"HPA078061: "	"prognostic unfavourable (3.88e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.36e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.98e-2)"	"unprognostic (8.08e-2)"	"prognostic unfavourable (2.95e-5)"	"unprognostic (9.69e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.65e-2)"	2.2	1.1	39.7	4.7	42.7	5.4	1.8	1.3	106.8	4.2	5.2	2.4	2.1	6.4	2.9	1.6	2.5	1.3	7.5	3.2	44.1	7.7	2.2	6.4	4.8	2.2	4.6	43.9	6.0	12.3	1.0	2.4	4.2	4.9	4.3	8.1	0.8	5.4	7.4	1.7	1.7	8.1	3.0	2.3	4.0	9.8	4.5	1.5	0.5	1.3	0.3	2.0	6.5	1.3	0.4	2.4	3.4	5.4	2.8	3.0	1.4	11.9	14.8	14.8	7.0	6.4	1.6	31.9	8.0	9.1	9.2	6.8	23.9	20.2	0.0	10.0	6.8	9.7	0.2	15.5	20.1	0.2	1.1	13.2	2.8	10.4	0.6	1.3	0.1	2.5	1.0	24.4	2.4	7.5	2.9	7.7	24.0	2.9	1.2	1.7	15.4	13.3	1.5	9.7	1.2	5.0	9.1	19.9	8.1	1.4	6.6	0.7	3.1	1.6	17.8	15.6	26.1	9.2	25.8	0.1	0.0	0.2	18.0	1.1	23.7	0.0	5.4	3.4	2.3	4.8	0.0	0.1	0.5	3.0	2.4	0.4	0.2	2.5	1.4	2.8	1.3	0.0	0.0	1.4	39.7	42.7	1.3	86.4	44.1	7.7	4.6	43.9	4.9	1.5
FAM181B	"LOC220382, MGC33846"	ENSG00000182103	"Family with sequence similarity 181 member B"	A6NEQ2	11	82729941-82733864	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 29.6"	"Cell line enhanced"	"Detected in some"		"RT4: 6.6;SH-SY5Y: 3.5;U-2 OS: 3.4"	"Cancer enriched"	"Detected in many"	19	"glioma: 29.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066861	Approved		Approved	"Nuclear membrane,Mitochondria"				Mitochondria	"Nuclear membrane"	"HPA066861: "	"unprognostic (2.84e-4)"	"unprognostic (3.47e-2)"	"unprognostic (1.80e-1)"	"prognostic favourable (8.07e-4)"	"unprognostic (6.71e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.27e-4)"	"unprognostic (2.52e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.20e-3)"	"unprognostic (7.20e-2)"	1.9	2.9	18.3	1.8	13.3	1.5	1.6	16.9	29.6	2.0	1.7	18.6	0.0	1.9	2.2	1.8	1.5	2.6	1.4	2.0	19.6	11.3	2.0	1.3	1.3	1.4	17.1	13.0	2.7	1.5	1.5	1.1	1.4	17.2	1.9	1.5	0.7	3.2	2.7	1.7	1.7	2.3	1.6	16.9	1.3	1.8	1.7	16.7	0.0	2.1	0.0	1.7	2.2	0.5	0.2	0.0	0.6	0.3	0.3	0.4	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.3	0.1	0.4	0.0	0.1	0.1	0.5	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.1	0.1	0.1	1.2	0.1	0.0	0.0	0.0	0.2	6.6	1.0	3.5	0.0	0.0	0.1	0.1	0.4	0.0	0.1	3.4	0.1	0.1	0.3	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.4	0.0	0.6	0.3	0.3	0.0	0.1	0.0	18.3	13.3	16.9	11.4	19.6	11.3	17.1	13.0	17.2	16.7
FSTL5	"DKFZp566D234, KIAA1263"	ENSG00000168843	"Follistatin like 5"	Q8N475	4	161383897-162164035	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 106.9"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 39.8"	"Cancer enriched"	"Detected in single"	6	"melanoma: 1.7"	"Region enriched"	"Detected in all"	6	"cerebellum: 106.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"							"unprognostic (4.90e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.08e-10)"	"unprognostic (8.45e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.60e-3)"	0.5	12.1	3.5	0.6	6.9	0.5	0.5	106.9	19.9	0.5	0.6	0.6	0.0	0.5	0.5	1.7	0.5	0.6	0.5	0.5	3.2	5.9	0.6	0.5	0.5	0.5	3.0	3.0	0.5	1.0	0.5	1.1	0.7	18.2	0.5	0.8	7.1	0.5	0.6	0.5	0.8	0.6	0.6	3.1	0.5	0.5	1.5	2.9	0.0	0.6	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	5.7	0.0	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	5.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	8.6	0.0	3.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	6.9	106.9	6.9	3.2	5.9	3.0	3.0	18.2	2.9
GABRG1		ENSG00000163285	"Gamma-aminobutyric acid type A receptor gamma1 subunit"	Q8N1C3	4	46035769-46124081	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 35.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.3;THP-1: 2.6;U-2 OS: 1.8;U-266/70: 5.3"	"Cancer enriched"	"Detected in single"	8	"glioma: 0.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035622	Approved									"HPA035622: AB_10603669"	"unprognostic (2.50e-1)"				"unprognostic (2.20e-1)"		"unprognostic (6.06e-2)"			"unprognostic (1.46e-2)"	"unprognostic (7.39e-4)"		"unprognostic (1.23e-1)"		"unprognostic (1.28e-1)"	"unprognostic (1.99e-1)"		1.5	1.5	20.3	1.2	25.9	1.2	1.3	26.4	35.7	1.3	1.3	12.2	0.0	1.4	1.4	1.3	1.3	1.7	1.3	1.2	26.0	14.6	1.4	1.4	1.2	1.3	10.2	14.0	3.9	1.2	1.3	1.6	1.2	17.9	1.2	1.3	0.0	1.2	1.3	1.2	1.2	1.4	1.4	17.8	1.4	1.3	1.8	17.8	0.0	1.5	0.0	1.2	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.6	0.0	0.3	1.8	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	25.9	26.4	18.5	26.0	14.6	10.2	14.0	17.9	17.8
GRM5	"GPRC1E, mGlu5, MGLUR5, PPP1R86"	ENSG00000168959	"Glutamate metabotropic receptor 5"	P41594	11	88504576-89065945	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 27.7"	"Cell line enhanced"	"Detected in some"		"Hep G2: 2.2;U-266/70: 1.5;U-937: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"						"unprognostic (1.94e-1)"			"unprognostic (9.62e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.79e-2)"		"unprognostic (1.80e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.16e-2)"		"unprognostic (8.15e-4)"	"unprognostic (3.43e-2)"				0.5	0.5	11.4	0.5	11.0	0.6	0.5	2.6	27.7	0.6	0.5	1.0	0.0	0.5	0.5	0.5	0.5	0.7	0.7	0.5	6.0	3.2	0.7	0.5	0.7	0.5	2.1	10.0	0.5	0.5	0.5	0.8	0.6	1.5	0.5	0.5	0.0	0.5	0.5	0.6	1.1	0.5	0.5	1.2	0.6	0.5	3.1	1.5	0.0	0.5	0.0	0.5	0.5	0.2	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.7	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.2	0.0	0.0	1.5	0.0	0.2	0.1	1.1	0.8	1.6	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	11.4	11.0	2.6	13.2	6.0	3.2	2.1	10.0	1.5	1.5
HTR6	"5-HT6, 5-HT6R"	ENSG00000158748	"5-hydroxytryptamine receptor 6"	P50406	1	19665287-19679562	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"brain: 24.6"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.2;NTERA-2: 2.4;SH-SY5Y: 6.5"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Group enriched"	"Detected in many"	5	"basal ganglia: 24.6;cerebral cortex: 6.6"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.4;naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 9.5"	HPA068165	Uncertain									"HPA068165: "	"unprognostic (2.34e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.84e-5)"	"unprognostic (1.38e-4)"	"unprognostic (2.69e-2)"		"unprognostic (1.36e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.33e-3)"	"unprognostic (8.63e-2)"	"unprognostic (5.47e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.02e-1)"	0.4	0.5	1.2	1.4	24.6	0.4	0.4	0.2	6.6	0.6	0.4	0.0	0.0	0.6	0.6	0.5	0.5	0.6	0.5	0.4	1.4	1.0	0.3	0.3	0.3	1.4	0.5	2.2	0.3	0.3	0.3	0.4	0.3	0.4	0.4	0.3	0.0	0.5	0.3	0.3	0.8	0.5	0.5	0.2	0.4	0.5	0.8	3.2	0.0	0.3	0.0	2.7	0.6	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	1.4	0.0	1.0	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.2	24.6	0.2	6.6	1.4	1.0	0.5	2.2	0.4	3.2
ICAM5	"TLCN, TLN"	ENSG00000105376	"Intercellular adhesion molecule 5"	Q9UMF0	19	10289981-10296778	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 32.6"	"Cell line enhanced"	"Detected in some"		"HEL: 13.2;K-562: 10.5;RPMI-8226: 12.0;U-266/70: 14.5;U-87 MG: 8.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.8"	"Group enriched"	"Detected in many"	15	"amygdala: 22.5;basal ganglia: 24.3;cerebral cortex: 32.6;hippocampal formation: 23.0;olfactory region: 15.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"amygdala: 111.1;basal ganglia: 75.7;cerebral cortex: 76.7;hippocampal formation: 105.7;olfactory region: 63.4"	"Group enriched"	"Detected in many"	14	"amygdala: 58.8;basal ganglia: 55.2;cerebral cortex: 67.5;hippocampal formation: 103.7;olfactory region: 57.5"	"HPA008943, HPA009083, CAB025178"	Enhanced						2400000			"CAB025178: , HPA008943: AB_1079095, HPA009083: AB_1079094"	"unprognostic (7.76e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.58e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.99e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.90e-3)"	"unprognostic (9.89e-3)"	"unprognostic (5.29e-5)"	"unprognostic (6.47e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.44e-3)"	"unprognostic (6.28e-3)"	0.8	0.9	22.5	0.8	24.3	2.0	0.9	0.0	32.6	0.8	0.8	1.0	0.0	0.8	0.8	0.8	0.8	0.9	0.8	1.0	23.0	1.4	1.1	0.8	3.6	1.2	0.9	15.9	1.4	0.8	0.8	0.1	1.1	0.0	0.9	0.8	0.0	0.8	0.9	0.8	0.8	1.0	0.8	0.1	1.0	1.0	1.9	1.6	0.0	0.8	0.0	0.9	0.8	0.3	0.0	0.0	0.4	0.0	0.0	0.4	0.0	2.8	0.0	0.0	6.1	0.0	0.0	0.1	4.3	0.7	0.1	0.4	0.0	0.1	4.6	1.9	0.0	5.3	0.2	0.0	0.0	0.1	0.9	13.2	4.2	0.4	0.1	0.0	2.6	0.0	0.5	0.1	0.0	0.0	10.5	0.1	0.0	0.6	0.0	1.8	0.0	4.3	0.1	0.0	12.0	0.2	0.0	0.8	0.1	1.9	0.1	0.3	2.2	0.0	0.0	1.3	0.0	0.6	0.0	14.5	2.3	2.6	8.6	0.0	1.3	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	24.3	0.0	32.6	23.0	1.4	0.9	15.9	0.0	1.6
KCNQ3	"EBN2, Kv7.3"	ENSG00000184156	"Potassium voltage-gated channel subfamily Q member 3"	O43525	8	132120858-132481019	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 29.5"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 3.8;hTERT-HME1: 10.2;RPMI-8226: 4.1;U-2 OS: 6.7;U-87 MG: 5.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (2.90e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.65e-5)"	"unprognostic (2.32e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.57e-6)"	"unprognostic (5.82e-2)"	"unprognostic (7.32e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.71e-4)"	"unprognostic (1.14e-3)"	"unprognostic (3.52e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.50e-2)"	1.8	3.3	10.6	1.5	13.1	0.7	1.4	0.9	29.5	1.4	1.0	1.7	0.0	1.0	1.0	0.9	0.8	1.2	1.3	1.8	8.0	7.3	1.8	0.7	2.0	0.9	7.4	11.5	0.8	1.2	1.2	1.4	1.0	6.5	1.4	1.0	0.0	1.0	1.8	0.7	1.3	1.7	1.6	2.1	1.3	0.9	1.0	4.7	0.0	1.2	0.0	1.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	0.5	1.6	0.0	0.5	1.6	0.0	0.0	0.0	1.6	0.0	1.8	2.3	0.0	0.0	3.8	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	2.7	10.2	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.7	0.3	0.0	0.0	4.1	2.4	0.0	1.9	1.7	0.7	0.0	0.0	0.0	1.5	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	13.1	0.9	13.3	8.0	7.3	7.4	11.5	6.5	4.7
KCNV1	Kv8.1	ENSG00000164794	"Potassium voltage-gated channel modifier subfamily V member 1"	Q6PIU1	8	109963645-109975847	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"brain: 22.4"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in single"		"renal cancer: 0.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"																"unprognostic (1.41e-1)"		"unprognostic (1.81e-2)"			"unprognostic (5.01e-4)"		"unprognostic (2.30e-1)"	"unprognostic (3.76e-2)"		"unprognostic (1.13e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.17e-2)"		0.5	0.5	10.6	0.6	10.2	1.1	0.6	0.2	22.4	0.4	1.1	0.0	0.0	0.5	0.6	1.2	0.5	0.4	0.5	0.5	3.9	1.6	0.6	0.5	0.5	0.7	0.9	8.2	0.8	1.0	0.4	0.7	0.6	0.9	0.7	0.9	0.0	0.6	0.5	0.5	1.1	0.8	0.4	0.4	0.6	0.5	0.7	0.0	0.0	0.9	0.0	0.5	0.4	0.2	0.8	0.6	2.5	0.9	0.6	0.5	0.1	2.0	2.6	1.9	0.8	0.3	0.3	0.7	0.6	0.0	0.4	0.4	0.5	0.8	0.7	0.6	0.1	2.1	0.7	0.3	0.5	1.0	0.3	1.2	2.0	0.5	0.1	1.1	1.5	0.3	0.4	0.6	0.5	0.4	1.0	2.6	0.3	0.6	0.8	1.2	0.9	1.2	0.2	1.0	0.3	3.4	1.0	1.5	0.7	0.4	0.4	0.6	1.0	0.5	1.3	2.3	1.9	1.5	0.6	0.9	0.5	0.4	1.0	0.9	0.9	2.5	0.8	0.3	0.5	0.9	0.4	0.6	0.5	0.5	0.5	0.8	0.5	0.5	1.1	0.6	0.8	0.6	0.3	0.1	10.6	10.2	0.2	19.5	3.9	1.6	0.9	8.2	0.9	0.0
MRGPRE	"GPR167, mrgE"	ENSG00000184350	"MAS related GPR family member E"	Q86SM8	11	3227698-3232386	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 34.9"	"Group enriched"	"Detected in some"	6	"NB-4: 2.6;RPMI-8226: 4.9;SCLC-21H: 8.0"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.9"	"Region enriched"	"Detected in many"	14	"pons and medulla: 34.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA046556	Uncertain									"HPA046556: AB_10961404"	"unprognostic (1.18e-1)"			"unprognostic (7.52e-4)"	"unprognostic (1.04e-1)"			"unprognostic (9.09e-2)"		"unprognostic (6.65e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.22e-2)"		"unprognostic (1.19e-1)"		0.1	0.8	0.1	0.1	0.3	2.1	0.8	1.5	2.0	3.5	0.8	0.0	0.0	0.0	2.0	0.7	0.6	1.7	0.5	1.1	0.6	2.3	0.1	0.0	0.3	0.0	2.5	0.0	0.1	0.3	0.0	0.5	1.8	34.9	1.1	0.0	3.9	1.6	1.3	0.1	0.3	0.3	0.5	1.5	1.9	0.1	0.2	0.1	0.0	0.9	0.2	0.0	0.6	1.6	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.9	0.0	0.0	8.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.1	0.3	1.5	2.0	0.6	2.3	2.5	0.0	34.9	0.1
MYT1	"MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A"	ENSG00000196132	"Myelin transcription factor 1"	Q01538	20	64102394-64242253	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 69.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.7;REH: 13.0;SCLC-21H: 16.2;SH-SY5Y: 4.2"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Region enriched"	"Detected in all"	13	"cerebellum: 69.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006303	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006303: AB_1079446"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.05e-7)"	"unprognostic (1.28e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.33e-3)"	"unprognostic (2.28e-2)"	"unprognostic (8.45e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.23e-1)"	0.4	7.4	4.3	0.5	5.0	2.4	0.4	69.5	11.0	0.3	0.7	2.7	0.0	0.9	0.4	0.5	0.3	0.6	0.5	0.8	4.2	5.3	0.6	0.4	0.4	0.4	3.7	2.2	0.4	4.7	0.4	3.7	0.4	5.1	0.6	0.6	3.7	0.3	0.4	0.3	0.4	0.6	0.4	2.0	0.5	1.0	2.1	4.8	0.0	1.4	0.0	0.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.6	0.0	0.0	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	1.4	0.0	0.7	0.2	13.0	0.0	0.0	0.0	0.0	16.2	4.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.3	5.0	69.5	3.1	4.2	5.3	3.7	2.2	5.1	4.8
NKAIN2	"FAM77B, TCBA1"	ENSG00000188580	"Sodium/potassium transporting ATPase interacting 2"	Q5VXU1	6	123804141-124825657	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 43.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;Daudi: 3.8;HEK 293: 6.4;HEL: 8.0;Karpas-707: 13.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	44	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045860			Approved	Cytosol				Cytosol		"HPA045860: AB_10983192"	"unprognostic (3.09e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.63e-1)"	2.2	1.6	12.9	1.1	12.1	1.9	1.3	17.3	43.2	1.4	1.7	24.9	0.0	1.1	1.2	1.6	1.4	1.4	1.3	2.6	17.5	8.8	1.3	1.2	1.3	1.3	18.1	10.9	1.2	1.0	1.0	1.1	1.2	18.0	1.4	1.3	0.5	1.1	1.3	4.8	1.1	1.5	1.5	42.9	1.1	1.0	1.6	16.1	0.0	1.2	0.5	1.3	1.5	0.2	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	6.4	8.0	0.0	0.0	0.5	0.0	0.0	1.6	0.2	0.0	0.5	0.0	0.0	13.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	12.1	17.3	15.3	17.5	8.8	18.1	10.9	18.0	16.1
NRXN1	"Hs.22998, KIAA0578"	ENSG00000179915	"Neurexin 1"	"P58400, Q9ULB1"	2	49918505-51225575	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Angiogenesis, Cell adhesion"		"Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 81.9"	"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 28.3"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 4.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071400			Supported	"Plasma membrane"	"Intracellular and membrane"		620000	"Plasma membrane"		"HPA071400: "	"unprognostic (7.01e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.74e-4)"	"unprognostic (2.46e-1)"	"unprognostic (8.95e-2)"		"unprognostic (2.02e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.37e-4)"	"unprognostic (2.85e-2)"	"unprognostic (6.68e-7)"	"unprognostic (3.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.99e-3)"	2.1	3.2	22.4	2.1	20.3	1.4	1.7	56.5	81.9	2.8	5.1	3.0	0.5	2.1	2.1	3.7	3.0	1.4	2.2	3.8	16.9	13.8	1.5	1.6	1.5	1.4	8.3	25.9	2.1	2.3	1.3	4.8	1.1	12.6	2.5	3.8	2.0	3.5	9.3	1.3	2.0	3.1	2.1	6.5	1.3	2.3	6.5	4.7	0.0	1.4	0.0	1.4	2.0	1.6	0.0	0.0	4.4	0.1	0.3	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.2	0.0	0.0	28.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	2.4	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.3	0.0	0.0	0.0	0.0	22.4	20.3	56.5	33.2	16.9	13.8	8.3	25.9	12.6	4.7
NRXN2		ENSG00000110076	"Neurexin 2"	"P58401, Q9P2S2"	11	64606174-64723188	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 101.5"	"Cell line enhanced"	"Detected in some"		"REH: 27.8;SCLC-21H: 13.9;U-2 OS: 16.2;U-87 MG: 11.4"	"Cancer enhanced"	"Detected in many"		"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 2.0;non-classical monocyte: 1.7"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.0"	"Low region specificity"	"Detected in all"																		"unprognostic (3.87e-2)"	"unprognostic (1.54e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.23e-1)"	"unprognostic (5.93e-3)"	"unprognostic (3.40e-1)"	"unprognostic (9.97e-3)"	"unprognostic (2.39e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.27e-4)"	"unprognostic (5.46e-3)"	3.4	7.5	33.3	4.1	26.3	2.5	2.3	68.8	101.5	7.3	4.6	6.5	1.0	3.1	11.7	3.3	2.5	6.4	4.4	2.9	28.8	23.5	3.8	2.4	2.5	3.0	15.2	32.8	6.3	2.5	2.2	1.3	2.8	14.0	4.5	2.7	3.5	3.2	5.6	2.5	2.2	3.0	4.7	12.4	3.5	2.4	11.6	8.7	0.0	2.9	0.0	2.5	2.4	2.5	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.2	0.0	0.2	0.2	1.5	0.0	1.9	0.0	0.0	0.2	0.2	3.8	0.0	0.0	0.0	0.0	0.3	0.7	0.0	2.7	0.0	0.0	0.0	5.4	1.8	0.0	0.4	0.2	4.6	0.0	27.8	0.8	1.1	0.0	0.0	13.9	6.4	0.0	0.0	0.0	0.0	0.0	0.2	0.7	16.2	0.3	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	33.3	26.3	68.8	41.2	28.8	23.5	15.2	32.8	14.0	8.7
OLFM3	NOE3	ENSG00000118733	"Olfactomedin 3"	Q96PB7	1	101802574-101997030	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 30.0"	"Group enriched"	"Detected in some"	11	"AF22: 9.3;HAP1: 6.4;HEL: 5.7;SCLC-21H: 3.7;SH-SY5Y: 3.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050297			Uncertain	Vesicles	"Secreted in brain"			Vesicles		"HPA050297: "			"unprognostic (4.19e-1)"	"unprognostic (4.19e-4)"	"unprognostic (1.26e-1)"				"unprognostic (4.61e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.47e-2)"			"unprognostic (3.58e-4)"	"unprognostic (2.48e-1)"	"unprognostic (5.68e-2)"		0.7	3.2	5.0	1.4	13.7	0.7	0.8	24.2	30.0	0.9	1.8	0.4	0.0	1.0	0.9	1.2	0.7	0.8	0.8	0.7	4.8	7.4	1.5	0.8	0.7	0.7	6.0	11.9	0.8	0.7	0.7	2.4	0.8	16.6	0.7	1.7	0.3	0.8	0.7	0.7	0.7	2.1	1.3	1.5	0.9	1.0	0.9	0.7	0.0	1.2	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.3	0.0	0.0	3.7	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	13.7	24.2	26.7	4.8	7.4	6.0	11.9	16.6	0.7
PCDH8	"ARCADLIN, PAPC"	ENSG00000136099	"Protocadherin 8"	O95206	13	52842889-52848641	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 20.6"	"Cell line enriched"	"Detected in some"	4	"AF22: 22.5"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010509	Uncertain		Uncertain	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA010509: AB_10601384"	"unprognostic (3.50e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.11e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.97e-2)"		"unprognostic (7.01e-2)"		"unprognostic (1.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.59e-1)"		"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.32e-1)"		0.8	0.9	11.5	1.1	18.6	0.8	0.8	0.4	20.6	0.9	1.0	1.1	0.0	0.9	1.0	0.8	0.8	0.8	0.8	0.8	18.2	4.8	0.8	0.8	0.9	0.8	3.6	8.4	0.8	0.8	0.8	1.4	0.8	0.8	1.7	0.9	0.8	0.8	0.8	1.4	0.8	1.1	0.9	0.9	0.8	1.2	2.3	2.5	0.0	1.4	0.0	0.8	0.9	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	1.6	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	18.6	0.4	20.6	18.2	4.8	3.6	8.4	0.8	2.5
PNMA2	"MA2, RGAG2"	ENSG00000240694	"PNMA family member 2"	Q9UL42	8	26504686-26514092	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 82.6"	"Cell line enhanced"	"Detected in many"		"AF22: 27.8;HAP1: 17.2;HUVEC TERT2: 16.4;NTERA-2: 15.3;SH-SY5Y: 20.0;U-87 MG: 16.1"	"Cancer enhanced"	"Detected in many"		"glioma: 28.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 3.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001936	Enhanced									"HPA001936: AB_1079647"	"unprognostic (1.25e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.43e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.76e-2)"	"prognostic favourable (1.81e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.98e-2)"	"prognostic unfavourable (6.23e-4)"	"unprognostic (5.12e-2)"	"unprognostic (4.58e-5)"	"unprognostic (9.00e-3)"	2.6	9.5	24.4	1.9	33.2	1.3	2.5	5.9	82.6	4.1	1.9	4.3	0.0	1.7	1.8	1.9	1.5	3.0	4.0	2.9	21.6	36.7	3.0	1.7	6.1	1.4	14.5	26.8	1.4	4.0	2.1	5.1	1.5	16.6	1.7	1.8	1.7	1.2	1.8	1.4	1.6	1.9	2.5	7.0	1.4	3.4	2.3	4.6	0.0	3.1	0.0	1.3	2.6	0.4	0.9	0.4	3.0	0.3	0.4	0.5	0.1	0.0	5.1	27.8	0.3	5.5	1.1	0.0	1.4	7.5	3.4	1.1	0.2	3.7	0.0	1.0	0.5	0.1	17.2	0.0	2.6	0.0	3.1	0.0	3.8	0.0	0.4	0.0	0.2	1.9	0.0	14.8	0.1	16.4	0.0	0.0	2.1	0.1	8.1	0.0	15.3	0.0	0.0	5.6	0.0	8.3	1.8	13.6	20.0	0.0	0.0	0.8	0.1	0.5	8.1	0.3	5.7	7.1	1.1	2.6	1.9	0.0	16.1	0.0	0.4	3.0	0.3	0.2	0.4	0.1	0.2	0.3	0.2	0.2	0.1	0.9	0.3	0.5	0.9	0.4	0.2	0.4	0.2	0.1	24.4	33.2	5.9	42.3	21.6	36.7	14.5	26.8	16.6	4.6
RASL10A	RRP22	ENSG00000100276	"RAS like family 10 member A"	Q92737	22	29312933-29319679	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	9	"brain: 35.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.6;NB-4: 5.6;U-2 OS: 2.5;U-266/70: 6.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"amygdala: 34.5;basal ganglia: 16.7;cerebral cortex: 33.9;hippocampal formation: 29.1"	"Region enhanced"	"Detected in many"		"cerebral cortex: 43.6"	HPA056169	Approved									"HPA056169: "	"unprognostic (1.94e-1)"	"unprognostic (2.51e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.99e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.00e-4)"	"unprognostic (2.44e-1)"	"unprognostic (7.00e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.61e-3)"	1.2	1.5	19.7	1.3	11.8	1.0	3.9	1.4	35.2	1.0	1.1	1.1	0.0	1.4	1.0	1.1	0.9	1.0	1.0	1.2	12.7	7.9	1.1	1.4	1.1	1.0	5.9	11.3	0.9	0.8	0.8	2.3	1.2	2.8	1.2	1.0	0.0	1.0	1.0	1.5	1.1	1.3	1.0	2.0	1.1	1.2	1.3	1.8	0.0	0.9	0.1	1.1	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.5	0.4	0.0	0.0	0.2	3.6	0.3	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.5	1.2	0.0	0.9	0.0	5.6	1.4	0.0	0.0	0.5	0.0	0.3	0.4	0.7	0.1	0.0	0.4	0.1	1.1	0.5	0.2	0.0	2.5	0.0	0.4	6.2	2.2	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	19.7	11.8	1.4	22.4	12.7	7.9	5.9	11.3	2.8	1.8
SCRT1	"DKFZp547F072, ZNF898"	ENSG00000261678	"Scratch family transcriptional repressor 1"	Q9BWW7	8	144330565-144336281	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 20.3"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 10.3"	"Cancer enhanced"	"Detected in single"		"glioma: 1.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045265	Uncertain		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA045265: AB_10959521"	"unprognostic (7.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.83e-4)"	"unprognostic (5.02e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.04e-1)"	0.3	2.3	2.1	0.3	6.6	0.3	0.3	5.7	20.3	0.3	0.3	0.0	0.0	0.4	0.3	0.3	0.3	0.3	0.3	0.3	2.2		0.3	0.3	0.3	0.3	0.0	3.8	0.4	0.7	0.3	0.0	0.3	4.2	0.3	0.3	0.0	0.3	0.3	0.5	0.3	0.3	0.3	0.4	0.3	0.3	1.2	2.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SEPT3	SEP3	ENSG00000100167	"Septin 3"	Q9UH03	22	41969475-41998221	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 101.6"	"Cell line enhanced"	"Detected in many"		"AF22: 13.5;SCLC-21H: 36.5"	"Cancer enhanced"	"Detected in many"		"glioma: 24.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.2;granulocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003548, CAB017633"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane,Actin filaments"				"Nucleoplasm, Plasma membrane"	"Actin filaments"	"CAB017633: AB_2301476, HPA003548: AB_1079908"	"unprognostic (2.10e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.16e-2)"	"prognostic unfavourable (1.78e-4)"	"unprognostic (4.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.67e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.15e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.04e-1)"	1.3	4.4	31.3	1.4	26.9	1.3	2.0	35.9	101.6	1.4	1.5	5.6	0.0	1.4	1.4	2.2	1.3	1.2	1.5	1.2	28.9	17.2	1.4	1.2	1.7	1.5	13.2	24.3	1.2	2.0	10.7	1.0	4.9	13.4	2.1	1.5	1.0	1.3	1.2	1.2	2.2	1.4	1.4	7.3	1.3	1.5	2.4	5.3	0.0	1.7	0.0	1.5	1.4	0.1	0.3	1.2	2.1	0.0	0.1	0.2	0.0	0.7	0.8	13.5	10.1	0.1	0.0	6.7	0.1	0.1	0.9	0.4	0.2	1.5	10.9	0.4	0.1	0.0	7.0	0.0	0.3	4.5	2.3	0.0	0.2	0.0	0.1	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.0	1.7	0.0	1.1	1.8	0.1	9.2	0.3	8.7	0.0	0.6	0.0	1.3	36.5	7.6	5.4	0.0	8.9	1.3	3.3	0.0	0.0	4.8	0.4	0.5	7.2	6.2	0.1	0.1	4.4	1.4	2.1	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.0	1.2	0.0	0.2	0.1	0.0	0.1	0.0	0.9	0.2	0.0	31.3	26.9	35.9	42.1	28.9	17.2	13.2	24.3	13.4	5.3
SHISA7		ENSG00000187902	"Shisa family member 7"	A6NL88	19	55428740-55442863	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 24.9"	"Group enriched"	"Detected in some"	5	"HEL: 6.5;HMC-1: 6.9;THP-1: 3.5"	"Cancer enriched"	"Detected in single"	9	"glioma: 2.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058935	Uncertain		Approved	Cytosol				Cytosol		"HPA058935: "	"unprognostic (3.98e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"		"unprognostic (3.08e-1)"	"unprognostic (4.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.87e-7)"	"unprognostic (7.53e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.29e-4)"	"unprognostic (4.04e-1)"	0.7	1.7	11.3	0.7	16.7	2.6	0.7	4.0	24.9	0.7	0.8	7.2	0.0	0.7	0.7	0.7	0.7	0.7	0.7	0.7	11.2	8.2	0.7	0.7	0.7	0.7	8.3	3.1	0.7	0.8	0.7	2.4	0.7	5.5	0.7	0.8	0.0	0.7	0.7	0.7	0.8	0.8	0.7	4.0	0.7	0.8	2.2	14.6	0.0	0.7	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	6.5	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	1.2	0.6	0.0	1.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	16.7	4.0	10.9	11.2	8.2	8.3	3.1	5.5	14.6
SLC32A1	"bA122O1.1, VGAT, VIAAT"	ENSG00000101438	"Solute carrier family 32 member 1"	Q9H598	20	38724462-38729372	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 38.3"	"Group enriched"	"Detected in some"	14	"MOLT-4: 5.4;SH-SY5Y: 1.6"	"Cancer enhanced"	"Detected in single"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037156, HPA058859, HPA059985"	Enhanced	Supported								"CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187"					"unprognostic (1.13e-2)"					"unprognostic (2.09e-1)"				"unprognostic (1.17e-1)"	"unprognostic (6.57e-2)"			1.0	1.1	4.6	1.0	38.3	1.5	1.0	4.9	25.8	1.0	1.0	0.8	0.0	1.0	1.0	1.0	1.0	1.1	1.0	1.0	3.9	9.7	1.0	1.0	1.0	1.0	4.4	6.8	1.0	1.1	1.0	4.1	1.0	10.4	1.0	1.0	0.7	1.0	1.0	1.0	1.0	1.1	1.0	4.4	1.0	1.0	1.6	7.9	0.0	1.0	0.0	1.0	1.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	4.6	38.3	4.9	11.9	3.9	9.7	4.4	6.8	10.4	7.9
SLC5A7	"CHT1, hCHT"	ENSG00000115665	"Solute carrier family 5 member 7"	Q9GZV3	2	107986523-108013994	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport"		"Congenital myasthenic syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	9	"brain: 45.1"	"Group enriched"	"Detected in some"	22	"RT4: 8.7;SCLC-21H: 2.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Group enriched"	"Detected in some"	13	"basal ganglia: 13.8;pons and medulla: 45.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 21.3;hypothalamus: 10.1;midbrain: 12.2;pons and medulla: 16.6;thalamus: 7.1"	"Group enriched"	"Detected in some"	15	"basal ganglia: 20.7;hippocampal formation: 7.2;pons and medulla: 26.3"	HPA046105			Approved	"Nuclear bodies,Cell Junctions,Intermediate filaments"				"Cell Junctions, Intermediate filaments"	"Nuclear bodies"	"HPA046105: "	"unprognostic (2.98e-1)"		"unprognostic (1.01e-1)"					"unprognostic (1.29e-3)"			"unprognostic (7.10e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.05e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.61e-2)"	0.3	2.4	0.1	1.6	13.8	0.0	0.3	0.1	0.4	3.3	5.2	0.1	0.3	2.3	1.6	0.7	1.0	0.2	0.5	1.2	0.2	2.2	0.9	0.2	0.9	0.0	0.3	0.5	0.8	0.5	0.0	0.1	0.0	45.1	0.8	2.5	1.0	0.9	4.2	0.1	0.1	2.5	3.1	10.0	0.1	1.7	0.3	0.8	0.0	4.0	0.3	0.1	4.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.8	0.1	0.4	0.2	2.2	0.3	0.5	45.1	0.8
SV2C		ENSG00000122012	"Synaptic vesicle glycoprotein 2C"	Q496J9	5	76083172-76353939	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 52.2"	"Group enriched"	"Detected in some"	5	"Karpas-707: 11.9;SCLC-21H: 4.9;SH-SY5Y: 11.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 52.2;pons and medulla: 26.6"	"Cell type enriched"	"Detected in single"	14	"basophil: 4.2"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040722, HPA040770"	Supported		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA040722: AB_10795624, HPA040770: AB_10805828"	"unprognostic (7.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.16e-1)"	0.5	5.5	0.8	1.3	52.2	0.7	1.2	1.2	9.5	0.7	0.8	0.5	0.0	1.0	0.7	0.9	0.6	1.8	0.6	0.8	0.6	8.3	0.4	0.4	0.4	0.5	5.6	1.9	2.6	0.8	0.9	0.8	0.4	26.6	1.0	1.1	1.1	1.7	1.2	0.3	0.7	1.3	1.0	5.8	0.6	1.6	1.0	6.7	0.0	0.5	0.0	0.4	0.6	0.4	0.1	0.1	4.2	0.2	0.1	0.2	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.3	4.9	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.2	0.2	0.8	52.2	1.2	9.5	0.6	8.3	5.6	1.9	26.6	6.7
SYT3		ENSG00000213023	"Synaptotagmin 3"	Q9BQG1	19	50621307-50639827	"Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 24.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 9.9;HMC-1: 7.0;NTERA-2: 7.2;SH-SY5Y: 8.1;U-2 OS: 5.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (5.17e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.57e-1)"	"unprognostic (6.62e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.00e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.19e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.49e-4)"	"unprognostic (1.82e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	0.9	1.8	8.7	1.0	8.8	0.7	0.8	16.1	24.2	1.0	0.9	1.0	0.0	1.0	0.9	1.1	0.9	0.9	0.8	0.7	10.9	8.9	1.2	0.8	1.1	0.9	6.7	6.6	0.7	2.1	1.0	2.2	2.3	6.3	1.2	0.8	0.3	1.4	1.7	0.8	0.8	1.0	0.9	2.4	0.8	0.8	2.7	2.2	0.0	1.3	0.0	0.9	1.0	0.0	0.0	1.3	0.1	0.0	0.0	0.7	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.1	0.0	0.1	0.4	0.0	0.0	0.1	9.9	0.0	0.0	0.0	0.4	0.0	7.0	0.3	0.0	0.0	0.0	0.2	1.2	0.0	0.0	2.9	0.0	0.0	7.2	0.0	2.4	0.0	0.1	0.0	0.0	0.1	8.1	0.4	0.0	0.2	0.2	2.3	0.0	0.0	5.1	0.0	0.0	0.8	0.1	0.0	0.3	3.6	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.0	0.0	1.3	0.0	0.1	8.7	8.8	16.1	16.3	10.9	8.9	6.7	6.6	6.3	2.2
TMEM151B	"bA444E17.5, C6orf137, TMEM193"	ENSG00000178233	"Transmembrane protein 151B"	Q8IW70	6	44270466-44307506	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 52.2"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 24.7"	"Cancer enhanced"	"Detected in single"		"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 1.0"	"Low region specificity"	"Detected in all"							HPA055167	Uncertain									"HPA055167: "	"unprognostic (1.28e-3)"	"unprognostic (6.25e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.02e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.01e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.65e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.56e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.66e-1)"	1.0	5.7	16.9	1.6	8.4	1.2	1.0	52.2	39.5	0.9	1.7	1.2	0.0	1.7	1.3	1.0	1.2	1.0	1.0	1.1	21.6	8.9	1.0	0.9	1.0	1.2	7.9	18.1	1.0	1.1	0.9	1.4	1.0	10.0	1.1	1.5	0.0	1.2	0.9	1.2	1.2	2.0	1.1	2.3	1.0	1.4	1.6	3.7	0.0	0.9	0.0	1.0	0.9	0.1	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	5.4	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	4.2	0.2	0.4	0.0	0.1	0.0	0.1	24.7	5.1	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.0	0.1	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	16.9	8.4	52.2	28.1	21.6	8.9	7.9	18.1	10.0	3.7
TPPP	"p25, p25alpha, TPPP/p25, TPPP1"	ENSG00000171368	"Tubulin polymerization promoting protein"	O94811	5	659862-693395	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 77.5"	"Cell line enhanced"	"Detected in some"		"A549: 8.4;AN3-CA: 6.2;SCLC-21H: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.5;NK-cell: 1.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036575, HPA036576"	Enhanced		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA036575: AB_10673501, HPA036576: AB_2675200"	"unprognostic (3.66e-2)"	"unprognostic (3.70e-3)"	"unprognostic (9.98e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.80e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-3)"	"unprognostic (5.48e-2)"	"prognostic favourable (5.40e-6)"	"unprognostic (4.03e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.31e-2)"	3.5	5.8	27.0	1.3	29.6	1.0	2.7	17.0	77.5	2.1	3.2	69.0	0.1	4.6	2.3	1.3	9.0	8.6	2.1	6.0	33.9	23.9	3.2	2.3	8.3	1.0	25.8	25.0	1.8	5.2	2.4	4.4	2.4	30.1	2.4	2.2	0.2	4.8	3.7	6.2	5.6	7.5	3.5	24.7	2.7	3.8	1.6	4.3	0.0	6.0	1.9	1.8	3.4	0.6	0.0	0.2	1.5	0.0	1.0	0.5	0.1	0.3	8.4	0.4	6.2	0.9	0.0	1.1	0.2	0.0	0.0	0.0	0.3	0.9	0.2	0.6	0.0	3.3	3.4	0.0	0.0	1.7	2.9	0.2	3.6	0.2	0.9	0.3	0.4	0.0	0.8	0.0	0.2	0.1	0.1	3.1	0.0	0.3	0.2	0.5	0.2	0.8	0.3	0.1	1.2	0.3	1.1	15.5	1.9	0.9	0.4	4.1	0.8	0.2	0.1	0.2	3.3	0.1	0.2	1.2	0.3	0.0	0.6	0.7	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.2	0.1	0.1	27.0	29.6	17.0	40.8	33.9	23.9	25.8	25.0	30.1	4.3
TRIM9	"RNF91, SPRING"	ENSG00000100505	"Tripartite motif containing 9"	Q9C026	14	50975262-51096061	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 61.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 19.3;HAP1: 13.7;HDLM-2: 21.0;SCLC-21H: 19.9"	"Cancer enriched"	"Detected in some"	8	"glioma: 25.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.22e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.00e-2)"	"unprognostic (7.57e-6)"	"unprognostic (1.85e-3)"	1.9	3.9	21.5	2.7	20.9	2.2	2.7	49.1	61.5	2.1	2.5	10.3	0.0	1.5	4.8	3.0	1.7	1.5	6.5	1.7	17.4	11.4	1.9	3.6	1.5	1.5	10.8	21.7	2.3	1.9	1.5	5.7	1.6	13.0	2.0	2.4	1.8	3.9	5.2	1.5	1.6	1.7	5.2	7.1	1.6	1.7	2.0	11.5	0.0	1.5	0.0	1.5	2.0	0.9	0.0	0.1	0.8	0.0	0.0	0.4	0.4	0.0	2.2	3.4	19.3	0.0	0.0	1.3	0.0	0.0	0.2	0.5	1.5	0.1	0.2	0.1	0.3	0.0	13.7	0.0	0.5	21.0	2.8	1.0	0.0	0.0	0.0	0.7	0.7	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.5	0.0	4.1	0.5	1.1	2.9	2.4	5.0	0.1	0.0	0.0	19.9	1.5	0.3	0.0	4.2	0.3	0.5	0.0	1.3	0.5	0.0	0.9	0.3	0.0	0.2	5.8	0.5	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.4	21.5	20.9	49.1	28.6	17.4	11.4	10.8	21.7	13.0	11.5
VSNL1	"HLP3, HPCAL3, HUVISL1, VILIP, VILIP-1"	ENSG00000163032	"Visinin like 1"	P62760	2	17539126-17657018	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 165.7"	"Group enriched"	"Detected in some"	5	"HaCaT: 43.2;Hep G2: 43.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053808			Approved	Cytosol				Cytosol		"HPA053808: "	"unprognostic (1.04e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (6.90e-4)"	"unprognostic (4.90e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.14e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.19e-3)"	"unprognostic (1.51e-2)"	1.4	13.6	36.5	1.7	48.8	1.2	3.9	91.6	165.7	1.8	3.0	3.3	0.0	1.3	1.7	1.2	18.0	1.9	1.3	17.5	34.8	27.9	2.0	10.5	2.4	1.2	19.9	66.1	2.8	1.7	1.2	0.2	3.4	64.0	3.0	3.6	0.1	3.2	1.5	1.7	5.2	1.3	1.6	7.1	1.3	1.7	1.5	1.4	0.0	1.5	3.1	4.1	2.3	3.4	0.1	0.7	0.2	0.1	0.1	0.5	0.1	0.2	0.0	0.5	7.8	0.9	1.3	0.0	0.0	0.0	0.0	0.2	0.1	4.7	0.0	0.0	0.0	43.2	0.3	1.5	0.0	0.0	0.2	0.0	0.0	43.6	0.0	0.0	0.1	0.3	2.3	0.0	1.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.1	3.5	3.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.6	0.0	0.0	0.1	0.4	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.5	0.1	0.2	0.1	0.1	0.7	0.0	0.1	36.5	48.8	91.6	138.6	34.8	27.9	19.9	66.1	64.0	1.4
ASIC1	"ACCN2, BNaC2, hBNaC2"	ENSG00000110881	"Acid sensing ion channel subunit 1"	P78348	12	50057548-50083611	"FDA approved drug targets, Predicted membrane proteins"	"Calcium transport, Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 43.7"	"Cell line enhanced"	"Detected in many"		"HEK 293: 16.8;SH-SY5Y: 19.4"	"Cancer enhanced"	"Detected in many"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058870			Supported	"Golgi apparatus,Plasma membrane"				"Golgi apparatus, Plasma membrane"		"HPA058870: "	"unprognostic (5.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.86e-3)"	"unprognostic (6.97e-7)"	"unprognostic (7.19e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.78e-3)"	"unprognostic (8.27e-5)"	2.5	1.7	13.9	1.8	20.3	0.8	2.9	20.1	43.7	5.3	3.1	12.8	0.3	2.3	2.5	1.2	3.4	3.6	4.0	2.2	12.3	14.3	1.6	0.9	1.3	1.3	12.9	8.5	1.4	1.4	5.2	0.5	1.5	10.2	4.5	2.5	1.8	5.6	3.4	1.3	1.5	2.5	3.6	5.4	1.1	4.3	1.4	11.0	0.4	1.1	0.0	1.0	2.6	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	2.1	4.7	6.2	14.0	1.9	2.9	3.5	1.5	4.1	2.7	2.7	3.3	1.7	1.3	3.2	0.9	2.2	6.1	5.2	1.6	1.3	16.8	4.2	6.6	2.0	2.7	6.3	15.8	7.4	2.5	0.4	0.6	0.5	2.8	0.1	2.2	2.6	6.0	12.3	2.6	8.3	6.1	5.9	2.8	1.3	0.2	9.2	19.4	3.5	1.2	2.1	7.7	4.1	0.4	2.7	9.1	1.8	0.8	0.0	0.0	0.0	3.5	5.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.3	13.9	20.3	20.1	18.3	12.3	14.3	12.9	8.5	10.2	11.0
CHRNB2		ENSG00000160716	"Cholinergic receptor nicotinic beta 2 subunit"	P17787	1	154567781-154580026	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 28.4"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 20.2;SH-SY5Y: 20.0"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.13e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.32e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.36e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.84e-1)"	0.9	3.2	7.8	1.2	16.4	1.0	1.8	8.1	28.4	0.9	1.1	1.6	0.0	1.4	1.0	0.9	1.1	1.0	0.9	0.9	9.4	8.9	0.9	0.9	0.9	0.9	7.9	9.8	1.0	2.1	0.9	3.3	0.9	15.4	0.9	1.2	3.1	1.0	0.9	0.9	1.3	1.2	1.1	1.4	0.9	1.6	2.0	1.7	0.0	0.9	0.0	0.9	0.9	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	20.2	20.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	7.8	16.4	8.1	22.1	9.4	8.9	7.9	9.8	15.4	1.7
CNIH2	"CNIH-2, Cnil, MGC50896"	ENSG00000174871	"Cornichon family AMPA receptor auxiliary protein 2"	Q6PI25	11	66278190-66285301	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	8	"brain: 74.5"	"Cell line enhanced"	"Detected in some"		"AF22: 8.9;NTERA-2: 8.3;SCLC-21H: 34.7;SH-SY5Y: 16.0"	"Cancer enhanced"	"Detected in many"		"glioma: 20.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"																		"unprognostic (1.84e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (9.18e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.25e-1)"	"unprognostic (3.80e-2)"	"unprognostic (7.66e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.95e-8)"	"unprognostic (3.53e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.55e-2)"	1.5	6.5	33.9	1.5	37.6	3.2	1.4	8.4	49.5	1.2	1.4	6.2	0.0	2.1	1.5	1.3	1.3	2.0	1.5	1.2	74.5	17.3	1.2	1.2	1.4	1.4	9.6	15.5	1.2	4.2	1.6	8.8	2.0	4.6	1.4	1.6	0.0	1.3	1.2	1.2	3.1	1.6	1.6	2.4	1.6	2.8	2.6	4.7	0.5	1.3	0.0	1.3	1.3	0.0	0.8	0.3	0.0	0.0	0.0	0.8	0.0	0.2	0.4	8.9	7.7	0.1	0.1	1.1	0.5	0.6	1.1	0.1	0.2	0.0	0.0	0.1	0.1	0.1	2.0	0.0	0.1	0.8	0.7	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.1	1.1	0.5	7.5	1.2	0.1	8.3	0.6	3.6	0.0	0.0	0.0	0.4	34.7	16.0	0.0	4.3	0.3	7.5	0.1	0.0	1.0	0.4	0.2	0.3	0.2	0.2	0.3	2.3	0.2	5.8	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.1	0.8	0.2	0.8	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	33.9	37.6	8.4	36.5	74.5	17.3	9.6	15.5	4.6	4.7
DIRAS2	"Di-Ras2, DKFZp761C07121"	ENSG00000165023	"DIRAS family GTPase 2"	Q96HU8	9	90609832-90643105	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 65.3"	"Cell line enhanced"	"Detected in some"		"AF22: 12.3;EFO-21: 3.6;SCLC-21H: 2.3"	"Cancer enhanced"	"Detected in many"		"glioma: 5.7"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.70e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.27e-5)"	"unprognostic (3.94e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.75e-3)"	"unprognostic (9.85e-3)"	"unprognostic (1.86e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.39e-1)"	"unprognostic (2.64e-3)"	"unprognostic (2.05e-1)"	0.9	2.8	6.1	0.9	24.5	1.1	1.4	64.5	65.3	8.5	1.1	2.1	0.0	2.4	1.1	1.1	0.9	1.2	4.6	0.8	13.6	5.4	1.4	1.0	0.9	1.0	4.3	23.0	0.8	1.8	3.3	0.6	1.3	3.9	0.9	0.9	2.2	2.1	1.1	0.8	1.5	2.7	0.9	6.2	1.0	1.7	1.0	0.9	0.0	2.9	0.0	0.8	0.8	0.3	1.9	1.0	1.9	1.6	1.6	0.9	0.4	0.1	1.4	12.3	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.6	0.0	0.5	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.0	0.9	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.9	0.0	0.3	0.2	0.4	0.0	0.2	2.3	0.3	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.6	0.3	0.0	0.2	0.1	0.2	0.2	0.2	0.2	1.8	1.6	1.6	0.7	0.3	0.4	0.8	0.8	0.6	0.2	1.9	0.9	0.9	1.9	1.6	0.6	1.0	0.2	0.4	6.1	24.5	64.5	41.4	13.6	5.4	4.3	23.0	3.9	0.9
DNAJC6	"KIAA0473, PARK19"	ENSG00000116675	"DnaJ heat shock protein family (Hsp40) member C6"	O75061	1	65248219-65415869	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Chaperone, Hydrolase, Protein phosphatase"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 91.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 20.9;HEL: 55.8;K-562: 21.7"	"Cancer enhanced"	"Detected in many"		"glioma: 5.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031182, HPA054917"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA031182: AB_10611957, HPA054917: "	"unprognostic (6.99e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.19e-1)"	"unprognostic (7.94e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.87e-4)"	"unprognostic (2.98e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.14e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.53e-1)"	"prognostic favourable (2.81e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.67e-3)"	2.1	12.1	18.6	2.2	28.5	5.0	2.0	24.2	91.4	2.2	2.8	26.9	0.0	2.3	1.9	1.8	1.7	2.4	2.3	9.0	25.0	26.7	8.5	1.6	2.7	1.6	28.8	23.8	1.9	3.4	2.1	7.5	8.0	40.5	2.5	3.0	2.2	1.7	2.1	1.6	2.1	2.3	2.2	28.7	3.2	2.9	3.2	21.1	0.0	3.0	0.0	1.7	1.8	0.6	0.5	0.5	0.0	0.0	0.6	1.5	0.3	3.5	0.9	0.0	1.6	0.7	0.2	8.3	7.0	11.4	11.5	11.3	0.9	0.1	3.3	0.6	2.9	0.8	5.0	1.1	9.1	20.9	2.4	55.8	1.9	0.2	0.0	1.8	1.4	1.0	0.8	1.1	4.9	0.2	21.7	0.4	2.3	0.6	0.7	0.0	2.3	0.7	0.0	1.7	0.1	8.7	0.0	13.9	9.6	4.1	5.5	1.9	2.6	0.1	2.1	1.7	1.2	0.2	2.0	2.1	1.3	1.0	4.7	1.4	2.8	0.0	0.0	0.0	1.5	0.0	0.1	0.5	0.5	0.9	0.0	0.0	0.4	0.6	0.0	0.6	0.0	0.5	0.0	0.3	18.6	28.5	24.2	37.4	25.0	26.7	28.8	23.8	40.5	21.1
GABRB2		ENSG00000145864	"Gamma-aminobutyric acid type A receptor beta2 subunit"	P47870	5	161288429-161549044	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 48.7"	"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 22.8"	"Cancer enriched"	"Detected in some"	20	"thyroid cancer: 10.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001964, HPA067632"	Enhanced									"CAB001964: , HPA067632: "	"unprognostic (5.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.26e-6)"	"unprognostic (2.33e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.24e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.04e-2)"	1.2	3.6	7.7	0.8	19.2	0.7	0.9	48.7	45.4	1.3	1.5	0.9	0.0	2.0	0.9	5.8	0.8	1.2	0.8	0.9	8.1	4.6	2.8	0.7	1.8	0.8	3.7	16.3	0.9	0.9	0.8	0.5	1.0	4.3	0.9	2.2	0.1	1.3	1.5	0.8	0.8	1.4	0.9	1.1	3.4	1.2	1.5	1.8	0.0	1.3	0.0	0.8	0.8	0.3	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.2	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.7	19.2	48.7	34.1	8.1	4.6	3.7	16.3	4.3	1.8
GBX2		ENSG00000168505	"Gastrulation brain homeobox 2"	P52951	2	236165236-236168369	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 11.9"	"Cell line enhanced"	"Detected in some"		"AF22: 31.8;BEWO: 5.5;PC-3: 9.3;TIME: 5.0"	"Group enriched"	"Detected in some"	6	"glioma: 1.7;testis cancer: 6.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 0.7;thalamus: 1.4"	"Region enhanced"	"Detected in many"		"thalamus: 6.3"	HPA067809			Approved	Nucleoplasm				Nucleoplasm		"HPA067809: "	"unprognostic (5.30e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.55e-4)"	"unprognostic (8.69e-7)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.39e-4)"	0.1	0.1	0.3	0.4	5.8	0.1	0.1	11.9	3.6	0.1	0.2	4.2	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.4	0.6	3.8	0.2	0.3	0.1	0.1	1.2	0.3	0.1	0.1	0.1	0.2	1.4	6.3	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.2	0.3	4.6	0.1	0.1	1.3	2.8	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	31.8	1.2	0.0	0.0	5.5	0.4	0.0	0.8	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.2	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.1	0.0	0.4	0.7	0.0	0.2	0.8	9.3	0.0	3.4	0.0	0.3	0.0	0.4	0.2	1.0	0.0	0.3	0.0	0.0	5.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.8	11.9	0.0	0.6	3.8	1.2	0.3	6.3	2.8
GSX1	"Gsh-1, GSH1"	ENSG00000169840	"GS homeobox 1"	Q9H4S2	13	27792643-27794768	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	8	"brain: 7.1"	"Cell line enhanced"	"Detected in some"		"AF22: 1.0;THP-1: 1.5"	"Cancer enriched"	"Detected in single"	29	"glioma: 3.9"	"Region enhanced"	"Detected in many"		"hypothalamus: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"																		"unprognostic (1.62e-1)"													0.1	0.1	1.6	0.1	3.2	0.1	0.1	0.9	4.0	0.1	0.1	2.5	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.7	7.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.9	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.2	0.9	1.5	0.7	7.1	0.2	0.0	0.1	0.0
HPCAL4	"DKFZp761G122, HLP4"	ENSG00000116983	"Hippocalcin like 4"	Q9UM19	1	39678648-39691689	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 80.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.9;SH-SY5Y: 13.1;SK-MEL-30: 4.1;U-2 OS: 2.8;U-266/70: 3.4;U-266/84: 4.2"	"Group enriched"	"Detected in some"	11	"glioma: 5.4;thyroid cancer: 4.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 5.6;naive CD4 T-cell: 5.0"	"Lineage enriched"	"Detected in single"	33	"T-cells: 5.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 336.7;basal ganglia: 201.9;cerebral cortex: 348.1;hippocampal formation: 324.0;olfactory region: 266.4"	HPA053808			Approved	Cytosol				Cytosol		"HPA053808: "	"unprognostic (2.62e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.56e-4)"	"unprognostic (4.73e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.78e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.63e-1)"	1.2	10.2	35.8	1.8	46.0	1.5	1.2	31.1	80.4	1.2	1.2	3.7	0.0	1.3	1.2	1.5	5.5	1.2	1.3	1.4	28.3	17.0	3.5	1.2	1.7	1.9	7.5	32.7	3.7	4.7	1.2	0.4	1.2	6.8	1.4	1.3	0.0	1.2	1.3	2.1	1.2	1.3	1.2	4.4	1.4	1.3	4.1	3.0	0.0	1.2	0.0	1.8	1.3	0.0	0.0	0.1	0.0	0.0	0.0	5.6	1.8	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.0	0.3	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.6	0.0	1.2	13.1	0.4	0.0	4.1	0.0	0.1	0.0	0.0	2.8	0.0	0.0	3.4	4.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.4	0.0	5.6	1.0	0.1	0.0	5.0	1.8	0.0	0.0	0.0	0.0	3.8	1.8	35.8	46.0	31.1	40.4	28.3	17.0	7.5	32.7	6.8	3.0
KCNH1	"eag, eag1, h-eag, Kv10.1"	ENSG00000143473	"Potassium voltage-gated channel subfamily H member 1"	O95259	1	210676823-211134180	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 20.2"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 4.2;RH-30: 7.1;RPTEC TERT1: 4.1;SH-SY5Y: 9.0;SK-MEL-30: 8.5;T-47d: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA014551, HPA019445"	Enhanced		Supported	Vesicles				Vesicles		"HPA014551: , HPA019445: AB_1852118"	"unprognostic (9.12e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.70e-2)"	0.9	2.3	6.3	1.3	13.3	0.7	0.6	19.1	20.2	1.0	1.3	3.3	0.2	1.2	1.5	1.0	0.9	1.2	1.0	0.7	3.8	1.7	1.0	0.7	0.7	0.7	1.1	7.5	0.8	0.9	0.9	0.8	1.1	1.7	1.3	1.3	0.0	0.8	0.9	0.7	0.9	1.0	1.0	2.1	0.6	1.5	2.4	1.5	0.0	0.8	0.0	0.7	0.9	0.7	0.1	0.7	0.7	0.1	0.1	0.3	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.1	0.6	0.1	1.4	1.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.1	0.0	0.0	7.1	0.0	4.1	0.0	0.3	9.0	1.6	0.1	8.5	6.3	0.0	0.0	1.1	0.1	1.3	0.8	0.0	0.0	0.0	0.2	0.0	0.5	0.7	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.7	0.1	0.0	6.3	13.3	19.1	20.2	3.8	1.7	1.1	7.5	1.7	1.5
KLHL1	"FLJ30047, KIAA1490, MRP2"	ENSG00000150361	"Kelch like family member 1"	Q9NR64	13	69700594-70108493	"Predicted intracellular proteins"		Actin-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"brain: 17.6"	"Cell line enriched"	"Detected in single"	14	"HeLa: 7.2"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021196	Uncertain									"HPA021196: AB_1852567"					"unprognostic (5.81e-2)"					"unprognostic (7.40e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.41e-1)"						0.3	1.4	2.0	0.5	5.0	0.3	0.3	3.5	6.9	0.3	0.5	0.0	0.0	0.4	0.3	0.3	0.4	0.3	0.3	0.3	1.8	7.6	0.8	0.3	0.3	0.3	17.6	2.3	0.3	0.7	0.5	1.9	0.3	16.2	2.1	0.4	1.0	0.3	0.4	0.3	0.3	0.6	0.4	5.3	0.3	0.7	1.5	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	5.0	3.5	4.2	1.8	7.6	17.6	2.3	16.2	0.0
LHFPL3	LHFPL4	ENSG00000187416	"LHFPL tetraspan subfamily member 3"	Q86UP9	7	104328656-104907232	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"brain: 36.5"	"Cell line enhanced"	"Detected in some"		"K-562: 2.2;SCLC-21H: 4.0;SH-SY5Y: 5.3;SK-BR-3: 4.5;SK-MEL-30: 2.3"	"Cancer enriched"	"Detected in some"	12	"glioma: 27.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069691			Approved	Vesicles				Vesicles		"HPA069691: "		"unprognostic (1.20e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.59e-3)"	"unprognostic (5.03e-2)"			"unprognostic (2.27e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.96e-2)"	"unprognostic (5.81e-2)"	"unprognostic (5.99e-3)"	"unprognostic (8.50e-3)"	"unprognostic (3.07e-1)"		"unprognostic (1.33e-1)"	0.5	0.6	6.4	0.6	7.7	0.5	0.5	2.3	36.5	4.3	0.8	6.1	0.0	2.0	0.7	0.5	0.5	0.9	0.5	0.5	4.9	5.6	1.4	0.5	2.2	0.5	4.8	4.2	0.7	1.5	0.5	0.1	0.5	5.6	0.7	0.6	3.8	0.5	0.5	0.5	0.7	1.4	0.5	6.0	0.9	0.8	0.7	6.7	0.0	0.5	0.0	0.6	0.5	0.2	0.5	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	4.0	5.3	0.0	4.5	2.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	7.7	2.3	7.1	4.9	5.6	4.8	4.2	5.6	6.7
MAP2	"MAP2A, MAP2B, MAP2C"	ENSG00000078018	"Microtubule associated protein 2"	P11137	2	209424058-209734118	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 122.3"	"Cell line enhanced"	"Detected in some"		"AF22: 74.6;NTERA-2: 26.7;SCLC-21H: 37.5;SH-SY5Y: 21.0"	"Cancer enhanced"	"Detected in many"		"glioma: 30.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 2.6;naive B-cell: 3.4"	"Lineage enriched"	"Detected in single"	15	"B-cells: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001984, HPA008273, HPA012828"	Enhanced	Supported								"CAB001984: , HPA008273: AB_1853945, HPA012828: AB_1853946"	"unprognostic (2.47e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.58e-2)"	"prognostic unfavourable (1.98e-6)"	"unprognostic (2.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.10e-5)"	4.6	9.2	62.1	2.1	63.1	1.5	4.9	24.7	122.3	4.4	2.5	3.8	0.0	2.0	2.9	4.0	5.6	2.8	6.3	6.2	73.6	53.8	3.9	3.7	9.3	2.4	31.0	48.8	6.4	8.2	12.5	14.7	1.9	35.4	6.5	2.5	7.6	4.9	4.7	2.2	12.1	2.0	3.2	19.9	2.4	2.6	5.4	11.4	0.0	12.2	0.4	2.9	2.8	1.5	3.4	0.1	0.0	0.0	0.0	0.2	0.3	0.6	0.1	74.6	0.0	1.0	0.5	0.0	0.4	0.5	0.1	0.5	0.0	4.0	0.0	0.4	0.9	1.0	5.7	0.4	0.2	0.0	0.3	0.2	2.3	0.0	9.4	0.0	0.0	0.8	2.4	0.0	1.4	1.9	0.0	0.7	0.0	0.2	0.0	0.0	26.7	0.1	0.0	0.1	0.0	0.9	0.0	37.5	21.0	1.5	0.2	0.9	2.0	0.0	0.0	0.0	0.4	0.0	1.0	0.5	0.0	0.0	3.9	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	62.1	63.1	24.7	79.6	73.6	53.8	31.0	48.8	35.4	11.4
NPTX1		ENSG00000171246	"Neuronal pentraxin 1"	Q15818	17	80467148-80477843	"Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 68.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 12.1;HeLa: 9.5;SiHa: 15.4;U-138 MG: 33.0;WM-115: 45.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 74.8;cerebellum: 228.3;cerebral cortex: 119.6;hippocampal formation: 173.6"	HPA077062	Enhanced				"Secreted in brain"		1000000			"HPA077062: "	"unprognostic (2.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.05e-6)"	"unprognostic (1.41e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.86e-6)"	"unprognostic (2.71e-3)"	1.0	3.4	28.8	1.4	14.7	0.8	1.1	68.9	62.5	0.8	9.1	0.2	0.0	1.3	1.3	2.5	1.4	1.4	1.7	0.7	15.5	3.0	0.8	0.7	1.0	1.4	1.0	18.2	0.7	0.7	0.7	0.8	1.6	4.6	1.3	2.5	0.6	0.7	2.9	1.0	3.2	1.5	1.4	1.9	2.3	1.5	1.3	0.0	0.9	0.7	0.0	0.7	0.9	0.2	0.0	0.0	0.0	0.0	1.5	0.3	0.1	0.0	0.7	0.2	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	12.1	0.0	0.0	0.0	7.5	0.0	9.5	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.5	0.0	0.0	3.1	0.0	0.0	8.2	0.0	15.4	0.0	0.0	0.0	0.2	0.1	33.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	45.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	28.8	14.7	68.9	29.9	15.5	3.0	1.0	18.2	4.6	0.0
OTOL1	"C1QTNF15, C1QTNF16"	ENSG00000182447	"Otolin 1"	A6NHN0	3	161496808-161503942	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	8	"brain: 3.7"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	HPA041030	Uncertain				"Secreted in other tissues"					"HPA041030: AB_10795000"																		0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.0	0.0	0.1		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PCDHGC4	PCDH-GAMMA-C4	ENSG00000242419	"Protocadherin gamma subfamily C, 4"	Q9Y5F7	5	141484997-141512979	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 23.6"	"Cell line enhanced"	"Detected in some"		"REH: 9.7;SCLC-21H: 8.2;SH-SY5Y: 15.9"	"Cancer enriched"	"Detected in single"	10	"glioma: 4.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (6.05e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.73e-3)"	"unprognostic (2.20e-4)"	"unprognostic (8.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.75e-2)"	0.7	2.9	5.7	0.7	9.5	0.5	0.8	23.6	21.9	1.0	1.1	2.3	0.0	0.6	0.9	1.2	0.8	1.0	1.0	1.3	4.1	10.1	0.6	0.6	1.0	0.9	3.3	4.5	0.8	1.2	0.8	1.3	0.8	8.6	0.8	0.8	1.9	1.0	0.7	1.2	1.5	0.7	0.9	2.3	0.8	0.7	1.5	0.8	0.0	0.7	0.0	1.0	0.6	0.2	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.2	0.2	0.8	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.3	0.9	0.9	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.0	1.5	0.0	9.7	0.6	0.0	0.0	0.1	8.2	15.9	0.1	0.0	0.2	0.1	0.3	0.1	0.9	0.1	0.2	0.7	0.2	0.0	0.2	0.6	0.1	2.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	9.5	23.6	15.6	4.1	10.1	3.3	4.5	8.6	0.8
PRMT8	"HRMT1L3, HRMT1L4"	ENSG00000111218	"Protein arginine methyltransferase 8"	Q9NR22	12	3381349-3593973	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 24.8"	"Cell line enriched"	"Detected in some"	10	"hTERT-HME1: 32.9"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039747, HPA069769"	Enhanced									"HPA039747: AB_10697554, HPA069769: "	"unprognostic (3.09e-1)"	"unprognostic (9.47e-2)"	"unprognostic (5.59e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.80e-3)"	"unprognostic (9.41e-2)"		"unprognostic (3.41e-5)"	"unprognostic (5.99e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.02e-2)"	"unprognostic (5.49e-2)"	0.6	0.6	4.6	0.6	18.3	0.6	0.7	8.7	24.8	0.8	0.7	0.2	0.1	0.7	0.7	0.6	0.6	3.1	0.6	2.3	4.0	2.1	1.2	0.6	2.2	0.6	3.5	10.0	0.7	1.8	0.6	0.0	0.6	1.4	0.6	0.7	0.0	0.6	0.7	0.6	0.6	0.6	0.6	0.4	0.6	0.7	3.0	1.8	1.0	0.6	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	32.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	18.3	8.7	14.6	4.0	2.1	3.5	10.0	1.4	1.8
RTN1	NSP	ENSG00000139970	"Reticulon 1"	Q16799	14	59595976-59870966	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 144.6"	"Group enriched"	"Detected in some"	4	"HEL: 22.7;SCLC-21H: 28.1;SH-SY5Y: 45.0"	"Cancer enhanced"	"Detected in many"		"glioma: 19.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 4.5;intermediate monocyte: 4.6;myeloid DC: 7.9"	"Group enriched"	"Detected in many"	15	"dendritic cells: 7.9;monocytes: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002745, HPA040945, HPA044249"	Enhanced		Supported	"Nuclear bodies,Endoplasmic reticulum"			140000	"Endoplasmic reticulum"	"Nuclear bodies"	"CAB002745: , HPA040945: , HPA044249: "	"unprognostic (9.40e-3)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-1)"	"prognostic favourable (3.69e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.62e-2)"	6.3	8.3	27.4	6.1	46.3	1.6	3.0	98.5	144.6	2.6	2.9	11.0	0.0	2.7	2.1	1.6	2.3	8.6	4.4	1.9	32.3	50.7	2.3	1.9	4.8	2.7	21.3	45.9	1.7	3.6	19.2	10.3	2.7	35.1	5.0	3.0	1.2	2.3	2.6	1.6	2.3	3.4	2.7	12.1	10.6	3.6	2.6	10.5	0.0	2.7	0.0	2.3	2.5	0.9	0.0	7.9	0.4	4.6	0.0	0.0	1.0	0.0	0.0	0.3	0.3	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.8	22.7	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	28.1	45.0	5.5	0.0	0.0	0.0	0.0	0.0	3.8	1.1	0.0	2.0	0.0	0.0	0.0	7.5	1.6	0.2	0.0	4.5	0.0	0.0	4.6	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	1.0	27.4	46.3	98.5	94.7	32.3	50.7	21.3	45.9	35.1	10.5
SCN2A	"HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2"	ENSG00000136531	"Sodium voltage-gated channel alpha subunit 2"	Q99250	2	165194993-165392310	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 68.0"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.3;SH-SY5Y: 3.1;U-138 MG: 5.7;U-266/84: 11.8;U-87 MG: 3.5"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022567	Enhanced									"CAB022567: "	"unprognostic (1.16e-1)"	"unprognostic (3.56e-4)"	"unprognostic (5.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.97e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.14e-1)"	1.3	3.0	19.1	1.3	36.4	1.1	2.2	68.0	50.3	1.5	1.3	1.1	0.0	1.5	1.9	2.6	1.2	1.3	2.3	1.3	30.3	8.2	4.0	1.4	1.5	1.2	3.8	23.5	1.5	1.3	1.1	8.2	1.3	9.9	1.3	1.3	0.0	1.5	1.8	1.1	1.2	1.5	2.0	3.7	1.3	1.5	1.5	4.1	0.0	1.1	0.0	1.2	1.3	0.5	1.4	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.7	0.0	0.0	2.7	0.0	2.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.1	1.0	0.7	0.0	0.4	0.0	0.4	0.0	0.2	3.3	0.1	0.3	0.0	0.0	0.0	0.3	1.5	0.0	0.2	0.0	2.0	0.2	0.0	0.0	0.0	0.1	0.1	2.8	3.1	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.4	0.3	0.0	0.5	11.8	0.0	3.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	19.1	36.4	68.0	43.7	30.3	8.2	3.8	23.5	9.9	4.1
SLC1A2	"EAAT2, GLT-1"	ENSG00000110436	"Solute carrier family 1 member 2"	P43004	11	35251205-35420063	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 160.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.4;BJ hTERT+: 4.8;fHDF/TERT166: 3.4;Hep G2: 5.6;NTERA-2: 6.2;SCLC-21H: 3.2"	"Cancer enriched"	"Detected in some"	5	"glioma: 28.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002574, HPA009172"	Enhanced									"CAB002574: AB_564087, HPA009172: AB_1849764"	"unprognostic (8.00e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.33e-4)"	"unprognostic (6.34e-2)"	"unprognostic (8.06e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.49e-2)"	1.7	4.1	65.1	1.9	79.4	1.8	3.7	7.2	160.9	2.0	1.7	9.8	0.0	1.8	2.1	1.8	1.7	1.7	1.7	2.1	47.6	11.7	1.7	20.5	1.9	2.5	15.2	43.1	1.6	4.2	1.6	0.4	2.1	27.6	1.7	1.7	0.0	3.9	1.7	1.7	2.3	1.6	1.8	17.2	1.8	2.6	2.4	16.3	0.0	1.7	0.0	2.4	1.7	0.3	1.1	0.7	3.9	0.7	1.2	0.9	0.4	0.0	0.2	1.1	0.1	0.5	4.4	0.0	1.0	4.8	0.2	0.2	0.2	0.0	0.1	0.1	3.4	0.3	0.0	0.0	0.4	0.0	0.0	0.4	0.5	5.6	0.2	0.6	0.2	0.9	0.0	0.4	0.0	0.0	0.0	0.4	0.1	2.1	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.5	0.0	2.3	0.0	1.1	0.0	0.6	0.2	0.2	0.5	0.1	0.6	0.0	0.0	1.1	0.0	0.3	3.9	0.7	0.8	0.5	0.3	0.3	0.4	0.5	0.4	0.7	1.1	0.9	0.7	2.1	1.2	0.4	0.6	0.4	0.4	65.1	79.4	7.2	64.9	47.6	11.7	15.2	43.1	27.6	16.3
SLC35F1	"C6orf169, dJ230I3.1"	ENSG00000196376	"Solute carrier family 35 member F1"	Q5T1Q4	6	117907526-118317676	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 41.9"	"Group enriched"	"Detected in some"	9	"AF22: 23.3;WM-115: 39.2"	"Group enriched"	"Detected in some"	16	"glioma: 15.1;melanoma: 3.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019576	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"				Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA019576: AB_2190216"	"unprognostic (1.46e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.44e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.83e-4)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.02e-1)"	2.8	2.7	13.8	2.1	14.5	0.9	1.2	3.6	41.9	1.7	3.5	4.3	0.0	1.6	2.7	5.5	1.8	1.5	1.8	5.3	10.4	10.2	1.7	1.0	1.1	1.0	9.3	15.3	1.4	1.4	1.0	0.6	1.0	5.6	2.3	2.3	2.6	1.7	2.9	1.2	1.6	1.8	2.6	4.1	1.6	1.4	1.8	5.6	0.0	1.8	0.0	1.0	1.4	2.6	0.2	0.6	1.0	0.1	0.3	0.9	0.1	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	2.9	3.3	0.0	0.0	0.1	0.0	39.2	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	1.0	0.3	0.0	0.6	0.0	0.1	13.8	14.5	3.6	17.4	10.4	10.2	9.3	15.3	5.6	5.6
SNAP91	"AP180, CALM, KIAA0656"	ENSG00000065609	"Synaptosome associated protein 91"	O60641	6	83552880-83709691	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 81.9"	"Group enriched"	"Detected in some"	13	"SCLC-21H: 21.3;SH-SY5Y: 13.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 6.3"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009745, HPA029632, HPA029633"	Enhanced		Uncertain	Centrosome,Cytosol				"Centrosome, Cytosol"		"CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615"	"unprognostic (1.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.55e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.42e-1)"		"unprognostic (2.56e-2)"		"unprognostic (1.17e-1)"	"unprognostic (4.54e-4)"	"unprognostic (6.99e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	1.2	8.0	17.8	1.9	25.5	1.1	1.7	44.2	81.9	2.1	1.7	3.4	0.0	1.4	1.7	1.2	1.3	1.8	2.0	1.3	19.2	19.9	1.2	1.1	1.4	3.3	14.3	20.5	3.1	2.4	1.1	9.3	1.6	34.7	3.9	1.7	4.5	1.6	1.7	1.2	1.3	1.7	1.8	7.0	2.2	1.9	10.8	2.9	0.0	2.0	0.0	2.7	1.3	0.2	0.0	6.3	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.3	1.2	0.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.1	0.1	0.2	21.3	13.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.1	17.8	25.5	44.2	43.6	19.2	19.9	14.3	20.5	34.7	2.9
ST18	"KIAA0535, NZF3, ZC2H2C3, ZC2HC10, ZNF387"	ENSG00000147488	"ST18, C2H2C-type zinc finger"	O60284	8	52110839-52460959	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 47.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.0;SCLC-21H: 14.3;U-87 MG: 2.3"	"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 0.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"myeloid DC: 1.7"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 1.7"	"Region enhanced"	"Detected in many"		"cerebellum: 45.1"	"Low region specificity"	"Detected in all"			HPA044919	Uncertain									"HPA044919: AB_10959756"	"unprognostic (3.66e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.53e-5)"	"unprognostic (3.29e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.84e-3)"	1.0	3.4	7.6	1.2	40.5	1.0	0.9	27.8	20.8	1.1	1.4	31.1	0.0	2.3	0.9	0.9	1.0	0.9	1.4	0.9	11.0	5.8	1.9	1.0	1.2	1.0	47.8	8.8	0.9	6.1	0.9	3.1	1.2	23.8	1.3	1.8	0.0	0.9	0.9	0.9	0.9	2.2	0.9	38.0	1.0	5.2	1.7	41.6	0.0	1.0	0.0	1.2	1.1	0.2	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	40.5	27.8	19.7	11.0	5.8	47.8	8.8	23.8	41.6
SYNPR	"MGC26651, SPO"	ENSG00000163630	Synaptoporin	Q8TBG9	3	63228315-63616921	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 99.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;SCLC-21H: 4.6;SH-SY5Y: 1.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Region enhanced"	"Detected in all"		"basal ganglia: 99.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051368, HPA061671"	Enhanced									"HPA051368: AB_2681456, HPA061671: AB_2684582"			"unprognostic (1.69e-1)"		"unprognostic (3.77e-2)"			"unprognostic (3.14e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.50e-1)"		"unprognostic (5.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.89e-1)"		1.1	1.5	13.3	1.3	99.9	1.1	1.1	26.9	58.4	1.2	1.2	1.5	0.0	1.4	1.1	1.2	1.1	1.2	1.2	6.1	20.4	7.6	1.2	1.1	1.1	1.1	4.6	14.4	1.1	1.3	1.1	0.1	1.1	4.3	1.1	1.2	11.9	1.8	1.2	1.1	1.1	1.2	1.2	2.2	1.1	1.8	1.1	4.6	0.0	1.2	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	4.6	1.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	99.9	26.9	31.2	20.4	7.6	4.6	14.4	4.3	4.6
SYP	MRX96	ENSG00000102003	Synaptophysin	P08247	X	49187804-49200259	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 179.2"	"Cell line enhanced"	"Detected in some"		"K-562: 8.5;SCLC-21H: 45.7;SH-SY5Y: 16.5"	"Group enriched"	"Detected in many"	6	"glioma: 12.8;pancreatic cancer: 5.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000076, HPA002858, CAB055505, CAB078999"	Enhanced	Supported								"CAB000076: AB_2315411, CAB055505: AB_564017, CAB078999: , HPA002858: AB_1080153"	"unprognostic (2.08e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.37e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.46e-5)"	"unprognostic (8.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.44e-3)"	"unprognostic (8.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.94e-1)"	2.7	21.4	34.5	3.2	42.5	1.9	1.9	53.8	179.2	2.0	3.6	7.2	0.0	7.4	2.2	2.6	2.2	2.0	2.0	2.3	44.4	45.3	2.7	1.8	2.8	2.0	25.5	39.0	2.1	5.2	1.9	17.4	2.0	46.7	2.1	3.5	11.5	2.0	2.1	2.4	2.3	8.1	2.5	15.5	2.4	3.9	2.0	4.0	0.0	2.1	0.0	1.9	1.8	0.2	1.3	1.6	5.3	0.8	0.5	0.7	0.1	0.4	1.7	1.3	2.6	1.4	0.2	0.2	0.1	0.0	0.3	0.3	1.5	0.9	1.3	0.2	0.0	1.3	1.3	0.1	0.3	2.7	1.5	2.1	0.5	0.5	0.0	0.2	4.7	0.2	0.0	0.2	0.3	0.1	8.5	3.3	0.3	0.5	0.7	0.1	4.2	0.3	0.3	0.2	0.6	0.1	0.2	45.7	16.5	0.5	0.2	0.6	0.8	0.8	0.2	0.3	1.4	0.4	0.2	0.2	2.8	0.3	0.7	0.5	1.4	1.7	0.8	0.4	0.2	0.7	0.4	0.7	0.5	0.7	0.4	1.3	0.5	0.5	5.3	0.5	0.4	1.6	0.3	0.1	34.5	42.5	53.8	84.8	44.4	45.3	25.5	39.0	46.7	4.0
AC091980.2		ENSG00000275038			5	171305981-171308755	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	7	"brain: 3.4"	"Group enriched"	"Detected in some"	20	"HeLa: 3.3;RH-30: 1.4;SH-SY5Y: 5.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (5.98e-2)"																0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ADGRB1	BAI1	ENSG00000181790	"Adhesion G protein-coupled receptor B1"	O14514	8	142449430-142545009	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity, Myogenesis, Neurogenesis, Phagocytosis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 27.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.5;MCF7: 4.2;NB-4: 5.6;RPMI-8226: 15.9;U-2 OS: 10.9"	"Cancer enhanced"	"Detected in many"		"glioma: 11.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"						"unprognostic (9.57e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.87e-3)"	"unprognostic (8.50e-3)"	"unprognostic (9.98e-2)"	"unprognostic (5.87e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.30e-11)"	"unprognostic (6.27e-2)"	"unprognostic (7.42e-2)"	"unprognostic (4.52e-3)"	"unprognostic (3.29e-2)"	1.0	3.4	13.6	1.4	18.1	0.9	1.1	5.4	27.4	2.0	1.0	3.1	0.1	1.4	1.8	2.3	0.9	1.4	0.9	0.9	11.0	11.9	1.1	0.8	1.2	1.6	8.7	9.2	1.6	1.1	0.9	2.7	2.5	9.1	1.3	0.9	0.9	2.6	1.9	0.7	3.1	1.4	1.0	2.3	3.7	1.5	2.1	3.2	0.0	0.9	0.0	1.0	0.9	0.4	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	5.6	1.8	0.0	0.1	0.0	15.9	0.0	0.0	3.1	3.1	0.0	0.0	0.2	0.1	0.3	0.0	0.1	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	18.1	5.4	19.5	11.0	11.9	8.7	9.2	9.1	3.2
AK5		ENSG00000154027	"Adenylate kinase 5"	Q9Y6K8	1	77282051-77559969	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 95.5"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.7;BJ: 20.3;fHDF/TERT166: 23.1;LHCN-M2: 58.2;U-2 OS: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 10.9;naive CD4 T-cell: 14.2"	"Group enriched"	"Detected in many"	15	"dendritic cells: 10.9;T-cells: 14.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019128, HPA057255"	Enhanced		Supported	"Centriolar satellite,Cytosol"				Cytosol	"Centriolar satellite"	"HPA019128: AB_1844682, HPA057255: "	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.91e-2)"	"prognostic favourable (3.88e-4)"	"unprognostic (3.56e-3)"	"unprognostic (6.17e-4)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-2)"	"unprognostic (6.76e-2)"	1.8	2.1	43.8	1.9	35.7	3.7	14.1	1.3	95.5	2.0	1.8	20.4	0.0	1.8	1.6	1.5	1.8	1.8	1.7	1.5	35.8	11.8	2.0	1.2	1.4	2.5	13.0	41.1	1.5	2.1	2.4	1.4	1.8	11.4	2.7	1.8	0.0	3.1	2.7	1.3	2.4	1.7	1.7	14.2	2.4	2.9	7.3	13.9	0.0	1.7	0.0	2.1	1.5	0.4	0.8	10.9	0.7	0.7	0.1	14.2	1.9	0.0	1.1	0.8	0.0	10.9	29.7	0.4	20.3	4.3	3.3	1.4	0.1	0.5	0.1	0.1	23.1	0.1	0.0	0.0	1.7	0.7	0.2	0.1	0.1	0.0	0.5	0.1	0.0	3.6	0.1	0.6	1.3	9.5	0.2	0.2	58.2	0.2	0.0	0.1	1.1	7.4	0.5	2.1	0.3	9.0	0.3	4.5	1.1	0.0	0.0	1.2	0.1	0.1	2.3	8.0	18.2	0.4	0.6	4.7	4.2	0.0	1.6	1.0	2.9	0.7	0.7	0.0	3.4	0.1	0.5	0.8	3.2	1.6	10.9	0.8	14.2	7.8	0.5	0.1	0.2	1.2	1.4	1.9	43.8	35.7	1.3	47.1	35.8	11.8	13.0	41.1	11.4	13.9
ATCAY	BNIP-H	ENSG00000167654	"ATCAY, caytaxin"	Q86WG3	19	3879864-3928079	"Disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 70.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 8.1;SCLC-21H: 15.0;SH-SY5Y: 10.6"	"Cancer enriched"	"Detected in some"	8	"glioma: 15.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017755	Enhanced									"HPA017755: "	"unprognostic (7.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.83e-4)"	"unprognostic (7.22e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.67e-1)"	1.3	8.2	19.6	1.8	19.8	1.5	1.3	14.1	70.1	1.8	1.5	3.4	0.1	1.7	1.3	1.3	1.4	1.2	1.4	1.3	16.9	25.5	1.3	1.3	1.3	1.4	12.2	21.4	1.3	1.5	1.2	10.1	1.3	16.0	3.1	1.6	1.1	1.3	4.6	2.3	1.6	1.8	1.4	4.3	1.3	1.6	1.4	4.2	0.0	1.4	0.0	1.2	1.4	0.3	1.4	0.8	3.2	0.7	1.7	0.8	0.6	0.5	0.1	3.1	0.3	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.2	0.7	0.5	0.2	0.0	0.5	0.2	0.0	0.0	0.2	0.3	0.9	1.1	0.2	0.0	1.1	1.3	0.0	0.0	0.0	0.1	0.0	0.5	0.6	0.1	0.2	0.2	0.4	8.1	0.1	0.3	0.5	0.3	0.1	0.2	15.0	10.6	0.2	0.2	0.1	0.2	0.3	0.5	0.5	0.7	0.5	0.7	0.4	0.3	0.3	0.4	1.5	0.2	2.2	0.7	0.9	0.6	0.5	0.5	0.6	0.7	0.6	0.3	1.4	0.8	0.8	3.2	1.7	0.4	0.8	0.5	0.6	19.6	19.8	14.1	33.0	16.9	25.5	12.2	21.4	16.0	4.2
CACNA1E	"BII, CACH6, CACNL1A6, Cav2.3"	ENSG00000198216	"Calcium voltage-gated channel subunit alpha1 E"	Q15878	1	181317690-181808084	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 30.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.0;NB-4: 2.5;NTERA-2: 2.9;SCLC-21H: 2.3;U-266/70: 7.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042515, CAB079032"		Approved	Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane"	"Actin filaments, Cytosol"	"CAB079032: , HPA042515: "	"unprognostic (3.96e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.54e-5)"	"unprognostic (6.56e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-7)"	"unprognostic (1.74e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.75e-2)"	0.6	3.0	17.9	2.1	19.7	3.1	0.5	3.9	22.5	0.6	0.8	1.3	0.0	0.6	0.6	4.4	1.1	2.3	0.6	0.6	30.8	5.8	3.8	0.6	0.6	1.4	2.4	10.6	0.5	0.6	0.5	0.2	0.8	4.2	0.5	0.8	0.5	0.5	0.5	0.6	0.5	1.1	1.0	5.2	0.9	0.8	2.8	2.4	0.0	0.6	0.0	1.0	0.6	0.1	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.9	0.0	0.0	0.0	1.0	1.3	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	7.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	17.9	19.7	3.9	22.5	30.8	5.8	2.4	10.6	4.2	2.4
CBLN1		ENSG00000102924	"Cerebellin 1 precursor"	P23435	16	49277917-49281831	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 106.6"	"Group enriched"	"Detected in some"	28	"NTERA-2: 16.3;SCLC-21H: 51.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.5"	"Region enriched"	"Detected in many"	12	"cerebellum: 106.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"cerebellum: 688.3"	"Region enriched"	"Detected in many"	15	"cerebellum: 300.1"						"Secreted in brain"		2900000				"unprognostic (1.39e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.18e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.06e-2)"	"prognostic favourable (7.10e-4)"	"unprognostic (1.60e-2)"	9.9	0.8	0.9	0.1	1.0	0.0	1.2	106.6	4.9	2.0	0.4	0.4	0.4	0.6	5.9	1.4	0.8	0.9	9.0	4.2	0.7	9.2	0.2	0.7	0.1	0.9	4.5	1.0	0.5	2.4	0.0	0.9	0.4	4.6	0.3	0.4	1.1	0.7	3.0	0.5	0.3	0.5	1.5	2.3	0.1	0.5	16.0	0.4	0.2	0.6	0.6	2.4	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.1	1.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.1	0.0	0.0	0.0	0.0	0.0	51.9	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	106.6	1.4	0.7	9.2	4.5	1.0	4.6	0.4
COL20A1	KIAA1510	ENSG00000101203	"Collagen type XX alpha 1 chain"	Q9P218	20	63293186-63334851	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"brain: 21.6"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.6;SK-MEL-30: 3.3;U-266/70: 2.4"	"Cancer enriched"	"Detected in single"	19	"glioma: 8.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051962	Uncertain				"Secreted to extracellular matrix"					"HPA051962: "	"unprognostic (6.34e-4)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.41e-7)"	"unprognostic (7.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.16e-1)"	0.6	0.9	6.9	0.6	3.9	0.6	0.5	2.2	21.6	1.0	0.6	14.0	0.0	0.5	0.5	1.2	0.5	0.6	0.5	0.6	5.6	3.0	0.6	0.6	0.5	0.5	4.7	4.5	0.7	0.5	0.5	1.1	0.6	3.5	0.6	0.5	0.7	0.8	0.6	0.5	0.5	0.6	0.5	4.3	2.0	0.5	3.0	5.0	0.0	0.5	0.2	0.5	0.5	0.1	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.9	0.0	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.7	0.1	2.4	0.5	0.3	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	6.9	3.9	2.2	6.3	5.6	3.0	4.7	4.5	3.5	5.0
CYP46A1	CYP46	ENSG00000036530	"Cytochrome P450 family 46 subfamily A member 1"	Q9Y6A2	14	99684304-99727301	"Enzymes, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 49.2"	"Group enriched"	"Detected in some"	4	"AF22: 4.3;U-937: 11.8"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"plasmacytoid DC: 7.0"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"						"unprognostic (2.16e-1)"	"unprognostic (4.30e-1)"	"unprognostic (2.50e-5)"	"unprognostic (9.48e-5)"	"unprognostic (1.15e-1)"	"unprognostic (5.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.32e-5)"	"unprognostic (5.21e-2)"	"unprognostic (2.44e-4)"	"unprognostic (5.97e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.88e-3)"	3.0	3.3	13.8	1.3	47.3	1.0	1.2	2.6	49.2	1.4	1.1	3.7	0.0	1.2	1.9	2.0	1.1	1.6	1.4	6.2	15.7	9.9	2.0	1.5	1.3	1.6	7.1	10.0	2.1	2.3	2.7	5.3	1.0	3.8	1.8	1.1	0.6	2.5	1.7	2.0	1.1	1.0	1.9	3.1	1.0	1.0	2.1	6.1	0.4	1.8	0.0	1.1	1.1	0.1	0.0	7.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.3	1.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.2	0.6	0.2	0.0	0.1	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.1	1.8	0.0	0.1	0.0	1.0	0.0	0.3	0.0	0.0	0.2	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.0	0.0	0.0	13.8	47.3	2.6	21.5	15.7	9.9	7.1	10.0	3.8	6.1
DLL3	SCDO1	ENSG00000090932	"Delta like canonical Notch ligand 3"	Q9NYJ7	19	39498895-39508481	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 38.5"	"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 41.1"	"Group enriched"	"Detected in many"	11	"glioma: 29.2;melanoma: 15.5;testis cancer: 8.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.4;naive CD8 T-cell: 3.3"	"Group enriched"	"Detected in many"	13	"B-cells: 5.4;T-cells: 3.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA056533			Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA056533: "	"unprognostic (2.52e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.82e-4)"	"unprognostic (4.94e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.97e-1)"	0.6	0.6	8.9	0.7	10.1	0.6	0.6	1.4	38.5	0.5	0.6	10.3	0.0	0.5	0.6	0.5	0.5	0.5	0.5	0.6	6.5	6.8	0.5	0.6	0.6	0.7	4.5	1.9	0.6	0.5	0.6	3.2	0.5	4.3	0.6	0.5	0.0	0.6	0.5	0.5	0.6	0.6	0.5	3.6	0.6	0.6	1.2	2.3	0.0	0.7	0.0	0.6	0.6	0.0	5.4	0.3	0.0	0.0	0.0	3.3	0.4	0.0	1.9	0.4	1.0	0.0	0.0	0.3	0.5	0.0	0.3	0.1	0.3	0.4	0.0	1.9	0.0	0.0	1.2	0.5	0.1	0.5	3.0	0.1	0.0	0.1	0.1	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.4	3.1	0.3	0.1	0.1	0.1	0.1	7.3	7.4	1.4	0.0	41.1	0.0	0.1	0.0	0.0	1.3	0.1	0.5	0.7	0.0	0.4	0.0	0.2	1.2	0.0	0.0	0.0	0.9	0.0	0.4	5.4	0.2	1.3	0.3	1.2	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.4	8.9	10.1	1.4	4.8	6.5	6.8	4.5	1.9	4.3	2.3
ELFN2	"dJ63G5.3, KIAA1904, LRRC62, PPP1R29"	ENSG00000166897	"Extracellular leucine rich repeat and fibronectin type III domain containing 2"	Q5R3F8	22	37367960-37427470	"Predicted membrane proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 30.0"	"Cell line enhanced"	"Detected in some"		"A-431: 8.7;CAPAN-2: 8.4;PC-3: 7.9;RPMI-8226: 8.4;RPTEC TERT1: 16.4;U-2 OS: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000781	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA000781: AB_1079280"	"unprognostic (2.74e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.31e-5)"	"unprognostic (3.28e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.51e-1)"	"prognostic unfavourable (7.21e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-1)"	1.0	2.1	26.8	0.9	10.9	0.9	0.9	0.7	30.0	0.9	0.9	1.9	0.0	0.9	0.9	0.9	0.9	1.0	1.9	0.8	16.2	8.7	1.2	0.8	2.0	1.0	6.7	15.0	0.8	1.1	0.8	0.1	0.8	5.8	2.2	0.9	0.9	0.9	0.9	0.9	1.5	0.9	0.8	3.8	0.9	1.1	4.2	3.9	0.1	0.8	0.0	0.9	0.9	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.7	3.7	0.0	0.0	0.0	0.7	0.0	3.9	2.1	0.9	0.0	1.4	8.4	0.2	5.2	2.8	6.1	0.4	0.8	0.1	0.2	0.0	0.0	3.9	0.0	0.2	0.0	0.1	0.7	0.1	0.3	1.2	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.2	7.9	0.1	0.0	8.4	16.4	0.0	0.7	0.0	3.6	4.6	0.0	0.0	0.1	0.4	0.0	18.6	0.1	2.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	10.9	0.7	16.8	16.2	8.7	6.7	15.0	5.8	3.9
FEZF2	"FEZL, FKSG36, FLJ10142, TOF, Zfp312, ZNF312"	ENSG00000153266	"FEZ family zinc finger 2"	Q8TBJ5	3	62369681-62374324	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"brain: 22.0"	"Group enriched"	"Detected in some"	5	"AF22: 5.0;NTERA-2: 3.4;U-266/84: 2.3"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Group enriched"	"Detected in many"	7	"amygdala: 12.2;basal ganglia: 6.4;cerebral cortex: 11.3;hippocampal formation: 22.0;olfactory region: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"amygdala: 15.6;cerebral cortex: 15.0;hippocampal formation: 26.2"																"unprognostic (2.37e-1)"					"unprognostic (1.74e-2)"				"unprognostic (1.70e-1)"				0.7	0.5	12.2	0.4	6.4	0.4	0.5	0.0	18.0	0.4	1.4	1.8	0.0	0.4	0.5	0.4	0.4	0.5	0.5	0.5	22.0	1.8	0.7	0.5	0.5	0.4	1.1	10.0	0.5	0.4	0.4	0.7	0.5	0.0	0.6	0.4	1.1	0.5	0.5	0.8	0.6	0.5	0.4	0.0	0.8	0.9	0.5	0.3	3.3	0.5	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.6	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	6.4	0.0	11.3	22.0	1.8	1.1	10.0	0.0	0.3
GALNT9	GALNAC-T9	ENSG00000182870	"Polypeptide N-acetylgalactosaminyltransferase 9"	Q9HCQ5	12	132196372-132329349	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	7	"brain: 52.4"	"Cell line enriched"	"Detected in some"	5	"U-87 MG: 26.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory B-cell: 2.6;naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	9	"B-cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075016			Approved	Vesicles				Vesicles		"HPA075016: "	"unprognostic (1.13e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.85e-1)"	"unprognostic (6.62e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.69e-2)"	2.6	2.2	9.3	1.0	6.7	0.6	0.5	52.4	27.9	1.1	0.8	0.8	0.0	1.1	1.8	7.7	0.5	1.9	0.7	0.6	12.9	6.8	3.2	0.5	0.9	1.3	4.3	10.8	1.3	0.4	1.9	2.7	0.5	6.9	1.0	0.6	0.3	1.2	1.7	0.5	0.9	1.0	0.6	1.7	1.2	0.7	0.9	1.1	0.0	6.1	0.0	0.4	0.7	0.1	2.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	26.3	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	2.6	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.3	6.7	52.4	20.2	12.9	6.8	4.3	10.8	6.9	1.1
GDAP1L1		ENSG00000124194	"Ganglioside induced differentiation associated protein 1 like 1"	Q96MZ0	20	44247099-44280917	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 47.4"	"Group enriched"	"Detected in some"	5	"NTERA-2: 9.6;SCLC-21H: 23.6;SH-SY5Y: 11.6"	"Cancer enriched"	"Detected in single"	14	"glioma: 6.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054182, HPA063265"	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA054182: , HPA063265: "	"unprognostic (6.58e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.23e-4)"	"unprognostic (3.69e-1)"	"unprognostic (5.15e-1)"	"unprognostic (6.45e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.07e-1)"	"unprognostic (4.74e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.81e-5)"	"unprognostic (8.57e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.13e-1)"	1.1	3.9	18.9	1.3	14.9	1.2	1.1	17.8	47.4	1.2	1.2	1.4	0.0	1.0	1.5	1.1	1.1	1.2	1.1	1.3	13.1	14.3	1.1	1.0	1.0	1.0	9.1	12.2	3.0	1.8	2.4	7.1	1.0	10.6	1.1	1.1	0.9	1.0	1.1	1.1	1.5	1.3	1.2	2.6	1.0	1.9	2.8	1.6	0.0	1.1	0.0	1.0	1.1	0.0	0.1	0.0	0.7	0.1	0.5	0.8	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	23.6	11.6	0.0	0.1	1.0	0.0	3.0	0.0	0.9	0.5	0.2	0.0	0.0	0.1	0.6	0.8	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.7	0.5	0.1	0.0	0.0	0.0	18.9	14.9	17.8	25.7	13.1	14.3	9.1	12.2	10.6	1.6
GJC2	"CX46.6, CX47, GJA12, SPG44"	ENSG00000198835	"Gap junction protein gamma 2"	Q5T442	1	228149852-228159826	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 34.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.7;SCLC-21H: 5.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069619			Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA069619: "	"unprognostic (2.67e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.99e-2)"	"unprognostic (7.09e-2)"	"unprognostic (7.88e-3)"	"unprognostic (9.67e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.02e-1)"	2.4	1.9	4.6	1.2	10.0	0.5	2.0	2.2	14.8	2.8	2.6	34.3	0.0	0.6	4.5	2.0	1.7	4.8	1.4	1.6	9.3	5.3	0.6	0.5	3.1	1.2	27.2	5.6	3.4	0.9	2.9	0.6	1.2	18.3	2.1	0.8	0.0	1.5	4.0	1.5	2.4	1.2	3.8	32.6	1.9	1.2	1.0	15.7	0.0	0.9	0.0	0.7	1.3	1.8	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.2	0.5	1.3	0.7	1.8	1.4	0.4	0.6	0.7	0.9	1.2	0.2	9.7	2.6	0.9	0.3	0.3	0.3	0.3	1.5	0.3	2.4	2.1	2.5	0.0	0.0	0.4	0.2	0.8	0.5	0.2	1.0	0.3	0.4	0.5	1.8	0.6	0.6	1.9	0.4	0.3	0.1	0.8	0.0	5.1	3.0	0.4	0.1	0.3	0.1	0.3	4.5	1.3	3.7	4.4	1.5	0.3	0.6	0.2	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	4.6	10.0	2.2	10.4	9.3	5.3	27.2	5.6	18.3	15.7
GPM6B	"M6B, MGC17150, MGC54284"	ENSG00000046653	"Glycoprotein M6B"	Q13491	X	13771031-13938638	"Predicted membrane proteins"	"Differentiation, Neurogenesis, Osteogenesis, Protein transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 219.5"	"Cell line enhanced"	"Detected in some"		"AF22: 41.9;AN3-CA: 41.6;ASC TERT1: 21.3;HSkMC: 31.4;SK-MEL-30: 41.3"	"Group enriched"	"Detected in many"	14	"glioma: 192.5;melanoma: 41.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	222	"plasmacytoid DC: 33.4"	"Lineage enriched"	"Detected in single"	240	"dendritic cells: 33.4"	"Low region specificity"	"Detected in all"							HPA002913	Approved									"HPA002913: AB_2263553"	"unprognostic (1.56e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.27e-2)"	"prognostic favourable (2.67e-4)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.38e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	4.6	5.5	68.4	3.9	55.1	2.0	12.4	24.1	219.5	10.2	5.7	68.7	1.1	3.6	4.3	6.7	6.4	4.2	3.9	5.9	62.6	33.1	4.5	2.0	6.7	2.6	68.9	47.3	3.1	2.9	1.9	2.6	2.1	44.1	9.9	4.9	3.2	7.4	16.9	2.1	7.1	4.3	3.8	109.4	7.2	3.3	3.0	64.8	0.0	3.5	0.0	2.3	3.3	2.7	0.1	33.4	0.1	0.0	0.1	0.1	0.2	0.1	0.1	41.9	41.6	11.9	21.3	0.1	0.2	1.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	2.1	0.2	0.0	0.1	6.8	0.1	2.8	0.1	0.4	0.1	0.2	31.4	0.2	0.0	0.5	0.0	0.1	1.9	0.4	0.1	0.8	0.1	13.1	0.7	0.5	3.8	6.3	0.0	0.1	2.1	1.2	0.2	1.2	41.3	0.2	0.9	0.0	0.2	0.3	0.1	0.5	0.1	0.0	0.0	0.3	0.0	3.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	33.4	0.0	0.2	68.4	55.1	24.1	43.1	62.6	33.1	68.9	47.3	44.1	64.8
GRIA2	"GluA2, GLUR2, GLURB"	ENSG00000120251	"Glutamate ionotropic receptor AMPA type subunit 2"	P42262	4	157204182-157366075	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 95.9"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 19.4"	"Group enriched"	"Detected in some"	10	"breast cancer: 2.7;endometrial cancer: 2.6;glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008441	Enhanced									"HPA008441: AB_1078983"	"unprognostic (1.36e-1)"	"unprognostic (9.60e-3)"		"unprognostic (4.15e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"		"unprognostic (8.70e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.40e-2)"	"unprognostic (2.91e-5)"	"unprognostic (2.42e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.55e-2)"	1.2	6.5	36.9	1.3	39.1	1.1	2.0	22.1	95.9	8.2	1.3	5.6	0.0	1.2	13.5	9.8	1.2	9.6	1.2	1.2	30.1	15.7	1.5	1.1	1.4	1.2	10.0	30.6	1.7	2.2	1.2	10.5	1.2	7.1	1.8	1.2	0.1	2.1	3.0	1.2	1.1	1.2	6.1	6.9	1.3	1.5	2.1	8.8	0.0	1.2	0.0	1.2	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	19.4	2.7	0.0	0.0	0.0	0.9	0.0	0.0	1.1	0.1	0.0	0.0	0.6	0.0	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	39.1	22.1	41.2	30.1	15.7	10.0	30.6	7.1	8.8
GRIA4	"GluA4, GLUR4, GLURD"	ENSG00000152578	"Glutamate ionotropic receptor AMPA type subunit 4"	P48058	11	105609994-105982092	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 55.4"	"Cell line enhanced"	"Detected in some"		"AF22: 15.5;NTERA-2: 5.1;RPMI-8226: 3.0;SCLC-21H: 5.6"	"Group enriched"	"Detected in some"	18	"glioma: 5.9;renal cancer: 1.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"						"unprognostic (1.45e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.09e-4)"	"unprognostic (4.45e-3)"	"unprognostic (1.92e-3)"	"unprognostic (4.14e-4)"	"unprognostic (1.40e-2)"	"unprognostic (3.73e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.28e-1)"	1.1	7.4	11.4	1.5	13.1	0.9	4.5	55.4	52.9	2.6	1.8	8.1	0.0	0.9	1.5	2.9	1.0	2.2	1.2	0.9	9.3	16.0	1.4	0.9	1.0	1.6	12.1	17.4	1.3	1.6	0.9	2.2	1.3	24.8	1.2	2.0	2.8	4.1	1.5	1.0	1.5	4.5	1.0	11.5	0.9	6.6	1.1	6.9	0.0	1.0	0.0	1.3	1.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.1	0.2	0.0	0.0	3.0	0.0	0.0	5.6	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	13.1	55.4	23.3	9.3	16.0	12.1	17.4	24.8	6.9
GRM2	"GPRC1B, mGlu2, MGLUR2"	ENSG00000164082	"Glutamate metabotropic receptor 2"	Q14416	3	51707070-51718613	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 13.2"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 11.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027868, HPA065166"	Approved	Supported								"HPA027868: , HPA065166: "	"unprognostic (1.01e-1)"	"unprognostic (8.61e-4)"	"unprognostic (7.66e-2)"	"unprognostic (7.29e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.19e-2)"	0.8	0.6	4.6	0.8	6.3	1.6	0.7	3.8	13.2	0.6	0.6	0.4	0.0	0.6	0.8	0.4	0.5	0.5	0.4	0.9	3.0	3.1	0.5	0.5	0.6	0.7	1.2	7.0	0.5	0.4	0.4	0.4	0.6	8.3	0.7	0.5	0.6	0.8	0.6	1.8	1.3	0.5	0.6	0.5	1.1	0.5	1.3	0.2	0.0	0.5	0.0	0.5	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	6.3	3.8	13.2	3.0	3.1	1.2	7.0	8.3	0.2
HTR2A	"5-HT2A, HTR2"	ENSG00000102468	"5-hydroxytryptamine receptor 2A"	P28223	13	46831550-46897076	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Behavior, Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	7	"brain: 30.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.7;ASC TERT1: 9.1;BEWO: 2.8;HEL: 2.8;U-138 MG: 4.6;U-2 OS: 2.9;U-87 MG: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"neutrophil: 1.2;plasmacytoid DC: 1.2"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.2;granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014011	Enhanced									"HPA014011: AB_1856709"	"unprognostic (8.01e-2)"	"unprognostic (2.71e-2)"	"unprognostic (9.49e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.94e-5)"	"unprognostic (4.78e-3)"	"unprognostic (2.54e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.28e-2)"	1.9	1.0	9.5	1.7	13.5	0.6	1.3	0.6	30.4	1.6	1.2	1.2	0.0	1.1	1.6	0.6	1.4	1.1	2.9	1.5	3.8	5.1	0.7	0.6	1.0	0.6	3.3	13.3	1.0	0.6	0.6	0.5	0.6	1.8	0.9	1.6	2.0	0.6	1.5	0.9	0.7	1.1	4.4	1.2	0.6	1.0	1.5	0.7	0.0	0.7	0.0	0.8	1.9	1.5	0.1	1.2	1.2	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	3.7	9.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.0	0.1	4.6	2.9	0.0	0.2	0.1	0.0	0.0	2.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	1.2	0.0	1.5	9.5	13.5	0.6	26.4	3.8	5.1	3.3	13.3	1.8	0.7
KCTD4	bA321C24.3	ENSG00000180332	"Potassium channel tetramerization domain containing 4"	Q8WVF5	13	45192853-45194717	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 45.5"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 4.7;RPTEC TERT1: 9.5;U-138 MG: 11.5;U-87 MG: 22.8"	"Group enriched"	"Detected in some"	5	"glioma: 1.2;renal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040734	Uncertain		Approved	"Centriolar satellite"				"Centriolar satellite"		"HPA040734: AB_10963227"	"unprognostic (1.36e-1)"		"unprognostic (1.02e-1)"		"unprognostic (2.08e-1)"	"unprognostic (1.19e-2)"		"unprognostic (1.70e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.98e-2)"			0.5	0.6	33.1	0.6	45.5	0.7	1.5	0.2	22.0	0.7	1.1	1.5	0.0	0.9	0.5	0.6	0.5	0.5	1.8	0.9	9.8	4.0	0.9	0.5	0.5	0.5	3.6	4.8	0.5	0.9	0.5	1.1	0.9	3.9	0.5	0.9	1.8	1.5	0.8	0.5	6.4	1.0	1.8	2.7	0.5	0.5	0.5	7.0	0.0	0.5	0.0	0.5	0.5	0.0	0.0	0.0	0.5	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.0	2.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.5	0.0	0.0	2.4	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.7	0.6	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	33.1	45.5	0.2	9.3	9.8	4.0	3.6	4.8	3.9	7.0
LINGO1	"FLJ14594, LERN1, LRRN6A"	ENSG00000169783	"Leucine rich repeat and Ig domain containing 1"	Q96FE5	15	77613027-77820900	"Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 67.2"	"Cell line enhanced"	"Detected in some"		"AF22: 13.2;AN3-CA: 11.0;HAP1: 16.6;HEK 293: 11.7;MCF7: 7.1;NTERA-2: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074653	Enhanced		Approved	"Plasma membrane"			8400	"Plasma membrane"		"HPA074653: "	"unprognostic (1.06e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavourable (3.23e-7)"	"unprognostic (2.07e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.59e-2)"	3.0	1.6	27.4	1.7	21.8	0.8	1.3	9.1	67.2	3.8	2.0	5.9	0.0	2.0	3.3	2.7	1.4	3.1	2.5	9.7	29.8	12.2	2.2	1.1	1.1	1.3	10.3	21.8	1.7	2.7	1.1	0.5	6.1	6.8	1.7	1.5	1.8	3.4	2.5	1.0	3.0	1.5	4.5	6.8	3.3	2.0	3.7	3.9	0.0	1.7	0.0	1.1	3.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	13.2	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	16.6	0.0	0.0	0.0	11.7	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.7	0.1	0.0	7.1	0.0	0.0	31.3	0.0	0.0	0.0	0.2	0.0	0.0	2.4	0.7	0.0	1.3	2.8	0.2	0.2	1.1	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	21.8	9.1	47.5	29.8	12.2	10.3	21.8	6.8	3.9
LRFN2	"FIGLER2, KIAA1246, SALM1"	ENSG00000156564	"Leucine rich repeat and fibronectin type III domain containing 2"	Q9ULH4	6	40391586-40587465	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 21.7"	"Group enriched"	"Detected in some"	5	"REH: 3.4;SH-SY5Y: 10.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.8;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;T-cells: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA076660	Enhanced		Supported	Vesicles				Vesicles		"HPA076660: "	"unprognostic (1.93e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.58e-4)"	"unprognostic (3.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.75e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.66e-4)"	0.5	1.4	5.9	0.5	7.6	1.3	0.6	4.5	21.7	0.5	0.8	0.0	0.0	0.5	0.6	0.4	1.8	0.6	0.6	0.4	5.0	5.2	0.5	0.4	0.4	0.5	2.3	7.4	2.1	0.7	0.4	0.6	0.5	0.9	0.5	0.7	2.7	0.4	0.4	0.4	0.5	0.5	0.5	0.8	3.1	0.7	2.5	0.5	0.0	0.7	0.0	0.6	0.5	0.2	0.0	1.3	0.0	0.0	0.3	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	3.4	0.0	0.0	0.0	0.3	1.4	10.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.4	0.0	0.3	0.0	1.3	0.0	0.2	5.9	7.6	4.5	21.7	5.0	5.2	2.3	7.4	0.9	0.5
LRRTM2	KIAA0416	ENSG00000146006	"Leucine rich repeat transmembrane neuronal 2"	O43300	5	138868923-138875368	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 33.1"	"Group enriched"	"Detected in some"	7	"HDLM-2: 17.8;SCLC-21H: 5.8"	"Cancer enriched"	"Detected in single"	11	"glioma: 4.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.77e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.58e-1)"	"unprognostic (8.72e-2)"	"unprognostic (4.31e-2)"	"unprognostic (4.48e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.05e-1)"	2.3	4.1	11.0	1.1	15.7	1.1	1.5	15.6	33.1	1.3	1.4	5.1	0.0	1.3	1.1	1.0	1.0	1.1	1.4	1.1	9.7	9.1	1.2	1.3	1.1	1.2	5.4	17.7	1.2	1.4	0.9	0.7	4.5	8.4	1.0	1.4	1.0	1.0	0.9	1.1	1.2	1.5	1.4	5.8	1.9	1.0	0.9	9.9	0.0	1.1	0.0	1.0	1.2	0.3	0.5	0.0	1.0	0.8	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.1	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	17.8	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	1.5	0.0	0.8	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	11.0	15.7	15.6	20.8	9.7	9.1	5.4	17.7	8.4	9.9
LY6H	NMLY6	ENSG00000176956	"Lymphocyte antigen 6 family member H"	O94772	8	143157914-143160711	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 58.2"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 6.7;NTERA-2: 1.3;SCLC-21H: 3.8"	"Cancer enhanced"	"Detected in many"		"glioma: 9.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077218	Enhanced				"Intracellular and membrane"					"HPA077218: "	"unprognostic (8.76e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.45e-4)"	"unprognostic (3.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.71e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-3)"	"unprognostic (3.76e-3)"	"unprognostic (5.97e-2)"	"unprognostic (2.20e-5)"	"unprognostic (6.43e-3)"	"unprognostic (1.54e-1)"	"unprognostic (8.98e-2)"	"unprognostic (9.89e-3)"	1.4	1.4	46.7	1.6	26.3	1.3	1.3	0.0	42.8	1.3	2.8	3.2	0.0	5.6	1.5	1.4	1.5	2.6	1.4	1.2	58.2	53.4	1.3	1.2	1.4	1.4	10.9	32.5	1.2	1.3	1.2	8.4	1.3	7.1	1.3	1.3	0.0	1.3	1.4	1.4	1.2	2.2	1.8	4.0	1.2	4.3	2.3	1.9	0.0	1.3	0.0	1.2	1.4	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.7	0.0	1.3	0.0	0.0	0.0	0.7	0.0	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	46.7	26.3	0.0	36.9	58.2	53.4	10.9	32.5	7.1	1.9
MAP1A	MAP1L	ENSG00000166963	"Microtubule associated protein 1A"	P78559	15	43510958-43531620	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 103.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.4;BJ hTERT+: 21.1;fHDF/TERT166: 31.5;hTEC/SVTERT24-B: 20.0;U-87 MG: 42.4"	"Cancer enhanced"	"Detected in many"		"glioma: 18.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	74	"plasmacytoid DC: 12.3"	"Lineage enriched"	"Detected in single"	74	"dendritic cells: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039063, HPA039064, HPA066488"	Enhanced		Approved	Cytosol				Cytosol		"HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: "	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.13e-3)"	"unprognostic (8.36e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavourable (6.59e-5)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavourable (1.09e-5)"	"prognostic unfavourable (1.66e-5)"	5.2	7.9	43.6	5.4	42.8	2.5	4.3	24.5	103.6	10.5	5.4	18.3	1.0	3.0	5.6	4.3	4.8	9.1	5.9	14.8	40.9	30.2	2.8	1.9	3.4	2.7	34.7	31.3	7.1	2.7	4.1	4.4	4.4	56.2	6.7	5.3	3.1	2.5	9.6	4.5	3.1	3.2	14.5	21.4	2.6	2.7	5.4	12.6	6.5	3.7	0.1	2.7	6.3	2.8	0.0	12.3	0.0	0.0	0.0	0.1	0.2	0.1	0.8	3.8	2.2	21.4	14.7	0.0	12.2	21.1	3.6	3.5	1.4	0.0	0.0	5.3	31.5	0.1	5.1	0.0	2.1	1.8	0.5	4.7	1.2	0.1	2.0	0.1	2.0	11.0	0.0	20.0	0.1	2.7	7.8	0.1	14.6	0.1	8.6	0.2	2.8	0.3	2.3	11.1	0.0	0.0	0.0	12.0	3.6	0.4	0.0	0.1	0.7	0.2	0.5	11.7	3.9	3.9	0.1	0.0	0.5	1.7	42.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.1	0.2	43.6	42.8	24.5	63.1	40.9	30.2	34.7	31.3	56.2	12.6
NAPB	"SNAP-BETA, SNAPB"	ENSG00000125814	"NSF attachment protein beta"	Q9H115	20	23374519-23421519	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 110.9"	"Cell line enhanced"	"Detected in all"		"SCLC-21H: 24.0;U-937: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037225, CAB037227, HPA046149, HPA050196"	Supported		Uncertain	Cytosol				Cytosol		"CAB037225: AB_477555, CAB037227: AB_477554, HPA046149: , HPA050196: "	"unprognostic (3.89e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.46e-3)"	"unprognostic (7.52e-3)"	"prognostic unfavourable (1.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.60e-2)"	3.2	15.5	32.7	3.8	32.7	6.0	4.4	46.0	110.9	4.0	4.0	4.4	2.6	3.8	4.7	6.3	3.7	4.6	3.8	3.7	30.5	32.0	4.4	3.8	3.9	4.0	26.1	40.1	6.4	3.4	6.1	4.6	5.9	50.2	4.0	5.0	6.1	4.0	4.6	3.4	5.0	5.5	4.5	9.7	4.5	4.3	5.3	4.0	0.7	5.1	0.1	3.4	3.6	2.3	2.4	1.9	6.0	2.1	1.5	5.1	2.1	4.2	2.7	4.5	4.7	5.1	4.7	6.4	5.5	3.0	4.4	3.9	3.2	3.8	6.2	6.5	3.2	5.4	5.8	3.7	5.4	2.0	4.3	6.8	3.6	7.6	6.0	5.0	4.0	4.7	4.9	3.1	4.0	3.3	5.7	8.2	7.0	2.8	5.1	4.6	1.9	5.0	3.4	3.6	4.6	5.8	4.6	24.0	7.6	3.1	3.1	5.1	3.2	3.1	3.8	4.3	3.2	4.7	3.9	6.0	4.7	2.8	2.2	23.9	4.2	6.0	1.2	0.0	5.1	1.3	1.5	1.7	2.0	2.4	1.9	2.4	2.0	3.3	1.5	1.5	2.1	1.5	2.5	2.1	32.7	32.7	46.0	57.7	30.5	32.0	26.1	40.1	50.2	4.0
NEFL	"CMT1F, CMT2E, NF68, NFL, PPP1R110"	ENSG00000277586	"Neurofilament light"	P07196	8	24950955-24957110	"Disease related genes, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 95.1"	"Group enriched"	"Detected in some"	5	"HEK 293: 112.2;PC-3: 30.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 24.0"					"Cell type enriched"	"Detected in some"	5	"memory CD4 T-cell: 13.7"	"Lineage enriched"	"Detected in single"	138	"T-cells: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014850, HPA015021"	Enhanced	Supported	Approved	"Nuclear speckles,Intermediate filaments"				"Nuclear speckles"	"Intermediate filaments"	"HPA014850: AB_1854397, HPA015021: "	"unprognostic (7.63e-2)"	"unprognostic (1.36e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (4.91e-4)"	"unprognostic (5.76e-3)"	"unprognostic (7.88e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.17e-3)"	0.7	12.0	10.3	1.4	20.1	0.6	0.6	2.3	92.1	1.8	1.8	3.0	0.0	1.0	0.7	0.8	3.8	0.7	0.6	0.6	14.1		3.5	0.6	0.6	0.7	0.0	23.8	0.7	0.7	0.6	0.0	0.6	95.1	1.6	1.5	5.0	0.6	9.5	0.6	0.7	1.7	1.2	18.0	0.7	1.1	1.6	2.1	0.0	1.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	13.7	2.1	0.0	0.1	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.1	0.0	0.0	112.2	0.0	0.0	0.0	4.9	0.0	0.1	1.8	0.4	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.8	30.1	0.0	0.0	0.0	6.9	1.0	6.2	6.4	2.6	0.0	0.4	0.0	0.0	0.0	0.6	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.7	1.5	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.2	2.1										
NEUROD1	"BETA2, BHF-1, bHLHa3, MODY6, NeuroD"	ENSG00000162992	"Neuronal differentiation 1"	Q13562	2	181673088-181680876	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"brain: 101.9"	"Cell line enriched"	"Detected in some"	72	"SCLC-21H: 79.2"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 4.3"	"Region enriched"	"Detected in many"	16	"cerebellum: 101.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in many"	14	"cerebellum: 242.4"	"Region enriched"	"Detected in some"	20	"cerebellum: 447.6"	"HPA003278, CAB022450"	Approved									"CAB022450: , HPA003278: AB_1845331"			"unprognostic (1.29e-1)"		"prognostic favourable (1.34e-4)"						"unprognostic (6.92e-3)"			"unprognostic (1.27e-1)"				0.2	0.2	6.3	0.2	0.8	0.1	0.2	101.9	5.6	0.2	3.1	0.0	0.0	8.9	0.2	0.1	0.2	0.2	0.0	0.2	4.7	0.4	0.2	0.2	0.2	0.0	0.4	1.2	0.2	13.3	0.0	0.8	0.0	3.9	0.2	1.9	14.4	0.2	0.0	0.2	0.2	5.8	0.0	1.4	0.2	7.6	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.2	1.1	1.0	3.5	1.8	1.4	1.5	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.6	1.0	0.8	1.1	1.5	1.1	1.1	0.8	0.8	1.0	1.3	1.4	1.8	1.4	1.8	1.0	1.0	0.7	6.3	0.8	101.9	2.5	4.7	0.4	0.4	1.2	3.9	0.0
NPTXR		ENSG00000221890	"Neuronal pentraxin receptor"	O95502	22	38818452-38843982	"Plasma proteins, Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 73.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 14.8;SiHa: 11.0;U-87 MG: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA001079	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"		280000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA001079: AB_1078414"	"unprognostic (6.29e-2)"	"prognostic favourable (3.93e-4)"	"unprognostic (6.82e-3)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (9.55e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.77e-2)"	2.3	3.8	39.1	1.8	17.5	0.8	1.9	16.2	73.6	5.8	2.6	4.3	0.5	1.5	5.6	3.3	2.7	6.1	2.0	10.5	57.4	15.2	1.3	0.8	1.7	1.6	5.6	20.7	6.2	3.6	5.9	2.0	0.9	4.5	6.2	1.7	1.0	3.2	5.6	0.9	1.2	1.4	5.7	3.3	2.1	2.0	1.6	4.0	0.0	2.5	0.0	1.6	2.5	1.9	0.3	0.2	0.6	0.2	0.6	2.3	0.4	0.4	2.9	0.1	0.8	5.9	0.6	0.0	1.9	0.4	3.8	1.3	2.9	0.6	0.0	3.4	0.5	0.4	0.8	0.1	1.2	0.2	1.0	0.0	0.1	4.4	0.6	0.0	0.1	1.9	0.1	3.4	0.0	0.1	3.5	0.1	0.1	4.4	0.0	0.2	3.5	1.0	0.7	0.0	6.9	0.9	7.9	14.8	0.9	11.0	0.0	0.3	4.7	1.1	0.2	6.8	4.2	0.0	0.3	1.0	0.0	0.0	42.5	8.6	3.5	0.5	0.2	0.1	1.8	0.0	1.3	0.1	1.0	2.3	0.0	0.3	1.5	1.2	0.6	0.6	0.1	0.2	0.0	0.4	39.1	17.5	16.2	49.0	57.4	15.2	5.6	20.7	4.5	4.0
OPCML	"IGLON1, OBCAM, OPCM"	ENSG00000183715	"Opioid binding protein/cell adhesion molecule like"	Q14982	11	132414977-133532519	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 49.9"	"Cell line enriched"	"Detected in some"	5	"BJ: 14.0"	"Group enriched"	"Detected in some"	10	"glioma: 3.7;renal cancer: 0.7;thyroid cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"		6300000				"unprognostic (1.59e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.31e-4)"	"unprognostic (8.23e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.19e-1)"	1.2	1.5	10.5	1.1	22.3	0.9	1.0	31.4	49.9	1.6	1.1	3.9	0.0	1.1	1.7	1.1	1.5	1.6	1.3	1.4	14.7	8.9	2.9	1.0	1.0	1.0	4.2	21.2	1.3	1.0	7.0	1.1	0.9	4.0	1.1	1.2	4.8	1.2	1.8	1.0	1.1	1.1	1.7	2.6	1.8	1.2	1.5	6.6	0.0	1.2	0.0	1.0	1.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	14.0	0.1	2.1	0.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	2.0	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.5	22.3	31.4	35.6	14.7	8.9	4.2	21.2	4.0	6.6
PDZD4	"FLJ34125, KIAA1444, LNX5, LU1, PDZK4, PDZRN4L"	ENSG00000067840	"PDZ domain containing 4"	Q76G19	X	153802166-153830565	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 71.6"	"Cell line enhanced"	"Detected in some"		"AF22: 15.8;NTERA-2: 8.0;RH-30: 11.3;SCLC-21H: 19.2;SH-SY5Y: 18.7;U-2 OS: 9.4"	"Cancer enhanced"	"Detected in many"		"glioma: 20.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.5"	"Group enriched"	"Detected in many"	25	"NK-cells: 1.5;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003878	Enhanced									"HPA003878: AB_2162807"	"unprognostic (9.18e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-4)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.90e-2)"	"prognostic favourable (2.96e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.54e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.87e-2)"	3.3	5.8	42.8	2.6	36.7	2.5	2.0	40.1	71.6	2.3	3.5	5.1	0.4	2.5	4.4	2.2	3.3	7.9	2.8	3.3	40.8	14.8	1.6	1.7	3.0	2.6	9.9	24.9	1.7	2.6	1.5	7.4	1.2	9.0	4.5	2.3	1.8	4.3	10.5	3.6	4.8	3.3	5.0	7.0	7.0	2.3	3.4	6.4	0.0	1.6	0.0	1.6	2.4	1.4	0.0	0.0	0.0	0.0	1.5	3.5	0.6	0.0	1.0	15.8	4.1	0.0	0.1	0.0	0.4	0.0	0.5	0.5	0.4	0.0	0.0	0.2	0.0	0.1	2.8	0.0	0.1	0.0	0.5	0.0	1.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.1	0.1	0.5	8.0	0.2	0.0	11.3	0.0	0.0	0.0	19.2	18.7	0.8	0.0	5.6	1.8	0.1	0.0	0.0	9.4	0.2	1.1	0.0	0.0	0.0	0.1	0.0	5.0	0.0	0.0	0.0	3.5	0.0	0.8	0.0	1.5	2.0	0.0	0.0	0.1	0.9	0.0	1.5	0.0	0.0	0.0	0.6	42.8	36.7	40.1	49.2	40.8	14.8	9.9	24.9	9.0	6.4
PHACTR3	"C20orf101, PPP1R123"	ENSG00000087495	"Phosphatase and actin regulator 3"	Q96KR7	20	59577509-59847711	"Predicted intracellular proteins"		"Actin-binding, Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 56.1"	"Cell line enriched"	"Detected in some"	4	"THP-1: 51.8"	"Group enriched"	"Detected in some"	5	"glioma: 3.8;lung cancer: 1.6;pancreatic cancer: 2.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 2.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051834, HPA054847"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA051834: , HPA054847: "	"unprognostic (7.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.43e-7)"	"unprognostic (1.99e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.83e-3)"	"unprognostic (8.92e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.71e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.32e-1)"	1.6	2.7	31.3	1.8	29.2	2.0	1.4	15.9	56.1	1.5	1.9	20.0	0.0	2.1	1.3	2.0	2.8	1.4	3.3	3.0	27.3	14.6	2.0	2.1	5.3	1.4	28.3	19.4	6.9	1.5	1.4	0.5	1.9	21.3	1.4	1.8	0.0	1.3	1.3	1.4	2.6	2.1	1.5	25.4	8.0	1.8	1.8	29.8	0.0	1.4	0.0	1.4	1.6	0.0	0.0	2.5	0.1	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.8	0.0	0.0	0.0	10.1	0.0	0.7	2.7	0.0	0.0	0.0	0.0	51.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	31.3	29.2	15.9	34.1	27.3	14.6	28.3	19.4	21.3	29.8
PRRT1	"C6orf31, IFITMD7, NG5"	ENSG00000204314	"Proline rich transmembrane protein 1"	Q99946	6	32148359-32153083	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 41.1"	"Group enriched"	"Detected in some"	4	"HEK 293: 1.5;SK-MEL-30: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055149, HPA059099"	Enhanced									"HPA055149: , HPA059099: "	"unprognostic (1.40e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.10e-3)"	"unprognostic (3.87e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.51e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.08e-5)"	"unprognostic (2.99e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-2)"	2.6	4.8	23.9	2.4	25.3	2.2	2.2	35.8	41.1	2.5	2.5	4.9	0.0	2.6	2.6	2.1	2.1	2.4	2.3	2.3	24.4	10.5	2.4	2.2	2.2	2.2	4.9	27.1	6.1	2.4	2.3	3.2	2.5	11.7	2.8	2.3	1.8	2.3	2.7	2.4	2.4	2.4	2.3	3.0	2.4	2.9	2.6	7.7	0.0	2.2	0.0	2.1	2.2	1.2	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.2	0.8	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.1	0.5	0.7	0.1	0.0	5.5	0.2	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	23.9	25.3	35.8	41.1	24.4	10.5	4.9	27.1	11.7	7.7
RAB3A		ENSG00000105649	"RAB3A, member RAS oncogene family"	P20336	19	18196784-18204074	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 114.7"	"Cell line enhanced"	"Detected in many"		"PC-3: 13.5;SCLC-21H: 24.7;SH-SY5Y: 11.8;U-2197: 17.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003160, CAB009949, CAB078998"	Enhanced	Supported	Approved	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"CAB009949: AB_632292, CAB078998: , HPA003160: AB_1079731"	"unprognostic (1.82e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.80e-3)"	"prognostic unfavourable (3.17e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.13e-1)"	"prognostic favourable (6.14e-7)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.14e-2)"	2.3	13.0	32.3	2.6	50.5	2.0	2.0	39.1	114.7	2.8	3.1	6.3	0.0	3.6	2.7	2.6	2.4	3.2	2.8	17.0	40.8	32.7	4.1	2.2	2.5	2.4	31.5	35.6	8.0	2.3	5.0	7.5	2.4	38.2	3.8	2.8	5.8	4.2	4.4	7.5	2.5	3.0	2.9	7.0	2.5	2.5	2.2	4.8	0.0	2.9	0.1	2.1	2.9	0.7	4.6	6.0	5.1	3.0	0.7	4.2	2.6	0.9	1.0	2.3	3.2	3.8	1.0	1.4	2.0	1.2	1.4	1.9	0.9	0.5	3.3	2.2	1.6	2.7	10.7	1.3	0.7	0.7	3.4	1.3	3.9	3.7	0.9	2.2	4.1	3.1	1.3	0.8	0.4	0.4	0.7	1.1	1.3	3.2	5.0	0.6	1.9	13.5	3.5	0.2	2.8	1.5	0.5	24.7	11.8	1.0	4.3	2.3	0.9	0.4	0.4	1.2	0.9	17.1	1.1	2.1	4.5	0.8	3.2	1.7	1.1	0.0	3.0	3.8	3.0	2.2	4.0	4.6	3.2	3.0	6.0	2.2	4.1	4.2	5.1	0.7	2.7	5.5	1.8	2.6	32.3	50.5	39.1	95.0	40.8	32.7	31.5	35.6	38.2	4.8
RIMS3	"NIM3, RIM3"	ENSG00000117016	"Regulating synaptic membrane exocytosis 3"	Q9UJD0	1	40620679-40665657	"Predicted intracellular proteins"	"Exocytosis, Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 47.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 37.0;SH-SY5Y: 17.5;U-87 MG: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 1.8;plasmacytoid DC: 4.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 4.6;T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055285			Approved	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA055285: "	"unprognostic (3.51e-3)"	"unprognostic (7.18e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-4)"	"unprognostic (3.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.44e-5)"	"unprognostic (2.41e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.54e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.19e-2)"	1.3	7.2	13.6	2.2	19.2	3.7	3.1	21.5	47.7	1.4	3.4	3.4	0.0	1.1	3.0	2.2	2.9	2.1	1.3	1.5	7.8	17.4	1.4	0.7	3.1	2.0	7.4	22.3	2.5	1.1	4.0	0.5	3.8	4.9	3.2	3.8	2.0	2.0	4.1	0.6	2.7	1.7	4.8	3.4	1.7	2.5	3.1	4.4	0.7	2.8	0.0	2.8	1.7	1.0	0.1	4.6	0.1	0.3	0.1	1.8	0.1	1.9	0.7	2.8	3.0	0.1	0.0	0.4	0.0	0.0	0.5	0.6	0.3	0.6	37.0	0.0	0.0	0.3	1.9	0.3	0.3	6.4	0.9	2.1	0.2	1.0	0.1	0.3	1.7	0.0	1.5	0.1	0.1	0.1	1.8	1.4	0.0	3.3	5.4	0.2	1.8	0.2	2.5	2.6	6.8	0.5	0.5	9.9	17.5	0.4	1.8	1.2	0.4	10.3	0.0	0.3	3.0	0.0	0.5	0.3	2.7	8.1	16.1	0.6	0.3	0.1	0.0	0.0	0.1	0.0	1.8	0.0	0.5	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.3	4.6	0.4	0.1	13.6	19.2	21.5	47.7	7.8	17.4	7.4	22.3	4.9	4.4
RPRML	MGC43894	ENSG00000179673	"Reprimo like"	Q8N4K4	17	46978156-46979248	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"brain: 27.0"	"Cell line enhanced"	"Detected in some"		"AF22: 2.6;Daudi: 15.8;HEK 293: 4.9;NTERA-2: 2.5;SCLC-21H: 2.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Group enriched"	"Detected in many"	13	"amygdala: 44.0;basal ganglia: 29.6;cerebral cortex: 41.6;hippocampal formation: 38.9;olfactory region: 24.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 311.4"	HPA062668	Uncertain									"HPA062668: "			"unprognostic (7.79e-4)"		"unprognostic (1.66e-2)"		"unprognostic (8.35e-2)"	"unprognostic (2.42e-2)"		"unprognostic (2.31e-1)"	"unprognostic (8.93e-4)"	"unprognostic (2.78e-2)"		"unprognostic (1.00e-1)"	"unprognostic (1.65e-1)"			0.8	0.6	6.6	0.6	27.0	0.6	0.8	3.6	16.5	0.6	0.8	0.0	0.0	0.8	0.6	2.5	0.6	0.7	0.6	0.6	4.9	1.3	0.7	0.6	0.6	0.6	0.8	10.1	0.6	0.6	0.6	0.1	0.6	0.0	0.8	0.6	0.4	0.7	0.6	3.9	1.0	0.8	0.6	0.0	0.7	1.3	0.7	2.7	0.0	0.6	0.0	0.6	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.5	0.6	0.9	0.3	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	27.0	3.6	11.6	4.9	1.3	0.8	10.1	0.0	2.7
SAMD14	FLJ36890	ENSG00000167100	"Sterile alpha motif domain containing 14"	Q8IZD0	17	50110040-50129882	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 45.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.6;HEL: 6.7;HMC-1: 22.7;SH-SY5Y: 10.7"	"Cancer enhanced"	"Detected in some"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051916	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA051916: "	"unprognostic (2.33e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.48e-4)"	2.8	3.8	18.3	3.9	19.5	2.0	1.0	45.8	18.5	2.4	2.2	3.1	1.1	2.0	3.2	4.3	1.6	1.3	2.2	1.5	15.4	10.3	2.9	1.7	5.4	2.2	7.9	16.1	1.7	1.5	2.9	2.1	3.9	10.9	3.9	1.8	4.3	1.3	4.0	6.1	1.6	2.6	2.8	6.8	3.0	3.2	4.6	6.9	0.0	1.3	0.0	3.2	2.2	0.9	0.0	0.0	2.3	0.0	0.3	0.0	0.4	0.0	0.1	3.9	0.0	1.0	0.2	0.0	2.5	0.9	0.0	0.0	0.5	0.0	0.1	3.6	1.0	0.1	0.2	0.0	0.1	10.6	0.1	6.7	0.2	0.0	0.6	0.0	22.7	0.3	0.0	0.0	0.0	0.6	0.2	0.3	0.0	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.1	0.0	0.0	3.6	10.7	0.0	0.0	0.0	0.2	0.1	0.1	0.4	1.4	0.2	0.0	0.2	0.0	0.0	1.9	0.0	0.8	2.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	18.3	19.5	45.8	18.5	15.4	10.3	7.9	16.1	10.9	6.9
SEPT8	"KIAA0202, SEP2"	ENSG00000164402	"Septin 8"	Q92599	5	132750817-132807241	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 150.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005665, HPA036534"	Approved		Approved	"Actin filaments,Cytosol"				Cytosol	"Actin filaments"	"HPA005665: AB_1079910, HPA036534: "	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.24e-2)"	"unprognostic (7.10e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.12e-1)"	"prognostic unfavourable (6.98e-5)"	"unprognostic (2.86e-2)"	"unprognostic (4.30e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.70e-1)"	9.5	8.4	43.1	7.0	49.4	2.9	7.1	27.8	74.9	9.3	10.2	66.8	5.2	10.7	6.7	8.2	13.4	7.0	10.7	13.1	56.3	37.0	9.2	4.3	8.4	5.6	76.1	29.3	10.9	9.4	15.9	5.0	18.5	45.8	8.1	11.5	7.9	13.6	9.3	4.1	20.4	10.5	9.0	150.3	5.9	11.0	2.9	64.1	1.5	9.5	5.2	7.5	18.3	6.2	0.8	2.4	1.1	2.0	0.3	5.2	1.7	17.1	8.3	12.0	24.4	16.7	16.4	39.4	18.6	17.8	17.7	21.7	14.5	12.4	0.1	16.6	17.9	13.3	22.4	30.4	19.5	21.9	16.1	16.8	10.5	12.5	12.2	5.9	24.5	11.8	9.8	8.1	11.6	24.5	25.7	3.3	9.4	16.3	19.1	5.5	6.3	5.4	17.6	14.0	1.4	10.3	44.2	16.1	10.0	15.7	3.6	10.4	32.1	7.8	25.4	19.7	12.9	4.8	13.2	4.6	4.3	0.6	12.6	8.8	14.8	1.1	2.0	0.0	4.1	1.1	4.2	0.8	3.4	5.2	2.4	0.3	0.9	2.2	0.0	0.3	0.5	0.0	3.6	1.7	43.1	49.4	27.8	44.6	56.3	37.0	76.1	29.3	45.8	64.1
SKOR1	"CORL1, FUSSEL15, LBXCOR1"	ENSG00000188779	"SKI family transcriptional corepressor 1"	P84550	15	67819704-67834561	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 17.8"	"Cell line enhanced"	"Detected in some"		"U-266/70: 5.8;U-266/84: 4.6;U-698: 5.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"cerebellum: 17.8;pons and medulla: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"cerebellum: 4.2;pons and medulla: 1.3"	"Region enriched"	"Detected in some"	6	"cerebellum: 9.0"	HPA071150	Enhanced									"HPA071150: "	"unprognostic (8.98e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.44e-7)"	"unprognostic (1.76e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.45e-3)"	"unprognostic (8.40e-5)"	"unprognostic (5.51e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.13e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.28e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.35e-1)"	1.1	0.6	0.7	0.4	1.3	1.7	0.7	17.8	2.4	0.5	0.7	0.4	0.4	1.4	1.0	0.5	0.4	0.6	0.7	0.4	0.6	1.1	0.5	0.4	0.7	0.4	0.5	0.4	1.2	1.3	0.1	1.3	0.9	4.4	0.8	0.3	0.4	0.7	0.9	1.5	0.7	0.9	0.6	5.4	0.7	0.4	2.4	0.4	0.4	0.5	0.4	0.4	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.2	0.4	0.4	0.3	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.2	0.1	0.1	0.2	0.4	0.0	0.4	0.8	1.0	0.3	0.0	0.2	2.4	0.7	0.1	0.2	0.0	0.1	0.0	0.1	0.8	0.0	0.2	0.4	1.0	0.0	0.2	0.6	0.3	1.2	0.0	0.1	0.2	2.1	0.1	0.0	0.4	0.3	1.1	0.3	0.1	0.5	0.2	0.3	5.8	4.6	5.0	0.5	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	1.3	17.8	1.2	0.6	1.1	0.5	0.4	4.4	0.4
SOX8		ENSG00000005513	"SRY-box 8"	P57073	16	981808-986979	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 64.9"	"Cell line enriched"	"Detected in some"	5	"RH-30: 50.5"	"Cancer enriched"	"Detected in many"	6	"glioma: 46.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.2;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041640, HPA058665"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA041640: AB_10964357, HPA058665: "	"unprognostic (1.40e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.58e-2)"	"unprognostic (7.16e-3)"	"unprognostic (6.05e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.53e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.20e-3)"	"unprognostic (8.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.47e-1)"	"unprognostic (9.09e-2)"	1.6	1.5	18.4	1.8	25.1	1.0	2.5	3.2	64.9	1.2	1.4	20.9	0.0	1.1	1.1	1.1	1.2	1.1	1.5	1.8	22.6	14.5	1.0	1.0	1.0	2.7	26.5	5.4	1.0	1.5	1.0	0.1	1.4	12.0	1.3	1.5	0.9	8.6	1.4	1.3	1.3	1.2	1.2	27.1	1.8	1.7	1.9	30.4	0.0	1.1	0.0	3.1	1.1	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.2	1.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.1	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	50.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.2	18.4	25.1	3.2	11.8	22.6	14.5	26.5	5.4	12.0	30.4
SRRM3	FLJ37078	ENSG00000177679	"Serine/arginine repetitive matrix 3"		7	76201900-76287288	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	7	"brain: 43.2"	"Group enriched"	"Detected in some"	11	"SCLC-21H: 14.1;SH-SY5Y: 10.4"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019337			Approved	"Plasma membrane,Intermediate filaments,Microtubules"				"Plasma membrane"	"Intermediate filaments, Microtubules"	"HPA019337: AB_1848909"	"unprognostic (1.65e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.07e-3)"	"unprognostic (6.37e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.05e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.15e-2)"	0.6	6.2	8.1	0.7	18.1	0.4	0.4	43.2	14.6	0.4	0.6	0.0	0.0	0.9	0.7	1.1	0.5	0.5	0.5	0.5	5.1		0.5	0.4	0.5	0.4	0.0	10.9	0.6	0.5	0.5	4.4	0.4	10.0	0.5	0.7	1.8	0.6	0.5	0.6	0.5	0.6	0.5	0.6	0.4	1.6	2.9	2.9	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.2	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	14.1	10.4	0.0	0.0	0.1	0.4	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0										
TMEM132B	"KIAA1786, KIAA1906"	ENSG00000139364	"Transmembrane protein 132B"	Q14DG7	12	125186836-125662377	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 19.3"	"Cell line enhanced"	"Detected in some"		"HSkMC: 7.8;NTERA-2: 8.9;RPMI-8226: 3.8;U-138 MG: 13.9;U-937: 3.9"	"Cancer enriched"	"Detected in single"	7	"glioma: 3.3"					"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.0"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035661, HPA035662"	Uncertain									"HPA035661: AB_10669774, HPA035662: "	"unprognostic (3.38e-3)"	"unprognostic (4.39e-2)"	"unprognostic (6.73e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.46e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.23e-3)"	"unprognostic (1.29e-2)"	"unprognostic (4.29e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.73e-3)"	0.2	0.2	6.1	0.1	7.5	0.0	0.1	0.2	19.3	0.6	0.3			0.2	0.8	1.0	0.5	0.2	0.3	0.7	5.1	2.6	0.1	0.0	0.0	0.1	2.6		0.1	0.2	0.0	1.1	0.2		0.4	0.4		2.8	0.6	0.5	2.4	0.2	0.2	0.5	0.0	0.3	0.8			2.7		0.3	0.1	0.0	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	3.6	0.0	2.6	2.8	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.1	0.0	0.0	2.9	0.3	0.0	0.0	0.0	8.9	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.9	0.0	0.1	0.0	0.0	0.2	0.0	2.2	3.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0										
TRIM67	TNL	ENSG00000119283	"Tripartite motif containing 67"	Q6ZTA4	1	231162112-231221556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 14.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.3;HMC-1: 1.6;HSkMC: 1.3;SCLC-21H: 7.0;SH-SY5Y: 1.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"cerebellum: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034776	Uncertain									"HPA034776: AB_10603997"	"unprognostic (1.56e-3)"	"unprognostic (1.54e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.93e-10)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.10e-3)"	0.3	0.7	1.3	0.2	1.3	0.1	0.1	13.3	14.4	0.2	0.2	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.2	0.3	1.2	1.9	0.2	0.1	0.1	0.2	1.5	0.0	0.2	0.2	0.1	1.9	0.4	1.9	0.1	0.2	1.7	0.2	0.1	0.1	0.4	0.3	0.2	0.9	0.2	0.2	0.5	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.6	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	7.0	1.9	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.3	13.3	1.9	1.2	1.9	1.5	0.0	1.9	0.2
YJEFN3	"FLJ44968, hYjeF_N3-19p13.11"	ENSG00000250067	"YjeF N-terminal domain containing 3"	A6XGL0	19	19528861-19537581	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 47.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.2;HEK 293: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA060789	Enhanced		Approved	Mitochondria				Mitochondria		"HPA060789: "	"unprognostic (2.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.99e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.37e-4)"	"unprognostic (2.38e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (7.25e-4)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (1.30e-7)"	"unprognostic (1.17e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.49e-3)"	1.2	0.9	24.2	1.4	47.8	0.8	1.0	0.8	26.5	1.1	1.3	1.1	0.0	1.0	1.3	6.6	1.0	1.6	0.9	0.8	29.5	8.3	1.0	0.8	1.4	1.4	7.7	10.2	1.1	1.0	1.7	0.8	1.3	3.6	2.0	1.6	4.1	0.9	1.5	1.6	3.0	1.6	1.2	1.0	1.1	1.4	7.1	5.1	0.0	1.7	0.0	1.3	1.5	0.0	0.5	0.5	0.3	1.1	0.0	2.2	0.3	0.2	0.8	1.9	0.8	0.3	0.5	11.2	0.5	0.1	0.4	0.7	0.9	0.6	0.4	1.4	0.1	1.1	0.3	0.2	0.0	0.1	13.1	0.0	1.5	0.0	0.1	0.3	0.5	0.1	0.5	0.2	0.4	0.0	0.9	0.6	0.0	0.9	0.0	0.1	3.5	2.6	2.1	0.4	0.4	0.0	0.1	0.3	3.1	0.2	0.0	0.2	1.2	1.6	0.7	0.3	0.7	3.4	0.7	3.2	2.1	0.6	0.2	1.7	0.4	0.0	0.7	0.0	0.7	1.1	0.8	0.3	1.2	0.6	0.5	0.5	0.7	1.1	0.3	0.0	0.7	0.0	2.2	0.3	24.2	47.8	0.8	26.5	29.5	8.3	7.7	10.2	3.6	5.1
ACTL6B	"ACTL6, BAF53B"	ENSG00000077080	"Actin like 6B"	O94805	7	100643097-100656461	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 43.6"	"Group enriched"	"Detected in some"	75	"SCLC-21H: 21.0;SH-SY5Y: 21.4"	"Group enriched"	"Detected in some"	11	"glioma: 3.9;pancreatic cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045126	Uncertain		Approved	Nucleoli				Nucleoli		"HPA045126: AB_10961265"	"unprognostic (3.31e-2)"	"unprognostic (6.89e-2)"		"unprognostic (4.59e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.27e-3)"	"unprognostic (4.81e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.01e-4)"	"unprognostic (1.64e-1)"	"unprognostic (6.84e-2)"		"unprognostic (2.01e-2)"	1.1	3.8	9.4	1.1	17.4	1.1	1.0	25.9	43.6	1.0	1.2	0.8	0.0	1.3	1.0	1.0	1.0	1.0	1.0	1.0	9.7	9.9	1.1	1.0	1.1	1.0	5.3	12.2	1.0	2.2	1.0	7.0	1.0	9.4	1.0	1.1	0.3	1.0	1.0	1.0	1.1	1.2	1.1	1.6	1.0	2.0	1.7	1.9	0.0	1.1	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	17.4	25.9	26.8	9.7	9.9	5.3	12.2	9.4	1.9
AKAP5	"AKAP75, AKAP79"	ENSG00000179841	"A-kinase anchoring protein 5"	P24588	14	64465499-64474503	"Plasma proteins, Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 39.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"basophil: 5.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 5.7"					"Group enriched"	"Detected in many"	5	"amygdala: 34.7;basal ganglia: 98.5;cerebral cortex: 52.2;hippocampal formation: 56.3"	"CAB004308, HPA053891"	Enhanced	Supported	Approved	Nucleoplasm				Nucleoplasm		"CAB004308: AB_626655, HPA053891: "	"unprognostic (4.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.44e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.49e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.45e-2)"	0.7	0.8	17.3	2.2	39.1	1.0	1.1	2.9	21.8	0.7	5.9	0.2	0.0	1.1	2.3	0.6	1.0	0.8	1.6	0.6	9.9	1.4	2.4	1.2	3.0	2.9	1.3	9.2	0.7	0.5	1.5	1.3	1.8	0.9	1.0	6.1	0.0	0.7	1.0	0.6	1.0	2.4	2.2	0.7	2.0	1.1	0.7	1.3	0.1	1.1	0.0	2.5	1.4	0.7	0.7	0.4	5.7	0.3	0.9	1.0	0.2	1.7	1.4	1.7	1.0	0.6	0.1	5.7	1.3	0.6	1.6	2.1	14.0	4.3	1.3	2.7	1.0	0.6	3.7	0.3	1.6	2.6	3.1	4.2	2.6	1.2	0.1	0.5	0.6	0.6	0.1	1.1	0.0	0.6	0.5	1.0	1.0	1.0	3.3	0.3	1.3	0.7	4.2	0.8	0.3	2.6	1.6	4.4	2.0	1.5	0.1	0.3	1.3	0.3	0.8	1.9	5.8	0.2	2.1	2.9	3.2	3.2	1.3	0.5	0.3	5.7	0.3	0.2	1.0	0.1	0.2	0.5	0.3	0.9	0.2	0.7	0.4	0.5	0.7	0.9	0.1	0.4	0.1	0.2	17.3	39.1	2.9	19.9	9.9	1.4	1.3	9.2	0.9	1.3
AL109810.2		ENSG00000235710			1	231184098-231187627	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	6	"brain: 1.4"	"Cell line enriched"	"Detected in single"	5	"A549: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		1.4	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.2		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ARNT2	"bHLHe1, KIAA0307"	ENSG00000172379	"Aryl hydrocarbon receptor nuclear translocator 2"	Q9HBZ2	15	80404350-80597937	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 73.2"	"Cell line enhanced"	"Detected in many"		"AF22: 16.0;BJ hTERT+ SV40 Large T+ RasG12V: 16.2;LHCN-M2: 14.5;SK-MEL-30: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001056, CAB005081"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB005081: AB_2243005, HPA001056: AB_1845042"	"unprognostic (2.04e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.00e-1)"	"prognostic favourable (1.46e-6)"	"unprognostic (2.20e-1)"	"prognostic favourable (7.51e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.62e-2)"	1.4	2.3	30.6	2.3	35.5	1.0	1.8	9.1	73.2	4.2	2.4	14.3	0.0	2.0	5.3	7.2	2.3	4.9	2.7	3.7	32.8	17.4	11.5	1.0	4.4	2.3	19.2	23.4	9.3	3.2	4.2	3.6	1.7	11.9	5.1	2.4	2.0	1.5	4.8	7.0	2.3	2.5	3.7	13.2	3.2	3.9	8.0	12.7	0.0	6.0	0.0	2.9	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.9	16.0	0.0	0.1	2.1	0.0	6.8	9.6	7.9	16.2	0.0	0.0	0.0	1.7	8.0	0.2	5.8	0.3	10.1	0.0	1.6	0.3	0.0	0.5	0.5	0.0	4.1	7.6	0.3	3.5	0.1	0.0	0.0	0.1	14.5	7.5	0.0	0.0	3.2	0.1	0.0	0.2	0.0	3.4	11.3	8.5	11.7	0.8	0.1	17.3	0.3	0.0	0.0	12.6	2.5	0.3	8.0	0.0	0.0	0.0	4.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	35.5	9.1	36.0	32.8	17.4	19.2	23.4	11.9	12.7
BHLHE22	"Beta3, BHLHB5, bHLHe22, CAGL85, TNRC20"	ENSG00000180828	"Basic helix-loop-helix family member e22"	Q8NFJ8	8	64580367-64583628	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 30.7"	"Cell line enriched"	"Detected in some"	23	"THP-1: 40.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 31.9;cerebellum: 34.4;cerebral cortex: 22.4;hippocampal formation: 50.8"	"Group enriched"	"Detected in many"	8	"amygdala: 37.8;cerebellum: 21.5;cerebral cortex: 22.5;hippocampal formation: 63.6"	"HPA064128, HPA064872, HPA067500"	Enhanced									"HPA064128: AB_2685195, HPA064872: AB_2685377, HPA067500: AB_2685855"	"unprognostic (9.17e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.28e-5)"	"unprognostic (7.22e-3)"	"unprognostic (6.47e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.86e-7)"	"unprognostic (3.20e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.86e-1)"	2.9	1.3	30.7	2.9	1.4	0.3	1.7	21.1	15.8	1.7	1.7	1.2	0.3	1.1	0.5	0.4	2.2	0.6	1.1	0.8	27.2	2.1	0.5	1.3	1.4	2.4	1.7	6.5	0.4	1.3	0.5	1.2	0.2	3.4	0.5	1.4	2.5	1.2	5.4	0.5	0.8	1.7	1.1	2.6	2.9	1.1	0.7	0.2	0.0	0.6	0.0	1.3	2.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	1.4	21.1	10.6	27.2	2.1	1.7	6.5	3.4	0.2
BRINP1	"DBC1, DBCCR1, FAM5A"	ENSG00000078725	"BMP/retinoic acid inducible neural specific 1"	O60477	9	119153458-119369467	"Predicted intracellular proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 47.0"	"Cell line enhanced"	"Detected in some"		"HSkMC: 9.2;NTERA-2: 17.5;SCLC-21H: 7.8;SH-SY5Y: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038828	Approved		Uncertain	Microtubules	"Intracellular and membrane"			Microtubules		"HPA038828: AB_10670909"	"unprognostic (8.60e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.09e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-4)"	"unprognostic (1.51e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	1.0	5.6	17.7	1.0	16.5	0.9	3.8	19.7	47.0	1.4	1.1	5.1	0.0	1.1	1.2	7.2	1.2	1.0	2.7	2.8	16.0	12.4	3.0	1.7	1.1	0.9	7.4	10.7	1.0	0.9	1.0	1.0	0.9	5.8	2.9	1.0	0.2	1.7	7.6	1.2	0.9	1.7	1.0	9.7	1.3	1.0	1.5	5.1	0.0	1.3	0.0	0.9	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	17.5	0.0	0.0	1.8	0.0	0.1	0.0	7.8	3.3	0.0	0.0	0.0	0.7	0.0	0.0	1.2	1.9	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	16.5	19.7	32.2	16.0	12.4	7.4	10.7	5.8	5.1
C1QL2	"C1QTNF10, CTRP10"	ENSG00000144119	"Complement C1q like 2"	Q7Z5L3	2	119156243-119158889	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 15.4"	"Group enriched"	"Detected in some"	14	"NTERA-2: 2.2;SCLC-21H: 7.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"hippocampal formation: 25.0"	"Low region specificity"	"Detected in many"			HPA057934	Uncertain				"Secreted in brain"					"HPA057934: "	"unprognostic (6.95e-2)"				"unprognostic (9.74e-2)"			"unprognostic (4.48e-3)"		"unprognostic (1.08e-1)"	"unprognostic (9.91e-4)"			"unprognostic (2.60e-5)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-1)"		0.7	0.7	15.3	0.7	6.8	0.7	1.1	0.9	15.1	0.7	0.7	3.1	0.0	0.7	0.7	0.7	0.7	0.7	0.7	0.8	15.4	9.0	0.7	0.8	0.7	1.3	4.5	5.4	0.7	0.7	0.7	0.3	0.7	1.3	0.7	0.7	2.4	1.0	0.7	0.7	0.9	0.7	0.7	1.5	0.8	0.7	1.1	3.1	0.0	0.7	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	6.8	0.9	15.1	15.4	9.0	4.5	5.4	1.3	3.1
C1QTNF4	"CTRP4, ZACRP4"	ENSG00000172247	"C1q and TNF related 4"	Q9BXJ3	11	47589664-47594659	"Predicted secreted proteins"		Cytokine	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 37.8"	"Cell line enriched"	"Detected in some"	6	"REH: 10.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041032	Approved				"Secreted in brain"					"HPA041032: AB_10671170"	"unprognostic (1.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.98e-4)"	"unprognostic (8.19e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.26e-3)"	"unprognostic (6.78e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.35e-2)"	"unprognostic (4.00e-1)"	"unprognostic (4.91e-4)"	"unprognostic (1.22e-1)"	"unprognostic (8.22e-6)"	"unprognostic (6.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.28e-2)"	2.5	1.5	14.2	1.4	34.2	4.1	1.6	16.8	37.8	1.6	1.5	2.0	0.0	1.7	2.1	1.4	1.3	1.5	1.6	1.4	9.7	7.1	1.4	1.4	1.4	1.5	7.9	15.5	3.3	2.2	6.3	4.7	1.4	14.5	1.8	1.4	0.0	1.3	1.7	1.8	1.5	1.6	1.8	5.2	1.6	1.5	2.0	3.7	0.0	1.5	0.0	1.4	1.3	0.3	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.0	0.7	0.0	10.9	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	14.2	34.2	16.8	37.8	9.7	7.1	7.9	15.5	14.5	3.7
CADM2	"IGSF4D, Necl-3, NECL3, SynCAM2"	ENSG00000175161	"Cell adhesion molecule 2"	Q8N3J6	3	84958981-86074429	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 52.7"	"Cell line enhanced"	"Detected in some"		"AF22: 6.3;AN3-CA: 17.9;U-266/70: 3.1"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 5.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010024	Enhanced						350000			"HPA010024: AB_2068039"	"unprognostic (2.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.90e-4)"	"unprognostic (8.64e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.07e-5)"	"unprognostic (9.82e-3)"	"unprognostic (1.26e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.16e-2)"	5.8	6.3	33.5	2.1	22.7	1.7	3.6	44.8	52.7	2.3	3.0	7.0	0.0	2.0	2.0	2.2	2.7	4.6	2.6	4.2	28.6	11.7	1.9	2.5	2.2	1.8	16.3	31.0	2.3	2.4	3.0	5.5	1.9	24.2	3.4	2.7	8.8	2.3	6.2	4.9	2.0	2.6	2.1	14.0	2.0	3.2	2.2	20.5	0.0	2.1	0.0	1.8	2.0	1.1	1.0	0.0	5.0	0.0	0.0	0.2	0.0	0.0	0.0	6.3	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	22.7	44.8	49.5	28.6	11.7	16.3	31.0	24.2	20.5
CCDC177	"C14orf162, PLPL"	ENSG00000267909	"Coiled-coil domain containing 177"	Q9NQR7	14	69569816-69574837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 17.5"	"Cell line enhanced"	"Detected in some"		"AF22: 1.9;NTERA-2: 2.8;SCLC-21H: 5.5;SH-SY5Y: 1.0;SK-BR-3: 1.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (2.21e-1)"	"unprognostic (2.33e-2)"		"unprognostic (6.94e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.77e-3)"	"unprognostic (6.34e-4)"	"unprognostic (2.58e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.84e-5)"	"unprognostic (2.15e-4)"	"unprognostic (3.81e-1)"		"unprognostic (1.45e-1)"	0.4	1.1	3.2	0.4	3.7	0.3	1.0	17.5	8.5	0.3	0.3	0.2	0.0	0.3	0.4	3.1	0.4	0.4	0.3	0.3	2.2	1.6	0.3	0.6	0.3	0.3	0.5	4.4	0.4	0.3	0.3	0.3	0.3	2.3	0.3	0.3	1.8	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	1.5	0.0	0.0	0.3	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	5.5	1.0	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	3.7	17.5	8.5	2.2	1.6	0.5	4.4	2.3	0.0
CDR1	"CDR, CDR34, CDR62A"	ENSG00000184258	"Cerebellar degeneration related protein 1"	P51861	X	140782405-140784871	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"brain: 56.2"	"Cell line enhanced"	"Detected in some"		"AF22: 3.3;BJ: 6.5;MOLT-4: 4.1;U-87 MG: 23.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA073147			Approved	"Nucleoplasm,Golgi apparatus,Centrosome"				"Nucleoplasm, Golgi apparatus, Centrosome"		"HPA073147: "	"unprognostic (7.10e-2)"				"unprognostic (2.87e-2)"	"unprognostic (2.85e-1)"		"unprognostic (3.49e-2)"		"unprognostic (1.44e-1)"	"unprognostic (1.03e-2)"		"unprognostic (2.41e-3)"	"unprognostic (1.46e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.84e-1)"		3.2	1.3	9.1	0.5	26.3	0.0	0.0	56.2	28.7	0.0	0.1			0.2	0.4	0.0	0.6	0.2	1.5	1.5	9.2	2.8	0.1	0.0	0.6	0.1	3.7		0.1	3.9	0.0	7.1	0.4		0.1	0.0		0.6	0.0	0.2	9.4	0.1	0.0	3.6	0.9	0.5	0.1			0.7		0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	3.3	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.1	0.0	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	0.0	1.2	0.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CELF4	BRUNOL4	ENSG00000101489	"CUGBP Elav-like family member 4"	Q9BZC1	18	37243047-37566037	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 69.1"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 31.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013322, HPA037986"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA013322: , HPA037986: AB_10673035"	"unprognostic (7.87e-3)"	"unprognostic (2.31e-2)"	"unprognostic (4.31e-3)"	"unprognostic (3.42e-7)"	"unprognostic (2.95e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.32e-3)"	"unprognostic (6.13e-2)"	1.4	10.7	40.2	1.7	25.2	1.1	1.3	45.3	69.1	1.1	1.6	0.9	0.0	1.6	1.3	1.5	1.4	1.3	2.0	1.7	27.0	26.3	1.4	1.3	1.4	1.6	13.5	26.3	2.0	4.2	1.2	8.1	1.7	13.1	1.5	1.3	0.5	2.5	1.1	8.3	2.0	1.9	1.3	3.7	1.7	1.6	3.9	5.6	0.0	2.3	0.0	1.0	1.2	0.0	0.7	0.5	2.4	0.9	0.9	0.9	0.4	0.1	0.1	0.5	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.2	0.7	0.0	0.4	0.0	0.1	0.0	0.5	0.3	0.0	1.2	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.0	0.2	0.1	0.4	1.1	0.2	0.1	0.0	1.4	0.0	0.1	31.0	7.6	0.8	0.2	0.0	0.1	0.1	0.0	1.0	0.4	0.2	0.1	2.0	0.3	0.1	0.1	0.1	0.1	2.4	0.5	0.5	0.7	0.6	0.7	0.7	0.4	0.4	0.3	0.7	0.8	0.9	1.3	0.9	0.9	0.5	0.6	0.4	40.2	25.2	45.3	31.1	27.0	26.3	13.5	26.3	13.1	5.6
CTNND2	"GT24, NPRAP"	ENSG00000169862	"Catenin delta 2"	Q9UQB3	5	10971840-11904043	"Disease related genes, Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein"	"Autism, Autism spectrum disorder, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 74.3"	"Cell line enhanced"	"Detected in some"		"AF22: 17.7;MCF7: 8.0;SK-BR-3: 5.3;U-266/84: 15.1"	"Cancer enriched"	"Detected in many"	16	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015077, CAB037339"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cell Junctions"				"Nucleoplasm, Golgi apparatus, Cell Junctions"		"CAB037339: , HPA015077: "	"unprognostic (7.32e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.23e-1)"	"unprognostic (5.16e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-2)"	"unprognostic (9.13e-2)"	"unprognostic (9.86e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.55e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.76e-2)"	1.7	2.4	30.9	1.8	26.3	1.4	2.8	21.6	74.3	1.7	1.8	16.6	0.0	1.7	1.6	1.9	1.6	1.7	4.8	6.0	26.0	17.7	1.5	1.7	2.4	1.6	22.8	20.2	2.1	12.5	1.5	5.7	1.9	11.0	2.6	1.9	2.6	1.7	1.7	1.6	1.5	2.0	1.6	13.3	5.7	1.9	4.2	14.7	0.0	1.7	0.0	1.5	1.6	0.1	0.0	0.0	0.8	0.4	0.0	0.3	0.6	0.0	0.1	17.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.0	0.0	0.0	2.7	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.3	0.0	15.1	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.6	30.9	26.3	21.6	29.1	26.0	17.7	22.8	20.2	11.0	14.7
DGKB	"DAGK2, DGK, DGK-BETA, KIAA0718"	ENSG00000136267	"Diacylglycerol kinase beta"	Q9Y6T7	7	14145049-14974777	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 37.7"	"Cell line enhanced"	"Detected in some"		"AF22: 2.7;fHDF/TERT166: 5.5;hTEC/SVTERT24-B: 2.1;SCLC-21H: 2.8;SH-SY5Y: 2.1;U-266/70: 7.4"	"Cancer enriched"	"Detected in single"	11	"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020321		Supported								"HPA020321: "	"unprognostic (9.89e-2)"	"unprognostic (9.72e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-4)"	1.1	5.2	11.5	1.1	37.7	0.8	0.8	1.3	34.0	4.9	1.6	1.4	0.0	0.9	6.1	0.9	1.6	2.7	1.3	1.4	10.5	4.3	2.6	1.1	0.8	0.8	2.2	11.3	0.8	0.9	0.8	1.8	0.7	4.8	1.1	1.7	0.0	0.9	0.9	1.2	0.9	1.2	3.1	3.5	0.8	0.8	0.9	7.9	0.0	0.9	0.0	0.8	1.5	0.6	0.7	0.6	1.3	0.3	0.6	0.5	0.1	0.1	0.0	2.7	0.1	0.0	0.2	0.1	0.0	1.2	0.0	0.3	0.2	0.0	0.1	0.0	5.5	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	2.8	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	7.4	0.0	0.0	0.1	0.1	0.1	0.7	0.3	0.3	0.5	0.2	0.4	0.3	0.5	0.2	0.1	0.7	0.5	0.4	1.3	0.6	0.2	0.6	0.2	0.1	11.5	37.7	1.3	19.1	10.5	4.3	2.2	11.3	4.8	7.9
FAM131B	KIAA0773	ENSG00000159784	"Family with sequence similarity 131 member B"	Q86XD5	7	143353400-143362770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 47.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 10.1;NTERA-2: 16.5;PC-3: 15.9;SCLC-21H: 16.2"	"Cancer enriched"	"Detected in many"	11	"glioma: 14.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021371, HPA029992"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA021371: AB_1852341, HPA029992: "	"unprognostic (1.70e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.54e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.53e-2)"	1.5	2.1	10.0	2.0	12.4	0.9	1.2	37.2	47.1	2.7	2.0	15.1	0.0	1.7	4.4	1.0	1.7	1.6	1.4	1.1	9.1	6.8	1.1	0.9	1.5	1.3	14.6	12.3	1.0	0.9	6.4	0.4	0.9	13.8	1.0	2.2	0.0	0.9	1.0	7.7	0.8	2.1	5.6	18.6	1.1	1.4	1.2	11.3	0.0	0.9	0.0	1.1	1.2	0.5	0.0	0.2	0.0	0.5	0.1	2.1	0.2	0.0	0.1	4.9	0.0	4.0	5.1	0.0	0.2	1.2	0.8	0.2	10.1	0.0	0.0	0.0	0.3	0.2	2.0	0.4	0.7	2.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	5.6	0.0	0.0	0.0	0.9	0.0	0.0	0.7	0.0	0.0	0.3	16.5	15.9	0.0	0.0	0.0	0.0	0.0	16.2	0.5	0.2	1.1	0.0	0.0	0.0	0.7	0.3	1.6	0.1	0.0	0.0	0.0	0.0	0.1	3.2	0.1	0.0	0.3	0.0	2.1	0.5	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.2	0.0	0.0	0.2	10.0	12.4	37.2	25.0	9.1	6.8	14.6	12.3	13.8	11.3
FGF17	FGF-13	ENSG00000158815	"Fibroblast growth factor 17"	O60258	8	22042398-22048809	"Cancer-related genes, Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor"	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 31.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.2;Hep G2: 2.3;MOLT-4: 2.2;RPMI-8226: 4.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.9"	"Region enriched"	"Detected in many"	4	"cerebellum: 31.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 2.2"	"Low region specificity"	"Detected in some"			HPA052600	Uncertain				"Secreted in brain"					"HPA052600: "	"unprognostic (3.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.92e-5)"	"unprognostic (6.85e-2)"	"unprognostic (2.58e-4)"	"unprognostic (6.55e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-3)"	0.4	4.9	2.5	0.4	3.2	0.2	0.4	31.3	7.7	0.5	0.4	0.4	0.4	0.2	2.2	0.6	0.4	0.7	0.6	0.4	2.2	4.7	0.4	0.4	0.5	0.4	1.3	2.9	0.5	2.6	3.6	2.1	0.4	3.3	1.2	0.2	0.4	2.4	0.5	0.4	0.9	0.4	1.0	0.9	3.0	0.8	0.6	0.4	1.6	2.3	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.2	0.6	0.6	1.0	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.0	3.2	0.0	0.0	0.0	0.0	0.9	0.7	0.0	2.3	0.1	0.0	1.5	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.7	2.2	0.8	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.0	1.5	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.2	31.3	7.7	2.2	4.7	1.3	2.9	3.3	0.4
FGFBP3	"C10orf13, MGC39320"	ENSG00000174721	"Fibroblast growth factor binding protein 3"	Q8TAT2	10	91906589-91909483	"Predicted secreted proteins"		"Growth factor binding, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 20.6"	"Cell line enriched"	"Detected in some"	9	"AF22: 83.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA053943	Uncertain				"Secreted in brain"					"HPA053943: "	"unprognostic (8.66e-2)"	"unprognostic (6.00e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.88e-1)"	"unprognostic (9.98e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.39e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.90e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.76e-3)"	1.4	2.1	6.4	1.4	4.6	1.0	2.0	3.4	20.6	1.3	1.6	4.1	0.3	1.1	1.8	2.8	1.0	1.1	0.6	2.1	6.9	5.9	1.4	0.8	1.1	2.2	4.0	5.6	2.5	1.9	2.0	2.3	0.9	6.7	2.3	1.9	0.5	1.9	1.4	3.3	1.8	1.1	1.0	3.9	1.7	2.2	1.1	4.4	0.9	2.7	0.3	1.2	1.0	0.8	3.7	0.6	2.0	0.5	0.9	1.9	0.2	0.0	0.6	83.8	1.2	0.3	0.1	0.3	0.0	0.0	0.1	0.2	0.2	0.3	0.1	0.1	0.1	0.3	0.5	0.0	0.2	0.3	0.9	1.6	0.6	0.9	0.2	8.9	0.2	0.2	0.1	0.4	0.4	0.0	0.8	0.3	0.0	0.7	1.0	3.6	6.2	0.3	2.6	0.5	0.1	0.1	0.2	0.8	1.1	0.2	0.0	1.4	0.3	0.1	0.1	0.1	0.6	0.1	0.2	0.2	0.5	0.3	0.0	1.0	0.1	2.0	0.5	0.0	1.7	0.1	0.6	2.1	1.1	0.9	0.6	3.7	1.9	1.4	0.0	0.9	0.0	0.3	0.1	0.2	6.4	4.6	3.4	6.4	6.9	5.9	4.0	5.6	6.7	4.4
FOXG1	"BF1, FKH2, FKHL1, FKHL2, FKHL3, FKHL4, FOXG1A, FOXG1B, FOXG1C, HBF-3, HFK1, HFK2, HFK3, QIN"	ENSG00000176165	"Forkhead box G1"	P55316	14	28760330-28770277	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 32.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 8.3;SCLC-21H: 21.6;U-138 MG: 13.3;U-251 MG: 13.3"	"Cancer enriched"	"Detected in some"	10	"glioma: 15.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"amygdala: 34.1;basal ganglia: 45.4;cerebral cortex: 40.1;hippocampal formation: 49.3;olfactory region: 31.7"	"Group enriched"	"Detected in many"	5	"amygdala: 84.2;basal ganglia: 118.5;cerebral cortex: 107.8;hippocampal formation: 165.6;olfactory region: 132.9"												"unprognostic (2.92e-2)"			"unprognostic (2.22e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.49e-1)"		"unprognostic (1.17e-3)"		"unprognostic (2.14e-2)"			"unprognostic (1.27e-11)"	"unprognostic (4.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.60e-2)"		0.8	0.8	15.0	0.8	22.4	0.8	0.8	0.0	32.4	0.8	0.8	8.3	0.0	0.8	0.8	0.8	1.2	0.8	0.8	0.8	16.7	2.2	0.8	0.8	0.8	1.5	1.0	14.2	1.3	0.8	0.9	2.1	0.8	0.0	0.8	0.8	0.0	0.8	0.8	0.8	0.8	0.8	0.8	0.0	0.8	0.8	5.4	7.8	0.0	0.8	0.0	0.9	0.8	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.4	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	1.3	13.3	0.0	0.0	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	15.0	22.4	0.0	18.8	16.7	2.2	1.0	14.2	0.0	7.8
GABRA3		ENSG00000011677	"Gamma-aminobutyric acid type A receptor alpha3 subunit"	P34903	X	152166234-152451358	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 30.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 7.8;Karpas-707: 13.2;PC-3: 7.6;U-2 OS: 6.5;U-266/70: 7.1;U-266/84: 11.7;U-87 MG: 7.7"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 16.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA000839	Approved	Supported								"HPA000839: AB_1078929"	"unprognostic (9.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.07e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.34e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.29e-6)"	"unprognostic (7.42e-3)"	"unprognostic (6.20e-2)"		"unprognostic (8.13e-2)"	0.7	0.7	7.7	0.6	15.2	0.7	0.7	1.3	30.1	2.2	0.8	3.3	0.0	0.8	1.2	0.8	1.3	0.7	0.7	0.7	10.9	15.9	0.7	0.7	0.7	0.7	4.7	10.5	0.6	0.7	0.6	0.9	5.2	6.2	0.8	0.8	0.4	0.7	1.8	0.8	1.1	0.9	0.8	2.1	0.7	0.7	1.8	1.1	0.0	0.7	0.0	0.9	1.8	0.4	0.0	0.1	1.5	0.3	0.3	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	1.3	13.2	0.0	0.0	0.0	0.0	2.4	7.6	0.0	0.0	0.0	0.0	0.0	0.2	4.8	0.0	4.9	0.4	0.1	1.2	0.0	5.0	6.5	0.3	1.4	7.1	11.7	0.0	7.7	0.0	4.9	1.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.3	0.1	0.2	0.0	7.7	15.2	1.3	28.4	10.9	15.9	4.7	10.5	6.2	1.1
GABRG2		ENSG00000113327	"Gamma-aminobutyric acid type A receptor gamma2 subunit"	P18507	5	162000057-162162977	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 47.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.7;Karpas-707: 8.5;RPMI-8226: 10.3;U-266/70: 17.9;U-266/84: 14.1"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.3"	"Group enriched"	"Detected in many"	5	"B-cells: 2.9;granulocytes: 7.3;T-cells: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB079060		Supported								"CAB079060: "					"unprognostic (2.88e-2)"			"unprognostic (1.56e-2)"			"unprognostic (6.31e-3)"			"unprognostic (3.07e-3)"	"unprognostic (1.52e-1)"			1.1	5.7	9.7	1.2	28.8	3.3	0.9	21.7	47.1	0.7	1.5	1.1	0.0	2.2	1.2	1.3	1.3	1.3	3.8	1.6	10.6	19.6	1.0	1.2	1.9	1.2	7.5	19.1	1.5	1.0	0.8	5.3	2.9	17.6	1.0	1.3	0.6	1.3	0.8	1.2	3.3	1.9	1.6	2.6	1.2	3.3	1.7	1.8	0.0	1.8	0.0	1.3	1.5	0.3	2.9	0.7	7.3	0.3	0.9	3.2	0.2	3.6	1.7	2.0	0.3	0.0	0.0	2.1	0.6	0.0	0.0	0.0	10.7	4.7	0.7	5.3	0.0	1.6	1.2	0.0	0.0	0.8	1.1	0.0	2.1	1.3	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	1.8	8.5	0.0	2.5	0.4	0.1	6.1	2.9	0.4	0.1	10.3	0.0	3.4	0.9	0.8	0.3	0.6	3.4	5.7	5.7	0.2	0.3	4.5	0.3	0.5	17.9	14.1	0.5	0.2	0.4	0.4	7.3	0.3	0.6	0.4	0.3	2.7	2.9	0.7	0.6	0.0	2.5	3.2	0.7	1.6	0.9	0.2	0.7	0.6	0.2	9.7	28.8	21.7	38.1	10.6	19.6	7.5	19.1	17.6	1.8
GAD1	GAD	ENSG00000128683	"Glutamate decarboxylase 1"	Q99259	2	170813213-170861151	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 53.9"	"Cell line enhanced"	"Detected in many"		"HaCaT: 10.5;HEL: 34.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"olfactory region: 888.9"	"CAB004415, HPA031949, HPA058412, CAB078176"	Enhanced	Supported	Approved	Vesicles				Vesicles		"CAB004415: AB_627650, CAB078176: , HPA031949: , HPA058412: "	"unprognostic (1.28e-1)"	"prognostic favourable (7.31e-4)"	"unprognostic (1.87e-2)"	"prognostic favourable (8.61e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.97e-7)"	"unprognostic (1.51e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.27e-4)"	"unprognostic (6.75e-2)"	"unprognostic (9.18e-3)"	"unprognostic (6.90e-5)"	"unprognostic (2.93e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.08e-3)"	1.2	2.0	14.5	0.9	28.1	3.7	1.0	10.6	53.9	1.8	1.0	3.1	0.0	1.0	2.6	5.5	1.2	1.1	1.0	1.0	10.8	24.4	6.0	1.0	1.1	1.1	8.6	17.5	1.1	1.1	9.5	2.8	1.4	6.0	1.8	1.0	1.3	1.0	1.3	0.9	1.0	1.1	1.0	2.6	1.0	1.0	4.0	3.4	0.0	1.1	0.0	1.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.3	0.0	3.7	0.0	0.0	0.0	0.2	0.0	1.4	0.9	2.5	3.5	0.0	0.5	0.2	10.5	1.2	0.3	0.8	1.4	7.2	34.2	3.0	0.1	0.0	0.1	0.6	0.0	3.1	0.0	1.2	0.0	8.8	0.1	0.4	0.8	0.0	0.0	4.2	3.7	0.5	2.5	0.2	4.6	4.9	3.6	1.1	6.5	0.0	1.8	0.1	0.0	0.0	6.4	0.9	1.3	3.7	0.0	0.0	0.0	6.2	1.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	28.1	10.6	36.7	10.8	24.4	8.6	17.5	6.0	3.4
GNAO1	G-ALPHA-o	ENSG00000087258	"G protein subunit alpha o1"	P09471	16	56191347-56357457	"Disease related genes, Predicted intracellular proteins"		Transducer	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 102.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 16.6;BJ hTERT+ SV40 Large T+: 11.1;SCLC-21H: 33.9"	"Cancer enriched"	"Detected in many"	5	"glioma: 11.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.7"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008387, HPA040878"	Enhanced									"CAB008387: AB_591430, HPA040878: "	"unprognostic (1.50e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.68e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (6.86e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.00e-1)"	"unprognostic (9.70e-5)"	4.6	9.4	42.6	4.7	50.8	1.8	2.3	40.6	102.5	3.4	9.9	24.4	9.1	4.7	5.2	4.6	4.5	4.3	4.2	12.8	37.9	34.8	2.3	7.7	2.6	2.7	28.1	38.5	2.6	5.4	1.9	10.2	2.2	25.2	6.9	6.7	3.1	2.7	18.2	3.5	2.7	5.3	11.2	20.5	2.9	6.2	10.2	32.5	0.0	2.5	0.0	2.7	5.9	0.9	0.0	0.1	0.0	0.0	0.0	1.7	1.0	4.0	0.0	0.3	0.0	0.0	0.0	0.5	4.2	16.6	11.1	5.3	0.2	0.0	0.0	0.1	0.0	0.3	2.6	0.0	7.4	0.1	0.5	0.0	1.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	6.2	0.0	0.0	3.9	0.0	0.0	0.0	33.9	6.7	6.8	0.1	0.4	0.1	0.0	0.0	0.1	3.9	0.0	1.9	0.4	0.0	0.0	0.2	0.3	0.6	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.7	0.5	0.1	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	1.0	42.6	50.8	40.6	45.7	37.9	34.8	28.1	38.5	25.2	32.5
GRIA1	"GluA1, GLUR1, GLURA"	ENSG00000155511	"Glutamate ionotropic receptor AMPA type subunit 1"	P42261	5	153489615-153813869	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 52.6"	"Cell line enhanced"	"Detected in some"		"AF22: 13.4;ASC diff: 4.1;BJ: 6.4;LHCN-M2: 9.4;U-266/70: 6.8"	"Cancer enriched"	"Detected in some"	15	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001965, HPA035202"	Enhanced									"CAB001965: , HPA035202: "	"unprognostic (2.51e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.20e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.35e-2)"	"unprognostic (5.14e-4)"	"unprognostic (7.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.61e-2)"	1.8	1.6	44.9	1.2	23.1	1.0	1.5	23.6	52.6	1.4	1.2	3.7	0.0	1.3	1.2	2.0	1.2	1.2	1.1	2.0	50.4	13.4	1.1	1.1	9.5	1.0	4.8	20.0	1.3	1.4	1.2	0.5	1.1	4.6	1.1	1.2	0.7	1.1	1.7	1.1	1.1	1.3	2.3	2.3	1.1	1.2	2.1	5.2	0.0	1.1	0.0	1.1	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	4.1	2.8	0.0	6.4	3.3	0.4	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	9.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.9	23.1	23.6	24.3	50.4	13.4	4.8	20.0	4.6	5.2
GRID2IP		ENSG00000215045	"Grid2 interacting protein"	A4D2P6	7	6497462-6551436	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 23.6"	"Cell line enriched"	"Detected in some"	4	"REH: 8.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 23.6"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebellum: 25.2;thalamus: 7.9"	"Group enriched"	"Detected in many"	5	"cerebellum: 14.3;midbrain: 10.0;pons and medulla: 9.7;thalamus: 14.7"	HPA045381			Approved	"Plasma membrane"				"Plasma membrane"		"HPA045381: AB_10962495"	"unprognostic (1.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.19e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.92e-3)"	"unprognostic (2.06e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.54e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.17e-1)"	0.2	1.7	0.8	0.6	3.6	1.1	1.1	23.6	6.6	0.6	1.4	6.5	0.0	1.8	0.4	0.1	1.2	1.1	0.6	0.3	1.6	1.6	0.7	0.3	1.2	0.5	0.7	1.2	0.9	1.8	3.9	3.0	0.2	5.5	2.3	0.7	0.3	2.1	1.6	0.2	3.4	1.6	0.0	1.5	1.4	2.2	1.2	6.8	2.5	1.6	0.0	0.6	0.9	0.8	0.7	0.2	0.0	0.2	1.1	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.6	0.7	0.0	0.2	0.0	8.7	0.3	0.2	0.1	0.3	0.1	1.1	0.0	0.8	0.0	2.0	0.2	0.1	0.0	0.9	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.6	0.4	0.0	0.0	1.1	0.2	0.2	0.0	0.1	0.8	3.6	23.6	6.6	1.6	1.6	0.7	1.2	5.5	6.8
KCNA1	"AEMK, HUK1, Kv1.1, MBK1, RBK1"	ENSG00000111262	"Potassium voltage-gated channel subfamily A member 1"	Q09470	12	4909893-4918256	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 24.1"	"Group enriched"	"Detected in some"	11	"LHCN-M2: 2.3;NTERA-2: 2.0;SCLC-21H: 3.8;U-2 OS: 3.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"basal ganglia: 13.7;cerebellum: 23.8;cerebral cortex: 21.1;pons and medulla: 24.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074471	Approved									"HPA074471: "	"unprognostic (6.39e-3)"	"unprognostic (2.64e-1)"			"unprognostic (1.09e-1)"	"unprognostic (8.44e-2)"		"unprognostic (1.33e-1)"		"unprognostic (1.79e-2)"	"unprognostic (4.69e-3)"	"unprognostic (2.48e-1)"		"unprognostic (8.77e-5)"	"unprognostic (6.30e-2)"	"unprognostic (1.08e-4)"		0.8	0.7	1.5	0.7	13.7	0.7	1.3	23.8	21.1	1.6	0.9	0.9	0.0	0.9	1.0	0.7	0.7	0.7	0.9	0.7	4.6	1.1	0.7	0.7	0.8	0.7	2.2	3.5	0.7	0.7	4.0	0.6	0.7	24.1	0.7	0.9	0.0	1.9	0.8	0.7	0.8	0.8	1.1	1.1	0.7	1.0	0.7	1.4	0.2	2.0	0.0	0.7	0.9	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	13.7	23.8	21.1	4.6	1.1	2.2	3.5	24.1	1.4
KCNC2	Kv3.2	ENSG00000166006	"Potassium voltage-gated channel subfamily C member 2"	Q96PR1	12	75040077-75209868	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 39.3"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.5;prostate cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019664, CAB022571"	Uncertain		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB022571: , HPA019664: AB_1855578"	"unprognostic (2.01e-1)"				"unprognostic (1.14e-1)"		"unprognostic (2.68e-1)"				"unprognostic (5.58e-3)"	"unprognostic (4.46e-2)"		"unprognostic (3.39e-2)"				0.7	0.7	8.7	0.7	12.9	0.7	3.3	0.4	39.3	0.7	0.8	1.9	0.0	0.7	0.9	0.9	0.7	0.7	0.7	0.7	7.4	10.4	0.7	0.9	0.7	0.7	4.7	13.5	0.7	0.7	0.7	6.0	0.7	19.1	4.4	0.8	1.3	1.1	0.7	0.7	0.7	0.8	0.7	1.0	0.7	0.7	1.0	0.6	0.0	0.7	0.0	0.7	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.7	12.9	0.4	27.3	7.4	10.4	4.7	13.5	19.1	0.6
KCND2	"KIAA1044, Kv4.2, RK5"	ENSG00000184408	"Potassium voltage-gated channel subfamily D member 2"	Q9NZV8	7	120273668-120750331	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 41.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.4;HSkMC: 4.0;NTERA-2: 3.1;RT4: 3.2;SCLC-21H: 16.2"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Region enhanced"	"Detected in all"		"cerebellum: 41.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029068	Enhanced									"HPA029068: AB_10601436"	"unprognostic (4.22e-1)"	"unprognostic (2.79e-4)"	"unprognostic (3.79e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-3)"	"unprognostic (9.07e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.77e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.51e-4)"	"unprognostic (4.07e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.83e-3)"	2.9	1.0	3.9	1.0	6.7	0.3	1.9	41.1	20.6	2.4	0.7	1.5	0.0	0.7	5.6	0.5	0.5	1.7	7.0	0.5	3.7	5.4	0.3	0.4	0.6	0.5	4.2	3.6	5.9	0.6	2.5	6.6	0.8	12.1	0.5	0.6	0.0	0.7	1.7	0.5	0.3	0.5	3.7	3.7	0.3	0.5	2.9	4.5	0.0	0.8	1.1	0.3	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	6.4	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.6	0.0	0.0	4.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.0	3.2	16.2	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	6.7	41.1	5.3	3.7	5.4	4.2	3.6	12.1	4.5
KCNK4	"K2p4.1, TRAAK"	ENSG00000182450	"Potassium two pore domain channel subfamily K member 4"	Q9NYG8	11	64291302-64300031	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"brain: 12.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;MCF7: 1.5;SH-SY5Y: 2.9;U-2197: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"																		"unprognostic (1.85e-1)"					"unprognostic (1.58e-1)"				"unprognostic (1.21e-1)"	"unprognostic (2.84e-1)"			0.7	0.5	12.2	0.5	11.6	0.5	0.5	1.0	12.3	1.6	0.6	0.3	0.0	0.6	1.2	0.5	0.5	0.6	0.6	0.6	10.2	3.1	0.7	0.5	0.6	0.6	1.5	4.0	0.5	0.5	0.5	0.0	2.0	2.7	0.9	0.5	1.1	0.5	0.8	0.5	0.5	0.7	0.5	0.3	0.6	0.6	0.9	0.1	0.0	0.6	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.2	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.2	0.0	1.5	0.0	0.0	0.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	1.2	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	11.6	1.0	12.3	10.2	3.1	1.5	4.0	2.7	0.1
LRRC4C	"KIAA1580, NGL-1"	ENSG00000148948	"Leucine rich repeat containing 4C"	Q9HCJ2	11	40114203-41459773	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 31.5"	"Group enriched"	"Detected in some"	6	"AF22: 16.9;U-2 OS: 18.6"	"Cancer enhanced"	"Detected in some"		"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"naive B-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"B-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054800, HPA075816"	Approved		Approved	Cytosol				Cytosol		"HPA054800: , HPA075816: "	"unprognostic (4.86e-3)"	"unprognostic (3.43e-2)"	"unprognostic (7.62e-3)"	"unprognostic (4.87e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.90e-13)"	"unprognostic (5.05e-4)"	"unprognostic (5.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-3)"	1.6	5.7	20.2	1.6	23.7	0.5	2.6	3.6	31.5	5.3	1.9	3.3	0.0	1.1	2.3	1.0	1.2	1.3	1.8	2.6	16.7	8.7	0.9	2.1	1.6	1.4	7.5	10.3	1.6	1.0	4.3	3.2	0.5	8.7	1.5	1.6	1.3	1.4	3.0	0.7	0.7	1.3	2.4	6.0	1.3	0.9	0.9	7.9	0.0	4.0	0.0	1.6	1.1	1.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	18.6	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	23.7	3.6	16.4	16.7	8.7	7.5	10.3	8.7	7.9
MAPK8IP2	"IB2, JIP2, PRKM8IPL"	ENSG00000008735	"Mitogen-activated protein kinase 8 interacting protein 2"	Q13387	22	50600685-50613981	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 48.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 8.7;SCLC-21H: 17.5;SH-SY5Y: 15.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034780	Uncertain									"HPA034780: AB_10670283"	"unprognostic (7.82e-2)"	"unprognostic (7.62e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.80e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.90e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.57e-3)"	"unprognostic (8.78e-3)"	"unprognostic (6.33e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.75e-2)"	1.9	8.4	12.2	0.9	14.5	0.6	1.9	13.4	48.9	3.0	2.0	2.1	0.0	1.3	1.6	0.8	2.3	1.7	0.7	2.0	12.0	1.3	2.0	1.8	1.8	0.7	1.4	19.0	4.7	3.1	2.4	4.1	1.2	20.1	1.9	0.9	0.9	4.3	1.1	1.7	1.6	2.0	1.0	3.1	2.1	2.4	3.5	3.8	0.0	2.2	0.0	0.7	3.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	4.4	4.0	0.5	0.0	4.6	0.0	0.1	1.4	0.7	2.6	0.8	0.6	1.2	0.1	0.0	5.6	0.0	0.0	0.2	8.7	0.0	0.2	1.6	0.5	0.0	0.9	0.2	5.6	0.0	0.2	0.0	1.3	2.1	0.0	0.2	0.0	0.0	2.9	2.4	0.8	0.5	0.0	0.0	0.0	17.5	15.8	4.7	5.1	0.2	1.1	0.0	0.0	0.1	0.2	0.4	0.0	1.1	2.8	0.3	0.3	0.4	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	14.5	13.4	29.7	12.0	1.3	1.4	19.0	20.1	3.8
MICAL2	KIAA0750	ENSG00000133816	"Microtubule associated monooxygenase, calponin and LIM domain containing 2"	"O94851, Q6ZW33"	11	12094008-12359144	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Actin-binding, Developmental protein, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 138.4"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 39.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebellum: 138.4;cerebral cortex: 39.8"	"Cell type enhanced"	"Detected in many"		"neutrophil: 12.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030437, HPA039895, HPA040438"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA030437: AB_10601873, HPA039895: , HPA040438: AB_10672896"	"unprognostic (2.68e-2)"	"unprognostic (1.77e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (6.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavourable (3.63e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.67e-1)"	4.1	3.3	15.4	7.3	15.1	6.8	2.9	138.4	39.8	6.6	14.7	2.7	2.9	7.2	14.7	7.7	11.5	5.4	11.1	24.8	22.0	6.9	2.9	3.9	12.8	2.3	5.6	17.9	3.9	4.4	0.7	2.4	5.0	5.5	3.3	15.1	2.8	2.9	8.4	14.6	9.3	10.8	22.7	7.6	2.6	5.9	24.6	0.6	0.0	4.5	1.9	2.2	7.8	3.2	0.2	5.5	12.2	6.7	3.7	3.5	2.1	11.6	6.2	0.2	1.4	1.6	2.9	7.4	18.6	21.1	7.3	11.4	13.0	8.4	0.3	4.0	13.0	8.2	2.2	30.0	18.2	13.5	1.5	11.0	1.2	0.9	14.1	2.0	1.4	5.2	5.3	32.2	31.5	16.6	19.3	0.5	11.7	0.7	0.1	1.0	0.4	5.8	0.1	7.4	7.8	1.5	14.7	6.1	0.5	6.1	17.1	1.2	1.7	0.6	29.7	39.8	15.0	6.5	16.2	0.4	0.9	0.4	24.2	2.9	0.8	0.1	6.7	0.5	2.8	1.7	3.5	0.2	1.7	1.7	5.5	0.2	0.2	0.9	12.2	3.7	0.5	1.0	2.1	2.1	15.4	15.1	138.4	39.8	22.0	6.9	5.6	17.9	5.5	0.6
MSANTD3-TMEFF1	C9orf30-TMEFF1	ENSG00000251349	"MSANTD3-TMEFF1 readthrough"		9	100442271-100577636	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	6	"brain: 21.4"	"Cell line enhanced"	"Detected in many"		"AF22: 42.0;NTERA-2: 21.2;SCLC-21H: 22.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"														"unprognostic (8.53e-3)"	"unprognostic (1.95e-3)"	"unprognostic (5.92e-2)"		"unprognostic (5.32e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.39e-4)"	"unprognostic (6.34e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.46e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-3)"	0.6	0.6	7.7	1.1	4.9	0.0	0.5	7.1	21.4	2.3	0.8			0.0	3.5	1.0	0.6	0.6	1.1	0.7	5.5	3.9	0.4	0.0	0.5	0.0	2.9		1.2	0.0	0.1	0.0	1.1		1.1	0.6		0.0	2.0	0.3	0.0	0.3	2.8	3.5	0.0	0.2	3.3			3.7		0.2	0.9	0.1	0.2	1.0	1.0	0.0	0.0	1.0	0.7	1.1	1.9	42.0	3.4	5.2	2.9	7.0	4.5	3.2	3.4	3.6	0.2	1.3	0.8	2.2	4.1	0.7	13.2	1.3	7.8	3.2	2.5	0.3	1.4	0.6	2.6	0.8	0.7	1.3	1.1	3.3	3.9	8.5	0.8	0.5	6.8	0.8	5.1	0.7	21.2	1.8	6.3	17.8	0.1	3.3	0.4	22.6	10.6	1.4	0.9	2.2	0.5	2.6	3.0	3.6	3.7	4.2	4.1	2.0	4.4	3.9	5.5	0.5	3.4	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.4	0.3	1.0	0.2	0.3	0.5	1.0	0.0	0.0	0.0	0.0	0.7										
NDST4		ENSG00000138653	"N-deacetylase and N-sulfotransferase 4"	Q9H3R1	4	114827763-115113876	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 34.6"	"Cell line enriched"	"Detected in some"	4	"RH-30: 17.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	17	"pons and medulla: 34.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA011129	Uncertain									"HPA011129: AB_1079460"	"unprognostic (5.58e-2)"				"unprognostic (5.90e-2)"					"unprognostic (4.82e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"		"unprognostic (6.55e-2)"	0.1	0.0	1.3	0.0	1.7	0.0	0.1	0.2	3.4	1.4	0.3	0.3	0.3	0.1	1.5	0.0	0.1	0.1	0.3	0.1	0.7	1.9	0.1	0.0	0.1	0.0	1.3	1.4	5.7	0.1	0.0	0.6	0.0	34.6	1.5	0.1	0.0	0.5	0.6	0.1	0.2	0.1	1.6	1.0	2.5	1.1	0.7	0.0	0.0	0.1	0.1	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.7	0.2	1.7	0.7	1.9	1.3	1.4	34.6	0.0
NPBWR2	GPR8	ENSG00000125522	"Neuropeptides B and W receptor 2"	P48146	20	64105820-64107171	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"brain: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"cerebral cortex: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"																							"unprognostic (1.44e-1)"								0.2	2.4	0.3	0.3	1.8	0.3	0.2	0.4	14.8	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.2	2.3	0.2	0.2	0.2	1.6	0.2	0.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.4	14.8	0.2	0.5	0.2	2.3	0.1	0.0
NPFFR1	"GPR147, NPFF1R1, OT7T022"	ENSG00000148734	"Neuropeptide FF receptor 1"	Q9GZQ6	10	70247329-70283676	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	6	"brain: 34.9"	"Cell line enhanced"	"Detected in some"		"U-2 OS: 4.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Group enriched"	"Detected in all"	5	"basal ganglia: 10.2;cerebellum: 34.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basal ganglia: 16.1;hypothalamus: 7.3"	"Low region specificity"	"Detected in many"			HPA037521	Uncertain									"HPA037521: "	"unprognostic (1.73e-3)"	"unprognostic (7.29e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.51e-1)"	"unprognostic (9.62e-2)"	"unprognostic (6.78e-2)"	"unprognostic (5.84e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	0.6	0.5	1.9	1.8	10.2	1.3	0.9	34.9	2.6	0.9	0.6	2.6	0.0	0.8	1.0	1.2	0.4	1.6	0.6	0.4	2.7	4.1	0.5	0.5	1.3	2.5	2.2	4.1	0.8	0.3	0.9	0.4	0.4	4.7	0.6	0.8	5.4	0.4	1.1	1.0	1.0	0.8	0.4	4.0	1.0	1.4	4.7	2.0	0.0	0.6	0.0	1.4	0.6	0.7	1.0	1.2	2.4	2.2	1.3	0.6	2.6	1.1	0.7	0.9	0.7	0.8	1.2	0.7	0.3	0.4	0.3	0.3	1.3	2.3	0.8	0.7	1.0	1.0	2.2	1.2	0.7	0.7	0.8	1.0	1.0	1.0	0.8	0.8	1.3	0.7	1.0	0.5	0.8	0.9	0.9	0.9	0.5	0.9	0.7	0.9	0.7	0.3	0.9	0.8	0.5	0.8	0.8	0.8	0.8	0.8	1.1	0.4	0.5	0.6	1.0	0.9	4.7	0.8	1.0	0.7	0.8	0.5	0.6	0.9	0.7	2.4	2.2	0.4	0.5	0.7	0.5	0.5	0.5	0.4	1.2	1.0	0.6	0.6	1.9	1.3	0.4	0.9	0.4	2.6	1.9	10.2	34.9	2.6	2.7	4.1	2.2	4.1	4.7	2.0
NR2E1	"TLL, TLX, XTLL"	ENSG00000112333	"Nuclear receptor subfamily 2 group E member 1"	Q9Y466	6	108166058-108188809	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"brain: 19.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.3;HEK 293: 2.2;RH-30: 1.6;U-251 MG: 8.1"	"Cancer enriched"	"Detected in single"	14	"glioma: 6.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	11	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036954, HPA055642"	Uncertain		Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA036954: AB_10670958, HPA055642: "	"unprognostic (3.43e-1)"	"unprognostic (1.41e-1)"			"unprognostic (1.77e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.00e-1)"	"unprognostic (1.78e-2)"		"unprognostic (7.31e-2)"	"unprognostic (8.64e-2)"	"unprognostic (9.59e-8)"	"unprognostic (2.87e-1)"	"unprognostic (2.49e-1)"		"unprognostic (3.07e-1)"	0.6	1.1	14.5	0.6	16.0	0.8	0.8	0.0	19.0	0.6	0.6	2.8	0.0	0.7	0.6	0.6	0.6	0.6	0.6	0.7	10.8	4.3	0.9	0.6	0.6	0.7	3.5	7.5	0.7	0.7	0.8	0.1	0.7	0.0	0.6	0.6	3.3	1.0	0.6	0.7	0.9	0.6	0.6	0.0	0.7	0.7	0.8	4.1	0.0	0.7	0.0	0.6	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	14.5	16.0	0.0	10.0	10.8	4.3	3.5	7.5	0.0	4.1
NSMF	NELF	ENSG00000165802	"NMDA receptor synaptonuclear signaling and neuronal migration factor"	Q6X4W1	9	137447573-137459334	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 96.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 12.1;non-classical monocyte: 10.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.0;granulocytes: 3.1;monocytes: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044316	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA044316: AB_10964877"	"unprognostic (1.48e-1)"	"unprognostic (4.03e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.96e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (2.34e-3)"	"prognostic favourable (1.85e-6)"	"unprognostic (1.97e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.97e-2)"	8.8	8.8	61.7	6.9	34.4	6.1	5.3	6.4	67.3	6.0	8.1	18.2	2.1	16.9	8.6	6.6	6.6	7.2	5.7	5.0	96.4	21.8	15.3	6.2	5.2	6.9	20.4	30.2	5.0	14.7	10.8	13.7	4.2	12.1	9.0	6.3	5.4	11.5	8.7	4.0	9.7	13.7	8.2	9.6	6.8	9.6	7.8	15.0	2.4	5.1	1.3	5.8	6.4	3.8	0.2	6.0	3.1	12.1	0.0	1.5	1.4	7.7	6.3	11.2	16.7	26.4	12.5	9.7	7.5	10.0	7.2	5.6	16.8	4.7	9.7	10.2	11.0	23.7	16.5	10.1	4.3	12.7	17.8	7.5	14.9	22.3	14.3	5.1	17.3	14.2	19.3	8.4	19.7	7.6	17.3	1.6	9.6	18.0	0.2	22.3	14.3	17.0	4.7	17.8	21.6	5.0	3.9	47.2	38.5	18.0	10.0	11.3	7.1	10.7	19.1	12.8	10.5	31.0	12.7	3.4	5.3	14.8	7.3	6.9	11.7	1.5	2.0	3.1	1.5	12.1	0.2	0.2	0.5	0.9	6.0	0.1	0.6	0.7	0.3	0.0	10.5	0.2	0.7	1.4	61.7	34.4	6.4	62.9	96.4	21.8	20.4	30.2	12.1	15.0
OLFM1	"AMY, NOE1, NOELIN, OlfA"	ENSG00000130558	"Olfactomedin 1"	Q99784	9	135075422-135121179	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 159.5"	"Cell line enhanced"	"Detected in some"		"HeLa: 25.2;MCF7: 21.2;NTERA-2: 28.3;SCLC-21H: 40.8;SiHa: 33.8;T-47d: 52.4;U-2197: 22.8"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	38	"classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	51	"dendritic cells: 5.1;monocytes: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057444			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in brain"		130000000	Nucleoli	"Nucleoplasm, Cytosol"	"HPA057444: "	"unprognostic (6.77e-2)"	"prognostic favourable (7.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (6.58e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.46e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (7.53e-4)"	7.7	10.0	80.5	5.0	41.5	0.9	4.7	30.9	159.5	7.4	5.4	4.6	0.7	2.5	6.9	26.4	5.0	4.4	3.8	3.9	77.2	19.1	3.4	2.4	4.7	5.2	18.8	36.5	6.2	5.1	3.6	9.9	1.1	13.5	4.8	5.7	0.9	2.6	7.5	6.1	4.5	3.5	6.9	6.1	5.8	3.9	2.8	2.8	0.3	2.7	0.8	7.1	4.1	6.2	0.0	5.1	0.0	5.0	0.0	0.0	0.6	0.0	1.5	3.1	0.0	0.4	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.2	1.3	0.6	0.6	0.0	0.0	3.6	0.2	0.0	25.2	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	21.2	0.1	0.0	28.3	0.0	0.0	0.0	11.9	0.0	0.0	40.8	5.4	33.8	0.1	2.1	52.4	0.0	0.0	2.0	4.5	22.8	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	3.4	0.0	0.0	5.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	80.5	41.5	30.9	119.7	77.2	19.1	18.8	36.5	13.5	2.8
PAK5	"KIAA1264, PAK7"	ENSG00000101349	"P21 (RAC1) activated kinase 5"	Q9P286	20	9537389-9839041	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 30.3"	"Group enriched"	"Detected in some"	9	"SCLC-21H: 10.0;SH-SY5Y: 3.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020444	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA020444: AB_1854947"	"unprognostic (5.14e-5)"			"unprognostic (3.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.63e-2)"		"unprognostic (3.21e-1)"		"unprognostic (3.04e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.76e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.58e-1)"	0.5	5.2	5.7	0.6	11.7	0.5	1.6	30.3	19.6	0.8	0.6	0.8	0.0	0.7	1.0	2.2	1.0	0.7	3.4	0.6	4.0	3.3	1.0	2.3	0.7	0.6	1.6	8.8	0.6	3.5	0.5	2.0	0.6	5.3	1.6	0.6	0.6	1.2	1.6	0.6	1.6	0.6	0.6	1.2	0.6	1.2	1.0	1.7	0.0	0.6	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	10.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	5.7	11.7	30.3	13.6	4.0	3.3	1.6	8.8	5.3	1.7
PLK5	"PLK5P, SgK384ps"	ENSG00000185988	"Polo like kinase 5"	Q496M5	19	1524074-1536046	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"brain: 50.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in all"	6	"cerebellum: 50.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA035024	Enhanced									"HPA035024: "	"unprognostic (4.32e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.69e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.18e-3)"	"unprognostic (3.21e-1)"	"unprognostic (7.49e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.01e-4)"	0.4	0.7	8.3	0.4	4.8	1.7	0.8	50.1	7.9	5.9	0.4	1.6	0.3	0.5	6.4	6.2	1.6	2.7	0.4	0.3	3.2	1.7	0.3	0.3	0.3	0.4	1.1	1.9	0.8	0.6	0.5	0.5	0.3	2.9	0.9	0.4	8.4	0.6	3.2	0.5	1.0	0.7	2.8	0.8	0.4	0.2	7.4	1.8	0.0	0.4	0.0	0.3	0.2	2.9	1.2	1.2	4.4	0.9	1.0	1.1	0.1	0.2	0.9	0.8	1.2	0.4	0.9	1.0	0.2	0.5	0.5	0.4	0.5	1.0	5.0	0.3	0.5	1.2	0.8	0.5	0.2	0.5	0.6	1.0	1.3	0.8	0.1	0.2	1.1	1.0	0.3	0.8	0.2	0.3	0.8	1.7	0.8	1.0	0.4	1.0	1.4	0.9	1.0	0.3	0.4	0.6	0.1	0.5	0.7	0.7	0.4	0.3	1.5	0.7	0.0	0.9	1.0	1.2	0.2	1.5	0.4	0.6	0.4	0.7	0.5	1.6	0.9	2.2	0.8	0.5	0.5	0.7	0.8	0.5	0.2	1.2	1.1	0.6	4.4	1.0	0.6	1.2	1.0	0.1	8.3	4.8	50.1	7.9	3.2	1.7	1.1	1.9	2.9	1.8
PLPPR4	"KIAA0455, LPPR4, PHP1, PRG-1"	ENSG00000117600	"Phospholipid phosphatase related 4"	Q7Z2D5	1	99263953-99309590	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 55.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 19.8;BJ hTERT+ SV40 Large T+ RasG12V: 7.7;fHDF/TERT166: 6.7;SH-SY5Y: 14.9;U-138 MG: 7.5;U-87 MG: 12.6"	"Cancer enhanced"	"Detected in many"		"glioma: 7.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"non-classical monocyte: 2.1"	"Lineage enriched"	"Detected in single"	22	"monocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (4.32e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.09e-2)"	"unprognostic (9.70e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.25e-12)"	"unprognostic (1.67e-5)"	"unprognostic (3.47e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.16e-3)"	3.0	1.7	25.1	1.2	25.8	0.8	1.8	2.0	55.3	4.6	1.5	2.6	0.0	1.2	1.7	1.7	3.2	1.3	6.0	1.4	39.2	10.8	1.4	0.8	3.5	1.5	5.2	16.7	0.8	1.5	1.7	9.0	1.9	6.1	1.1	1.9	0.6	1.4	1.3	1.2	4.6	1.5	2.1	2.2	1.3	1.1	5.2	2.7	0.0	1.5	0.4	1.7	7.0	1.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.3	0.0	0.0	3.8	19.8	4.4	7.7	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	14.9	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.1	0.0	0.0	0.0	12.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	25.1	25.8	2.0	33.8	39.2	10.8	5.2	16.7	6.1	2.7
PPFIA2		ENSG00000139220	"PTPRF interacting protein alpha 2"	O75334	12	81257975-81759553	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 48.8"	"Group enriched"	"Detected in some"	8	"HAP1: 24.7;SCLC-21H: 8.5"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	27	"basophil: 2.6"	"Lineage enriched"	"Detected in single"	27	"granulocytes: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (4.31e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.78e-5)"	"unprognostic (4.69e-3)"	"unprognostic (2.13e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.10e-2)"	"unprognostic (8.92e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.76e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.45e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.06e-3)"	2.6	8.3	23.0	1.4	17.7	0.9	1.8	7.2	48.8	6.0	2.3	10.5	0.0	1.4	3.2	1.8	1.8	2.4	3.2	1.2	19.2	10.6	2.0	1.3	1.9	1.1	10.1	20.9	2.2	1.7	1.0	4.5	1.0	8.6	2.7	2.7	2.5	1.2	5.5	1.0	1.9	1.7	3.7	7.7	1.2	2.0	8.2	9.7	0.0	1.3	0.0	1.1	2.4	2.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.1	0.0	1.2	0.0	8.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.6	0.0	1.7	0.0	0.0	0.0	0.8	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	17.7	7.2	38.3	19.2	10.6	10.1	20.9	8.6	9.7
PRKAR1B		ENSG00000188191	"Protein kinase cAMP-dependent type I regulatory subunit beta"	P31321	7	549197-727650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 83.6"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026719	Approved									"HPA026719: AB_1855419"	"unprognostic (4.90e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.02e-3)"	"unprognostic (3.28e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.64e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.00e-1)"	5.0	6.8	33.6	4.3	30.4	4.5	4.0	24.0	83.6	4.8	5.7	3.4	1.6	7.2	7.2	2.7	4.2	6.2	4.6	7.7	35.5	42.8	5.4	3.8	5.5	5.2	22.5	29.2	12.9	4.1	5.6	7.0	3.5	29.7	6.0	4.2	2.5	3.9	5.5	3.8	3.0	7.6	5.3	9.1	8.2	3.8	4.8	3.7	2.5	2.9	1.4	3.3	3.5	2.6	7.0	5.5	1.5	2.6	3.5	12.8	10.3	24.8	17.2	2.6	6.3	1.7	1.5	7.3	5.0	2.3	3.2	1.8	30.7	5.5	18.9	3.5	2.2	18.4	8.6	9.5	1.3	3.9	6.2	1.2	11.1	20.2	3.2	11.9	3.0	4.2	3.0	2.1	6.1	3.4	18.0	3.8	2.8	23.9	14.4	7.8	40.3	6.8	9.3	0.5	8.4	8.0	6.5	33.7	25.5	12.7	12.6	9.9	6.5	4.5	4.1	1.4	3.2	1.9	10.1	2.4	6.8	12.3	2.6	9.3	18.8	1.5	2.0	0.0	4.6	2.6	6.9	6.2	7.9	7.1	2.4	7.0	12.8	11.7	0.8	3.5	0.9	5.5	5.2	10.3	33.6	30.4	24.0	68.6	35.5	42.8	22.5	29.2	29.7	3.7
PRR18	MGC35308	ENSG00000176381	"Proline rich 18"	Q8N4B5	6	166305300-166308448	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 35.7"	"Group enriched"	"Detected in some"	7	"SCLC-21H: 9.1;SH-SY5Y: 5.3"	"Cancer enhanced"	"Detected in some"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077250	Enhanced									"HPA077250: "	"unprognostic (2.91e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.65e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.79e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.35e-3)"	"unprognostic (9.49e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.07e-1)"	1.3	0.9	12.4	0.9	17.3	0.9	0.9	1.7	34.8	1.1	0.9	35.7	0.0	1.4	0.9	0.9	0.9	4.4	0.9	0.9	18.6	9.0	1.0	6.4	1.1	0.9	23.1	7.0	1.0	1.1	3.3	0.4	0.9	11.0	1.3	0.9	0.0	1.0	1.1	0.9	0.9	1.0	0.9	21.7	0.9	1.2	0.9	18.9	0.0	1.1	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	9.1	5.3	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	17.3	1.7	14.9	18.6	9.0	23.1	7.0	11.0	18.9
PRR35	C16orf11	ENSG00000161992	"Proline rich 35"	P0CG20	16	560422-565528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"brain: 51.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 2.3;HMC-1: 1.0;K-562: 2.1;NTERA-2: 1.0;RT4: 1.3;U-2 OS: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	27	"cerebellum: 51.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 4.8"	"Region enhanced"	"Detected in single"		"cerebellum: 0.9"	HPA069297	Uncertain									"HPA069297: "		"unprognostic (6.96e-2)"		"unprognostic (3.08e-2)"	"unprognostic (5.25e-1)"	"unprognostic (8.11e-2)"				"unprognostic (2.56e-1)"				"unprognostic (3.38e-2)"	"unprognostic (1.17e-1)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	51.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.8	0.0	0.0	1.1	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.1	0.2	0.0	0.0	0.0	0.0	1.8	0.0
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase, receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 118.1"	"Group enriched"	"Detected in some"	9	"AF22: 92.1;NTERA-2: 25.6;WM-115: 40.3"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"		950000	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavourable (9.36e-4)"	2.0	2.5	33.1	2.3	44.1	1.5	4.0	15.4	118.1	2.4	2.2	19.3	0.0	1.9	1.6	2.0	7.0	1.7	1.9	2.0	39.6	15.9	1.6	1.6	2.1	1.5	18.6	17.8	2.0	3.3	1.5	1.6	1.6	67.6	2.1	2.3	0.8	2.4	2.0	1.5	19.3	1.9	2.4	76.6	2.1	9.8	1.7	23.6	0.0	1.5	1.8	3.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	1.1	0.0	0.1	0.0	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	44.1	15.4	39.6	39.6	15.9	18.6	17.8	67.6	23.6
RLN2	"bA12D24.1.1, bA12D24.1.2, H2, RLXH2"	ENSG00000107014	"Relaxin 2"	P04090	9	5299868-5304969	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"brain: 44.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.1;HEL: 19.7;T-47d: 5.7;U-266/84: 9.0"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.7"	"Region enriched"	"Detected in single"	64	"basal ganglia: 44.0"	"Group enriched"	"Detected in many"	39	"gdT-cell: 2.1;MAIT T-cell: 6.5;memory B-cell: 2.8;memory CD4 T-cell: 4.3;memory CD8 T-cell: 3.5;naive B-cell: 2.1;naive CD4 T-cell: 6.2;naive CD8 T-cell: 4.6;NK-cell: 4.9;T-reg: 2.0"	"Group enriched"	"Detected in many"	47	"B-cells: 2.8;NK-cells: 4.9;T-cells: 6.5"														"Secreted to blood"	24440					"unprognostic (1.63e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.03e-2)"	"unprognostic (9.99e-2)"		"unprognostic (1.48e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.50e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.74e-6)"	"unprognostic (2.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.88e-2)"	"unprognostic (8.41e-4)"	0.6	0.0	0.6	1.6	44.0	0.0	3.2	0.6	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	7.5	0.6	0.6	0.6	0.6	2.0	0.6	0.7	3.5	0.6	0.6	0.6	0.9	5.2	5.8	0.7	0.6	6.2	0.3	0.6	0.6	0.7	0.6	0.4	0.8	0.6	0.6	1.4	0.4	4.2	0.6	0.6	0.9	0.6	3.0	0.6	0.6	2.8	0.0	0.0	0.0	4.9	6.5	1.4	2.8	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.9	0.3	1.5	5.1	0.4	0.0	0.9	0.0	2.6	0.7	4.0	1.9	19.7	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.1	0.2	0.5	0.0	0.2	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.5	2.6	2.9	0.0	0.6	0.1	5.7	0.1	0.2	0.0	0.5	0.0	0.1	1.3	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	6.5	2.8	4.3	3.5	0.0	2.1	6.2	4.6	0.0	4.9	0.0	0.0	2.0	1.4	0.6	44.0	0.6	0.6	0.6	0.6	0.6	0.6	0.6	0.6
RUNDC3A	"RAP2IP, RPIP8"	ENSG00000108309	"RUN domain containing 3A"	Q59EK9	17	44308413-44318671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 92.6"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 34.1;SH-SY5Y: 21.8"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023548, HPA070733"	Enhanced	Supported	Approved	Vesicles				Vesicles		"HPA023548: AB_1856069, HPA070733: AB_2732162"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.58e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.87e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.87e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.17e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.84e-1)"	1.4	12.9	40.5	1.6	28.5	2.8	1.5	33.0	92.6	1.3	1.8	4.8	0.0	2.2	1.6	1.5	1.5	1.5	1.6	1.8	40.9	20.6	1.7	1.3	1.5	1.4	22.0	23.2	1.7	4.3	2.4	16.1	2.5	15.6	1.5	1.8	1.6	1.4	1.6	1.3	4.1	2.2	1.8	8.0	1.5	3.3	5.2	4.4	0.0	2.4	0.0	1.4	1.5	0.0	0.3	0.1	0.0	0.2	0.1	1.3	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.2	0.2	0.0	0.0	0.5	0.1	0.0	34.1	21.8	0.2	0.0	0.2	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.3	1.3	0.3	0.1	0.1	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	40.5	28.5	33.0	49.2	40.9	20.6	22.0	23.2	15.6	4.4
SCN3B	HSA243396	ENSG00000166257	"Sodium voltage-gated channel beta subunit 3"	Q9NY72	11	123629187-123655244	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 70.3"	"Group enriched"	"Detected in some"	4	"CACO-2: 2.9;hTCEpi: 9.4;RH-30: 4.2;SCLC-21H: 9.4;SH-SY5Y: 7.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041707			Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments"	Cytosol	"HPA041707: "	"unprognostic (1.41e-1)"	"unprognostic (8.72e-2)"	"unprognostic (8.13e-4)"	"unprognostic (3.93e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.29e-3)"	"unprognostic (5.64e-2)"	"unprognostic (3.34e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.16e-4)"	"unprognostic (4.01e-1)"	"unprognostic (1.89e-4)"	"unprognostic (2.01e-2)"	"unprognostic (9.01e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.43e-2)"	2.2	8.5	17.7	1.5	23.5	1.3	2.0	2.8	70.3	1.6	1.5	1.2	0.0	1.6	1.5	1.5	1.5	1.8	1.4	1.9	26.2	13.2	1.6	1.0	1.4	1.2	5.2	18.8	1.7	1.9	3.9	12.6	1.1	3.8	1.8	1.6	3.7	1.2	1.4	5.8	1.7	1.5	2.1	1.5	1.3	1.4	2.2	1.2	0.0	3.7	0.0	1.2	1.1	0.4	1.2	1.3	2.7	0.6	1.1	0.8	0.1	0.0	0.2	0.3	0.2	0.1	0.1	0.3	0.2	0.3	0.0	0.0	2.9	0.1	0.3	1.4	0.4	0.2	1.0	0.1	0.1	0.1	0.6	0.0	0.5	0.3	0.1	0.0	0.5	0.4	9.4	0.1	0.1	0.3	0.4	0.5	0.0	0.1	0.1	0.2	0.8	0.1	0.2	4.2	0.0	0.0	0.2	9.4	7.0	0.6	0.1	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.6	0.6	0.5	0.6	0.4	0.4	0.7	0.7	0.7	0.3	1.2	0.5	0.8	2.7	1.1	0.5	1.3	0.4	0.1	17.7	23.5	2.8	39.5	26.2	13.2	5.2	18.8	3.8	1.2
SERPINI1	"neuroserpin, PI12"	ENSG00000163536	"Serpin family I member 1"	Q99574	3	167735243-167825568	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 96.0"	"Cell line enhanced"	"Detected in many"		"Daudi: 15.6;HeLa: 16.2;Karpas-707: 18.1;U-266/84: 16.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001565, HPA056092"	Enhanced		Approved	Cytosol	"Secreted in brain"		200000	Cytosol		"HPA001565: AB_1079924, HPA056092: "	"unprognostic (1.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (4.25e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.11e-1)"	5.9	8.2	31.9	2.4	27.9	1.3	6.1	3.6	96.0	4.2	2.8	7.1	0.4	1.5	4.3	4.3	3.2	3.9	3.4	6.4	35.9	35.3	14.5	2.5	3.4	2.3	36.9	35.7	4.0	16.3	3.7	10.3	3.5	22.9	5.8	2.5	2.4	9.9	3.6	1.7	2.1	2.5	3.1	51.6	4.1	3.6	7.0	15.9	0.0	5.2	0.3	3.8	3.1	1.6	15.4	4.4	1.0	0.4	6.0	16.0	3.4	0.4	1.9	3.2	0.2	5.9	1.5	0.2	1.1	1.8	0.8	1.3	0.7	3.8	15.6	6.0	0.8	0.8	2.1	2.1	0.8	4.9	4.5	5.3	16.2	6.6	0.4	0.8	0.6	2.2	0.8	0.4	0.7	0.2	9.9	18.1	0.6	1.5	0.4	1.1	2.0	2.4	1.8	0.1	2.0	6.7	0.5	1.3	8.2	2.2	4.3	5.0	6.4	2.4	0.5	3.4	0.3	0.3	5.5	13.7	16.7	11.4	2.9	4.0	1.9	1.0	0.2	0.5	6.2	0.4	4.5	12.7	6.5	6.6	0.3	15.4	4.7	5.7	0.6	6.0	0.3	4.4	16.0	3.4	31.9	27.9	3.6	78.9	35.9	35.3	36.9	35.7	22.9	15.9
SH3GL2	"CNSA2, EEN-B1, SH3D2A, SH3P4"	ENSG00000107295	"SH3 domain containing GRB2 like 2, endophilin A1"	Q99962	9	17579082-17797129	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 83.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.7;HeLa: 13.8;RT4: 26.7;SCLC-21H: 17.4"	"Cancer enhanced"	"Detected in many"		"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010056, HPA026685, HPA063573"	Enhanced	Supported	Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"				Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB010056: AB_628099, HPA026685: AB_1856817, HPA063573: "	"unprognostic (4.78e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.68e-2)"	"unprognostic (5.05e-5)"	"unprognostic (4.23e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.07e-3)"	"unprognostic (8.76e-3)"	"unprognostic (1.26e-1)"	"prognostic favourable (6.68e-12)"	"unprognostic (2.65e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-2)"	1.1	1.2	16.7	1.1	17.3	1.0	1.1	68.4	83.0	3.1	1.5	1.6	0.0	1.2	2.8	2.1	1.4	2.6	1.1	4.1	17.1	11.3	13.7	1.1	1.9	1.0	9.1	22.2	2.5	3.4	1.2	6.6	1.0	12.8	2.5	1.6	1.6	1.0	1.1	1.1	1.1	1.5	2.4	6.3	1.1	4.5	5.8	2.2	0.0	2.2	0.0	1.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	4.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.7	0.0	13.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	1.5	0.0	0.0	0.0	0.0	26.7	17.4	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.9	0.0	0.2	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	17.3	68.4	41.1	17.1	11.3	9.1	22.2	12.8	2.2
SLC12A5	"KCC2, KIAA1176"	ENSG00000124140	"Solute carrier family 12 member 5"	Q9H2X9	20	46021690-46060152	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 64.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 13.4;NB-4: 27.6;SK-BR-3: 14.0;U-2 OS: 16.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 5.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072058	Enhanced									"HPA072058: "	"unprognostic (2.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.55e-2)"	"unprognostic (9.44e-4)"	"prognostic unfavourable (5.60e-4)"	"unprognostic (2.48e-1)"	"unprognostic (5.16e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.61e-4)"	"unprognostic (8.78e-4)"	"unprognostic (3.25e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.34e-2)"	1.4	11.2	21.1	2.0	28.8	1.5	1.7	52.1	64.6	2.3	2.1	2.7	0.0	2.2	1.6	2.2	1.3	1.7	1.9	2.1	20.5	19.2	1.4	2.2	2.7	3.1	9.5	32.1	2.0	3.6	1.5	4.8	3.3	15.3	1.5	2.1	4.9	1.9	1.8	1.5	1.5	2.1	1.6	6.3	2.8	3.1	3.4	5.8	0.0	1.3	0.0	2.6	1.2	0.5	1.3	0.2	0.1	1.5	0.7	5.7	1.3	0.0	8.4	3.7	2.7	0.3	0.0	0.8	0.3	0.0	0.0	0.3	1.1	0.0	3.1	12.8	0.2	0.7	2.4	1.2	0.2	2.0	3.2	2.7	1.6	13.4	1.4	0.0	3.7	0.5	0.0	0.0	0.2	0.7	5.0	0.0	0.0	12.7	1.8	27.6	1.3	4.3	3.1	2.4	0.7	1.3	0.0	4.6	6.6	1.6	14.0	4.0	5.1	7.9	1.3	1.5	16.0	0.1	0.6	0.0	2.1	4.4	3.4	3.2	0.1	0.0	1.5	0.0	2.6	0.8	1.0	1.0	0.3	0.4	0.2	1.3	5.7	3.2	0.1	0.7	0.2	0.0	3.5	1.3	21.1	28.8	52.1	36.4	20.5	19.2	9.5	32.1	15.3	5.8
SLIT1	"MEGF4, SLIL1, Slit-1, slit1, SLIT3"	ENSG00000187122	"Slit guidance ligand 1"	O75093	10	96998038-97185920	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 44.3"	"Cell line enriched"	"Detected in some"	15	"MOLT-4: 41.2"	"Group enriched"	"Detected in many"	10	"glioma: 9.2;prostate cancer: 2.2;thyroid cancer: 10.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.6;plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006879			Approved	"Plasma membrane"	"Secreted in brain"			"Plasma membrane"		"HPA006879: AB_1078197"	"unprognostic (2.72e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.43e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.60e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.39e-3)"	1.2	0.8	13.4	0.9	16.1	0.9	0.8	0.4	44.3	0.8	0.9	0.5	0.0	0.9	0.8	0.7	0.8	1.0	0.8	0.8	13.9	10.5	0.8	0.7	1.0	0.9	4.6	13.2	0.8	1.4	0.8	8.0	0.8	2.2	1.1	0.8	0.3	0.8	0.7	0.9	0.8	0.9	0.8	1.4	0.9	1.1	2.0	0.3	3.3	3.6	0.0	0.9	0.8	0.0	0.0	1.6	0.4	0.7	0.0	0.0	0.2	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	41.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.6	1.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.4	1.6	0.0	0.2	13.4	16.1	0.4	24.8	13.9	10.5	4.6	13.2	2.2	0.3
SMIM17		ENSG00000268182	"Small integral membrane protein 17"	P0DL12	19	56643145-56655766	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in many"	6	"brain: 26.5"	"Cell line enhanced"	"Detected in some"		"AF22: 5.3;HEK 293: 5.2;RH-30: 4.2;SCLC-21H: 4.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.4"									"HPA071857, HPA071861"	Enhanced		Approved	Vesicles				Vesicles		"HPA071857: , HPA071861: "	"unprognostic (1.32e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.62e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (9.02e-3)"	"unprognostic (3.46e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.71e-3)"	"unprognostic (7.51e-3)"	1.8	1.2	7.0	0.6	10.4	0.8	2.4	4.5	17.3	0.9	1.1	0.9	0.0	1.0	2.2	4.8	1.2	1.5	1.0	1.7	6.0	13.8	1.3	0.8	1.3	0.7	5.9	7.7	1.8	1.2	0.5	2.2	1.1	26.5	1.7	1.2	0.4	1.3	2.6	1.1	1.9	0.7	1.4	2.7	1.0	0.7	1.6	0.1	0.0	1.1	0.0	0.8	0.5	0.5	0.0	1.4	0.0	0.4	0.0	0.0	0.1	0.2	0.0	5.3	1.5	1.2	0.9	1.1	0.7	0.6	1.2	0.3	0.0	0.2	0.4	0.8	0.3	0.3	0.1	0.4	0.7	0.0	5.2	3.1	0.6	0.8	0.8	2.4	0.4	1.7	0.7	0.0	1.4	0.5	0.1	0.0	1.1	0.0	2.8	0.3	0.0	0.6	1.5	4.2	0.1	0.7	0.0	4.8	0.9	1.2	0.1	0.7	0.0	0.8	0.8	1.8	0.2	0.5	0.5	0.3	0.8	1.3	0.6	1.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.0	10.4	4.5	17.3	6.0	13.8	5.9	7.7	26.5	0.1
STXBP1	"hUNC18, MUNC18-1, rbSec1, UNC18"	ENSG00000136854	"Syntaxin binding protein 1"	P61764	9	127579370-127696027	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 127.4"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 47.1;SK-MEL-30: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008209, HPA023483, CAB034434"	Enhanced		Approved	Nucleoplasm,Cytosol			6400	"Nucleoplasm, Cytosol"		"CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625"	"unprognostic (2.32e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavourable (4.78e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (1.47e-4)"	"prognostic unfavourable (5.73e-4)"	"unprognostic (2.87e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.08e-3)"	"prognostic favourable (9.81e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.51e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.36e-3)"	14.1	16.0	32.4	4.7	42.2	1.5	5.1	86.8	127.4	8.1	4.6	6.5	1.9	3.7	13.2	4.7	6.3	17.9	6.7	12.7	35.0	31.5	7.1	2.7	16.8	3.7	24.6	55.5	14.3	13.2	8.1	22.3	7.9	61.9	6.5	5.3	12.6	8.1	6.6	5.0	5.6	4.6	11.7	13.3	5.9	5.2	5.4	5.3	0.0	10.7	0.9	4.3	5.7	7.6	0.0	0.5	0.0	0.4	0.0	3.4	0.6	4.0	8.5	8.2	9.2	18.6	16.0	7.4	14.3	7.3	8.6	7.6	0.4	4.8	4.0	8.0	9.3	1.4	7.2	8.8	10.6	9.2	4.8	5.4	23.1	1.5	9.4	0.5	4.7	12.1	4.9	22.6	11.0	10.2	5.4	6.2	14.5	7.5	3.8	1.7	7.0	11.8	2.3	3.9	9.7	7.1	0.2	47.1	22.9	24.1	11.9	40.8	1.8	1.7	15.2	9.8	5.0	19.2	5.3	13.4	22.1	5.4	19.2	5.8	9.0	0.0	0.4	0.0	0.8	0.1	0.3	0.0	2.2	3.4	0.5	0.0	1.4	1.7	0.0	0.0	0.1	0.3	0.3	0.6	32.4	42.2	86.8	87.7	35.0	31.5	24.6	55.5	61.9	5.3
SV2B	"HsT19680, KIAA0735"	ENSG00000185518	"Synaptic vesicle glycoprotein 2B"	Q7L1I2	15	91099950-91301309	"Predicted membrane proteins"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 44.2"	"Group enriched"	"Detected in some"	4	"RPMI-8226: 4.6;SCLC-21H: 8.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046247	Approved									"HPA046247: AB_10963538"	"unprognostic (2.92e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (4.01e-5)"	"unprognostic (2.66e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.10e-4)"	3.5	2.7	13.1	1.4	16.8	1.1	1.6	26.2	44.2	1.2	1.4	1.4	0.0	1.2	1.2	1.3	1.2	1.3	1.4	1.8	19.7	3.3	1.3	1.3	1.4	1.6	5.1	21.3	1.1	3.1	1.1	1.3	1.4	25.6	2.2	1.6	7.3	2.4	1.2	1.7	1.4	1.6	1.3	1.5	1.3	1.4	2.2	0.2	0.0	1.2	0.0	2.7	1.2	0.6	0.6	0.4	1.2	0.3	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	4.6	0.0	0.1	8.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.1	0.2	0.9	0.4	1.2	0.3	0.3	0.2	0.1	0.1	0.6	0.3	0.3	0.0	0.6	0.4	0.3	1.1	0.7	0.1	0.4	0.1	0.0	13.1	16.8	26.2	31.3	19.7	3.3	5.1	21.3	25.6	0.2
SYT2		ENSG00000143858	"Synaptotagmin 2"	Q8N9I0	1	202590596-202710417	"Disease related genes, FDA approved drug targets, Predicted membrane proteins"	Differentiation		"Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 40.1"	"Cell line enhanced"	"Detected in some"		"AF22: 12.4;NTERA-2: 8.6;U-2 OS: 2.6"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 3.8"	"Group enriched"	"Detected in many"	5	"cerebellum: 36.2;cerebral cortex: 14.7;pons and medulla: 40.1"	"Cell type enriched"	"Detected in single"	8	"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA063655	Enhanced	Supported								"HPA063655: "	"unprognostic (1.32e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.35e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.23e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.17e-3)"	1.1	6.1	0.4	1.1	5.9	0.5	0.3	36.2	14.7	0.6	0.7	0.3	0.0	1.1	1.7	4.1	0.4	0.8	1.1	1.5	0.6	1.5	0.5	0.4	0.6	0.7	5.5	0.4	3.1	0.4	0.2	0.3	0.5	40.1	0.9	0.7	1.6	1.1	0.5	1.1	0.7	1.3	0.5	7.1	1.2	0.7	2.4	1.1	0.0	0.6	0.0	0.5	1.0	0.3	0.1	0.0	2.4	0.1	0.1	0.2	0.0	0.0	0.2	12.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.2	1.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	8.6	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.4	5.9	36.2	14.7	0.6	1.5	5.5	0.4	40.1	1.1
TAGLN3	"NP22, NP25"	ENSG00000144834	"Transgelin 3"	Q9UI15	3	111998664-112013887	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 139.0"	"Group enriched"	"Detected in some"	5	"AF22: 38.5;RPTEC TERT1: 15.7;SCLC-21H: 21.0;SH-SY5Y: 35.5"	"Cancer enhanced"	"Detected in many"		"glioma: 24.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062620	Enhanced									"HPA062620: "	"unprognostic (1.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.28e-1)"	"unprognostic (4.07e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.51e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.67e-3)"	1.7	21.9	47.3	2.4	40.6	1.5	1.6	40.2	139.0	1.5	2.7	4.6	0.0	1.9	1.6	1.5	1.6	1.6	1.7	1.7	32.9	37.9	4.2	1.5	1.8	1.6	30.5	33.2	1.6	4.6	1.6	13.5	1.5	29.8	1.7	2.9	2.3	1.5	1.7	1.5	1.6	2.2	2.2	8.3	1.5	3.7	1.6	2.7	0.0	1.8	0.0	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.1	0.1	0.0	1.4	0.0	0.2	0.0	2.7	0.5	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	1.4	3.4	5.3	1.0	0.0	15.7	0.0	21.0	35.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	40.6	40.2	65.7	32.9	37.9	30.5	33.2	29.8	2.7
TMEM144	FLJ11155	ENSG00000164124	"Transmembrane protein 144"	Q7Z5S9	4	158201604-158255411	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	6	"brain: 88.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.3;hTCEpi: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.3;intermediate monocyte: 1.4;myeloid DC: 3.7;plasmacytoid DC: 4.3"	"Group enriched"	"Detected in many"	10	"dendritic cells: 4.3;monocytes: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063554			Approved	Mitochondria				Mitochondria		"HPA063554: "	"unprognostic (1.26e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.06e-2)"	"prognostic favourable (2.89e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.27e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavourable (8.48e-4)"	"unprognostic (9.34e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.05e-2)"	4.7	6.7	20.7	2.0	60.9	1.5	9.2	4.7	37.7	4.7	7.4	88.7	0.2	14.3	3.7	8.3	3.1	3.9	6.8	8.2	31.5	18.3	1.9	1.7	3.5	0.9	80.4	26.6	8.6	3.8	3.0	1.4	3.5	48.9	5.4	8.6	0.0	3.1	7.2	1.4	1.9	9.6	4.2	79.2	2.2	5.4	15.8	67.4	0.0	9.2	0.0	0.8	5.1	1.9	0.0	4.3	0.1	3.3	0.4	0.1	0.7	2.5	7.0	0.1	1.4	5.1	7.7	23.3	1.1	1.9	1.0	1.6	8.8	9.6	0.0	1.4	0.3	1.2	3.2	10.8	1.4	0.0	3.2	4.3	2.1	7.8	1.8	5.4	1.3	5.5	13.4	4.6	1.6	5.8	2.8	0.1	8.0	3.0	0.0	0.0	1.8	1.7	0.0	0.0	0.3	2.0	7.4	1.1	0.0	0.2	9.5	2.6	6.7	1.5	1.1	2.2	1.7	0.4	1.3	0.0	0.6	0.6	3.0	0.8	1.5	0.0	3.3	0.0	0.0	1.4	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.4	0.7	4.3	0.0	0.7	20.7	60.9	4.7	35.1	31.5	18.3	80.4	26.6	48.9	67.4
TTYH1		ENSG00000167614	"Tweety family member 1"	Q9H313	19	54415219-54436900	"Predicted membrane proteins, Transporters"	"Cell adhesion, Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 66.9"	"Group enriched"	"Detected in some"	4	"AF22: 6.2;AN3-CA: 19.2;U-2 OS: 7.1"	"Cancer enriched"	"Detected in many"	15	"glioma: 63.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023617, HPA050655"	Approved									"HPA023617: AB_10600836, HPA050655: "	"prognostic favourable (3.64e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.50e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.60e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.09e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.69e-1)"	2.2	2.7	49.5	2.1	55.4	2.1	2.3	17.9	66.9	2.4	2.3	33.9	0.0	2.4	2.6	2.1	2.2	4.4	2.3	2.3	31.0	23.4	2.1	2.1	2.1	2.1	39.3	24.4	2.2	10.4	2.1	1.9	2.1	19.7	2.5	2.1	1.9	2.8	2.4	3.0	2.2	2.1	2.2	29.7	2.4	2.2	7.4	18.0	0.0	2.1	0.0	2.1	2.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.2	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	49.5	55.4	17.9	42.9	31.0	23.4	39.3	24.4	19.7	18.0
TUBB2A	"dJ40E16.7, TUBB, TUBB2"	ENSG00000137267	"Tubulin beta 2A class IIa"	Q13885	6	3153669-3157526	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 158.3"	"Cell line enhanced"	"Detected in many"		"AF22: 53.3;CACO-2: 53.8;WM-115: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 6.0;monocytes: 2.6;T-cells: 5.5"	"Low region specificity"	"Detected in all"							"CAB015339, HPA043640, HPA046280"	Supported		Supported	Microtubules				Microtubules		"CAB015339: AB_2210539, HPA043640: , HPA046280: "	"unprognostic (2.57e-1)"	"unprognostic (9.86e-3)"	"unprognostic (5.90e-3)"	"unprognostic (7.98e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.48e-3)"	"unprognostic (9.99e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.42e-2)"	"prognostic favourable (4.65e-4)"	"unprognostic (2.39e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavourable (1.61e-4)"	19.6	9.1	59.4	8.7	46.9	26.8	7.9	46.5	158.3	5.4	8.7	9.1	1.2	11.1	6.7	13.5	17.2	4.8	10.9	6.1	56.5	76.0	7.7	16.9	4.1	5.4	58.4	43.3	2.6	14.3	1.6	6.9	11.0	78.6	6.1	4.5	4.6	5.8	8.0	7.3	24.7	13.8	17.7	24.3	2.3	17.6	2.9	5.4	0.1	1.9	10.4	4.7	5.4	5.8	6.0	0.9	0.7	2.6	0.6	5.5	1.8	11.4	9.7	53.3	12.0	6.7	7.5	3.1	25.5	9.5	17.5	25.4	53.8	3.9	5.7	15.8	24.1	5.5	18.8	5.8	6.1	27.6	12.5	1.9	2.8	16.2	7.0	0.3	1.9	7.8	6.8	18.3	1.2	8.0	6.8	2.0	15.6	5.1	3.0	0.6	45.6	12.5	2.6	5.0	4.3	5.9	5.9	13.3	12.2	6.4	1.9	36.5	4.1	0.4	16.0	11.8	12.9	25.5	13.7	0.8	0.9	3.8	4.3	1.5	59.5	0.0	1.9	0.0	4.0	2.6	4.4	6.0	3.9	5.5	0.9	1.2	2.1	3.7	0.7	0.6	2.0	0.3	5.3	1.8	59.4	46.9	46.5	89.2	56.5	76.0	58.4	43.3	78.6	5.4
UCHL1	"PARK5, PGP9.5, Uch-L1"	ENSG00000154277	"Ubiquitin C-terminal hydrolase L1"	P09936	4	41256413-41268455	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 225.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 97.1;SCLC-21H: 96.9;U-251 MG: 88.7;U-266/84: 85.5;U-87 MG: 94.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 3.6"	"Lineage enriched"	"Detected in single"	37	"B-cells: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002580, HPA005993, CAB079024"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol			440000	Cytosol	Nucleoplasm	"CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (4.08e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.77e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.10e-2)"	"prognostic unfavourable (1.93e-4)"	8.2	40.2	52.4	8.9	65.1	2.0	3.1	17.5	225.8	4.5	6.3	11.5	0.0	5.5	6.0	1.8	2.7	5.7	6.5	5.4	53.4	97.4	14.0	2.0	2.7	6.5	62.0	57.1	15.4	6.3	1.8	30.5	2.7	100.6	5.3	4.7	6.0	3.0	4.4	7.5	2.7	8.6	5.2	38.6	2.3	2.8	8.0	8.3	0.0	3.9	0.0	4.5	5.6	2.8	3.6	0.0	0.0	0.0	0.0	0.0	0.6	0.2	55.0	11.4	0.0	1.5	1.9	0.0	57.6	29.7	20.4	20.6	11.1	0.0	0.0	97.1	29.3	0.1	21.0	0.0	8.3	0.1	8.6	0.0	0.3	0.0	44.0	0.0	0.0	10.6	0.2	16.3	0.0	0.1	0.0	0.2	10.8	0.0	0.0	0.9	32.9	62.2	0.0	24.4	0.0	30.8	0.0	96.9	60.9	0.3	0.2	0.1	0.0	0.4	0.3	1.3	0.4	0.0	88.7	45.5	85.5	0.2	94.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	52.4	65.1	17.5	92.6	53.4	97.4	62.0	57.1	100.6	8.3
YWHAH	YWHA1	ENSG00000128245	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta"	Q04917	22	31944461-31957603	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 154.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025918, HPA061603"	Uncertain		Approved	Nucleoli,Cytosol			130000000	Cytosol	Nucleoli	"CAB025918: , HPA061603: "	"unprognostic (3.77e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (1.59e-5)"	"unprognostic (8.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.81e-2)"	21.5	18.6	87.9	20.6	47.4	16.3	19.3	41.9	154.3	13.7	24.4	10.0	4.3	17.2	13.1	14.1	14.0	16.4	18.6	15.2	78.8	59.1	11.7	11.5	25.0	13.5	35.5	101.6	10.0	16.7	5.2	10.4	22.4	49.5	12.3	20.1	6.8	9.9	15.6	13.9	9.9	17.4	25.9	19.4	12.8	26.9	3.7	9.1	6.3	10.5	5.5	15.1	18.5	10.6	8.1	16.6	14.9	14.4	17.7	12.8	9.6	67.9	27.2	30.4	17.7	18.5	17.1	19.3	66.1	32.7	38.1	43.6	28.8	23.7	40.1	16.1	60.6	32.9	36.4	36.3	36.0	35.5	31.7	23.7	21.4	25.7	18.7	76.3	26.5	15.5	19.4	32.1	22.9	31.1	32.7	29.4	29.0	27.4	23.1	35.1	36.2	29.8	33.2	41.9	21.3	24.0	29.4	65.4	21.5	37.6	26.3	23.5	15.0	18.9	49.7	38.5	38.5	28.2	41.9	16.4	25.3	50.2	27.9	30.8	33.8	7.8	14.4	14.9	5.7	11.8	8.1	8.1	7.0	8.1	16.6	7.6	2.8	3.6	8.7	17.7	12.2	4.5	12.8	9.6	87.9	47.4	41.9	126.3	78.8	59.1	35.5	101.6	49.5	9.1
ZNF536	KIAA0390	ENSG00000198597	"Zinc finger protein 536"	O15090	19	30228290-30713538	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 44.5"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 3.9;HAP1: 8.7;SH-SY5Y: 23.8;U-937: 5.8;WM-115: 10.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077341			Approved	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"		"HPA077341: "	"unprognostic (1.98e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-1)"		"unprognostic (4.70e-2)"	"unprognostic (4.68e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.46e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.45e-1)"	1.1	6.0	9.9	2.0	21.0	0.6	0.8	14.3	24.1	4.2	4.0	44.5	0.0	2.7	1.7	1.3	6.9	1.0	1.3	2.9	13.3	7.7	0.8	0.7	1.0	0.7	20.9	9.6	0.9	0.9	0.7	3.4	0.7	18.3	3.7	4.1	4.8	1.6	2.4	1.4	1.2	4.2	1.2	23.1	1.5	2.1	5.0	18.4	0.0	6.9	0.0	0.7	2.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	8.7	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	23.8	0.0	0.0	1.5	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	5.8	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.9	21.0	14.3	15.1	13.3	7.7	20.9	9.6	18.3	18.4
AC005726.1		ENSG00000258472			17	28455752-28614197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	5	"brain: 16.8"	"Cell line enhanced"	"Detected in some"		"A549: 6.4;Karpas-707: 3.4;PC-3: 3.2;THP-1: 3.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046590	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	Nucleoplasm	"HPA046590: "	"unprognostic (1.26e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.76e-3)"	"unprognostic (7.25e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.58e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.17e-3)"	"unprognostic (1.49e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.79e-4)"	0.5	0.6	6.3	0.4	16.4	1.6	0.5	3.5	16.8	2.8	0.9	0.0	0.0	1.6	1.3	0.6	1.4	2.3	2.4	1.0	5.1	3.6	0.9	1.5	3.6	0.5	1.6	6.6	0.8	3.6	0.2	3.1	0.4	6.9	1.0	0.2	3.6	0.5	0.2	0.6	0.5	0.5	0.8	1.1	0.5	1.0	0.6	2.1	0.0	2.6	0.0	1.3	3.5	0.5	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	6.4	0.2	0.8	0.0	0.0	0.2	0.3	0.0	0.2	0.0	2.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	3.4	0.0	0.5	0.0	0.9	0.0	3.2	0.3	0.0	0.0	0.2	1.3	0.0	0.4	0.3	0.9	0.0	0.6	3.4	0.0	0.8	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	6.3	16.4	3.5	16.8	5.1	3.6	1.6	6.6	6.9	2.1
AC245033.1		ENSG00000260836			15	82536788-82573194	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	5	"brain: 11.3"	"Cell line enriched"	"Detected in some"	5	"U-2197: 18.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055060	Uncertain		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum"	"Nucleoli, Cytosol"	"HPA055060: "									"unprognostic (2.91e-2)"									1.5	0.9	5.3	0.9	7.1	0.9	1.3	6.1	11.3	0.9	1.0	1.4	0.0	0.9	0.9	0.9	1.5	0.9	0.9	1.3	3.9	1.6	0.9	1.0	1.1	0.9	3.2	6.1	0.9	1.0	0.9	2.0	1.0	7.3	1.1	1.1	1.9	0.9	0.9	2.0	0.9	1.4	0.9	2.4	1.1	0.9	1.4	1.7	0.0	1.0	0.0	1.0	1.7	0.8	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	1.7	0.0	0.0	0.0	0.7	0.7	18.5	0.3	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.1	6.1	11.3	3.9	1.6	3.2	6.1	7.3	1.7
AMPH		ENSG00000078053	Amphiphysin	P49418	7	38383704-38631567	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 57.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 31.8;ASC TERT1: 18.8;BJ hTERT+ SV40 Large T+: 12.3;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HBF TERT88: 11.3;HSkMC: 11.0;U-138 MG: 12.1;WM-115: 10.8"	"Cancer enhanced"	"Detected in many"		"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008559, HPA019828, HPA019829"	Enhanced		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802"	"unprognostic (1.76e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.24e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.08e-1)"	"prognostic favourable (9.96e-4)"	"unprognostic (5.06e-2)"	"unprognostic (5.81e-5)"	"unprognostic (1.23e-2)"	"unprognostic (5.63e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"	3.8	2.4	17.4	2.5	17.7	1.0	2.8	29.7	57.2	7.7	2.2	1.8	0.0	1.4	5.1	4.7	4.5	5.7	4.2	6.5	13.5	16.0	3.7	1.4	1.6	1.3	10.4	20.4	1.7	2.9	1.2	12.6	1.0	26.5	2.4	2.5	4.8	1.5	4.2	2.9	1.3	1.9	5.0	4.9	1.9	2.0	3.5	1.5	0.0	1.2	0.2	1.1	2.9	1.7	0.2	1.6	0.0	0.8	0.7	2.9	0.2	0.0	0.0	8.0	0.0	31.8	18.8	0.0	1.1	0.0	12.3	14.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	11.3	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	11.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.1	0.0	0.1	4.0	0.0	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.1	8.5	4.2	4.5	0.0	0.1	0.0	8.2	0.1	10.8	0.0	0.8	0.0	2.9	0.2	1.7	0.0	1.0	1.5	0.2	0.2	0.4	2.0	0.0	0.7	0.2	1.6	0.2	0.2	17.4	17.7	29.7	32.9	13.5	16.0	10.4	20.4	26.5	1.5
ANKRD34A	ANKRD34	ENSG00000272031	"Ankyrin repeat domain 34A"	Q69YU3	1	145959442-145964582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 18.1"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.4"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.5;T-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029642, HPA029643"	Uncertain		Enhanced	Cytosol				Cytosol		"HPA029642: AB_10599277, HPA029643: AB_10601878"	"unprognostic (1.98e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.68e-3)"	"unprognostic (9.66e-8)"	"unprognostic (6.36e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.23e-2)"	0.8	1.3	6.4	2.0	10.5	0.3	0.6	7.8	18.1	0.9	0.7	1.2	0.0	1.6	1.5	1.2	0.9	0.7	1.1	1.7	4.2		0.5	0.2	0.7	1.4	0.4	6.7	1.6	0.5	2.0	1.2	0.5	5.7	1.7	0.4	1.3	0.8	2.2	2.3	0.8	1.6	1.6	0.0	1.4	1.1	0.5	1.0	0.0	0.6	0.0	1.5	0.9	0.0	1.5	0.4	0.6	0.3	0.3	3.5	1.0	1.4	0.7	0.7	2.4	3.5	2.7	0.3	2.7	5.1	0.6	1.7	0.2	0.8	2.7	0.3	3.4	0.6	1.1	0.8	0.4	5.8	1.7	0.2	2.1	0.0	0.5	0.3	2.3	2.4	0.3	2.2	2.5	0.9	1.3	6.3	4.0	2.5	1.1	0.8	0.3	3.0	0.3	0.6	12.4	1.1	0.1	3.4	2.5	0.5	0.1	1.6	3.6	0.4	0.8	6.2	4.2	5.3	1.3	4.4	8.4	0.4	6.1	2.2	0.4	0.0	0.1	0.6	3.5	0.3	2.6	1.5	1.7	1.9	0.4	1.4	2.3	3.4	0.3	0.3	0.0	0.1	1.7	1.0										
APLP1	APLP	ENSG00000105290	"Amyloid beta precursor like protein 1"	P51693	19	35867899-35879791	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Endocytosis"	Heparin-binding	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 147.5"	"Cell line enhanced"	"Detected in many"		"AF22: 24.8;AN3-CA: 46.0;EFO-21: 24.4;HMC-1: 23.8;SCLC-21H: 26.8;SH-SY5Y: 27.2"	"Cancer enhanced"	"Detected in many"		"glioma: 63.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028970, HPA028971"	Enhanced						3900000			"HPA028970: AB_2672847, HPA028971: AB_10601334"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.36e-3)"	"prognostic unfavourable (3.87e-4)"	"unprognostic (7.32e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.57e-11)"	"unprognostic (1.38e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.43e-2)"	"prognostic unfavourable (2.65e-5)"	2.6	15.6	37.0	2.9	47.9	1.6	1.6	13.1	147.5	2.4	2.6	91.6	0.0	2.0	2.3	2.1	2.2	2.3	4.3	6.0	53.2	37.4	2.4	1.5	2.4	2.1	54.6	24.6	1.9	32.1	5.6	17.6	1.9	38.4	2.3	2.6	3.3	2.4	2.4	1.5	2.0	2.4	2.9	118.2	1.7	9.6	5.7	36.9	0.0	2.2	0.0	2.2	2.1	0.1	1.5	0.4	2.2	0.7	3.0	0.6	0.2	1.4	10.4	24.8	46.0	2.4	1.0	3.2	2.1	1.1	2.4	0.3	2.4	1.4	0.2	24.4	5.3	0.7	7.7	0.5	1.6	17.3	0.9	0.1	3.1	1.4	0.7	0.0	23.8	1.1	0.6	1.0	0.0	0.8	0.9	0.4	7.0	2.3	0.0	0.0	1.2	6.1	2.4	0.1	0.3	0.4	0.3	26.8	27.2	8.0	1.1	0.3	6.0	1.3	0.6	16.7	9.6	9.4	1.3	1.1	0.4	0.1	11.0	0.3	8.4	2.2	0.7	0.4	0.4	0.5	0.3	0.7	0.4	0.6	0.2	1.5	0.5	0.6	2.1	3.0	0.7	0.4	0.2	0.2	37.0	47.9	13.1	54.6	53.2	37.4	54.6	24.6	38.4	36.9
ATP1B2	AMOG	ENSG00000129244	"ATPase Na+/K+ transporting subunit beta 2"	P14415	17	7646627-7657768	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 148.8"	"Cell line enhanced"	"Detected in some"		"AF22: 13.9;HAP1: 4.2;K-562: 6.3"	"Cancer enriched"	"Detected in many"	17	"glioma: 200.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010698	Enhanced						17000			"HPA010698: AB_1845174"	"unprognostic (9.39e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.89e-3)"	"unprognostic (4.96e-3)"	"unprognostic (3.90e-3)"	"unprognostic (9.33e-2)"	"unprognostic (4.86e-1)"	"unprognostic (5.93e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.29e-2)"	"prognostic favourable (1.05e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (4.17e-4)"	"unprognostic (4.60e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.79e-2)"	4.1	6.5	54.7	2.5	61.6	8.1	2.5	62.9	148.8	9.4	3.4	25.1	0.0	2.7	8.0	15.1	3.4	10.9	4.4	5.0	46.1	33.4	6.9	3.4	3.9	2.9	42.4	41.9	23.3	3.3	3.8	10.8	5.0	68.9	4.6	3.8	28.4	3.3	7.6	4.6	2.7	3.0	5.8	58.7	4.8	2.4	4.3	25.7	0.0	4.4	0.0	2.6	3.3	2.0	1.3	0.7	1.5	1.0	1.3	2.0	0.5	0.0	0.0	13.9	0.6	0.4	0.3	0.1	0.2	0.0	0.5	0.4	0.5	0.0	0.4	0.3	0.1	0.4	4.2	0.3	0.2	0.1	1.7	0.3	0.1	0.1	0.2	0.1	1.3	0.8	0.0	0.5	0.0	0.0	6.3	0.8	0.0	0.4	0.3	0.4	2.9	0.3	0.2	0.1	0.2	0.1	0.1	0.2	2.7	0.0	0.1	0.1	0.2	0.3	0.0	0.2	1.1	0.1	0.2	0.6	0.2	0.1	1.3	0.3	0.3	0.9	1.0	0.5	2.0	0.3	1.8	1.3	0.7	1.4	0.3	0.8	1.1	1.0	1.5	1.3	0.2	0.7	0.2	0.5	54.7	61.6	62.9	50.8	46.1	33.4	42.4	41.9	68.9	25.7
BRSK1	KIAA1811	ENSG00000160469	"BR serine/threonine kinase 1"	Q8TDC3	19	55282072-55312533	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 65.0"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 25.9;SH-SY5Y: 23.2;WM-115: 21.1"	"Cancer enhanced"	"Detected in all"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021212, HPA061719"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA021212: AB_1845455, HPA061719: "	"unprognostic (1.42e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.06e-6)"	"unprognostic (4.24e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.04e-1)"	"prognostic favourable (1.02e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavourable (7.98e-6)"	"unprognostic (1.16e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	1.4	9.8	28.6	3.2	23.6	1.0	1.6	26.7	65.0	1.8	2.2	7.9	0.1	3.3	5.4	3.7	3.0	2.3	3.9	6.5	33.4	20.0	1.4	0.8	1.7	2.4	20.4	14.8	2.4	2.6	12.4	11.0	1.5	13.3	3.8	1.9	2.8	2.5	4.6	1.0	1.1	2.6	4.9	9.2	1.5	1.9	4.4	7.2	0.0	3.0	0.0	1.6	3.2	0.7	0.0	0.3	0.0	0.9	0.1	0.8	0.2	0.3	1.2	15.3	8.0	0.0	0.6	0.1	2.4	3.4	3.3	4.8	5.9	2.7	3.1	1.7	2.7	0.1	3.2	0.1	3.1	14.4	12.6	2.0	1.6	0.6	3.3	0.6	5.9	2.1	0.3	3.3	0.0	0.1	2.8	18.8	2.9	0.8	3.6	0.7	11.1	1.0	8.3	3.8	0.5	0.2	0.0	25.9	23.2	0.0	0.4	5.6	1.3	1.7	0.0	6.3	6.7	3.5	4.6	15.6	11.4	7.0	6.5	1.4	21.1	0.0	0.9	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.2	28.6	23.6	26.7	40.2	33.4	20.0	20.4	14.8	13.3	7.2
BSN	ZNF231	ENSG00000164061	"Bassoon presynaptic cytomatrix protein"	Q9UPA5	3	49554489-49671545	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 36.9"	"Cell line enhanced"	"Detected in some"		"K-562: 3.8;SCLC-21H: 8.9;SH-SY5Y: 5.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034757	Enhanced									"HPA034757: AB_10671233"	"unprognostic (8.57e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.50e-4)"	"unprognostic (7.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.21e-5)"	"unprognostic (2.50e-3)"	"unprognostic (5.38e-5)"	"unprognostic (9.33e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.34e-2)"	1.2	3.9	23.0	1.3	22.4	1.1	1.2	25.4	36.9	1.3	1.2	1.8	0.0	1.3	1.5	7.0	1.2	1.4	1.2	1.3	13.1	5.1	1.4	1.3	1.3	1.2	3.9	19.1	1.6	2.1	1.7	4.4	1.3	7.9	1.3	1.2	0.7	1.3	1.4	1.4	1.3	1.3	1.3	1.6	1.3	1.7	5.1	4.0	0.0	1.4	0.0	1.1	1.1	0.3	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.2	0.4	2.1	1.4	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.5	0.4	2.4	0.5	0.0	0.3	0.3	0.0	0.1	0.4	1.0	0.3	0.6	1.1	0.0	0.4	0.9	0.1	0.0	0.0	0.4	0.0	3.8	0.4	0.1	0.8	0.4	0.2	1.7	1.0	0.0	0.2	0.4	0.0	0.4	8.9	5.5	0.8	0.1	0.1	0.1	0.4	0.0	0.2	0.2	0.2	0.1	0.3	1.0	0.2	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	23.0	22.4	25.4	36.9	13.1	5.1	3.9	19.1	7.9	4.0
BTBD8		ENSG00000189195	"BTB domain containing 8"	Q5XKL5	1	92080305-92184725	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 42.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 10.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA024216, HPA035311"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA024216: AB_1852385, HPA035311: AB_10671933"	"unprognostic (2.94e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.73e-3)"	"unprognostic (5.04e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.15e-1)"	3.4	4.6	11.7	1.2	27.3	0.7	3.3	20.3	42.3	2.3	2.4	4.0	0.6	1.7	3.4	4.7	2.0	3.3	2.3	2.8	7.8	2.1	2.4	1.9	2.5	1.4	4.5	23.3	5.0	2.7	5.1	6.0	2.5	16.4	3.3	2.5	1.2	2.8	2.7	2.3	1.8	2.1	2.0	6.6	1.8	2.4	8.3	9.9	0.2	3.7	0.0	1.1	4.7	2.7	0.5	0.8	0.6	0.7	0.9	2.3	0.4	2.8	2.3	1.7	0.0	5.2	10.5	5.7	1.8	2.5	1.5	1.9	0.5	3.3	1.2	6.7	1.6	0.8	1.3	3.3	2.4	2.9	1.9	2.1	0.6	0.9	1.1	1.1	1.3	6.1	2.8	0.9	1.8	1.6	2.5	0.8	2.8	1.7	0.8	2.2	1.7	1.8	1.8	1.7	0.2	3.3	2.1	0.9	1.5	3.0	1.5	1.5	2.3	1.6	1.1	2.0	1.2	1.1	0.7	2.2	0.9	0.0	1.6	0.2	0.4	0.0	0.6	0.0	2.3	0.1	0.5	0.5	1.0	0.9	0.0	0.5	1.8	1.4	0.6	0.9	0.7	0.8	0.9	0.4	11.7	27.3	20.3	42.3	7.8	2.1	4.5	23.3	16.4	9.9
CADPS2	CAPS2	ENSG00000081803	"Calcium dependent secretion activator 2"	Q86UW7	7	122318425-122886759	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 105.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 21.6;Karpas-707: 28.2;MCF7: 14.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 105.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 325.7"	HPA056398			Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA056398: "	"unprognostic (1.93e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.67e-3)"	"unprognostic (8.69e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.30e-1)"	"prognostic favourable (1.01e-7)"	"unprognostic (9.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-2)"	5.1	11.2	5.1	1.9	7.1	0.0	9.5	105.4	21.1	16.5	5.3	1.4	13.3	6.1	16.3	16.4	5.7	5.7	8.0	4.6	6.8	8.8	20.3	6.2	9.0	1.3	14.0	9.3	5.2	13.2	15.4	17.7	2.7	7.0	10.4	5.4	4.7	23.0	11.5	2.6	2.4	4.7	11.2	4.1	3.3	9.8	1.9	1.4	0.4	9.4	2.4	1.6	4.4	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.6	2.7	0.1	0.2	6.7	1.5	6.8	0.0	6.2	0.0	0.0	3.1	0.0	0.2	0.9	0.6	0.0	5.5	2.1	0.0	12.1	8.7	0.0	0.1	2.8	1.2	1.1	0.9	21.6	0.0	28.2	0.1	14.8	0.0	0.0	6.3	10.7	0.0	0.0	11.1	0.3	7.0	10.9	0.0	0.3	12.2	0.5	4.7	0.0	6.1	2.4	1.6	0.0	4.3	8.4	0.3	0.0	9.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	7.1	105.4	21.1	6.8	8.8	14.0	9.3	7.0	1.4
CAMKK2	"CAMKK, CAMKKB, KIAA0787, MGC15254"	ENSG00000110931	"Calcium/calmodulin dependent protein kinase kinase 2"	Q96RR4	12	121237691-121298308	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 125.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 125.5"	"Group enriched"	"Detected in many"	5	"classical monocyte: 14.2;eosinophil: 26.1;intermediate monocyte: 19.4;myeloid DC: 7.2;neutrophil: 17.2;non-classical monocyte: 16.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 7.2;granulocytes: 26.1;monocytes: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017389, HPA063713"	Approved	Supported	Supported	Cytosol				Cytosol		"HPA017389: AB_1845956, HPA063713: "	"unprognostic (5.08e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	11.7	6.5	19.7	7.8	30.2	13.8	8.8	125.5	45.5	9.0	9.5	7.1	2.6	12.8	8.6	5.3	8.3	11.8	6.3	6.9	11.2	5.1	7.1	8.9	9.6	6.9	6.2	17.3	10.5	5.8	6.4	4.1	7.5	9.1	12.2	9.7	6.2	7.5	13.2	5.1	9.1	13.2	10.3	6.2	14.1	7.6	3.6	5.8	5.2	6.1	4.5	7.2	7.2	7.4	2.2	7.2	26.1	19.4	3.6	2.2	6.3	12.3	9.3	6.9	13.4	20.8	19.4	10.6	10.2	10.9	8.4	7.7	9.7	5.3	19.1	8.6	20.7	10.2	8.5	11.0	6.6	13.1	16.7	9.5	6.2	9.5	14.1	21.6	9.1	12.5	16.4	7.9	18.0	19.6	11.0	10.4	8.1	12.0	23.9	17.8	5.0	10.5	15.6	8.0	16.9	8.1	13.8	26.6	10.6	13.4	7.2	8.5	17.9	26.4	14.3	6.9	5.6	5.8	5.6	39.7	23.6	14.5	12.9	15.1	6.8	0.7	14.2	26.1	2.1	19.4	2.2	2.2	1.7	1.9	7.2	1.2	1.5	1.7	17.2	3.6	16.5	1.6	1.3	6.3	19.7	30.2	125.5	45.5	11.2	5.1	6.2	17.3	9.1	5.8
CDH10		ENSG00000040731	"Cadherin 10"	Q9Y6N8	5	24487100-24644978	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 45.4"	"Cell line enhanced"	"Detected in some"		"AF22: 11.5;AN3-CA: 1.8;HAP1: 7.3;U-138 MG: 2.5"	"Group enriched"	"Detected in some"	7	"glioma: 5.3;prostate cancer: 1.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010651	Approved									"HPA010651: AB_1078370"	"unprognostic (4.31e-3)"			"unprognostic (2.77e-1)"	"unprognostic (1.88e-1)"			"unprognostic (3.66e-2)"		"unprognostic (4.48e-1)"	"unprognostic (6.11e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.59e-7)"	"unprognostic (1.65e-2)"	"unprognostic (1.41e-1)"		"unprognostic (8.74e-3)"	0.9	2.1	9.4	0.8	9.6	0.8	1.0	45.4	34.0	0.9	1.1	1.5	0.0	0.9	0.9	0.8	0.9	0.9	1.2	0.9	9.4	5.2	1.0	0.8	1.1	0.8	3.6	13.4	0.8	0.9	0.8	2.1	0.8	6.0	8.6	1.3	0.0	0.8	1.4	0.8	0.8	1.1	0.9	7.0	0.8	1.0	1.4	3.7	0.0	0.8	0.0	0.9	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	2.5	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	9.6	45.4	21.3	9.4	5.2	3.6	13.4	6.0	3.7
CDH22	"C20orf25, dJ998H6.1"	ENSG00000149654	"Cadherin 22"	Q9UJ99	20	46173733-46308498	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 55.8"	"Cell line enriched"	"Detected in single"	18	"SCLC-21H: 8.3"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in all"		"cerebellum: 55.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012164, HPA012715"	Uncertain	Supported								"HPA012164: AB_1845902, HPA012715: "	"unprognostic (2.41e-4)"	"unprognostic (1.72e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.39e-2)"	"unprognostic (4.73e-1)"	"unprognostic (4.32e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.54e-2)"	"unprognostic (4.50e-4)"	"unprognostic (2.62e-1)"	"unprognostic (3.09e-1)"	"unprognostic (7.26e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.83e-2)"	0.7	4.2	10.2	0.5	5.7	0.5	0.8	55.8	15.5	0.7	0.6	1.0	0.0	0.6	0.7	0.7	1.2	4.0	0.5	1.0	3.5	3.7	0.7	0.5	0.6	0.5	1.2	8.7	0.9	4.2	0.5	1.1	0.5	3.0	1.5	0.7	1.8	1.0	1.8	1.2	10.4	0.9	0.5	1.9	0.5	0.9	1.4	1.3	0.0	0.7	0.0	0.5	0.5	0.6	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	10.2	5.7	55.8	14.8	3.5	3.7	1.2	8.7	3.0	1.3
CDH7		ENSG00000081138	"Cadherin 7"	Q9ULB5	18	65750252-65890341	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 16.7"	"Cell line enhanced"	"Detected in some"		"AF22: 16.9;HEK 293: 3.2;Karpas-707: 6.2;RH-30: 8.1;U-87 MG: 3.8"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061419	Approved									"HPA061419: "	"unprognostic (2.81e-3)"		"unprognostic (6.95e-2)"		"unprognostic (2.26e-1)"			"unprognostic (2.24e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.28e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.49e-1)"		"unprognostic (1.72e-1)"	0.4	0.6	2.6	0.3	4.3	0.6	0.4	15.3	7.5	0.3	0.3	0.0	0.0	0.4	0.3	0.6	0.3	0.3	0.4	0.4	0.5	2.5	0.3	0.6	0.4	0.3	1.5	2.1	1.6	0.3	0.3	1.2	0.3	16.7	3.6	0.5	1.3	0.4	1.9	1.0	0.5	0.3	0.2	1.3	0.4	0.3	1.8	0.1	0.7	0.5	0.0	0.4	0.3	0.2	0.8	0.5	1.9	0.4	0.6	0.4	0.1	0.0	0.2	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.7	0.3	0.1	8.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.8	1.3	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	3.8	0.0	0.0	1.2	0.4	0.4	0.3	0.2	0.3	0.3	0.3	0.3	0.0	0.8	0.4	0.4	1.9	0.6	0.3	0.5	0.2	0.1	2.6	4.3	15.3	5.2	0.5	2.5	1.5	2.1	16.7	0.1
CDK5R1	"Nck5a, p35, p35nck5a"	ENSG00000176749	"Cyclin dependent kinase 5 regulatory subunit 1"	Q15078	17	32486619-32491256	"Predicted intracellular proteins"	"Biological rhythms"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 58.8"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 31.5;SK-MEL-30: 22.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000252			Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA000252: "	"unprognostic (1.08e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.74e-5)"	"unprognostic (1.81e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.90e-2)"	"unprognostic (5.60e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.92e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.03e-1)"	1.6	3.3	21.9	6.4	21.1	4.9	1.8	26.0	58.8	1.2	1.6	3.6	0.0	2.0	1.6	1.0	5.5	1.5	1.6	1.6	21.4	17.3	1.5	1.3	1.4	11.5	7.6	24.5	3.2	2.0	1.3	3.0	1.4	7.8	1.4	1.5	0.9	1.2	1.3	1.8	2.2	2.0	1.3	4.1	7.7	2.2	5.2	3.2	1.2	1.1	0.3	12.3	1.7	1.1	0.6	1.8	2.9	0.9	0.7	4.2	1.5	2.0	1.1	5.2	1.6	0.6	1.0	0.6	1.2	0.7	1.5	2.0	3.0	0.5	1.0	1.2	1.0	0.9	2.0	1.2	2.1	0.3	3.9	0.3	0.5	1.1	0.2	0.6	1.1	0.6	3.1	1.6	1.3	1.1	2.0	1.2	3.2	0.8	1.7	0.8	3.3	1.1	1.5	3.1	3.6	0.7	0.9	31.5	8.5	1.2	0.7	22.6	1.3	2.4	1.1	2.1	3.2	0.8	3.2	0.6	0.8	1.0	1.8	2.9	5.1	0.0	0.9	1.2	2.3	0.8	1.8	0.6	3.1	1.3	0.2	0.5	4.2	2.6	2.9	0.7	0.4	1.8	0.4	1.5	21.9	21.1	26.0	37.3	21.4	17.3	7.6	24.5	7.8	3.2
CELF5	BRUNOL5	ENSG00000161082	"CUGBP Elav-like family member 5"	Q8N6W0	19	3224703-3297076	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 35.8"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 6.0;REH: 7.4;SCLC-21H: 7.6;SH-SY5Y: 4.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042012, HPA060336"	Enhanced									"HPA042012: AB_10796896, HPA060336: "	"unprognostic (1.09e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.70e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.07e-2)"	0.8	1.1	16.2	0.8	21.2	0.7	1.5	19.6	35.8	0.8	1.0	0.8	0.0	0.8	1.3	1.1	0.8	1.5	0.7	0.8	9.5	12.2	0.8	0.8	0.8	0.7	2.6	15.5	7.1	1.1	2.6	0.5	0.8	3.4	0.9	1.0	0.0	2.0	1.0	1.3	0.8	0.9	0.8	0.9	0.8	1.2	2.5	2.7	0.2	0.8	0.0	0.7	0.7	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.4	1.3	1.6	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	1.0	0.1	0.0	6.0	0.1	7.4	0.0	0.0	0.0	0.0	7.6	4.6	0.3	0.5	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.2	21.2	19.6	19.6	9.5	12.2	2.6	15.5	3.4	2.7
CERS1	"LAG1, LASS1, UOG1"	ENSG00000223802	"Ceramide synthase 1"	P27544	19	18868545-18896727	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 86.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.4;EFO-21: 12.7;HEK 293: 17.7;NB-4: 19.0;NTERA-2: 13.0"	"Cancer enhanced"	"Detected in many"		"glioma: 13.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.7"									HPA045724	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"		"HPA045724: AB_10969762"	"unprognostic (8.25e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.04e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.49e-1)"	2.4	4.7	28.9	2.3	32.9	1.7	1.7	12.5	86.3	2.2	2.1	40.5	0.0	1.6	2.0	2.1	2.5	2.1	3.9	3.4	29.5	23.2	1.6	1.6	1.9	1.6	31.9	20.5	4.3	2.4	1.7	3.2	1.9	33.8	2.0	1.8	1.8	2.3	2.1	17.8	2.0	1.9	3.0	37.8	1.7	1.8	15.7	22.2	0.0	2.4	0.0	1.6	2.6	0.4	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.1	1.7	10.7	17.4	0.6	0.2	0.3	1.1	0.1	3.0	2.2	8.5	0.6	0.0	12.7	0.8	0.1	7.8	0.3	1.2	0.0	17.7	0.1	0.4	6.4	1.4	1.7	0.2	0.6	0.1	1.0	0.3	0.7	1.1	0.1	2.0	4.4	0.1	19.0	13.0	0.3	0.0	0.3	0.3	2.3	0.0	9.1	9.1	0.4	0.0	7.7	2.9	10.6	0.2	0.0	2.4	1.7	2.5	0.3	0.2	0.0	0.0	0.6	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	28.9	32.9	12.5	35.7	29.5	23.2	31.9	20.5	33.8	22.2
CHN1	"ARHGAP2, CHN, DURS2, n-chimerin, RhoGAP2"	ENSG00000128656	"Chimerin 1"	P15882	2	174799363-175005369	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"GTPase activation"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 145.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 58.9;BJ hTERT+ SV40 Large T+ RasG12V: 29.7"	"Cancer enhanced"	"Detected in all"		"glioma: 18.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 9.0;memory CD8 T-cell: 2.9;T-reg: 10.0"	"Lineage enriched"	"Detected in single"	35	"T-cells: 10.0"	"Low region specificity"	"Detected in all"							HPA036111			Approved	Cytosol				Cytosol		"HPA036111: AB_10671241"	"unprognostic (3.18e-3)"	"unprognostic (4.19e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (5.07e-4)"	"unprognostic (7.31e-3)"	"unprognostic (4.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.46e-2)"	3.8	5.2	63.4	3.4	60.8	1.0	2.4	9.1	145.3	4.7	2.5	4.4	0.2	1.7	3.9	15.1	3.2	2.9	4.7	5.2	74.0	21.4	2.1	1.4	7.1	7.4	21.4	51.7	2.8	1.9	31.7	5.2	14.4	23.0	7.2	2.6	3.1	1.4	4.6	1.2	1.9	1.8	5.5	5.1	2.7	2.1	7.5	9.1	0.0	4.0	0.0	7.2	4.5	1.2	0.2	0.2	0.0	0.0	0.1	10.0	1.1	0.0	3.3	14.6	4.2	4.5	20.7	0.1	14.1	58.9	20.3	29.7	0.1	1.9	0.1	0.4	21.2	0.5	18.6	0.4	8.2	0.2	8.1	2.5	4.8	1.4	10.0	1.3	0.3	18.4	0.5	9.8	3.1	7.5	0.1	0.6	14.9	2.7	6.7	0.6	17.3	5.0	2.1	20.6	0.1	0.2	0.1	18.0	19.5	11.2	0.1	1.7	0.6	0.3	2.3	8.6	1.3	2.8	5.1	1.6	7.8	0.2	1.9	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.7	0.2	9.0	2.9	0.0	0.0	1.3	0.3	0.0	0.1	0.0	0.2	10.0	1.1	63.4	60.8	9.1	135.3	74.0	21.4	21.4	51.7	23.0	9.1
CLVS2	"bA160A10.4, C6orf212, C6orf213, RLBP1L2"	ENSG00000146352	"Clavesin 2"	Q5SYC1	6	122995971-123072927	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.9"	"Group enriched"	"Detected in some"	8	"HEL: 14.3;SCLC-21H: 11.2"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043764	Uncertain									"HPA043764: AB_10960281"	"unprognostic (1.35e-1)"		"unprognostic (3.28e-2)"		"unprognostic (4.68e-2)"				"unprognostic (3.60e-1)"		"unprognostic (2.38e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.72e-3)"	"unprognostic (9.60e-2)"		"unprognostic (8.71e-2)"	0.7	2.8	5.0	0.9	9.6	0.7	0.8	39.9	22.6	2.1	1.1	0.6	0.0	0.9	3.1	0.7	0.8	0.7	0.8	0.7	5.8	3.9	0.7	0.8	0.7	0.8	3.0	10.2	0.7	0.7	0.7	6.3	0.7	8.5	7.9	1.1	0.1	0.8	1.1	0.7	0.8	0.9	2.8	1.3	0.7	0.8	1.0	1.8	0.0	0.7	0.0	0.7	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	9.6	39.9	22.6	5.8	3.9	3.0	10.2	8.5	1.8
CNKSR2	"CNK2, KIAA0902, KSR2"	ENSG00000149970	"Connector enhancer of kinase suppressor of Ras 2"	Q8WXI2	X	21372801-21654695	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 38.4"	"Cell line enhanced"	"Detected in some"		"A549: 6.7;AF22: 4.7;NTERA-2: 10.8;PC-3: 5.5;RH-30: 10.1;U-251 MG: 6.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.9;naive CD4 T-cell: 3.0"	"Group enriched"	"Detected in many"	5	"B-cells: 2.9;T-cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001502			Approved	"Golgi apparatus,Plasma membrane"				"Golgi apparatus, Plasma membrane"		"HPA001502: AB_1078542"	"unprognostic (1.33e-2)"	"unprognostic (1.00e-3)"	"unprognostic (5.35e-2)"	"unprognostic (4.90e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.13e-2)"	2.0	5.2	23.5	1.4	29.6	1.3	2.1	31.3	38.4	1.4	1.2	1.7	0.0	1.1	1.4	1.8	1.1	2.3	1.2	1.7	26.4	4.4	1.0	2.0	2.8	2.4	3.1	20.8	1.9	4.9	1.0	1.0	1.1	1.8	2.2	1.1	3.5	1.7	1.2	7.4	1.1	1.2	1.2	1.7	1.8	1.3	1.8	5.0	0.6	1.2	0.0	2.6	1.3	0.7	2.9	0.1	0.6	0.0	0.0	3.0	0.3	0.0	6.7	4.7	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	1.4	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.1	10.8	5.5	0.0	10.1	0.0	0.0	0.0	4.6	1.8	0.0	0.1	0.2	0.0	0.6	0.0	0.1	2.1	0.0	6.7	3.5	0.0	3.5	0.9	0.0	2.6	0.1	0.0	0.6	0.1	0.0	0.4	1.1	0.6	0.0	0.0	2.9	3.0	1.0	0.0	0.0	0.0	0.1	0.8	0.3	23.5	29.6	31.3	24.4	26.4	4.4	3.1	20.8	1.8	5.0
CNTF	HCNTF	ENSG00000242689	"Ciliary neurotrophic factor"	P26441	11	58622673-58625733	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"brain: 47.5"	"Cell line enhanced"	"Detected in many"		"U-2197: 12.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"midbrain: 47.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA019654	Approved		Approved	Vesicles				Vesicles		"HPA019654: AB_1859050"	"unprognostic (1.88e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.25e-4)"	"unprognostic (5.42e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.50e-2)"	"unprognostic (9.67e-2)"	2.0	0.7	1.4	0.9	4.8	10.0	0.8	1.2	1.6	0.3	0.9	2.5	1.1	1.4	0.3	1.4	0.9	8.3	0.8	2.5	1.8	1.6	0.9	0.9	0.8	0.6	47.5	0.9	0.3	0.5	1.2	0.5	0.6	9.3	0.6	1.3	3.1	1.3	0.4	3.7	0.9	0.9	0.6	22.8	0.6	0.5	0.7	1.2	0.2	1.0	3.7	0.6	0.6	0.3	0.4	0.0	0.0	0.3	0.0	0.7	0.2	2.1	0.8	3.4	3.5	1.0	0.3	1.7	1.6	2.2	1.6	1.2	2.9	2.9	4.3	1.2	2.2	3.8	3.6	3.9	3.2	3.0	2.1	2.3	4.3	1.6	0.4	3.3	4.2	1.0	1.3	5.3	1.7	1.7	3.4	1.0	2.0	0.9	3.2	3.1	2.1	1.5	2.2	2.4	3.0	1.9	2.5	1.5	4.2	2.2	2.3	5.8	2.9	2.4	1.2	2.5	1.9	12.7	4.0	2.4	4.9	3.7	6.6	1.7	2.9	0.0	0.3	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	1.4	4.8	1.2	1.4	1.8	1.6	47.5	0.9	9.3	1.2
CNTNAP5	"caspr5, FLJ31966"	ENSG00000155052	"Contactin associated protein like 5"	Q8WYK1	2	124025287-124915287	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 22.4"	"Cell line enhanced"	"Detected in some"		"AF22: 3.2;HMC-1: 2.1;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 7.2"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA069095, HPA069356"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"				"Nucleoli fibrillar center"	"Nucleoplasm, Vesicles"	"HPA069095: , HPA069356: "				"unprognostic (6.32e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.23e-1)"		"unprognostic (2.25e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.62e-6)"	"unprognostic (3.65e-3)"	"unprognostic (5.32e-2)"		"unprognostic (9.58e-2)"	0.7	2.8	12.9	0.7	7.9	1.0	0.7	3.3	22.4	0.6	0.8	1.5	0.0	1.0	0.7	0.7	0.7	0.6	4.2	0.7	14.0	4.0	1.2	0.7	0.7	0.7	2.2	8.4	0.6	1.1	0.7	0.8	0.7	15.2	0.8	0.8	0.4	0.6	1.0	0.7	0.8	0.9	0.8	1.9	0.7	0.7	0.9	2.8	0.0	0.7	0.0	0.6	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.1	0.0	1.3	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.9	7.9	3.3	22.4	14.0	4.0	2.2	8.4	15.2	2.8
CRTAM	CD355	ENSG00000109943	"Cytotoxic and regulatory T cell molecule"	O95727	11	122838500-122872639	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 140.8"	"Cell line enriched"	"Detected in single"	34	"SCLC-21H: 17.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	24	"cerebellum: 140.8"	"Cell type enhanced"	"Detected in many"		"NK-cell: 25.7"	"Group enriched"	"Detected in many"	5	"NK-cells: 25.7;T-cells: 16.7"	"Region enriched"	"Detected in single"	44	"cerebellum: 115.2"	"Low region specificity"	"Detected in all"										3200000				"unprognostic (3.51e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.25e-4)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-4)"	"unprognostic (6.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.59e-2)"	0.4	0.3	0.3	2.7	0.4	1.9	0.4	140.8	0.4	0.3	0.4	0.2	0.1	0.4	0.8	0.4	0.3	0.3	1.8	0.3	0.3	0.3	0.3	1.0	2.2	10.6	0.4	0.1	0.3	0.3	0.0	0.3	0.2	5.8	0.3	0.5	0.3	0.7	0.1	0.3	0.3	1.3	0.2	1.2	4.4	0.7	0.3	0.1	3.3	0.3	0.2	4.3	1.1	0.3	0.1	1.7	0.6	4.4	25.7	16.7	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.2	0.2	6.7	2.7	6.5	0.0	0.7	13.5	1.7	0.1	2.2	16.7	0.6	25.7	4.4	0.1	0.0	2.8	0.3	0.4	140.8	0.4	0.3	0.3	0.4	0.1	5.8	0.1
CSMD3		ENSG00000164796	"CUB and Sushi multiple domains 3"	Q7Z407	8	112222928-113437099	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 26.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 2.3;hTCEpi: 2.3;hTERT-HME1: 1.6;LHCN-M2: 3.3;RH-30: 2.1;SCLC-21H: 1.4;U-2 OS: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029007	Uncertain									"HPA029007: AB_10601802"	"unprognostic (2.26e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.26e-2)"		"unprognostic (3.54e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.33e-2)"	"unprognostic (5.03e-10)"	"unprognostic (1.95e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.74e-3)"	1.0	1.0	26.6	1.0	21.9	1.0	1.0	6.0	18.3	1.6	1.1	2.2	0.0	1.1	1.1	1.1	1.0	2.3	1.0	1.0	14.2	6.7	1.1	1.0	1.1	1.0	3.0	15.8	1.0	1.0	1.0	5.7	1.0	10.9	2.1	1.2	0.0	1.0	2.1	1.0	1.0	1.2	1.1	3.6	2.4	1.3	5.0	7.0	0.0	1.0	0.0	1.0	1.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	2.3	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.3	0.0	1.6	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	21.9	6.0	18.3	14.2	6.7	3.0	15.8	10.9	7.0
CTXN1	FLJ25968	ENSG00000178531	"Cortexin 1"	P60606	19	7924485-7926166	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"brain: 91.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.2;HEK 293: 23.1;NTERA-2: 25.2;REH: 19.1;SCLC-21H: 19.6;SH-SY5Y: 32.9"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 138.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016669	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"				Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA016669: AB_1847330"	"unprognostic (1.49e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.69e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"unprognostic (9.41e-2)"	2.1	4.8	47.7	2.5	91.1	1.6	2.1	0.0	74.2	5.2	6.1	5.0	3.6	2.6	17.5	5.1	2.4	16.4	1.8	1.6	49.4	16.8	3.1	1.5	3.0	1.6	15.7	20.1	2.7	2.1	2.3	6.5	2.0	4.0	5.5	2.1	0.0	2.1	16.5	1.6	2.8	2.1	7.1	1.5	2.0	2.2	6.1	8.3	0.0	1.8	0.0	1.6	2.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	2.7	7.1	33.2	0.0	0.1	1.6	2.9	0.8	1.4	0.8	0.8	1.7	0.0	5.6	0.7	12.1	1.6	0.3	0.0	1.0	23.1	0.2	1.9	0.5	0.3	0.5	0.6	0.0	0.9	0.5	0.3	1.8	7.0	0.1	0.1	13.4	6.1	4.5	25.2	11.7	19.1	0.0	2.1	5.1	0.5	19.6	32.9	1.7	0.9	3.0	7.3	0.2	2.8	0.7	11.7	1.3	1.6	0.2	0.3	1.5	2.8	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.7	91.1	0.0	63.8	49.4	16.8	15.7	20.1	4.0	8.3
DLG4	"PSD-95, PSD95, SAP-90, SAP90"	ENSG00000132535	"Discs large MAGUK scaffold protein 4"	P78352	17	7189890-7219702	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 83.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6;plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001999, CAB002000, HPA010122"	Enhanced				"Intracellular and membrane"					"CAB001999: , CAB002000: , HPA010122: AB_1855169"	"unprognostic (7.08e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.72e-2)"	"prognostic favourable (8.82e-6)"	"unprognostic (3.45e-2)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.77e-3)"	5.5	16.0	58.3	7.5	73.3	4.1	4.5	47.4	83.2	9.7	4.1	5.4	4.3	4.7	13.8	5.0	5.0	9.2	10.7	8.9	58.7	24.2	3.3	3.1	6.0	4.2	14.4	53.9	12.8	4.6	11.5	15.1	8.7	14.8	7.3	3.8	3.1	6.3	12.5	3.6	4.0	4.4	10.7	11.3	7.8	5.7	10.1	17.0	1.7	5.8	0.0	3.5	7.0	4.2	0.0	1.6	0.0	0.9	0.0	1.6	0.6	0.2	7.7	19.3	6.5	7.4	10.9	0.5	10.2	8.8	7.6	7.3	0.3	3.2	1.4	4.5	8.7	0.7	1.1	4.0	3.7	10.1	1.9	5.7	13.8	0.9	6.2	0.1	32.3	12.1	0.5	6.4	6.6	8.9	2.3	5.2	11.4	0.2	4.4	3.5	2.8	0.5	8.0	0.8	0.7	5.5	0.2	7.9	6.3	0.2	0.4	1.2	4.6	3.6	11.0	18.3	8.9	3.7	5.3	0.8	0.5	0.7	13.8	3.7	5.6	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.3	0.1	0.0	0.0	0.1	1.6	0.0	0.6	58.3	73.3	47.4	71.2	58.7	24.2	14.4	53.9	14.8	17.0
DLGAP1	"DAP-1, GKAP, SAPAP1"	ENSG00000170579	"DLG associated protein 1"	O14490	18	3496032-4455335	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 55.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 14.3;HAP1: 5.1;U-2197: 4.5;U-87 MG: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.0"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.50e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.63e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.93e-3)"	"unprognostic (5.49e-3)"	"unprognostic (5.87e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.78e-3)"	"unprognostic (3.10e-2)"	"unprognostic (4.93e-3)"	"unprognostic (8.93e-2)"	"unprognostic (9.68e-2)"	1.0	5.1	18.3	1.0	22.6	0.8	2.4	25.9	55.9	1.4	1.0	1.3	4.1	0.9	1.6	9.0	1.0	7.1	4.8	1.2	17.2	4.7	1.4	0.9	1.4	1.0	4.2	20.8	2.7	1.0	0.8	2.0	1.4	6.1	3.8	1.0	0.0	2.4	11.4	0.9	1.0	0.9	1.1	2.2	1.3	0.9	4.3	1.6	0.0	1.3	0.0	0.9	0.9	0.7	0.5	0.0	2.0	0.0	0.0	0.1	0.2	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	14.3	0.0	0.3	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.4	0.0	1.2	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.7	0.0	1.9	1.2	1.7	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	1.4	4.5	0.0	0.4	0.0	0.2	3.3	0.0	1.3	0.9	0.0	2.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	18.3	22.6	25.9	40.3	17.2	4.7	4.2	20.8	6.1	1.6
DPYSL5	"CRAM, CRMP-5, CRMP5, Ulip6"	ENSG00000157851	"Dihydropyrimidinase like 5"	Q9BPU6	2	26847747-26950351	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 47.1"	"Group enriched"	"Detected in some"	4	"AF22: 41.0;HAP1: 34.1;SCLC-21H: 48.9;SH-SY5Y: 28.9"	"Group enriched"	"Detected in some"	15	"glioma: 17.7;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034544, HPA072387"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA034544: AB_10671228, HPA072387: "	"unprognostic (1.07e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.64e-6)"	"unprognostic (3.94e-1)"	"unprognostic (6.21e-2)"		"unprognostic (6.12e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.43e-1)"	1.2	4.7	6.1	1.6	18.4	1.1	1.1	7.8	36.6	1.4	1.6	43.5	0.0	1.7	1.2	1.1	1.3	1.2	1.1	1.1	10.3	11.3	1.2	1.1	1.1	1.1	24.3	8.8	1.1	1.1	1.1	2.8	1.2	21.9	1.3	1.5	1.6	1.1	1.1	1.2	1.2	1.7	1.6	47.1	1.1	1.1	10.3	19.7	0.0	1.1	0.0	1.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	41.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	0.0	0.0	34.1	0.0	0.0	0.0	7.4	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	48.9	28.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	18.4	7.8	11.8	10.3	11.3	24.3	8.8	21.9	19.7
DRP2		ENSG00000102385	"Dystrophin related protein 2"	Q13474	X	101219769-101264497	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 20.3"	"Cell line enhanced"	"Detected in some"		"RH-30: 11.0;TIME: 18.5;U-87 MG: 4.5"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002949			Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles, Plasma membrane"		"HPA002949: AB_1078706"	"unprognostic (8.47e-4)"	"unprognostic (3.56e-3)"	"unprognostic (1.01e-2)"	"unprognostic (5.58e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.47e-2)"	"unprognostic (7.93e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.27e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.44e-16)"	"unprognostic (3.71e-4)"	"unprognostic (4.22e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.25e-1)"	1.1	1.5	9.3	1.2	17.2	1.1	0.8	0.4	20.3	1.7	2.8	1.2	0.0	1.1	2.5	2.7	1.3	1.0	1.3	0.9	5.8	4.2	0.7	0.6	0.8	0.8	4.6	10.1	4.4	0.6	0.6	2.4	0.7	2.6	4.1	1.8	0.5	0.7	3.1	0.7	0.8	1.2	2.2	3.1	0.7	0.7	1.6	2.2	0.9	0.6	0.0	0.8	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	2.3	0.1	0.1	0.2	0.1	0.4	0.1	0.3	1.0	0.0	0.4	0.3	0.3	0.1	0.0	0.3	0.0	0.7	0.1	0.2	0.2	0.5	0.0	0.2	0.1	0.4	1.5	0.0	0.7	0.0	1.4	0.0	0.9	1.6	0.0	1.3	0.5	0.1	0.1	0.3	11.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.0	0.1	18.5	0.2	0.7	0.2	0.4	0.0	0.1	0.0	4.5	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	9.3	17.2	0.4	20.3	5.8	4.2	4.6	10.1	2.6	2.2
EN2		ENSG00000164778	"Engrailed homeobox 2"	P19622	7	155458129-155464831	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 26.5"	"Cell line enhanced"	"Detected in some"		"AF22: 26.9;AN3-CA: 9.9;HAP1: 5.8;HEK 293: 16.3;SK-MEL-30: 7.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 6.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	8	"cerebellum: 31.1"	"Region enriched"	"Detected in some"	6	"cerebellum: 71.6"	"HPA045646, HPA069809"			Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA045646: , HPA069809: "	"unprognostic (2.44e-3)"	"unprognostic (1.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.99e-3)"	"prognostic unfavourable (1.74e-6)"	"unprognostic (2.54e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.03e-13)"	"unprognostic (4.91e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.64e-3)"	0.3	0.2	0.1	0.0	0.1	0.0	0.1	26.5	0.1	0.0	0.0			0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.3		1.3	1.2	5.0	0.0	0.0		0.0	0.0		0.0	0.0	0.8	1.1	0.0	0.0	0.4	0.0	0.0	2.1			0.0		0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.4	26.9	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	5.8	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.2	3.4	0.0	0.0	0.0	1.3	0.0	2.1	0.0	0.1	0.2	0.0	0.0	1.9	0.0	7.9	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FAIM2	"KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2"	ENSG00000135472	"Fas apoptotic inhibitory molecule 2"	Q9BWQ8	12	49866896-49904217	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 138.5"	"Cell line enhanced"	"Detected in some"		"HHSteC: 9.2;SH-SY5Y: 4.9;U-87 MG: 28.6"	"Cancer enriched"	"Detected in many"	8	"glioma: 21.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 1.7;T-reg: 6.2"	"Lineage enriched"	"Detected in single"	9	"T-cells: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018790, HPA048800"	Enhanced		Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA018790: AB_1852822, HPA048800: AB_2680526"	"unprognostic (1.74e-1)"	"unprognostic (5.98e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.61e-4)"	"unprognostic (2.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.28e-6)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.78e-4)"	3.9	27.2	35.6	4.1	57.5	1.4	2.5	42.4	138.5	3.2	4.7	29.1	0.2	2.7	4.2	6.4	3.9	5.8	7.5	7.4	38.8	51.0	2.0	1.5	2.5	3.5	35.9	33.7	2.6	2.8	14.7	7.8	1.5	65.6	8.8	3.5	3.9	3.0	7.1	2.0	1.8	4.0	8.7	36.9	2.5	2.6	12.1	20.5	0.0	1.7	0.0	3.1	4.7	2.0	0.0	0.0	0.0	0.4	0.6	6.2	0.2	0.0	0.3	0.4	0.5	2.0	1.3	0.1	0.5	2.6	0.5	0.3	0.3	0.0	0.0	0.1	3.6	0.2	1.2	0.0	0.3	0.0	0.0	2.0	0.0	0.0	9.2	0.1	0.0	0.8	0.2	2.0	0.0	0.0	1.1	0.3	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	4.9	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.0	28.6	0.0	0.2	0.0	0.1	0.0	1.7	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	6.2	0.2	35.6	57.5	42.4	99.5	38.8	51.0	35.9	33.7	65.6	20.5
FAM163B	C9orf166	ENSG00000196990	"Family with sequence similarity 163 member B"	P0C2L3	9	133578415-133586197	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 41.7"	"Cell line enriched"	"Detected in some"	21	"SH-SY5Y: 39.0"	"Cancer enriched"	"Detected in some"	6	"glioma: 3.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067336	Supported		Approved	"Nuclear bodies,Plasma membrane,Cytosol"				"Nuclear bodies, Plasma membrane, Cytosol"		"HPA067336: "	"unprognostic (2.94e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.31e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.75e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.73e-4)"	0.1	8.2	10.0	0.0	2.7	0.0	0.0	3.2	41.7	0.0	0.4			0.0	0.0	0.3	0.0	0.0	0.4	1.2	6.1	3.9	0.1	2.7	0.0	1.3	3.3		0.0	0.1	0.0	0.0	0.6		0.0	0.4		0.4	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.8			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.5	0.1	0.0	0.0	0.0	1.8	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FNTB	FPTB	ENSG00000257365	"Farnesyltransferase, CAAX box, beta"	P49356	14	64986720-65062652	"Enzymes, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 75.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062743	Uncertain		Approved	Centrosome				Centrosome		"HPA062743: "	"unprognostic (2.79e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavourable (6.03e-4)"	"unprognostic (6.21e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.11e-3)"	7.4	9.0	6.3	4.9	21.9	2.3	7.8	11.4	13.7	8.0	6.3	24.3	6.2	5.6	6.4	6.6	13.5	9.0	5.1	12.0	8.1	7.9	8.0	5.6	7.0	5.1	34.0	7.2	7.4	5.9	13.6	7.9	8.2	25.4	8.9	7.9	4.4	8.0	9.6	14.3	10.3	5.1	11.6	75.0	4.6	5.7	9.0	22.2	4.7	5.6	5.8	7.3	7.4	7.8	2.4	6.4	12.3	10.3	2.8	8.8	5.3	18.3	13.4	10.4	5.9	6.7	5.9	7.6	10.6	7.8	12.0	12.4	7.1	7.6	3.1	6.1	11.2	12.2	25.0	8.3	9.9	4.4	7.0	12.4	3.6	10.3	4.4	4.2	17.2	5.0	7.2	5.2	2.8	10.0	6.7	4.5	7.0	12.1	6.4	7.0	4.5	13.6	6.3	9.7	3.9	8.3	6.8	6.6	6.6	6.6	13.0	14.4	12.0	7.4	7.9	8.7	18.0	3.9	6.8	2.3	2.6	3.2	10.1	5.5	20.1	12.3	10.3	9.2	3.6	8.6	8.8	2.4	5.5	4.3	6.4	1.9	4.5	3.3	2.7	2.8	4.3	4.9	5.1	5.3	6.3	21.9	11.4	13.7	8.1	7.9	34.0	7.2	25.4	22.2
FOCAD	"FLJ20375, KIAA1797"	ENSG00000188352	Focadhesin	Q5VW36	9	20658309-20995955	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 62.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"pons and medulla: 62.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055015	Uncertain		Uncertain	Mitochondria				Mitochondria		"HPA055015: "	"unprognostic (3.05e-2)"	"unprognostic (1.02e-1)"	"prognostic favourable (3.25e-4)"	"unprognostic (3.69e-3)"	"unprognostic (4.14e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavourable (4.41e-5)"	"unprognostic (9.64e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.26e-2)"	"unprognostic (9.15e-2)"	"prognostic favourable (3.09e-8)"	"unprognostic (1.90e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.41e-2)"	3.6	9.0	4.5	3.6	7.2	1.9	3.9	8.7	9.0	4.9	4.8	15.0	3.6	1.8	3.9	6.3	3.6	7.4	3.6	5.3	7.1	7.3	3.8	3.6	3.7	3.6	4.4	3.6	3.6	5.5	10.4	11.8	4.1	62.1	5.6	5.6	6.8	5.8	3.7	5.1	4.2	3.6	4.7	3.6	3.6	4.2	3.6	3.6	3.6	11.8	3.6	3.6	3.6	3.6	3.4	6.9	8.9	5.7	4.5	7.1	3.1	16.1	11.2	12.2	9.1	11.4	13.1	6.4	9.6	15.4	6.8	7.9	7.4	5.6	6.6	5.1	13.7	5.6	10.5	19.0	12.0	29.4	7.8	5.2	13.8	9.1	5.9	8.6	6.7	12.1	13.1	6.8	11.2	26.1	0.1	9.8	11.4	6.2	6.4	16.2	9.6	11.3	0.0	5.5	4.4	10.6	7.0	8.1	4.1	6.3	10.9	2.6	6.8	5.0	15.9	0.0	4.5	7.5	8.7	2.4	13.5	7.5	0.0	12.1	4.0	8.9	2.8	8.0	5.3	5.7	7.1	2.7	4.7	5.1	6.9	3.4	4.2	5.0	2.2	4.5	3.1	2.8	4.3	3.1	4.5	7.2	8.7	9.0	7.1	7.3	4.4	3.6	62.1	3.6
GAD2	GAD65	ENSG00000136750	"Glutamate decarboxylase 2"	Q05329	10	26216307-26304558	"Enzymes, Predicted intracellular proteins"	"Neurotransmitter biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 66.2"	"Group enriched"	"Detected in some"	12	"MOLT-4: 5.0;SCLC-21H: 11.4"	"Group enriched"	"Detected in some"	21	"glioma: 0.7;pancreatic cancer: 3.0;testis cancer: 1.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 66.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044637, CAB078177"	Enhanced									"CAB078177: , HPA044637: AB_10794053"		"unprognostic (8.67e-2)"			"unprognostic (1.11e-1)"						"unprognostic (4.93e-2)"		"unprognostic (2.52e-5)"	"unprognostic (5.44e-2)"	"unprognostic (8.08e-2)"			1.0	0.9	6.3	0.9	66.2	1.0	0.9	5.6	28.7	0.9	0.9	1.4	0.0	1.2	0.9	1.1	0.9	0.9	0.9	0.9	5.2	13.2	1.0	0.9	0.9	0.9	5.4	10.0	0.9	12.9	0.9	0.4	0.9	6.8	1.2	1.0	0.0	0.9	0.9	0.9	1.3	1.1	0.9	1.3	0.9	1.2	1.7	8.1	0.0	0.9	0.0	0.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.3	66.2	5.6	18.2	5.2	13.2	5.4	10.0	6.8	8.1
GHRH	GHRF	ENSG00000118702	"Growth hormone releasing hormone"	P01286	20	37251082-37261835	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 37.3"	"Group enriched"	"Detected in some"	7	"NTERA-2: 3.5;U-266/84: 12.4"	"Cancer enriched"	"Detected in some"	7	"urothelial cancer: 8.5"	"Region enriched"	"Detected in some"	15	"hypothalamus: 37.3"	"Cell type enhanced"	"Detected in single"		"eosinophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in some"	9	"hypothalamus: 38.7"	"Low region specificity"	"Detected in many"								"Secreted in other tissues"						"unprognostic (4.78e-2)"				"unprognostic (2.57e-2)"									"unprognostic (1.58e-1)"	"unprognostic (3.10e-1)"			0.1	2.7	0.3	0.1	2.4	0.0	0.6	0.1	1.0	0.1	4.0	0.1	0.1	8.1	0.1	0.1	0.7	0.0	0.1	6.5	0.1	37.3	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	7.7	0.1	0.1	0.1	1.9	0.1	0.1	7.5	0.4	0.1	0.1	0.1	0.1	0.0	0.7	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.1	1.0	0.1	37.3	0.1	0.8	0.1	0.1
GNG7	FLJ00058	ENSG00000176533	"G protein subunit gamma 7"	O60262	19	2511219-2702709	"Predicted intracellular proteins, RAS pathway related proteins"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 115.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.3;REH: 30.3;SK-MEL-30: 14.0;U-266/70: 29.2;U-266/84: 13.4"	"Cancer enhanced"	"Detected in all"		"glioma: 21.9"	"Region enriched"	"Detected in all"	5	"basal ganglia: 115.9"	"Group enriched"	"Detected in many"	4	"memory B-cell: 23.9;naive B-cell: 20.5;plasmacytoid DC: 19.9"	"Group enriched"	"Detected in many"	4	"B-cells: 23.9;dendritic cells: 19.9"	"Region enriched"	"Detected in many"	6	"basal ganglia: 1142.7"	"Region enriched"	"Detected in all"	6	"basal ganglia: 484.6"	HPA057790	Supported	Supported								"HPA057790: "	"unprognostic (3.97e-3)"	"unprognostic (1.16e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.42e-4)"	"prognostic favourable (3.05e-4)"	"prognostic favourable (1.35e-5)"	"unprognostic (1.27e-2)"	"unprognostic (4.95e-2)"	"prognostic favourable (3.71e-4)"	"unprognostic (1.27e-1)"	"prognostic favourable (0.00e+0)"	"unprognostic (6.96e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.96e-2)"	3.1	4.8	19.8	4.5	115.9	5.4	4.1	9.7	28.2	2.6	3.8	23.4	0.8	4.7	4.8	4.9	11.1	6.5	3.3	22.5	20.3	11.4	6.0	2.2	3.0	8.0	20.0	10.0	10.0	7.2	5.4	4.6	1.4	20.9	7.1	3.0	12.2	22.8	5.7	2.9	1.7	4.9	3.4	28.5	11.0	5.8	5.5	22.0	0.1	3.7	0.4	8.2	3.4	1.4	23.9	19.9	5.0	0.6	0.0	0.5	1.3	0.1	0.0	1.5	3.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	10.3	0.5	0.1	0.1	1.6	0.0	0.0	0.0	1.4	0.2	0.0	1.2	0.7	0.0	6.1	0.2	0.2	0.0	0.1	0.0	0.1	6.7	0.0	1.0	0.2	0.6	1.2	0.6	30.3	0.0	2.7	0.1	0.0	0.0	4.4	0.0	0.0	14.0	0.2	2.6	0.0	0.0	1.5	0.1	0.1	29.2	13.4	2.2	0.1	3.2	7.7	1.1	0.6	3.2	0.1	0.2	0.4	23.9	0.2	0.1	2.5	20.5	0.5	0.3	5.0	0.0	0.0	19.9	0.0	1.3	19.8	115.9	9.7	20.0	20.3	11.4	20.0	10.0	20.9	22.0
GPR88		ENSG00000181656	"G protein-coupled receptor 88"	Q9GZN0	1	100538137-100542018	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Mental retardation"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"brain: 62.7"	"Group enriched"	"Detected in some"	8	"HSkMC: 4.8;SCLC-21H: 5.9"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 12.0"	"Group enriched"	"Detected in many"	7	"basal ganglia: 62.7;thalamus: 32.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	11	"basal ganglia: 643.5"	"Region enriched"	"Detected in some"	35	"basal ganglia: 223.4"	HPA007488		Approved								"HPA007488: "	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.37e-3)"	"unprognostic (5.41e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.76e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.93e-4)"	"unprognostic (1.85e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-2)"	0.7	0.6	1.2	0.5	62.7	0.2	10.9	0.0	6.8	0.1	0.3	0.8	0.0	0.6	0.2	0.2	0.2	0.1	0.2	0.4	0.9	0.8	0.3	13.1	0.2	0.3	0.7	1.1	3.8	0.1	4.6	0.5	0.2	7.0	0.6	0.5	0.3	0.7	0.1	0.3	0.1	0.5	0.3	0.5	13.7	0.4	0.2	32.8	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	62.7	0.0	6.8	0.9	0.8	0.7	1.1	7.0	32.8
GRIN2A	"GluN2A, NMDAR2A"	ENSG00000183454	"Glutamate ionotropic receptor NMDA type subunit 2A"	Q12879	16	9753404-10182754	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 25.2"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 7.7;RPMI-8226: 2.9;U-138 MG: 8.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB022725	Enhanced									"CAB022725: "	"unprognostic (6.43e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-3)"	"unprognostic (4.79e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.33e-2)"	0.9	1.0	5.4	0.5	5.9	0.4	0.6	8.5	25.2	0.6	0.7	1.5	0.0	0.9	0.8	4.5	2.1	4.1	0.5	4.0	8.0	1.9	0.9	0.4	1.0	0.5	1.7	10.3	0.5	0.6	0.4	0.3	0.4	1.4	0.5	0.7	1.4	0.7	1.0	0.5	1.2	0.7	0.9	1.2	0.4	1.1	5.2	0.8	0.0	0.8	0.0	0.7	0.6	0.5	0.6	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.8	0.5	1.4	0.0	0.1	0.0	0.0	7.7	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.8	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	5.4	5.9	8.5	17.9	8.0	1.9	1.7	10.3	1.4	0.8
GRM1	"GPRC1A, mGlu1, MGLUR1, PPP1R85"	ENSG00000152822	"Glutamate metabotropic receptor 1"	Q13255	6	146027646-146437598	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.6;HeLa: 1.4;Karpas-707: 1.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 39.9"	"Cell type enriched"	"Detected in single"	4	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015701	Approved	Supported	Approved	Vesicles				Vesicles		"HPA015701: AB_1853917"	"unprognostic (1.04e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.77e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.48e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.76e-2)"	0.5	0.5	6.6	0.4	6.0	0.4	0.5	39.9	13.0	0.5	0.5	0.9	0.0	0.4	0.5	0.7	0.5	0.7	0.5	7.7	6.0	2.7	2.7	0.5	0.6	0.5	2.6	4.1	0.5	0.5	0.4	0.2	0.5	3.6	0.5	0.4	2.6	0.5	0.8	0.4	0.5	0.5	0.5	1.0	0.6	0.5	1.3	0.9	0.0	0.8	0.0	0.4	0.5	0.1	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.1	1.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.4	1.4	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	1.5	0.1	0.0	0.0	0.4	0.2	0.8	0.0	0.0	0.0	0.1	0.0	1.1	0.6	0.1	0.1	0.5	0.0	0.5	0.1	0.1	0.1	0.7	0.2	0.2	0.1	0.1	0.5	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	6.6	6.0	39.9	10.5	6.0	2.7	2.6	4.1	3.6	0.9
HCRTR2	OX2R	ENSG00000137252	"Hypocretin receptor 2"	O43614	6	55106460-55282620	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 17.4"	"Cell line enriched"	"Detected in single"	6	"AF22: 4.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"pons and medulla: 17.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054516	Enhanced									"HPA054516: "						"unprognostic (4.86e-1)"		"unprognostic (2.69e-2)"		"unprognostic (1.86e-2)"	"unprognostic (2.32e-1)"			"unprognostic (7.45e-2)"	"unprognostic (7.39e-2)"			0.1	0.2	1.7	0.0	1.3	0.0	0.1	0.6	2.2	0.1	0.1	0.3	0.0	0.0	0.1	0.5	0.0	0.1	0.1	1.1	0.9	4.2	3.7	0.1	0.4	0.1	2.6	1.7	1.7	0.0	0.0	0.3	2.2	17.4	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	1.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.7	1.3	0.6	2.2	0.9	4.2	2.6	1.7	17.4	0.0
HEPN1		ENSG00000221932	"Hepatocellular carcinoma, down-regulated 1"	Q6WQI6	11	124919244-124920677	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	5	"brain: 43.3"	"Cell line enriched"	"Detected in single"	335	"Hep G2: 33.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA043768, HPA063054"	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA043768: , HPA063054: "																		8.4	0.5	22.0	0.4	20.4	0.3	0.3	4.2	43.3	0.3	0.4			0.3	0.4	0.3	0.4	0.3	0.3	0.5	17.9	11.0	0.4	4.5	0.3	0.5	19.3		0.4	0.3	0.3	0.0	0.3		0.3	0.3		0.5	0.3	0.5	0.3	0.5	0.3	19.4	0.3	0.4	0.4			0.3		0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HS3ST4	3OST4	ENSG00000182601	"Heparan sulfate-glucosamine 3-sulfotransferase 4"	Q9Y661	16	25692026-26137688	"Enzymes, Predicted membrane proteins"		Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"brain: 23.9"	"Group enriched"	"Detected in some"	4	"NTERA-2: 5.4;SCLC-21H: 2.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (1.09e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.95e-1)"		"unprognostic (2.24e-1)"	"unprognostic (1.43e-3)"		"unprognostic (1.27e-1)"		"unprognostic (3.84e-1)"	"unprognostic (8.81e-3)"	"unprognostic (6.71e-2)"		"unprognostic (2.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.67e-2)"	0.7	0.8	6.9	0.6	9.3	0.6	5.1	6.8	23.9	1.1	0.6	2.6	0.0	0.6	0.7	1.3	0.9	0.7	0.6	0.6	11.5	10.0	0.7	0.6	0.6	0.6	5.9	10.8	0.7	0.6	0.6	0.1	0.6	14.3	2.0	0.6	0.3	0.8	0.6	0.6	0.7	0.6	0.6	2.2	3.7	1.1	1.3	1.5	0.0	0.6	0.0	0.8	1.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.9	9.3	6.8	13.4	11.5	10.0	5.9	10.8	14.3	1.5
HTR5A	5-HT5A	ENSG00000157219	"5-hydroxytryptamine receptor 5A"	P47898	7	155070324-155085749	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"brain: 15.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB017467	Approved									"CAB017467: AB_2122566"					"unprognostic (1.62e-2)"										"unprognostic (1.15e-1)"			0.4	0.4	2.6	0.4	3.9	0.4	0.4	15.4	15.0	0.4	0.4	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	2.6	5.9	0.4	0.4	0.4	0.4	2.3	2.5	0.4	0.4	0.4	0.1	0.4	2.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.8	0.4	0.4	1.4	0.3	3.3	0.4	0.0	0.4	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	3.9	15.4	9.8	2.6	5.9	2.3	2.5	2.4	0.3
KCNA2	"HK4, Kv1.2"	ENSG00000177301	"Potassium voltage-gated channel subfamily A member 2"	P16389	1	110519837-110631474	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 28.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 10.6;SCLC-21H: 2.7;U-2 OS: 2.4;U-266/70: 3.5;U-266/84: 5.3;WM-115: 2.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.1"	"Lineage enriched"	"Detected in single"	8	"T-cells: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001976	Enhanced									"CAB001976: "	"unprognostic (1.84e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.17e-3)"	"unprognostic (6.68e-3)"		"unprognostic (5.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.08e-3)"	"unprognostic (2.93e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.83e-1)"	3.2	1.4	7.1	2.2	13.1	0.8	1.2	17.2	28.0	1.2	1.6	3.1	0.0	1.4	1.0	1.3	1.7	1.1	1.6	1.6	7.2	6.1	0.9	0.9	1.0	1.9	7.2	14.5	1.1	1.9	0.8	1.4	0.7	21.1	1.8	2.0	1.4	1.8	2.4	2.1	1.6	1.6	1.6	2.8	1.3	1.3	2.5	3.8	0.3	5.3	0.0	3.5	1.4	0.5	0.5	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	1.4	0.0	0.0	2.7	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	2.4	0.0	0.0	3.5	5.3	0.2	0.1	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.3	0.5	1.8	1.3	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	4.1	0.1	7.1	13.1	17.2	26.3	7.2	6.1	7.2	14.5	21.1	3.8
KCNQ2	"BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2"	ENSG00000075043	"Potassium voltage-gated channel subfamily Q member 2"	O43526	20	63400210-63472677	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 50.8"	"Cell line enhanced"	"Detected in some"		"AF22: 8.3;AN3-CA: 13.7;NTERA-2: 7.6;SCLC-21H: 26.9;SH-SY5Y: 47.2"	"Cancer enriched"	"Detected in some"	9	"glioma: 8.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.2;T-reg: 1.5"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016642, HPA057112"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA016642: AB_1855555, HPA057112: "	"unprognostic (2.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-4)"	"unprognostic (8.21e-6)"	"unprognostic (6.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.96e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.43e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.70e-2)"	1.2	10.0	18.7	1.3	21.4	1.2	1.2	24.1	50.8	1.2	1.3	2.4	0.0	1.3	1.2	1.3	1.2	1.7	1.7	1.2	15.4	10.0	1.2	1.2	1.2	1.2	8.4	14.1	1.2	1.9	1.2	9.2	1.2	8.9	2.8	1.2	0.0	1.2	1.2	1.2	1.2	1.3	1.2	2.6	1.2	1.3	6.9	4.2	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	8.3	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	26.9	47.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	1.5	0.0	18.7	21.4	24.1	31.2	15.4	10.0	8.4	14.1	8.9	4.2
KCNS2	Kv9.2	ENSG00000156486	"Potassium voltage-gated channel modifier subfamily S member 2"	Q9ULS6	8	98427022-98432848	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"brain: 20.9"	"Group enriched"	"Detected in some"	6	"HSkMC: 3.9;SCLC-21H: 11.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 20.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051417	Uncertain									"HPA051417: "	"unprognostic (7.83e-2)"	"unprognostic (9.39e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.30e-5)"	"unprognostic (2.43e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-3)"	1.6	1.4	2.9	0.6	6.6	0.3	0.7	0.7	20.9	2.0	1.0	0.1	0.5	0.4	1.3	1.7	0.9	1.0	1.5	0.4	1.9	2.8	0.7	0.3	0.7	0.4	0.8	6.4	1.9	0.8	0.8	1.2	4.4	3.4	0.9	0.9	0.1	0.3	3.3	0.2	0.3	0.7	0.6	0.9	0.3	1.5	1.0	0.4	0.0	0.5	0.0	0.3	2.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	1.3	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	6.6	0.7	20.9	1.9	2.8	0.8	6.4	3.4	0.4
KCTD16	KIAA1317	ENSG00000183775	"Potassium channel tetramerization domain containing 16"	Q68DU8	5	144170832-144485686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 25.1"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 6.9;TIME: 13.1;U-87 MG: 3.0"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.7"	"Group enriched"	"Detected in many"	5	"amygdala: 11.4;basal ganglia: 14.5;cerebral cortex: 25.1;hippocampal formation: 14.5;olfactory region: 12.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA044590, HPA050154"	Approved		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA044590: AB_2679008, HPA050154: AB_2681034"	"unprognostic (7.22e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.54e-2)"	"unprognostic (6.81e-5)"	"unprognostic (9.88e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.74e-3)"	"unprognostic (3.23e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.57e-2)"	"unprognostic (9.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (2.52e-8)"	"unprognostic (1.55e-3)"	"unprognostic (2.34e-1)"	"unprognostic (5.80e-3)"	"unprognostic (1.22e-2)"	1.0	2.0	11.4	0.7	14.5	0.6	0.9	0.7	25.1	1.5	0.8	0.4	0.0	1.0	0.9	1.5	0.8	1.2	1.4	0.9	14.5	3.2	2.9	0.8	2.4	0.7	1.7	12.0	1.0	5.2	0.8	1.7	0.9	1.3	0.8	0.7	0.0	0.7	1.1	0.6	0.7	1.2	0.9	1.6	0.7	0.8	4.4	2.4	0.0	2.2	0.0	0.7	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.1	0.6	0.0	1.9	1.6	0.6	0.8	0.4	0.0	0.0	0.6	0.5	0.0	0.0	0.3	0.8	0.2	0.1	0.0	0.5	0.1	0.2	0.0	0.0	0.4	0.1	1.1	0.1	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	6.9	0.3	0.1	0.0	0.1	0.0	0.0	13.1	1.0	0.7	0.2	0.0	0.2	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	14.5	0.7	25.1	14.5	3.2	1.7	12.0	1.3	2.4
KIAA0319	NMIG	ENSG00000137261	KIAA0319	Q5VV43	6	24544104-24646155	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 23.5"	"Cell line enhanced"	"Detected in some"		"A-431: 3.6;A549: 4.1;HDLM-2: 4.8;SCLC-21H: 7.8;U-266/84: 6.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"memory B-cell: 1.4;neutrophil: 5.0"	"Group enriched"	"Detected in many"	32	"B-cells: 1.4;granulocytes: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015607, HPA076313"	Enhanced	Supported	Approved	Vesicles	"Secreted in brain"			Vesicles		"HPA015607: AB_1852299, HPA076313: "	"unprognostic (1.64e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.65e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.21e-5)"	"unprognostic (7.88e-4)"	"unprognostic (9.53e-4)"	"unprognostic (1.44e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.41e-2)"	0.9	1.9	9.9	1.3	10.2	0.9	1.1	10.7	23.5	0.9	1.6	4.0	0.0	0.9	0.9	0.9	0.8	4.8	1.4	0.8	9.7	7.7	0.9	0.8	2.2	0.9	5.8	12.1	0.8	3.0	0.8	3.8	1.1	10.2	1.7	1.7	0.0	0.8	0.9	0.8	2.4	1.1	1.1	1.4	1.1	3.2	3.5	2.3	0.0	0.8	0.0	1.1	0.9	0.1	1.4	0.0	5.0	0.0	0.0	0.0	0.0	3.6	4.1	0.2	2.6	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.2	1.5	1.1	2.0	0.0	1.7	0.7	0.0	0.0	4.8	1.8	0.0	3.5	0.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.0	0.5	0.3	0.2	0.0	0.8	0.1	0.2	7.8	0.5	0.1	2.2	0.0	0.8	0.0	0.0	0.0	0.6	0.4	0.7	0.6	6.3	0.3	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	9.9	10.2	10.7	14.9	9.7	7.7	5.8	12.1	10.2	2.3
KIF1A	"ATSV, C2orf20, SPG30, UNC104"	ENSG00000130294	"Kinesin family member 1A"	Q12756	2	240713764-240820308	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 144.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 18.8;HAP1: 33.3;K-562: 29.1;SCLC-21H: 89.7;SH-SY5Y: 14.4"	"Cancer enhanced"	"Detected in many"		"glioma: 20.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Low region specificity"	"Detected in all"							HPA005442			Approved	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA005442: AB_1079210"	"unprognostic (1.19e-1)"	"unprognostic (2.17e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavourable (4.97e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.90e-2)"	2.1	15.2	47.0	2.9	37.0	2.0	2.0	28.4	144.1	1.9	2.7	35.8	0.0	2.9	2.3	3.1	2.0	2.3	2.1	8.2	40.9	28.4	2.1	2.3	2.1	2.0	35.1	46.8	3.5	31.3	2.0	15.7	2.0	38.7	6.4	2.6	8.6	2.0	2.2	1.9	2.8	2.9	2.3	35.0	2.2	5.0	10.0	30.9	0.0	2.9	0.0	1.9	2.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.5	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	1.0	0.0	0.0	33.3	0.0	0.0	2.6	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	29.1	0.1	0.0	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	89.7	14.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	47.0	37.0	28.4	62.2	40.9	28.4	35.1	46.8	38.7	30.9
LLGL1	"DLG4, HUGL, HUGL-1, Lgl1, LLGL, Mgl1"	ENSG00000131899	"LLGL1, scribble cell polarity complex component"	Q15334	17	18225587-18244875	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 53.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022924, HPA023569"	Enhanced									"HPA022924: AB_1852926, HPA023569: AB_1852928"	"unprognostic (1.15e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (2.72e-4)"	"unprognostic (7.71e-2)"	"unprognostic (3.06e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.40e-2)"	5.6	10.0	15.0	5.1	21.2	3.5	3.7	7.3	24.1	6.0	3.7	53.5	3.1	3.6	8.1	4.6	10.3	8.0	6.1	6.0	18.4	11.9	3.4	1.4	4.5	5.7	30.4	12.5	10.6	5.1	3.8	4.4	8.2	17.3	5.2	2.4	3.0	6.6	6.5	8.5	8.8	4.2	5.6	32.5	6.1	4.3	6.8	24.2	3.9	3.9	2.9	4.5	6.9	4.8	0.6	0.2	1.0	0.5	1.2	1.6	0.2	11.4	7.5	18.9	18.3	7.3	6.7	7.8	5.1	8.2	10.1	9.1	16.8	2.2	6.9	8.9	4.4	10.6	5.6	6.7	3.0	11.5	15.0	3.2	5.5	5.9	3.5	1.2	7.3	8.3	3.7	5.1	2.4	6.4	2.3	1.5	3.9	8.1	8.2	1.9	8.0	4.2	10.5	13.5	3.8	3.0	4.3	5.0	10.7	6.2	2.9	4.8	3.5	2.0	8.9	8.0	10.3	10.6	7.9	2.4	1.6	2.2	15.9	3.0	7.0	1.0	0.3	0.0	0.4	0.5	0.3	0.5	0.4	0.3	0.1	0.6	0.3	0.1	1.0	1.2	0.1	0.2	1.6	0.2	15.0	21.2	7.3	17.2	18.4	11.9	30.4	12.5	17.3	24.2
MAG	"GMA, S-MAG, SIGLEC-4A, SIGLEC4A"	ENSG00000105695	"Myelin associated glycoprotein"	P20916	19	35292125-35313804	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 113.6"	"Cell line enriched"	"Detected in some"	22	"WM-115: 28.1"	"Cancer enriched"	"Detected in some"	7	"glioma: 20.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 6.4"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009345, HPA012499"	Enhanced									"CAB009345: AB_670104, HPA012499: AB_1854238"	"unprognostic (2.70e-3)"	"unprognostic (2.70e-2)"		"unprognostic (8.06e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.18e-4)"	"unprognostic (6.29e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.66e-1)"	1.5	2.3	19.5	1.4	29.9	1.4	1.5	3.6	90.8	1.5	1.4	97.0	0.0	1.4	1.6	1.4	1.5	5.1	1.4	1.4	36.7	19.1	1.5	1.6	1.7	1.5	48.9	18.0	21.8	1.4	1.4	0.1	1.7	38.0	1.5	1.4	0.0	1.4	1.7	1.4	1.4	1.5	1.4	113.6	1.6	1.4	1.7	38.1	0.0	1.8	0.0	1.5	1.4	0.1	0.4	6.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	28.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	6.4	0.0	0.1	19.5	29.9	3.6	38.5	36.7	19.1	48.9	18.0	38.0	38.1
MAST1	"KIAA0973, SAST"	ENSG00000105613	"Microtubule associated serine/threonine kinase 1"	Q9Y2H9	19	12833951-12874951	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 51.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.8;SCLC-21H: 26.2;SH-SY5Y: 13.0;U-266/70: 10.7"	"Cancer enhanced"	"Detected in many"		"glioma: 3.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 3.6;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	8	"T-cells: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028181, HPA073106"	Enhanced		Approved	Vesicles				Vesicles		"HPA028181: AB_10603872, HPA073106: "	"unprognostic (6.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.83e-5)"	"unprognostic (1.72e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.89e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	1.2	5.2	20.4	1.7	13.6	1.6	1.5	51.0	40.1	1.1	1.5	1.4	0.0	1.7	1.3	1.2	1.3	1.2	1.6	1.3	16.1	16.3	1.2	1.3	1.2	1.3	8.8	19.5	1.5	1.6	1.2	10.4	1.2	19.9	1.2	1.3	1.6	1.3	1.2	1.2	4.1	1.6	1.3	4.2	1.2	1.5	3.9	2.7	0.0	1.2	0.0	1.3	1.2	0.2	0.4	0.0	0.0	0.2	0.0	3.6	0.1	2.2	1.0	0.9	14.8	0.0	0.0	1.2	0.1	0.1	0.2	0.6	0.5	0.9	3.6	1.6	0.0	0.0	4.3	0.0	0.0	2.5	2.9	0.3	3.6	1.6	0.0	0.7	0.7	0.3	0.0	0.5	0.5	0.0	3.1	1.9	0.0	0.5	1.5	0.4	4.4	4.5	9.8	2.9	5.1	0.2	0.1	26.2	13.0	0.5	0.9	2.6	2.4	1.3	0.0	1.8	2.8	2.0	0.4	10.7	8.5	2.1	3.3	2.0	0.1	0.0	0.2	0.0	0.0	0.2	3.6	0.1	0.0	0.2	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	2.0	0.1	20.4	13.6	51.0	34.3	16.1	16.3	8.8	19.5	19.9	2.7
MC3R	MC3	ENSG00000124089	"Melanocortin 3 receptor"	P41968	20	56248732-56249815	"G-protein coupled receptors, Predicted membrane proteins"	"Biological rhythms"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 6.4"	"Cell line enriched"	"Detected in single"	24	"hTERT-HME1: 2.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basal ganglia: 4.8;hypothalamus: 3.3;thalamus: 2.6"	HPA074739	Uncertain									"HPA074739: "																		0.0	0.4	0.1	0.0	0.3	0.0	0.1	0.0	0.6	0.0	0.0			0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MTCL1	"CCDC165, KIAA0802, SOGA2"	ENSG00000168502	"Microtubule crosslinking factor 1"	Q9Y4B5	18	8705661-8832778	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 61.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebellum: 61.5"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 63.6"	HPA046245	Uncertain									"HPA046245: AB_10962580"	"unprognostic (2.64e-1)"	"prognostic unfavourable (6.45e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.41e-4)"	"unprognostic (1.30e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavourable (5.19e-4)"	"unprognostic (2.82e-1)"	"unprognostic (3.67e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.08e-2)"	1.4	1.2	1.8	3.2	3.4	0.4	1.4	61.5	10.0	5.5	8.5	2.4	4.1	2.3	3.4	2.0	3.8	1.3	12.5	3.8	1.7	2.4	1.4	1.3	1.4	0.9	2.4	3.8	1.3	3.4	4.8	2.7	3.0	5.2	1.7	2.3	8.4	1.5	4.4	2.4	1.6	2.7	7.0	3.3	1.1	4.9	8.2	1.2	1.4	1.1	1.1	0.6	9.9	4.8	0.6	1.1	0.0	0.0	0.0	0.0	0.0	8.8	19.0	9.5	5.5	4.3	8.0	0.3	12.4	9.2	10.3	7.4	5.5	3.1	5.5	7.1	8.6	1.3	3.0	5.0	4.7	1.1	2.4	2.7	5.0	4.9	6.1	0.1	4.0	4.7	3.8	5.8	4.0	8.0	0.6	9.7	4.7	2.6	0.3	1.3	4.3	8.3	7.4	6.9	2.0	14.7	16.0	21.8	4.9	5.7	1.6	1.5	0.5	0.3	15.2	18.9	9.9	15.1	12.7	1.9	1.4	2.7	4.7	0.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.8	3.4	61.5	10.0	1.7	2.4	2.4	3.8	5.2	1.2
MYT1L	"KIAA1106, NZF1, ZC2H2C2, ZC2HC4B"	ENSG00000186487	"Myelin transcription factor 1 like"	Q9UL68	2	1789113-2331348	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Autism spectrum disorder, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 50.2"	"Group enriched"	"Detected in some"	9	"SCLC-21H: 11.0;SH-SY5Y: 8.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3;naive CD8 T-cell: 1.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 2.3;T-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060245			Approved	Vesicles				Vesicles		"HPA060245: "	"unprognostic (9.90e-3)"	"unprognostic (3.74e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.61e-3)"	"unprognostic (7.17e-2)"		"unprognostic (3.73e-2)"		"unprognostic (2.44e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-2)"	1.2	3.4	11.0	1.4	20.0	1.1	1.1	19.5	50.2	1.1	1.2	0.5	0.0	1.1	1.2	1.1	1.3	1.1	1.1	1.1	15.6	10.3	1.1	1.1	1.1	1.2	5.1	14.5	1.1	1.5	1.0	10.7	1.1	6.8	1.3	1.3	0.4	1.1	1.1	1.1	1.1	1.2	1.1	1.5	1.0	1.1	4.6	2.0	0.0	1.1	0.0	1.1	1.1	0.0	0.0	0.2	2.3	0.0	0.0	1.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.6	0.1	0.0	0.0	11.0	8.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.2	0.0	0.6	11.0	20.0	19.5	26.7	15.6	10.3	5.1	14.5	6.8	2.0
NAP1L2	"BPX, MGC26243"	ENSG00000186462	"Nucleosome assembly protein 1 like 2"	Q9ULW6	X	73212299-73214848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 49.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 12.0;Karpas-707: 10.0;NTERA-2: 12.8;U-2 OS: 7.5;U-2197: 10.4;U-266/84: 20.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054050, HPA057065"			Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA054050: , HPA057065: "	"unprognostic (1.12e-1)"	"unprognostic (6.64e-5)"	"unprognostic (4.22e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.66e-1)"	"prognostic favourable (5.41e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.95e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.45e-2)"	2.3	5.8	15.7	2.2	20.0	0.9	3.2	37.5	49.8	4.5	2.8	2.0	0.2	1.3	4.9	8.0	2.8	4.2	2.5	7.2	21.0	22.8	8.0	1.3	2.5	2.9	15.7	28.7	8.6	2.6	10.5	10.2	0.5	20.5	10.4	3.1	2.6	3.1	5.9	1.1	4.9	1.7	4.6	8.3	3.9	2.0	2.2	4.9	0.0	8.0	0.0	1.8	2.6	2.5	0.9	0.0	0.0	0.0	1.2	3.6	1.4	0.0	3.3	0.1	6.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	12.0	0.0	0.7	2.4	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.6	0.3	0.9	0.1	1.7	0.2	0.2	10.0	0.0	1.2	3.9	0.0	12.8	5.9	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.1	0.0	7.5	10.4	0.8	4.7	20.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.4	0.9	3.4	2.3	0.0	0.1	1.6	3.6	0.0	1.2	0.0	0.0	2.6	1.4	15.7	20.0	37.5	42.1	21.0	22.8	15.7	28.7	20.5	4.9
NECAB1	EFCBP1	ENSG00000123119	"N-terminal EF-hand calcium binding protein 1"	Q8N987	8	90791550-90959408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 56.4"	"Cell line enhanced"	"Detected in many"		"HEL: 6.1;MOLT-4: 6.4;U-266/70: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB068208: , CAB068209: , CAB068210: , HPA023252: AB_1848013, HPA023629: AB_1848014, HPA025963: AB_1848015, HPA031262: AB_2673815"	"unprognostic (8.09e-3)"	"unprognostic (3.78e-1)"	"unprognostic (8.17e-3)"	"unprognostic (5.96e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-3)"	"unprognostic (8.38e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.45e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.39e-3)"	2.7	4.9	19.7	2.0	27.3	3.2	1.5	0.5	56.4	1.4	3.7	12.1	0.3	1.7	4.1	4.4	3.6	1.6	3.1	10.9	19.5	9.8	3.4	1.1	6.8	1.4	16.0	30.7	3.8	1.3	1.9	1.9	2.8	10.8	2.6	1.1	4.1	2.5	2.0	1.3	1.9	1.8	1.3	18.7	2.4	2.1	5.2	17.4	0.0	2.9	0.0	1.0	4.2	1.2	0.5	1.8	0.3	0.0	0.7	0.9	0.2	0.2	0.1	2.3	0.4	0.0	0.1	0.1	2.5	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.0	0.0	1.0	0.0	0.1	0.0	4.7	6.1	2.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.0	4.1	4.4	0.0	4.9	6.4	3.1	0.9	0.1	0.0	4.0	0.0	0.0	0.0	4.1	4.4	0.1	0.0	2.1	0.0	0.2	1.5	3.9	3.8	0.0	1.6	6.1	3.7	3.2	3.8	0.0	1.8	0.0	0.0	0.1	0.6	0.0	0.4	0.2	0.4	0.6	0.1	0.5	0.6	0.9	0.3	0.7	0.0	1.8	0.9	0.2	19.7	27.3	0.5	37.1	19.5	9.8	16.0	30.7	10.8	17.4
NEFM	"NEF3, NF-M, NFM"	ENSG00000104722	"Neurofilament medium"	P07197	8	24913012-24919098	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 144.7"	"Cell line enriched"	"Detected in some"	23	"HEK 293: 286.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"MAIT T-cell: 1.0;memory CD4 T-cell: 1.0;naive CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010900, CAB012976, HPA022845, HPA023138"	Enhanced		Enhanced	"Intermediate filaments"				"Intermediate filaments"		"CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398"	"unprognostic (1.41e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.17e-2)"	"unprognostic (6.32e-3)"		"unprognostic (6.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.61e-2)"	1.5	18.9	20.3	2.0	24.2	1.3	1.3	10.9	87.6	9.7	2.0	5.6	0.0	1.3	3.8	1.3	4.7	1.3	1.4	1.3	36.1	25.0	2.2	1.2	1.3	1.3	52.2	22.4	2.0	2.5	1.2	3.3	1.4	144.7	2.5	1.9	3.4	1.3	26.9	1.9	1.3	1.5	3.3	26.7	1.3	1.5	12.4	4.9	0.0	1.3	0.0	1.6	1.3	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	286.0	0.0	0.0	0.0	6.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	1.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.3	24.2	10.9	71.9	36.1	25.0	52.2	22.4	144.7	4.9
NKAIN4	"bA261N11.2, C20orf58, FAM77A"	ENSG00000101198	"Sodium/potassium transporting ATPase interacting 4"	Q8IVV8	20	63240784-63272694	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"brain: 51.7"	"Cell line enhanced"	"Detected in some"		"AF22: 4.9;BEWO: 16.6;MOLT-4: 26.9;REH: 4.8;SK-MEL-30: 6.0"	"Cancer enriched"	"Detected in many"	6	"glioma: 45.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"amygdala: 3.2;cerebral cortex: 3.9;hippocampal formation: 2.5"	HPA029876	Approved									"HPA029876: AB_10602038"	"unprognostic (1.26e-1)"	"unprognostic (4.27e-1)"	"unprognostic (6.07e-5)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (6.65e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.44e-4)"	"unprognostic (5.66e-2)"	"unprognostic (6.74e-2)"	"unprognostic (4.01e-1)"	1.1	1.9	21.7	1.2	23.0	1.0	1.0	5.7	51.7	1.3	1.1	9.9	0.0	1.2	1.4	1.3	0.9	1.3	1.0	0.9	15.5	15.5	10.9	0.9	0.9	0.9	18.5	11.8	0.9	1.0	0.9	0.4	3.9	6.2	1.0	1.0	1.0	0.9	1.1	0.9	1.4	1.1	1.0	9.1	1.0	1.1	2.7	7.1	0.0	1.2	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.9	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.7	0.5	0.0	2.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	26.9	0.0	3.3	0.0	4.8	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.1	6.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	23.0	5.7	13.2	15.5	15.5	18.5	11.8	6.2	7.1
NRSN1	"p24, VMP"	ENSG00000152954	"Neurensin 1"	Q8IZ57	6	24126122-24154900	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"brain: 67.2"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 14.3;SH-SY5Y: 11.4"	"Cancer enriched"	"Detected in single"	17	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019681, HPA061006"	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA019681: , HPA061006: "	"unprognostic (1.22e-1)"		"unprognostic (4.26e-2)"	"unprognostic (8.00e-3)"	"unprognostic (8.01e-3)"					"unprognostic (1.70e-1)"	"unprognostic (4.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"		1.3	6.9	21.5	1.7	27.7	1.7	1.3	5.3	67.2	1.3	1.7	2.1	0.0	1.7	1.5	1.4	1.4	1.3	1.5	1.4	15.3	25.0	1.5	1.4	1.4	1.5	12.4	25.4	1.3	2.6	1.4	12.9	1.3	27.4	1.4	1.7	0.3	1.5	1.3	3.3	1.5	1.6	1.6	6.7	1.5	1.9	1.6	5.0	0.0	1.4	0.0	1.3	1.3	0.1	0.5	0.2	1.8	0.2	0.1	0.3	0.0	0.7	0.0	0.3	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.6	0.1	1.6	0.0	0.3	0.1	0.0	0.1	1.6	0.6	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	1.9	1.2	0.1	0.2	0.3	0.9	0.7	2.5	0.5	0.2	0.5	0.0	0.0	14.3	11.4	0.0	0.1	0.9	1.7	3.4	0.2	0.4	0.6	0.1	0.4	0.8	2.2	0.9	0.7	0.0	1.3	1.8	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.5	0.1	0.3	1.0	0.1	0.2	0.2	0.0	0.0	21.5	27.7	5.3	34.1	15.3	25.0	12.4	25.4	27.4	5.0
NSG2	"CALY3, HMP19, Nsg2"	ENSG00000170091	"Neuronal vesicle trafficking associated 2"	Q9Y328	5	174045604-174243501	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 120.8"	"Group enriched"	"Detected in some"	58	"SCLC-21H: 21.3;SH-SY5Y: 34.3"	"Cancer enriched"	"Detected in some"	8	"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046531, HPA056191"	Enhanced		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"HPA046531: , HPA056191: "	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.36e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.20e-2)"	"unprognostic (9.31e-4)"	"unprognostic (1.55e-1)"	1.7	23.1	31.6	3.0	92.4	1.4	1.4	19.7	120.8	1.4	3.6	5.0	0.0	2.8	1.4	1.7	1.5	1.4	1.6	1.6	27.3	40.2	1.6	1.4	1.6	1.4	20.2	27.6	1.4	2.0	1.4	0.9	1.4	22.5	1.4	4.1	0.8	1.4	1.5	1.4	1.4	3.8	2.5	4.6	1.4	3.3	5.0	11.7	0.0	1.8	0.0	1.4	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	92.4	19.7	49.8	27.3	40.2	20.2	27.6	22.5	11.7
OPRM1	MOR1	ENSG00000112038	"Opioid receptor mu 1"	P35372	6	154010496-154246867	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 37.9"	"Cell line enriched"	"Detected in single"	24	"SH-SY5Y: 12.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 37.9"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014509, HPA067435"	Enhanced	Supported								"HPA014509: AB_1854801, HPA067435: "											"unprognostic (7.34e-2)"			"unprognostic (6.91e-2)"				0.5	3.4	7.0	0.6	17.5	1.8	0.9	37.9	7.6	0.5	0.6	0.8	0.0	0.6	0.7	1.4	3.7	0.5	1.0	0.5	2.6	2.3	0.5	0.5	0.5	0.9	0.6	9.3	0.8	0.7	0.4	0.6	0.5	5.2	0.7	0.4	0.0	0.6	0.2	0.9	1.8	0.5	0.3	1.9	0.6	1.0	8.0	0.5	0.0	1.0	0.0	0.3	0.5	0.5	0.5	0.2	2.1	0.1	0.1	0.7	0.0	0.1	0.0	0.2	0.4	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.2	0.4	0.4	0.1	0.0	0.3	0.3	0.2	0.1	0.2	0.1	0.1	0.4	0.1	0.0	0.3	0.5	0.1	0.5	0.0	0.1	0.1	0.1	0.3	0.3	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.1	0.3	12.8	0.0	0.0	0.3	0.3	0.1	0.3	0.4	0.1	0.3	0.1	0.4	0.2	0.1	0.3	0.1	0.0	0.2	0.1	0.6	0.6	0.0	0.7	0.2	0.3	0.5	0.1	0.5	0.4	0.1	2.1	0.1	0.0	0.2	0.3	0.0	7.0	17.5	37.9	7.6	2.6	2.3	0.6	9.3	5.2	0.5
OR14I1	"OR5BU1, OR5BU1P"	ENSG00000189181	"Olfactory receptor family 14 subfamily I member 1"	A6ND48	1	248681369-248682304	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"brain: 7.4"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 2.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																	"unprognostic (3.68e-1)"	"unprognostic (1.63e-1)"					0.0	0.0	1.2	0.0	1.9	0.0	0.0	0.0	7.4	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.4	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.4	0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PACSIN1	SDPI	ENSG00000124507	"Protein kinase C and casein kinase substrate in neurons 1"	Q9BY11	6	34466061-34535231	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 81.7"	"Cell line enhanced"	"Detected in some"		"MCF7: 9.7;RPMI-8226: 11.3;T-47d: 18.0;U-266/84: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 15.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009929, HPA028852, HPA055491"	Enhanced		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: "	"unprognostic (3.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.95e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.33e-2)"	1.5	2.1	42.5	2.4	33.8	2.0	1.4	29.3	81.7	1.5	1.7	2.1	0.0	1.8	1.9	1.5	1.4	2.0	1.7	4.7	32.8	21.9	1.6	1.4	1.5	4.4	14.6	32.9	1.7	6.1	1.4	1.2	1.4	31.6	1.8	1.6	5.5	1.6	1.7	1.5	1.4	1.8	1.5	3.7	2.5	2.4	1.9	4.1	0.0	1.4	0.0	3.4	2.0	0.0	0.0	15.0	0.0	0.0	3.1	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	3.7	0.7	0.0	0.1	1.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	9.7	0.5	0.0	2.4	0.0	0.1	0.0	11.3	0.0	0.3	3.6	0.2	0.0	1.8	0.0	18.0	1.9	0.0	0.0	0.3	0.0	0.0	3.0	13.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.1	0.0	15.0	0.0	0.1	42.5	33.8	29.3	56.3	32.8	21.9	14.6	32.9	31.6	4.1
PCDHA5	"CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5"	ENSG00000204965	"Protocadherin alpha 5"	Q9Y5H7	5	140821604-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 13.6"	"Cell line enhanced"	"Detected in some"		"A549: 2.6;EFO-21: 7.3;T-47d: 7.5;WM-115: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							HPA044557	Approved		Approved	"Nuclear speckles,Plasma membrane,Mitochondria"				"Plasma membrane"	"Nuclear speckles, Mitochondria"	"HPA044557: AB_10970597"	"unprognostic (4.95e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.81e-4)"	"unprognostic (5.10e-2)"	"unprognostic (6.25e-3)"	"unprognostic (6.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-4)"	"unprognostic (9.30e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.17e-5)"	"unprognostic (2.11e-1)"	0.9	1.2	3.4	0.5	3.6	0.6	0.6	13.6	10.2	0.6	0.6	0.4	0.0	0.5	1.2	0.5	0.4	0.5	1.1	0.3	1.6	2.0	1.1	0.4	0.7	0.4	1.3	5.1	0.6	1.2	0.4	2.5	0.4	2.3	0.6	0.5	0.0	0.4	0.4	0.4	0.5	0.5	0.7	1.1	0.4	0.7	0.9	0.1	0.0	0.5	0.0	0.3	0.5	0.2	0.6	0.6	1.6	0.5	0.3	0.3	0.2	0.0	2.6	0.9	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.0	7.5	0.1	0.1	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.5	0.5	0.5	0.3	0.3	0.2	0.4	0.3	0.2	0.1	0.6	0.3	0.3	1.6	0.3	0.4	0.6	0.2	0.2	3.4	3.6	13.6	7.2	1.6	2.0	1.3	5.1	2.3	0.1
PCDHGA10	PCDH-GAMMA-A10	ENSG00000253846	"Protocadherin gamma subfamily A, 10"	Q9Y5H3	5	141412987-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 33.7"	"Cell line enhanced"	"Detected in many"		"AF22: 12.0;HSkMC: 13.5;T-47d: 16.0;U-2197: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077276"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA077276: "	"unprognostic (2.92e-1)"	"unprognostic (2.17e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.64e-3)"	"unprognostic (2.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.83e-3)"	5.2	4.2	7.9	1.6	11.4	1.2	2.7	2.4	33.7	3.6	2.9	9.8	1.2	2.4	3.0	2.4	4.3	3.6	3.7	2.3	9.1	4.4	2.0	6.5	3.5	1.7	5.1	7.2	3.6	1.9	1.4	2.4	7.4	5.3	3.6	2.6	4.9	4.1	4.6	2.0	4.7	2.9	3.1	6.7	2.5	4.7	2.0	6.5	0.0	4.9	1.5	3.3	2.5	3.5	0.9	1.1	1.5	0.7	0.8	1.0	0.2	0.0	0.0	12.0	6.1	5.3	2.3	5.7	2.0	0.1	2.9	4.7	0.2	0.7	0.6	7.9	2.9	0.3	2.8	1.9	2.3	0.7	0.0	0.0	0.3	0.0	2.1	1.2	0.2	13.5	0.3	2.0	0.8	1.1	0.0	0.1	7.3	0.0	0.1	0.3	1.1	0.1	0.1	1.0	0.0	2.0	0.0	1.6	0.6	0.3	0.0	0.3	16.0	1.5	2.6	5.5	0.3	9.4	0.1	0.2	0.9	0.1	2.8	0.0	0.3	1.5	0.3	0.3	1.0	0.4	1.0	0.6	0.4	0.6	0.1	0.9	0.4	0.9	0.9	0.8	0.7	1.1	0.3	0.2	7.9	11.4	2.4	8.5	9.1	4.4	5.1	7.2	5.3	6.5
PGM2L1	"BM32A, FLJ32029"	ENSG00000165434	"Phosphoglucomutase 2 like 1"	Q6PCE3	11	74330318-74398473	"Enzymes, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Isomerase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 48.6"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 13.1;LHCN-M2: 15.7;RH-30: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056995, HPA060948"	Enhanced		Approved	Mitochondria			64000	Mitochondria		"HPA056995: , HPA060948: "	"unprognostic (7.44e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.28e-3)"	"unprognostic (8.91e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.16e-6)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.33e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.03e-2)"	3.0	4.0	30.6	4.9	19.8	4.0	3.2	6.3	48.6	6.1	4.5	1.3	1.0	2.3	6.1	1.9	2.1	4.7	4.8	1.6	30.1	15.1	2.5	2.1	2.7	4.0	9.7	20.4	1.7	4.4	1.4	4.5	2.1	11.7	3.8	5.1	2.9	3.2	2.5	7.1	1.7	2.6	5.6	2.6	2.5	3.4	2.3	0.3	10.0	4.1	1.3	4.0	5.2	2.6	2.4	1.7	2.5	0.6	3.0	7.5	1.1	2.0	2.9	11.5	2.1	3.5	1.5	0.3	2.7	2.1	2.4	2.6	1.0	5.4	0.2	6.8	1.8	1.0	2.3	0.5	2.3	0.8	1.2	1.6	1.6	0.9	0.4	1.9	2.6	0.8	0.5	5.4	1.0	13.1	2.1	1.4	15.7	0.3	7.4	1.6	2.3	2.6	2.3	15.0	0.1	6.2	0.4	0.5	2.3	4.4	1.0	2.0	0.2	0.3	10.9	5.3	5.0	2.1	2.8	1.9	2.8	0.2	0.5	2.6	1.2	2.5	0.6	1.1	2.1	0.6	2.8	2.4	3.5	2.3	0.5	1.8	3.3	1.9	0.7	3.0	0.3	1.7	7.5	1.1	30.6	19.8	6.3	24.4	30.1	15.1	9.7	20.4	11.7	0.3
PIANP	"C12orf53, DKFZp547D2210, PANP"	ENSG00000139200	"PILR alpha associated neural protein"	Q8IYJ0	12	6693792-6700800	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 55.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.0;HAP1: 8.0;NTERA-2: 16.9;SH-SY5Y: 15.9;U-2 OS: 8.9"	"Cancer enhanced"	"Detected in many"		"glioma: 14.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010631	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA010631: AB_10603680"	"unprognostic (1.82e-1)"	"unprognostic (9.21e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.41e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.30e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.34e-2)"	1.5	8.3	28.0	2.2	55.7	1.2	1.5	27.4	52.8	7.2	2.7	2.6	0.5	1.9	11.6	4.1	1.8	2.2	3.3	1.5	19.5	26.2	1.5	1.1	1.5	2.4	11.0	20.9	1.8	1.7	1.2	4.0	1.5	9.0	3.4	2.0	1.7	2.2	8.7	1.3	1.7	2.2	8.1	4.6	1.6	2.1	4.4	8.3	0.0	1.4	0.0	1.7	1.8	2.5	0.3	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.4	6.0	1.2	0.2	0.3	0.2	1.6	8.0	4.2	3.8	0.1	0.2	0.1	0.0	2.8	0.2	8.0	0.2	2.0	0.2	1.0	0.3	0.2	0.0	0.2	0.3	0.3	1.0	0.0	1.7	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	16.9	0.0	1.1	0.0	0.1	0.1	0.1	2.2	15.9	0.0	0.1	0.0	0.0	0.0	0.0	4.3	8.9	4.5	1.1	0.2	0.0	0.3	5.9	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.4	0.0	0.7	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	28.0	55.7	27.4	27.8	19.5	26.2	11.0	20.9	9.0	8.3
PLEKHB1	"KPL1, PHR1, PHRET1"	ENSG00000021300	"Pleckstrin homology domain containing B1"	Q9UF11	11	73646178-73662819	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 220.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 10.4;Hep G2: 38.0;U-266/84: 14.5"	"Cancer enhanced"	"Detected in all"		"glioma: 59.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 33.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.20e-1)"	"unprognostic (5.07e-1)"	"unprognostic (2.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.01e-1)"	"unprognostic (3.94e-2)"	"prognostic favourable (6.02e-4)"	"unprognostic (3.59e-1)"	"prognostic favourable (1.99e-6)"	"unprognostic (2.64e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.47e-1)"	"unprognostic (7.44e-2)"	2.0	4.3	87.5	4.3	85.7	1.6	5.8	18.4	144.2	4.2	5.9	120.2	0.4	6.3	2.5	8.3	3.3	12.5	5.8	7.0	89.2	72.8	6.5	1.7	8.0	4.8	143.1	48.7	1.9	11.4	45.4	12.9	1.5	70.1	5.1	5.3	27.8	25.9	5.4	4.8	1.3	7.0	2.5	220.2	2.9	10.1	5.6	69.5	0.0	14.5	0.0	4.4	2.3	0.7	6.9	0.3	0.4	0.1	1.5	33.1	9.9	0.3	1.0	2.4	1.9	1.0	0.3	0.1	0.1	0.0	0.1	0.1	4.2	8.1	0.0	10.4	0.2	0.2	1.3	0.2	0.2	5.4	6.4	0.0	0.4	38.0	0.6	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	5.4	0.1	3.1	2.6	0.1	1.6	0.5	1.9	0.0	1.2	0.4	0.7	6.1	1.4	0.0	0.1	0.6	2.8	0.5	0.0	0.0	1.2	0.1	0.7	9.1	14.5	5.4	1.4	0.0	0.3	0.0	0.1	0.4	6.5	0.0	15.9	6.9	16.1	11.8	0.2	2.9	33.1	18.4	0.3	1.5	0.0	0.3	9.3	9.9	87.5	85.7	18.4	47.9	89.2	72.8	143.1	48.7	70.1	69.5
PNMA8C		ENSG00000277531	"PNMA family member 8C"	A0A1B0GUJ8	19	46424697-46428951	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"brain: 23.5"	"Group enriched"	"Detected in some"	6	"AF22: 2.6;HMC-1: 5.5;SH-SY5Y: 8.3"	"Cancer enriched"	"Detected in some"	11	"glioma: 7.4"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (3.25e-2)"			"unprognostic (2.38e-1)"	"unprognostic (3.89e-2)"			"unprognostic (4.91e-3)"		"unprognostic (2.58e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.92e-2)"		0.4	2.1	5.3	0.5	8.1	0.6	0.6	2.1	23.5	0.4	0.5	3.3	0.0	0.4	0.4	3.7	0.4	2.3	0.7	0.6	4.8		0.4	0.3	0.6	0.3	1.9	11.5	0.6	0.4	0.7	4.6	0.3	7.0	0.9	0.4	0.0	0.4	1.0	1.3	0.5	0.5	0.5	1.8	0.4	0.4	1.2	1.6	0.0	0.4	0.0	0.3	0.4	0.0	1.1	1.4	2.7	0.5	1.7	0.6	0.1	0.0	0.0	2.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	8.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	2.7	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.3	0.2	1.1	0.5	0.6	2.3	1.7	0.5	1.4	0.2	0.1										
PPP2R2B	"B55beta, PR52B, PR55-BETA, SCA12"	ENSG00000156475	"Protein phosphatase 2 regulatory subunit Bbeta"	Q00005	5	146581146-147084784	"Disease related genes, Predicted intracellular proteins"	Apoptosis		"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 73.2"	"Cell line enriched"	"Detected in some"	4	"HDLM-2: 46.4"	"Cancer enriched"	"Detected in some"	8	"glioma: 7.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 15.1;MAIT T-cell: 13.8;memory CD4 T-cell: 7.1;memory CD8 T-cell: 16.1;naive CD8 T-cell: 12.0;NK-cell: 9.5;T-reg: 8.0"	"Group enriched"	"Detected in many"	33	"NK-cells: 9.5;T-cells: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038118, HPA042122, HPA042770"	Approved		Approved	Cytosol				Cytosol		"HPA038118: AB_10697238, HPA042122: , HPA042770: "	"unprognostic (4.54e-5)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.80e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.20e-2)"	"unprognostic (9.73e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.49e-8)"	"unprognostic (2.02e-1)"	"unprognostic (3.67e-1)"	"unprognostic (5.48e-5)"	"unprognostic (1.14e-4)"	2.0	9.7	30.8	2.5	35.2	2.9	1.8	10.2	73.2	1.6	2.7	26.0	0.0	3.0	1.7	1.8	2.9	14.5	2.9	2.9	26.4	20.9	4.7	2.4	2.5	4.3	25.5	22.4	1.6	2.9	16.0	6.4	2.6	27.5	2.7	2.8	4.6	2.0	2.9	1.5	4.9	2.3	3.5	18.6	2.9	2.2	15.7	29.3	0.0	4.2	0.0	2.4	6.8	1.1	0.0	0.0	0.3	0.0	9.5	16.1	4.1	0.4	0.4	2.4	1.0	0.1	0.1	0.2	0.5	0.2	1.1	1.5	1.3	4.7	0.2	0.1	0.0	10.0	0.8	1.0	1.1	46.4	0.2	0.6	2.7	0.5	0.1	0.0	0.2	0.1	0.6	0.0	0.2	0.1	0.6	0.5	0.7	0.3	0.0	0.0	6.1	1.0	0.7	0.1	0.1	4.1	10.7	1.9	0.2	0.3	0.0	0.2	0.4	0.1	0.3	0.2	0.7	2.5	0.4	0.3	0.2	0.0	1.7	4.2	1.3	0.2	0.0	0.0	15.1	0.0	13.8	0.0	7.1	16.1	0.0	0.0	1.3	12.0	0.3	9.5	0.0	0.0	8.0	4.1	30.8	35.2	10.2	34.1	26.4	20.9	25.5	22.4	27.5	29.3
PTPRR	"EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ"	ENSG00000153233	"Protein tyrosine phosphatase, receptor type R"	Q15256	12	70638073-70920843	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 56.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 14.0;RT4: 26.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 56.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"cerebellum: 100.5"	"Low region specificity"	"Detected in all"			"CAB011461, HPA011851, HPA071067"	Uncertain		Supported	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions, Cytosol"		"CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: "	"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.48e-5)"	"unprognostic (5.44e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.72e-1)"	"prognostic favourable (1.40e-5)"	0.4	3.8	18.8	1.6	11.3	0.3	0.4	56.1	20.9	0.5	11.2	0.1	0.0	5.1	8.4	0.3	0.4	0.5	1.9	0.4	8.6	4.9	0.4	0.4	0.4	0.4	1.3	13.2	0.4	0.6	0.3	0.9	0.7	3.3	0.5	7.8	0.8	0.4	2.1	0.4	0.4	11.3	4.9	3.1	0.4	4.4	0.4	1.4	0.0	0.4	0.0	0.3	4.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.3	0.0	0.5	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	26.7	0.1	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.8	11.3	56.1	20.9	8.6	4.9	1.3	13.2	3.3	1.4
RNF112	"BFP, ZNF179"	ENSG00000128482	"Ring finger protein 112"	Q9ULX5	17	19411125-19417276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"brain: 47.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.1;fHDF/TERT166: 4.7;SCLC-21H: 4.7;SH-SY5Y: 8.2;U-87 MG: 26.9"	"Cancer enriched"	"Detected in some"	8	"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015970	Supported		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA015970: AB_1859103"	"unprognostic (1.16e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.43e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.31e-9)"	"unprognostic (1.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.24e-1)"	2.5	8.1	11.3	2.3	15.9	0.6	1.8	47.5	29.1	1.2	3.6	1.4	0.0	2.9	2.0	6.9	1.1	1.5	4.4	2.3	12.4	8.2	1.2	0.7	1.7	1.4	3.9	14.1	1.3	0.8	0.5	1.9	1.1	3.1	10.2	4.4	1.6	1.3	3.5	2.1	1.9	3.6	3.5	2.9	1.7	2.1	2.0	3.7	0.0	0.9	0.0	0.8	2.8	1.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	4.1	0.1	0.2	0.9	0.0	0.0	0.2	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	3.3	0.0	0.0	1.7	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.1	0.1	0.1	0.0	0.0	4.7	8.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	26.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	15.9	47.5	15.9	12.4	8.2	3.9	14.1	3.1	3.7
SCG3	"FLJ90833, SgIII"	ENSG00000104112	"Secretogranin III"	Q8WXD2	15	51681353-51721031	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 118.3"	"Group enriched"	"Detected in some"	7	"NTERA-2: 20.0;SCLC-21H: 47.9;SH-SY5Y: 22.6"	"Group enriched"	"Detected in many"	7	"glioma: 41.0;pancreatic cancer: 15.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006880, CAB033274, HPA053715"	Enhanced	Supported	Supported	Vesicles	"Secreted in brain"		4800000	Vesicles		"CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: "	"unprognostic (1.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	1.7	12.9	29.6	2.1	25.4	1.7	1.7	33.4	118.3	1.5	2.4	6.5	0.0	2.9	1.5	1.6	1.6	1.6	1.6	1.5	22.6	23.5	1.5	1.5	1.8	1.7	13.6	37.7	1.5	11.5	1.4	23.7	1.5	27.1	1.6	2.8	1.3	1.5	1.4	1.5	1.8	2.6	1.7	13.2	1.5	8.7	2.9	7.3	0.0	2.1	0.0	1.5	1.6	0.1	0.9	1.2	1.9	0.5	0.3	0.8	0.2	0.0	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	20.0	0.0	0.1	0.0	0.1	0.0	0.2	47.9	22.6	0.1	0.1	0.0	0.0	1.4	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.3	0.1	4.3	0.4	0.4	0.6	0.8	0.2	0.5	0.9	0.6	0.4	0.4	0.7	0.5	0.6	1.9	0.3	0.5	1.2	0.2	0.2	29.6	25.4	33.4	40.6	22.6	23.5	13.6	37.7	27.1	7.3
SCN1A	"FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI"	ENSG00000144285	"Sodium voltage-gated channel alpha subunit 1"	P35498	2	165984641-166149214	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 33.9"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 11.3;Hep G2: 6.0"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078664			Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA078664: "	"unprognostic (9.25e-2)"	"unprognostic (3.97e-2)"		"unprognostic (6.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.03e-9)"	"unprognostic (6.92e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.93e-1)"	1.1	1.3	5.2	1.1	13.6	1.0	1.1	10.3	26.6	1.1	1.1	2.3	0.0	1.0	1.1	1.1	1.0	6.8	1.0	1.1	6.9	8.3	1.1	1.1	5.6	1.0	5.7	9.7	1.0	1.0	1.1	2.9	1.2	33.9	1.1	1.1	0.3	1.0	1.0	1.2	1.1	1.1	1.1	3.6	1.1	1.1	1.4	4.2	0.0	1.1	0.0	1.0	1.1	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	11.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.2	13.6	10.3	26.6	6.9	8.3	5.7	9.7	33.9	4.2
SEZ6L		ENSG00000100095	"Seizure related 6 homolog like"	Q9BYH1	22	26169474-26383597	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 60.8"	"Group enriched"	"Detected in some"	7	"SCLC-21H: 30.0;SH-SY5Y: 8.0"	"Group enriched"	"Detected in some"	6	"glioma: 14.6;pancreatic cancer: 3.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 7.4;myeloid DC: 7.2;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	73	"dendritic cells: 7.2;monocytes: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045135			Approved	Vesicles			2400000	Vesicles		"HPA045135: "	"unprognostic (1.01e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.49e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.09e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.39e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.40e-6)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.18e-1)"	1.2	12.5	26.4	1.6	11.3	1.3	1.1	20.1	60.8	2.4	1.3	4.3	0.0	1.5	1.1	1.1	1.1	1.1	1.2	2.5	39.1	23.6	1.1	1.1	1.3	1.1	11.2	25.5	1.1	2.7	1.0	3.8	1.1	15.0	1.3	1.4	0.0	1.3	1.2	1.1	1.2	1.6	1.4	5.3	1.3	2.9	1.4	5.4	0.0	1.2	0.0	1.1	1.2	0.2	0.0	7.2	0.0	7.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	30.0	8.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.4	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.5	26.4	11.3	20.1	29.3	39.1	23.6	11.2	25.5	15.0	5.4
SLAIN1	"C13orf32, FLJ30046"	ENSG00000139737	"SLAIN motif family member 1"	Q8ND83	13	77697854-77764242	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 89.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 20.5;HL-60: 27.3;MOLT-4: 31.3;REH: 21.9;SCLC-21H: 21.7"	"Cancer enhanced"	"Detected in many"		"glioma: 25.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 2.2;T-cells: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (8.76e-5)"	"unprognostic (1.78e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.25e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.20e-2)"	"prognostic favourable (9.07e-4)"	"unprognostic (4.80e-3)"	"unprognostic (3.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.97e-2)"	1.4	6.0	27.6	3.0	41.5	8.7	4.1	14.2	73.1	3.6	1.7	74.8	0.3	1.9	4.4	7.4	2.6	10.2	2.4	3.7	39.1	20.7	5.1	4.5	6.0	5.8	56.7	19.6	4.8	6.5	7.5	2.7	2.4	38.3	4.5	2.0	1.3	5.6	3.8	1.9	1.3	1.6	3.2	89.3	4.6	6.6	17.6	51.9	4.1	6.5	0.0	6.0	2.5	1.0	0.7	2.2	0.0	0.2	0.8	4.7	1.0	0.1	1.2	15.1	0.3	0.0	0.0	2.6	0.1	0.0	0.0	0.0	1.4	3.1	11.5	0.7	0.0	0.1	14.3	0.0	0.0	14.3	20.5	9.8	2.8	0.2	0.4	27.3	0.7	0.0	0.0	0.0	0.0	0.5	0.3	15.4	0.0	0.3	31.3	2.7	5.7	4.6	21.9	1.3	0.0	7.0	1.2	21.7	11.0	0.0	4.2	2.8	0.0	12.4	0.1	0.1	0.6	0.1	3.9	14.9	6.8	13.8	1.7	3.2	0.9	0.0	0.1	0.0	2.1	0.2	3.0	0.7	2.5	2.3	0.2	0.6	2.7	4.2	0.0	0.8	0.2	2.2	4.7	1.0	27.6	41.5	14.2	26.2	39.1	20.7	56.7	19.6	38.3	51.9
SLC24A2	NCKX2	ENSG00000155886	"Solute carrier family 24 member 2"	Q9UI40	9	19507452-19786928	"Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport, Vision"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 31.8"	"Group enriched"	"Detected in some"	6	"K-562: 5.6;NTERA-2: 1.9;SCLC-21H: 5.0;U-87 MG: 6.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.30e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.48e-2)"		"unprognostic (8.46e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.08e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.51e-2)"	0.2	6.1	4.0	0.2	11.2	0.3	0.1	2.4	31.8	0.2	0.2			0.2	0.5	0.2	0.2	0.2	0.3	0.2	8.9	4.0	0.3	0.2	0.1	0.2	8.2		0.2	0.2	0.2	0.0	0.3		0.2	0.2		0.2	0.2	0.2	0.3	0.2	0.2	10.7	0.2	0.2	0.4			0.2		0.1	0.2	0.0	1.2	1.0	2.6	1.3	1.7	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	5.6	0.2	0.1	0.3	0.0	0.1	1.9	0.1	0.1	0.0	0.0	0.0	0.0	5.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.0	0.2	0.0	0.0	6.7	0.0	0.1	2.6	0.8	0.9	0.7	0.8	1.0	0.9	0.8	0.6	0.5	1.2	1.1	1.0	2.0	1.7	1.3	1.0	0.8	0.4										
SLC6A7	PROT	ENSG00000011083	"Solute carrier family 6 member 7"	Q99884	5	150189957-150222788	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 40.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.9;SK-BR-3: 1.5;U-87 MG: 1.1"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028907	Uncertain									"HPA028907: AB_10602404"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.82e-4)"	"unprognostic (6.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.50e-1)"	"unprognostic (3.73e-4)"	"unprognostic (8.11e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.70e-3)"	0.5	0.4	3.9	1.0	9.7	0.4	0.5	40.2	22.4	0.6	5.7	0.3	0.0	2.6	0.5	0.6	0.4	0.4	0.5	0.5	6.5	4.5	0.4	0.4	0.5	0.7	1.3	14.5	0.4	0.5	0.4	0.2	0.4	1.6	0.4	7.7	0.0	0.8	0.4	0.5	0.5	4.9	0.7	1.4	0.4	0.4	0.5	0.0	0.0	0.4	0.0	0.7	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	9.7	40.2	22.4	6.5	4.5	1.3	14.5	1.6	0.0
SLC8A2	"KIAA1087, NCX2"	ENSG00000118160	"Solute carrier family 8 member A2"	Q9UPR5	19	47428017-47472168	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 50.9"	"Group enriched"	"Detected in some"	6	"NTERA-2: 4.3;SCLC-21H: 12.2;SH-SY5Y: 6.6;SiHa: 5.1;U-2 OS: 7.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"amygdala: 80.3;basal ganglia: 95.4;cerebral cortex: 125.2;hippocampal formation: 110.1"	"Low region specificity"	"Detected in all"			"HPA050818, HPA054671"	Enhanced									"HPA050818: AB_2681248, HPA054671: AB_2682568"	"unprognostic (3.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.95e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-2)"	1.2	4.0	16.6	1.0	18.1	0.9	0.9	50.9	50.7	1.0	2.4	1.8	1.0	1.3	5.4	1.0	2.3	2.2	1.1	0.9	21.4	6.8	1.0	0.9	0.9	0.9	2.1	21.1	0.9	10.3	0.9	3.2	1.0	2.0	1.4	1.4	0.0	1.2	4.4	0.9	1.0	1.2	5.5	2.0	1.0	1.3	1.9	1.2	0.0	1.0	0.0	0.9	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.4	0.1	12.2	6.6	5.1	0.6	0.4	0.1	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	18.1	50.9	34.6	21.4	6.8	2.1	21.1	2.0	1.2
SNX32	"FLJ30934, SNX6B"	ENSG00000172803	"Sorting nexin 32"	Q86XE0	11	65833641-65856896	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 16.6"	"Cell line enhanced"	"Detected in some"		"HHSteC: 6.0;HSkMC: 7.8;REH: 2.5;SH-SY5Y: 3.0;U-266/70: 9.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 1.0;dendritic cells: 1.2;T-cells: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041775	Uncertain		Uncertain	"Cell Junctions,Focal adhesion sites"				"Cell Junctions, Focal adhesion sites"		"HPA041775: AB_10797268"	"unprognostic (6.74e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.67e-2)"	"unprognostic (4.50e-5)"	"unprognostic (1.00e-1)"	"unprognostic (9.28e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.36e-2)"	0.8	1.0	9.0	1.1	16.6	1.3	1.3	3.5	16.1	1.6	2.2	1.6	0.0	3.4	2.0	1.3	0.9	2.5	2.8	0.9	10.2	5.0	0.9	0.7	0.8	1.0	3.6	10.9	1.3	0.8	0.8	0.3	0.9	3.4	0.8	1.9	0.1	0.7	0.9	0.6	1.1	1.5	2.0	1.8	0.9	0.9	3.5	3.7	0.0	0.7	0.0	1.3	1.0	0.2	1.0	1.2	0.2	0.3	0.1	3.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.6	7.8	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.3	0.1	0.0	2.5	0.0	2.2	0.1	0.0	0.0	3.0	0.0	0.0	1.7	0.0	0.4	0.0	0.3	0.0	0.0	0.0	9.1	1.5	0.0	0.7	0.0	0.3	0.0	0.1	0.0	1.2	0.3	3.0	0.3	1.6	1.2	1.2	1.0	1.4	0.6	0.2	0.1	0.0	0.7	1.2	0.4	9.0	16.6	3.5	15.4	10.2	5.0	3.6	10.9	3.4	3.7
SOX2		ENSG00000181449	"SRY-box 2"	P48431	3	181711924-181714436	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 80.1"	"Cell line enhanced"	"Detected in some"		"AF22: 67.5;HAP1: 28.7;NTERA-2: 55.0;U-251 MG: 12.6"	"Cancer enhanced"	"Detected in many"		"glioma: 136.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045725, HPA062851, HPA071379, CAB079745"	Enhanced	Supported	Enhanced	Nucleoplasm				Nucleoplasm		"CAB079745: , HPA045725: , HPA062851: , HPA071379: "	"unprognostic (1.80e-2)"	"unprognostic (3.18e-3)"	"unprognostic (5.69e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.81e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.12e-2)"	1.8	2.5	30.3	2.0	25.8	1.5	1.6	13.9	80.1	1.8	2.3	24.3	0.0	2.0	1.5	1.8	15.9	5.0	1.8	1.7	36.0	19.2	1.5	1.5	3.4	1.5	19.4	18.5	1.7	1.6	1.5	5.8	1.5	18.6	3.9	2.0	1.0	6.3	1.9	1.6	1.8	2.3	1.7	18.4	1.6	9.7	3.0	22.4	0.0	1.5	2.1	6.9	2.3	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	67.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	28.7	0.7	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	55.0	0.1	0.0	0.1	0.0	7.4	0.1	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	25.8	13.9	20.0	36.0	19.2	19.4	18.5	18.6	22.4
ST8SIA3	SIAT8C	ENSG00000177511	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3"	O43173	18	57350813-57371731	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 24.0"	"Group enriched"	"Detected in some"	42	"NTERA-2: 5.9;SCLC-21H: 10.1;SH-SY5Y: 11.4"	"Group enriched"	"Detected in some"	11	"glioma: 0.9;pancreatic cancer: 1.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063398, HPA066783"	Enhanced		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA063398: , HPA066783: "					"unprognostic (1.75e-1)"		"unprognostic (7.85e-2)"			"unprognostic (1.41e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.11e-1)"		"unprognostic (5.49e-2)"	"unprognostic (1.82e-1)"			0.1	4.5	3.4	0.1	12.0	0.0	0.0	7.9	24.0	0.0	0.2			0.9	0.0	0.0	0.0	0.0	1.1	0.0	3.8	4.8	0.1	0.2	0.1	0.0	1.2		0.0	4.2	0.0	3.5	0.0		0.1	0.2		0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.3	0.9			0.1		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	10.1	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
STRC	DFNB16	ENSG00000242866	Stereocilin	Q7RTU9	15	43599563-43618800	"Disease related genes, Predicted intracellular proteins"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"brain: 22.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.5;hTCEpi: 2.2;SCLC-21H: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048083	Enhanced									"HPA048083: "	"unprognostic (8.60e-3)"	"unprognostic (5.77e-3)"	"unprognostic (6.14e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.99e-4)"	"unprognostic (1.58e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.59e-4)"	0.2	0.5	1.7	0.2	4.2	0.1	0.8	22.9	5.1	0.0	0.2			0.4	0.1	4.7	0.1	0.3	0.2	0.0	2.3	3.2	0.0	0.1	0.1	0.0	1.6		0.4	0.5	0.1	1.7	0.0		0.7	0.2		1.5	0.1	0.4	2.7	0.4	0.0	1.1	0.2	0.2	3.3			0.6		0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.2	0.0	0.8	0.0	0.0	0.1	1.0	1.5	0.0	0.7	0.0	0.0	0.5	0.6	0.5	2.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.2	0.0	0.3	0.5	0.0	0.0	0.1	0.1	1.9	0.1	0.0	0.4	0.9	0.4	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SYNGR3		ENSG00000127561	"Synaptogyrin 3"	O43761	16	1989660-1994275	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 55.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.1;HMC-1: 16.2;Karpas-707: 13.7;SK-BR-3: 17.1;U-266/70: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 3.7;NK-cells: 4.6;T-cells: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034278, HPA042842"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"		"CAB034278: AB_2200905, HPA042842: "	"unprognostic (8.89e-3)"	"prognostic favourable (6.92e-4)"	"unprognostic (6.07e-3)"	"unprognostic (2.94e-3)"	"unprognostic (2.92e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.52e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.05e-1)"	"prognostic favourable (7.12e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.78e-2)"	1.1	11.1	20.3	3.7	21.8	1.6	1.1	24.2	55.3	1.5	2.3	2.6	0.0	2.2	1.0	1.0	1.3	1.1	1.3	1.4	14.6	40.8	1.7	1.0	1.3	4.0	27.1	20.1	1.5	1.0	9.4	3.1	5.4	28.2	1.3	2.2	0.9	2.1	1.1	0.9	1.1	2.5	1.7	4.4	2.2	2.1	4.2	2.0	0.0	1.0	0.0	4.7	1.4	0.2	3.7	0.7	0.0	0.8	4.6	2.7	0.9	0.4	2.1	1.9	0.2	0.2	0.2	2.4	0.9	1.6	0.8	0.6	3.2	1.5	3.1	0.7	0.7	1.8	2.1	0.3	0.2	25.1	1.5	0.0	2.7	1.5	1.1	0.0	16.2	0.5	0.1	0.0	0.5	0.2	9.0	13.7	0.4	2.4	0.1	0.1	10.1	0.9	0.0	0.2	2.4	1.3	0.0	4.5	5.7	2.3	17.1	0.2	2.3	0.2	0.3	0.5	7.9	0.0	0.3	21.6	2.5	3.6	0.3	2.8	0.3	0.0	0.8	0.0	0.9	0.3	2.1	3.2	1.7	2.7	0.7	3.7	2.0	0.8	0.0	4.6	0.7	0.0	1.6	0.9	20.3	21.8	24.2	39.3	14.6	40.8	27.1	20.1	28.2	2.0
TFAP2D	TFAP2BL1	ENSG00000008197	"Transcription factor AP-2 delta"	Q7Z6R9	6	50713828-50772988	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	5	"brain: 4.4"	"Group enriched"	"Detected in some"	5	"HAP1: 5.1;U-2197: 1.6"	"Cancer enriched"	"Detected in single"	10	"lung cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"midbrain: 14.1"	"Region enriched"	"Detected in some"	7	"midbrain: 16.3"																													0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0			0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TIAM1		ENSG00000156299	"T cell lymphoma invasion and metastasis 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 110.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 18.9;HEL: 18.3;HMC-1: 16.0;RT4: 19.0;SCLC-21H: 17.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"cerebellum: 110.1"	"Group enriched"	"Detected in many"	5	"classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 574.6"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"				"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	3.3	11.4	13.4	5.3	12.4	2.1	4.4	110.1	15.1	10.1	2.2	9.7	0.5	1.5	7.9	3.0	18.9	9.4	4.0	2.1	11.6	7.0	1.7	3.7	4.1	8.8	6.2	7.9	1.5	1.9	0.3	4.2	4.4	8.9	3.7	2.8	7.0	2.2	3.1	0.7	20.4	1.7	10.0	6.4	4.2	2.1	5.9	7.1	6.2	1.3	5.3	9.3	8.1	5.0	0.1	5.9	0.6	12.4	6.9	16.8	3.6	1.5	0.5	11.9	0.7	0.2	2.8	18.9	0.0	0.0	1.4	0.5	0.1	2.1	4.0	0.8	0.3	2.8	1.4	2.4	2.4	0.3	6.5	18.3	0.3	0.1	0.3	0.0	16.0	1.2	0.8	8.1	3.2	0.0	0.0	6.0	6.0	7.7	2.8	0.1	3.8	5.1	3.6	3.7	0.0	1.8	19.0	17.9	4.4	0.8	6.2	0.7	2.5	0.0	0.1	1.7	6.9	0.0	0.8	6.7	5.0	3.6	4.0	1.4	13.1	0.6	10.7	0.0	0.3	9.6	2.1	0.1	8.3	1.6	5.9	0.0	10.9	0.6	0.6	6.9	12.4	0.3	16.8	3.6	13.4	12.4	110.1	14.4	11.6	7.0	6.2	7.9	8.9	7.1
TMEFF1	"C9orf2, CT120.1, H7365"	ENSG00000241697	"Transmembrane protein with EGF like and two follistatin like domains 1"	Q8IYR6	9	100473113-100577636	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 21.1"	"Cell line enhanced"	"Detected in some"		"AF22: 7.7;BEWO: 9.6;NTERA-2: 19.4;REH: 13.0;SCLC-21H: 16.6;SH-SY5Y: 11.1"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA051501	Uncertain									"HPA051501: "	"unprognostic (1.96e-1)"	"unprognostic (2.30e-1)"		"unprognostic (9.69e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.02e-2)"		"unprognostic (3.59e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.04e-6)"	"unprognostic (1.30e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.44e-3)"	1.2	1.2	5.0	1.0	13.9	1.2	1.1	1.4	21.1	1.6	1.3	15.0	0.0	1.0	3.0	1.0	1.0	1.2	1.6	1.0	9.1	8.9	1.2	1.0	1.1	1.4	10.3	7.9	1.0	1.0	1.1	0.4	1.8	11.7	1.5	1.1	0.1	1.1	1.4	1.0	1.0	1.3	1.4	13.8	1.2	1.3	4.1	12.6	0.0	3.1	0.0	1.1	1.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	7.7	0.4	0.1	0.2	9.6	0.6	0.1	0.4	0.5	0.5	0.1	0.0	1.7	0.2	0.0	2.9	0.0	0.4	0.0	4.3	0.0	0.2	0.4	0.4	0.0	0.0	0.2	0.0	0.4	0.1	1.2	0.1	0.0	0.6	0.0	4.8	0.0	19.4	0.2	13.0	6.6	0.0	0.3	0.0	16.6	11.1	0.0	0.0	0.2	0.0	0.0	1.7	1.5	2.6	0.1	0.6	3.0	2.1	2.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.0	13.9	1.4	15.4	9.1	8.9	10.3	7.9	11.7	12.6
TMEM145	FLJ90805	ENSG00000167619	"Transmembrane protein 145"	Q8NBT3	19	42313325-42325062	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"brain: 74.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 11.7;SCLC-21H: 22.2;SH-SY5Y: 10.6"	"Cancer enhanced"	"Detected in many"		"glioma: 8.8"	"Region enriched"	"Detected in all"	4	"cerebellum: 74.5"	"Group enriched"	"Detected in some"	8	"basophil: 4.5;neutrophil: 15.5"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060462	Enhanced	Approved	Approved	Vesicles				Vesicles		"HPA060462: "	"unprognostic (9.56e-3)"	"unprognostic (8.61e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.27e-3)"	"unprognostic (1.53e-2)"	"unprognostic (9.85e-2)"	"unprognostic (4.20e-4)"	"unprognostic (7.35e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.31e-2)"	1.6	6.2	8.0	1.2	7.7	2.5	1.3	74.5	30.5	0.6	1.2	3.8	0.0	1.7	1.1	1.6	1.0	1.1	1.4	1.3	5.8	8.5	0.9	1.4	0.8	1.5	5.1	7.6	1.2	3.7	3.0	6.4	0.6	9.3	1.2	1.2	2.8	1.1	0.9	2.3	3.3	1.1	1.2	3.9	1.5	2.0	3.3	3.2	0.0	1.3	0.0	1.1	1.0	0.3	1.3	0.8	15.5	0.9	0.6	0.9	0.8	0.5	2.7	2.1	6.4	0.2	0.2	0.8	0.2	0.1	1.0	2.6	0.5	0.7	1.5	0.3	0.6	0.2	1.5	0.4	1.2	6.7	1.6	2.8	2.5	2.4	0.2	1.6	11.7	0.5	0.5	0.4	0.6	1.1	1.5	5.5	0.1	0.6	0.4	1.9	1.3	8.6	0.2	0.6	5.2	0.1	1.0	22.2	10.6	0.9	0.7	1.3	1.9	1.8	0.3	1.8	1.9	1.3	0.7	1.2	3.0	1.4	0.7	1.1	5.1	4.5	0.9	0.9	0.6	0.8	0.3	1.0	0.6	0.4	0.2	1.3	0.6	0.9	15.5	0.6	0.7	0.8	0.4	0.8	8.0	7.7	74.5	18.1	5.8	8.5	5.1	7.6	9.3	3.2
TMEM178A	"MGC33926, TMEM178"	ENSG00000152154	"Transmembrane protein 178A"	Q8NBL3	2	39664982-39717963	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 87.4"	"Cell line enriched"	"Detected in some"	5	"AF22: 55.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.0"	"Region enriched"	"Detected in all"	5	"cerebellum: 87.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052128	Uncertain		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA052128: "	"unprognostic (3.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.82e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.11e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.01e-3)"	2.9	4.2	13.3	0.9	10.6	0.6	6.8	87.4	35.6	1.6	1.9	6.4	0.0	2.3	3.8	2.0	1.8	3.3	3.1	3.6	16.4	7.4	18.9	2.7	5.8	0.8	10.7	10.9	1.8	2.2	1.3	2.5	3.6	17.0	12.2	2.2	3.7	3.8	2.1	2.3	3.5	2.4	2.9	22.6	1.6	3.5	1.2	5.3	0.0	5.7	0.8	2.2	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	0.1	1.7	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	7.0	0.0	0.6	0.0	0.0	0.4	0.1	10.2	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	10.6	87.4	18.8	16.4	7.4	10.7	10.9	17.0	5.3
TMEM266	"C15orf27, FLJ38190"	ENSG00000169758	"Transmembrane protein 266"	Q2M3C6	15	76059837-76229121	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 50.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.9;HEK 293: 3.6;NTERA-2: 3.6;U-937: 3.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Region enriched"	"Detected in many"	12	"cerebellum: 50.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	6	"cerebellum: 65.8"	"Region enriched"	"Detected in all"	6	"cerebellum: 66.4"	"HPA041921, HPA049425"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041921: AB_10796789, HPA049425: "	"unprognostic (8.63e-3)"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-3)"	"unprognostic (9.17e-5)"	"unprognostic (4.67e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.86e-2)"	0.1	1.9	1.1	0.2	1.9	0.2	0.4	50.7	4.2	0.2	0.2	0.6	0.0	0.3	0.2	0.1	0.3	0.3	0.1	0.1	0.9	1.3	0.9	0.1	1.1	0.3	0.7	0.3	0.1	2.4	0.2	5.1	2.4	1.9	0.4	0.2	1.1	0.2	0.1	10.6	1.5	0.1	0.1	0.4	0.6	0.3	1.4	0.0	0.0	0.2	0.7	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.8	0.8	0.0	1.9	3.6	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	50.7	4.2	0.9	1.3	0.7	0.3	1.9	0.0
TMOD2	NTMOD	ENSG00000128872	"Tropomodulin 2"	Q9NZR1	15	51751561-51816368	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 68.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 26.3"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.8"	"Group enriched"	"Detected in all"	4	"granulocytes: 12.8;monocytes: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041365	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA041365: AB_10794665"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.34e-3)"	"unprognostic (9.11e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.32e-1)"	"unprognostic (5.33e-4)"	"prognostic favourable (4.53e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.36e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.89e-1)"	5.9	6.3	25.4	6.1	29.6	1.6	5.1	22.0	68.6	7.0	6.1	9.1	4.6	3.1	6.0	4.4	4.9	6.0	5.2	4.9	21.6	18.1	3.5	2.2	4.5	4.9	16.9	22.6	6.5	3.1	6.7	4.4	3.0	29.5	3.7	5.1	2.9	3.8	9.6	2.7	4.6	4.7	6.7	11.4	4.5	3.7	3.1	9.6	1.2	4.3	0.2	4.7	4.7	4.6	2.5	1.6	12.8	8.8	1.3	2.2	1.1	0.8	0.5	1.7	4.0	8.2	8.8	0.3	4.5	1.5	3.4	3.7	0.0	0.4	3.6	0.1	3.5	2.3	7.1	4.0	1.1	0.0	3.5	0.0	0.7	0.0	1.4	1.4	0.2	5.1	5.4	0.5	1.0	0.7	0.0	0.1	4.2	0.6	2.9	0.5	1.1	0.8	2.2	1.0	0.1	0.5	1.2	26.3	6.4	4.2	0.0	1.2	1.0	0.2	1.6	9.3	0.7	5.8	3.2	0.0	0.0	0.0	2.9	9.7	4.2	0.1	5.9	7.8	2.2	2.3	1.0	2.5	1.3	1.0	1.6	1.8	1.7	0.7	12.8	1.3	8.8	1.2	0.4	1.1	25.4	29.6	22.0	38.3	21.6	18.1	16.9	22.6	29.5	9.6
TSPAN7	"A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2"	ENSG00000156298	"Tetraspanin 7"	P41732	X	38561370-38688920	"CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 131.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.3;Hep G2: 10.6;MOLT-4: 55.3;SCLC-21H: 31.0;U-266/70: 20.5"	"Cancer enhanced"	"Detected in all"		"glioma: 71.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.9"	"Low lineage specificity"	"Detected in single"											"HPA003140, CAB062566, CAB068245"	Enhanced									"CAB062566: , CAB068245: , HPA003140: AB_1078454"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (3.40e-4)"	"unprognostic (5.06e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-2)"	"prognostic favourable (1.70e-4)"	"unprognostic (1.54e-1)"	"prognostic favourable (5.48e-7)"	"unprognostic (5.65e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-3)"	15.2	28.7	39.6	3.5	83.0	0.8	7.3	83.8	131.1	12.4	18.5	11.5	2.3	7.9	11.6	9.2	7.9	10.5	5.8	17.1	34.5	30.7	15.8	12.0	16.2	8.8	19.4	37.7	5.2	4.4	4.1	11.4	6.6	23.8	5.6	17.3	8.1	3.3	7.4	17.9	4.9	7.8	14.5	11.9	21.3	4.6	1.7	9.5	0.0	11.8	5.4	8.2	8.2	4.2	0.9	0.5	0.3	0.2	0.3	2.9	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.9	0.3	0.0	13.3	2.5	0.0	0.0	10.6	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	55.3	0.0	2.9	0.0	2.7	1.1	0.0	1.4	0.2	31.0	3.2	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.7	0.0	0.2	20.5	5.8	0.0	1.3	0.1	0.4	0.2	0.1	0.0	0.6	0.2	0.7	0.4	1.1	2.9	0.1	0.9	2.1	1.8	0.3	0.3	0.0	0.5	0.0	0.1	39.6	83.0	83.8	86.3	34.5	30.7	19.4	37.7	23.8	9.5
TTYH2	C17orf29	ENSG00000141540	"Tweety family member 2"	Q9BSA4	17	74213514-74262020	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 84.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 11.5;SK-MEL-30: 40.1"	"Group enriched"	"Detected in all"	6	"glioma: 16.7;melanoma: 20.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 16.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 11.5;monocytes: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.19e-1)"	"unprognostic (5.08e-1)"	"unprognostic (1.58e-3)"	"unprognostic (3.51e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-2)"	"unprognostic (5.90e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavourable (9.74e-5)"	"unprognostic (8.98e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.50e-3)"	"unprognostic (3.51e-3)"	4.6	4.4	20.7	5.8	32.1	2.8	2.9	4.6	63.5	3.8	3.1	84.1	0.0	2.6	4.4	3.4	3.1	4.8	4.5	12.8	31.6	15.9	1.8	1.9	4.3	5.9	59.3	19.0	12.9	4.9	5.4	3.1	8.2	28.7	2.8	2.6	8.5	5.4	3.9	10.5	4.5	3.2	3.6	48.6	8.8	2.3	9.2	45.6	0.7	8.5	2.1	4.8	3.0	2.1	0.2	11.5	0.8	16.6	0.1	3.1	3.8	0.1	0.9	4.6	4.3	0.5	0.6	0.1	0.2	0.0	0.2	0.0	2.9	0.0	2.6	0.6	0.1	7.2	4.5	0.1	0.1	6.0	2.5	2.8	0.1	0.2	3.2	0.3	1.9	11.5	2.3	0.1	0.8	0.1	0.5	1.3	0.1	0.5	1.3	0.2	0.9	7.9	4.3	8.2	4.9	0.1	0.3	1.6	5.6	0.0	2.8	40.1	1.5	0.5	0.1	0.0	2.3	0.0	0.1	0.2	0.1	0.0	0.1	0.8	2.4	0.6	8.0	0.7	1.6	13.9	0.2	0.2	3.1	2.6	9.0	0.2	0.5	1.1	0.8	0.1	16.6	11.5	2.7	3.8	20.7	32.1	4.6	29.8	31.6	15.9	59.3	19.0	28.7	45.6
TUNAR	"HI-LNC78, LINC00617, TUNA"	ENSG00000250366	"TCL1 upstream neural differentiation-associated RNA"		14	95876392-95925571	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	5	"brain: 28.7"	"Group enriched"	"Detected in some"	4	"AF22: 4.8;EFO-21: 2.8;NTERA-2: 10.0;SCLC-21H: 10.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"																		"unprognostic (1.28e-3)"			"unprognostic (3.94e-1)"	"unprognostic (4.10e-2)"					"unprognostic (1.69e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.34e-1)"	"prognostic favourable (1.55e-4)"	"unprognostic (5.33e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.18e-1)"		0.2	0.2	0.9	0.2	18.6	0.5	0.4	1.2	8.8	0.4	0.3	1.3	0.0	0.5	3.7	0.2	0.2	5.1	0.5	0.3	6.0		0.3	0.2	0.2	0.4	0.0	3.7	0.2	6.1	0.2	0.0	0.3	28.7	0.2	0.4	0.7	0.2	3.4	0.2	0.7	0.2	0.3	1.3	0.2	0.3	1.1	6.8	0.0	0.9	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	1.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	10.0	0.0	0.4	0.0	0.0	0.2	0.0	10.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0										
UGT8	CGT	ENSG00000174607	"UDP glycosyltransferase 8"	Q16880	4	114598455-114678224	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 96.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 25.3;RH-30: 12.1;RPTEC TERT1: 25.0;SCLC-21H: 14.2;U-87 MG: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 7.3;naive B-cell: 10.6"	"Lineage enriched"	"Detected in single"	12	"B-cells: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014405, HPA065785"	Enhanced		Approved	Mitochondria				Mitochondria		"HPA014405: AB_1858606, HPA065785: "	"unprognostic (7.38e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-1)"	"prognostic favourable (8.55e-5)"	"unprognostic (2.80e-1)"	"unprognostic (1.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.49e-1)"	0.9	0.8	13.2	2.8	30.0	1.0	3.1	2.7	44.8	4.9	15.5	66.6	0.0	18.4	2.7	0.6	1.2	3.0	7.1	0.9	24.2	12.4	20.1	0.8	1.0	3.2	53.9	15.9	0.8	4.8	0.3	0.9	0.5	38.3	0.9	17.3	0.0	4.5	0.8	0.8	1.8	16.1	1.5	96.6	1.3	10.0	3.3	42.6	0.0	8.5	0.0	3.4	0.8	1.0	10.6	0.0	0.9	0.0	0.0	0.6	0.3	0.3	0.1	2.0	0.3	0.1	0.0	0.3	0.1	0.0	0.0	1.5	6.8	25.3	7.6	0.6	0.1	10.7	0.0	0.0	0.0	0.1	5.3	0.1	11.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	6.4	1.5	0.0	0.1	0.1	0.8	3.0	3.8	0.7	12.1	0.2	25.0	0.3	14.2	2.1	0.1	2.2	0.3	0.4	2.4	0.5	0.5	8.6	0.3	7.9	2.5	0.4	0.2	12.5	0.4	7.8	0.2	0.0	0.9	0.0	0.0	0.6	7.3	0.1	0.0	0.0	10.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.3	13.2	30.0	2.7	24.4	24.2	12.4	53.9	15.9	38.3	42.6
ZFYVE28	KIAA1643	ENSG00000159733	"Zinc finger FYVE-type containing 28"	Q9HCC9	4	2269582-2418663	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 63.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 11.0;NB-4: 11.9;U-266/70: 12.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 63.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038175, HPA057587"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA038175: AB_10697244, HPA057587: "	"unprognostic (1.59e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.08e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.64e-2)"	"prognostic favourable (1.35e-6)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	4.5	8.6	7.7	5.1	15.8	3.1	3.7	63.6	15.1	3.7	7.4	4.6	1.8	10.4	4.1	3.1	3.4	4.3	5.9	2.4	7.1	5.5	5.7	4.2	4.4	6.1	7.9	8.0	3.4	7.3	7.9	7.5	1.8	9.9	2.9	5.1	5.8	9.5	5.4	4.3	5.7	11.9	2.8	9.4	7.0	7.5	7.9	6.7	1.2	5.3	3.1	4.0	4.5	3.2	3.1	0.7	0.9	0.4	0.3	4.4	1.3	0.8	1.0	0.2	3.7	2.1	0.7	0.1	1.8	3.1	1.0	0.3	0.1	6.6	0.0	1.9	3.2	3.8	1.2	0.3	0.6	9.5	1.3	0.2	4.2	0.3	4.3	0.7	11.0	3.0	0.6	1.1	0.1	3.0	1.8	8.1	0.9	2.2	0.1	11.9	0.1	8.1	0.0	0.0	3.9	1.5	0.5	5.8	0.4	1.8	0.1	1.0	2.4	0.3	0.5	1.7	0.0	5.4	0.1	12.6	9.1	0.1	5.3	2.3	1.8	0.9	0.4	0.1	4.4	0.0	1.9	0.9	2.3	3.2	0.7	3.1	3.2	3.2	0.1	0.3	0.3	0.2	4.0	1.3	7.7	15.8	63.6	15.1	7.1	5.5	7.9	8.0	9.9	6.7
ZIC5		ENSG00000139800	"Zic family member 5"	Q96T25	13	99962964-99971909	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 48.9"	"Cell line enhanced"	"Detected in some"		"AF22: 10.9;HEK 293: 6.3;NTERA-2: 7.5;SCLC-21H: 42.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	24	"cerebellum: 48.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 19.3;cerebellum: 20.7;thalamus: 5.7"	"Region enriched"	"Detected in many"	6	"cerebellum: 53.2"	HPA074045			Uncertain	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA074045: "	"unprognostic (2.78e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.38e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.87e-2)"		"unprognostic (1.13e-1)"	"unprognostic (3.12e-2)"		"unprognostic (4.94e-2)"	0.1	0.0	1.2	0.0	0.5	0.0	0.1	48.9	4.2	0.0	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.5	0.5	0.1	0.1	0.1	0.1	0.4	0.3	0.0	0.0	0.1	0.0	0.0	2.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	10.9	0.9	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	1.6	0.0	0.0	2.2	0.0	0.0	1.9	6.3	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	1.5	0.0	0.0	0.8	0.0	0.8	7.5	0.1	0.9	0.4	0.0	0.0	0.0	42.8	0.0	1.1	1.0	0.0	0.0	1.3	0.0	0.6	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.5	48.9	1.3	1.5	0.5	0.4	0.3	2.0	0.0
ACBD7	"bA455B2.2, FLJ38219"	ENSG00000176244	"Acyl-CoA binding domain containing 7"	Q8N6N7	10	15077523-15088776	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 35.3"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 21.7;U-266/84: 16.3;U-698: 18.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"olfactory region: 21.6"	"Low region specificity"	"Detected in all"			"HPA043326, HPA062478"			Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA043326: , HPA062478: "	"unprognostic (2.15e-1)"	"unprognostic (8.94e-2)"	"unprognostic (7.79e-3)"	"unprognostic (6.53e-3)"	"unprognostic (7.30e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.18e-4)"	"unprognostic (9.72e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.90e-2)"	1.1	1.1	25.0	1.5	27.1	3.9	8.3	12.9	35.3	1.1	1.4	9.3	0.0	2.5	1.4	2.7	1.7	4.4	1.7	1.2	25.3	9.8	1.4	1.7	1.4	2.1	15.0	16.2	1.7	1.5	1.5	0.7	1.3	14.0	1.5	1.6	0.0	4.7	1.4	2.0	3.0	1.9	1.3	6.6	1.6	1.8	5.9	11.7	2.9	4.2	0.0	1.7	1.4	0.5	1.7	1.5	3.8	0.6	2.1	1.1	0.2	2.6	0.6	10.5	5.0	0.6	0.5	1.2	0.7	0.6	1.9	3.2	2.9	3.2	2.4	3.6	2.4	0.6	6.2	1.9	2.7	5.4	8.5	2.6	0.8	1.6	0.1	0.5	1.1	0.1	0.2	0.7	0.1	2.6	2.0	2.9	2.1	8.3	21.7	2.3	5.2	1.9	11.7	3.7	5.7	1.2	1.0	8.6	5.2	2.6	5.9	1.1	8.5	0.7	0.7	0.4	5.8	1.0	2.2	8.2	16.3	18.7	1.7	0.5	0.7	3.8	0.6	0.8	1.1	0.6	0.9	1.3	0.6	0.6	0.3	1.7	1.1	1.1	3.7	2.1	0.5	1.5	0.5	0.2	25.0	27.1	12.9	21.8	25.3	9.8	15.0	16.2	14.0	11.7
ANKRD34B	DP58	ENSG00000189127	"Ankyrin repeat domain 34B"	A5PLL1	5	80556755-80570488	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 31.0"	"Cell line enriched"	"Detected in some"	29	"RPTEC TERT1: 45.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.3"	"Region enriched"	"Detected in many"	6	"basal ganglia: 31.0"	"Cell type enriched"	"Detected in some"	5	"neutrophil: 7.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043327	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria"	Cytosol	"HPA043327: AB_10794180"	"unprognostic (1.05e-1)"	"unprognostic (4.16e-6)"		"unprognostic (2.07e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.03e-1)"		"unprognostic (8.25e-4)"	"unprognostic (6.44e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.94e-2)"	0.1	0.3	0.9	1.5	31.0	5.7	0.3	0.0	0.9	0.5	0.1	0.4	0.3	0.1	0.2	0.2	0.1	0.1	0.2	0.1	1.0	4.1	2.8	0.1	0.2	3.0	1.2	0.2	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.2	0.0	0.3	0.2	0.0	0.1	0.1	0.2	0.4	1.0	0.1	1.0	5.1	0.0	0.1	0.0	4.6	0.1	0.0	0.0	0.0	7.2	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	45.8	0.0	0.1	0.2	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.3	0.9	31.0	0.0	0.9	1.0	4.1	1.2	0.2	0.7	5.1
APBA2	"D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L"	ENSG00000034053	"Amyloid beta precursor protein binding family A member 2"	Q99767	15	28884483-29118315	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 33.4"	"Cell line enhanced"	"Detected in some"		"HEL: 7.4;SH-SY5Y: 18.3;U-937: 13.1"	"Cancer enhanced"	"Detected in many"		"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.8;naive CD8 T-cell: 7.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037065, HPA058796, HPA070376"	Uncertain		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"CAB037065: AB_477178, HPA058796: , HPA070376: "	"unprognostic (2.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.21e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.28e-1)"	1.8	3.3	17.6	3.0	12.1	3.0	1.7	33.4	28.9	1.2	2.0	3.6	0.0	2.5	2.1	2.5	6.7	1.4	2.1	1.6	24.2	14.9	1.4	1.8	2.1	3.6	15.1	14.9	1.8	2.6	1.2	2.3	1.6	7.5	3.0	2.1	1.6	1.8	1.7	1.6	1.8	2.7	1.4	16.2	7.9	1.8	5.6	2.7	1.9	1.9	0.0	3.4	2.9	0.4	0.0	0.0	0.1	0.0	1.8	7.8	2.5	0.0	1.4	0.6	3.4	0.0	0.0	0.0	0.8	1.2	0.1	0.5	0.0	0.0	0.0	3.2	0.0	0.0	0.5	0.0	0.0	0.0	2.8	7.4	0.0	0.1	2.9	0.0	0.2	0.4	2.3	0.4	0.0	3.9	4.3	0.1	0.0	0.4	0.2	2.1	1.0	3.0	0.0	0.3	0.1	0.0	0.0	4.9	18.3	0.0	0.0	0.1	0.0	0.9	3.9	0.0	4.0	0.0	0.8	0.0	0.1	0.0	0.1	13.1	1.6	0.0	0.0	0.0	1.4	0.0	0.2	0.0	2.1	4.7	0.0	0.0	7.8	7.5	0.1	1.8	0.0	0.0	0.0	2.5	17.6	12.1	33.4	28.9	24.2	14.9	15.1	14.9	7.5	2.7
ARHGAP22	RhoGAP2	ENSG00000128805	"Rho GTPase activating protein 22"	Q7Z5H3	10	48446034-48656265	"Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 32.3"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 15.4;LHCN-M2: 26.1;TIME: 27.7;U-87 MG: 34.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.2;myeloid DC: 2.9;naive B-cell: 2.6"	"Group enriched"	"Detected in many"	29	"B-cells: 2.6;dendritic cells: 2.9;monocytes: 3.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020696, HPA040391, HPA064439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB020696: , HPA040391: , HPA064439: "	"unprognostic (1.87e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.81e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (2.16e-8)"	"unprognostic (7.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.66e-2)"	2.6	3.1	10.2	6.7	12.5	3.0	2.0	7.3	12.2	1.8	2.7	32.3	1.0	1.7	2.1	1.9	1.6	2.2	4.4	3.3	12.5	9.6	1.2	0.8	2.9	6.0	18.3	6.6	7.7	1.5	2.7	1.8	2.2	24.6	3.2	2.8	1.6	3.4	3.2	3.9	3.4	2.5	3.4	27.3	6.2	2.3	4.6	18.4	2.0	6.0	0.4	5.4	3.1	1.9	2.6	2.9	0.0	3.2	0.0	0.0	0.9	2.5	0.5	0.1	0.0	2.2	8.8	1.7	13.5	6.2	1.2	1.7	2.7	0.3	0.0	0.5	5.2	4.9	0.1	4.5	2.2	0.2	4.6	7.1	0.0	0.0	1.1	0.8	0.8	2.1	4.6	15.4	1.2	8.4	6.7	1.3	26.1	0.1	0.1	0.0	2.9	0.2	0.0	0.0	3.2	2.6	0.2	0.4	2.7	0.6	0.0	0.2	0.1	0.1	27.7	12.7	0.2	1.6	9.4	0.0	0.0	0.0	34.4	0.1	2.0	0.0	3.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.9	2.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	10.2	12.5	7.3	9.2	12.5	9.6	18.3	6.6	24.6	18.4
ARHGEF33		ENSG00000214694	"Rho guanine nucleotide exchange factor 33"	A8MVX0	2	38889841-38975449	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 42.5"	"Group enriched"	"Detected in some"	4	"BEWO: 8.8;HeLa: 3.9;SiHa: 11.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	5	"cerebellum: 42.5"	"Cell type enriched"	"Detected in single"	8	"eosinophil: 6.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.7"	"Region enriched"	"Detected in single"	32	"cerebellum: 314.4"	"Region enriched"	"Detected in many"	11	"cerebellum: 47.0"	"HPA034661, HPA041051"	Enhanced		Supported	Vesicles				Vesicles		"HPA034661: AB_10669679, HPA041051: "	"unprognostic (8.38e-2)"	"unprognostic (7.05e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.99e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.99e-1)"	0.3	4.0	3.7	1.0	8.6	0.0	1.7	42.5	3.4	2.3	0.7	0.6	0.7	0.1	2.8	5.1	0.7	2.2	1.4	0.8	3.3	3.6	1.4	0.2	1.2	0.5	2.0	2.9	6.8	0.2	2.2	3.5	0.8	3.2	1.7	0.6	0.8	0.4	1.2	0.4	1.3	0.6	1.0	1.5	0.5	0.9	10.1	2.4	0.2	1.4	0.2	0.4	1.2	0.6	0.2	0.1	6.7	0.8	0.0	0.2	0.1	0.3	0.0	0.4	0.2	0.2	0.2	8.8	0.8	0.0	0.0	0.0	0.1	0.2	0.4	0.1	0.8	0.0	0.0	0.0	0.0	1.8	0.9	0.2	3.9	0.3	0.7	0.3	0.3	0.8	0.9	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.9	0.4	0.4	0.3	11.0	0.4	0.0	0.0	0.3	0.6	0.2	1.4	0.0	0.1	0.5	0.2	0.0	0.2	0.2	0.1	0.0	0.6	6.7	0.0	0.8	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	3.7	8.6	42.5	3.4	3.3	3.6	2.0	2.9	3.2	2.4
BARHL2		ENSG00000143032	"BarH like homeobox 2"	Q9NY43	1	90711539-90717237	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 29.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.4;HEK 293: 8.7;HEL: 1.2;HMC-1: 2.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	42	"cerebellum: 29.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"cerebellum: 14.5"	"Region enriched"	"Detected in single"	21	"cerebellum: 48.3"																"unprognostic (1.83e-1)"				"unprognostic (1.73e-1)"	"unprognostic (6.80e-2)"				"unprognostic (3.10e-1)"	"unprognostic (1.60e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	8.7	1.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0
C17orf51	"FLJ12977, FLJ31874, FLJ33618"	ENSG00000212719	"Chromosome 17 open reading frame 51"	A8MQB3	17	21524790-21574458	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 41.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA052106	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"				"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA052106: "	"unprognostic (1.99e-1)"	"unprognostic (5.29e-2)"	"unprognostic (6.35e-3)"	"unprognostic (2.78e-3)"	"unprognostic (3.72e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.36e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.51e-3)"	"unprognostic (7.42e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.17e-1)"	"unprognostic (6.42e-5)"	"unprognostic (9.05e-3)"	6.1	7.2	8.0	4.2	8.4	0.8	3.0	41.2	20.5	5.3	4.5	5.2	3.1	3.2	8.3	10.1	3.2	6.7	3.6	6.5	8.6	7.3	4.0	3.8	3.0	3.0	5.9	8.1	5.9	6.6	7.8	8.9	2.1	5.5	6.3	3.2	3.8	5.0	7.0	7.3	3.0	2.4	6.6	5.0	3.3	4.1	9.2	5.9	1.2	2.9	2.2	3.0	4.0	4.7	4.2	4.1	1.2	3.9	2.6	6.0	1.8	2.6	6.1	2.3	7.9	7.3	6.9	2.1	7.1	3.5	5.2	5.9	12.1	0.4	3.5	4.0	3.9	0.3	9.8	3.7	8.6	11.0	15.2	0.7	5.6	5.0	13.6	0.9	3.9	6.5	3.4	10.5	11.4	3.7	1.9	0.8	4.4	0.0	7.6	0.3	4.3	5.2	7.4	4.8	0.5	1.9	0.5	5.1	0.9	6.6	0.2	5.2	0.1	0.3	6.6	6.1	6.3	14.5	8.5	2.3	2.8	13.5	7.3	1.3	7.1	0.0	3.9	0.0	4.0	1.8	3.1	2.2	1.9	1.8	1.9	4.2	6.0	5.1	1.2	2.6	1.0	4.1	1.7	1.8	8.0	8.4	41.2	14.5	8.6	7.3	5.9	8.1	5.5	5.9
C2orf80	"GONDA1, LOC389073"	ENSG00000188674	"Chromosome 2 open reading frame 80"	Q0P641	2	208165343-208190073	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 35.3"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 5.8"	"Cancer enriched"	"Detected in single"	41	"glioma: 11.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.4"					"Low region specificity"	"Detected in all"			HPA042639			Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA042639: AB_10794915"					"unprognostic (6.36e-2)"					"unprognostic (2.12e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.05e-1)"		"unprognostic (1.83e-1)"	"unprognostic (2.98e-2)"			0.9	1.0	20.8	1.3	20.8	2.4	0.9	0.4	35.3	0.7	1.1	1.1	0.0	1.0	1.0	0.9	2.2	1.0	1.4	0.9	16.3	14.2	0.9	1.1	1.0	1.1	8.0	13.1	1.0	0.7	0.8	0.4	0.9	9.6	1.1	1.1	0.5	1.4	1.4	1.2	2.0	1.3	0.9	2.1	1.0	1.2	1.7	2.4	0.0	1.1	0.0	0.8	0.9	0.0	1.5	1.7	8.4	1.2	1.0	0.7	0.2	0.4	0.5	2.7	0.9	0.0	0.0	0.2	0.6	0.6	0.0	0.0	0.9	1.1	1.5	0.9	0.3	0.4	0.0	0.0	0.0	0.4	0.3	0.9	1.3	0.4	0.0	1.1	1.8	0.4	0.5	0.3	0.3	0.0	0.5	1.4	0.0	0.8	0.0	1.5	5.8	1.8	0.4	0.3	0.4	0.0	1.2	0.8	1.3	0.3	0.9	0.2	0.5	0.0	0.7	0.5	0.3	0.3	0.5	0.8	0.3	1.1	0.0	0.6	0.9	4.3	1.2	0.9	0.7	0.7	0.5	0.9	0.7	0.7	0.3	1.5	0.6	0.7	8.4	1.0	0.5	1.7	0.3	0.2	20.8	20.8	0.4	23.1	16.3	14.2	8.0	13.1	9.6	2.4
CBLN2		ENSG00000141668	"Cerebellin 2 precursor"	Q8IUK8	18	72536680-72638521	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 33.8"	"Cell line enriched"	"Detected in some"	9	"SH-SY5Y: 34.7"	"Cancer enriched"	"Detected in single"	7	"breast cancer: 3.1"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted in brain"		1300000				"unprognostic (2.03e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.13e-3)"	"unprognostic (9.09e-5)"	"unprognostic (7.10e-2)"	"unprognostic (6.27e-3)"		"unprognostic (7.39e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.37e-4)"	"unprognostic (5.01e-4)"	"unprognostic (8.15e-2)"	"unprognostic (6.07e-4)"	"unprognostic (7.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.93e-2)"	0.6	0.7	5.4	0.8	10.4	0.4	0.6	0.8	33.8	1.0	2.9	0.9	0.0	2.5	0.5	0.4	0.5	0.5	0.4	0.4	4.5	9.5	1.5	0.9	0.4	0.5	7.0	16.4	0.6	0.4	0.4	0.3	0.4	17.8	1.8	2.6	1.9	0.4	8.2	0.4	0.9	3.8	1.5	2.6	0.4	0.6	0.6	0.0	0.0	0.4	0.0	1.3	0.5	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	34.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	10.4	0.8	33.8	4.5	9.5	7.0	16.4	17.8	0.0
CDH9		ENSG00000113100	"Cadherin 9"	Q9ULB4	5	26880600-27121150	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 46.8"	"Cell line enhanced"	"Detected in some"		"K-562: 9.2;NTERA-2: 13.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"amygdala: 46.8;basal ganglia: 24.6;cerebral cortex: 23.7;hippocampal formation: 15.9;olfactory region: 15.6"	"Cell type enhanced"	"Detected in some"		"neutrophil: 8.3"	"Group enriched"	"Detected in many"	5	"B-cells: 4.1;granulocytes: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA007167	Approved									"HPA007167: AB_1078489"					"unprognostic (1.49e-1)"								"unprognostic (2.27e-4)"					0.7	0.5	46.8	1.0	24.6	2.8	0.7	0.5	23.7	0.5	0.8	0.0	0.0	0.6	0.9	1.2	0.7	0.5	0.7	0.5	15.9	3.5	10.5	0.5	0.6	1.6	1.2	15.6	0.6	1.1	1.0	0.5	0.8	1.5	1.0	1.2	0.0	0.5	0.1	0.5	1.9	1.5	0.8	0.6	0.8	0.9	3.7	2.6	0.0	1.9	0.0	1.7	0.5	0.5	4.1	0.9	8.3	1.1	0.1	0.8	1.1	2.4	0.9	0.5	0.8	0.4	0.0	1.6	0.0	0.9	0.3	0.6	0.0	0.9	1.3	0.3	0.3	0.3	0.1	0.5	0.0	0.1	0.2	0.5	0.7	2.5	0.0	0.0	1.5	0.6	0.7	0.0	0.0	0.2	9.2	2.3	0.0	1.5	0.8	0.5	13.6	0.5	0.3	0.3	0.4	0.5	0.5	3.1	0.3	0.0	0.4	0.4	0.5	0.9	1.7	0.1	0.8	0.8	0.3	2.7	1.0	4.3	1.0	1.0	0.8	1.3	0.2	0.4	0.2	0.7	0.6	4.1	0.4	0.2	0.1	2.5	0.3	0.5	8.3	0.1	1.1	0.9	0.8	1.1	46.8	24.6	0.5	23.7	15.9	3.5	1.2	15.6	1.5	2.6
CHRM5		ENSG00000184984	"Cholinergic receptor muscarinic 5"	P08912	15	33968720-34067457	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 22.8"	"Group enriched"	"Detected in some"	5	"BEWO: 5.4;HMC-1: 18.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 15.4"	"Low region specificity"	"Detected in many"			HPA013172	Uncertain									"HPA013172: AB_1854212"	"unprognostic (8.19e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.67e-2)"	"unprognostic (4.32e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.61e-4)"	"unprognostic (7.95e-2)"	"unprognostic (1.33e-6)"	"unprognostic (1.42e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.07e-2)"	0.3	0.5	1.2	0.9	15.7	1.3	2.1	0.8	6.9	0.3	0.4	5.1	0.0	1.1	0.5	0.8	0.5	0.3	0.6	0.3	6.8	4.4	0.6	0.9	0.4	1.0	5.8	4.5	0.5	1.0	0.1	0.5	4.8	17.8	0.6	0.3	0.0	0.5	0.1	0.7	1.8	1.8	0.2	22.8	0.7	0.6	5.2	0.0	0.0	2.3	0.0	0.3	0.4	0.3	0.3	0.9	4.8	0.3	0.2	0.3	0.0	0.1	0.2	0.8	0.3	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.5	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.7	0.3	0.2	0.0	0.5	18.8	0.4	0.0	0.2	0.1	0.0	0.6	1.2	0.1	0.2	0.2	2.2	0.2	0.3	0.1	0.3	0.2	0.0	0.4	0.3	0.3	0.3	0.7	0.2	0.2	1.1	0.2	0.2	0.2	0.2	0.1	0.9	0.3	0.4	0.1	0.2	0.3	1.5	0.3	0.2	0.3	0.1	0.3	0.2	0.2	0.2	0.1	0.3	0.1	0.2	4.8	0.2	0.1	0.9	0.2	0.0	1.2	15.7	0.8	6.9	6.8	4.4	5.8	4.5	17.8	0.0
CNP		ENSG00000173786	"2',3'-cyclic nucleotide 3' phosphodiesterase"	P09543	17	41966741-41977731	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 211.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 49.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002672, HPA023266, HPA023278, HPA023280, HPA023338"	Enhanced	Supported	Enhanced	Nucleoplasm,Cytosol			730000	Nucleoplasm	Cytosol	"CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062"	"unprognostic (2.17e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.10e-3)"	9.1	8.9	51.4	9.5	72.8	6.7	8.1	13.4	125.3	10.3	7.5	211.7	2.3	7.1	8.0	12.7	15.0	9.3	10.8	7.6	78.4	40.7	14.7	9.6	6.7	10.5	86.7	49.0	11.2	9.2	5.8	4.4	7.8	66.7	11.7	6.4	3.6	15.1	13.2	7.6	11.1	6.4	10.1	160.2	7.1	7.4	4.6	63.5	2.1	7.2	2.2	11.2	9.8	5.7	9.9	49.1	7.3	13.1	7.3	7.5	9.1	13.7	23.5	22.3	27.5	19.1	18.0	9.6	17.2	26.5	44.8	50.6	18.4	12.6	14.6	13.9	22.4	23.7	15.0	11.4	15.6	14.5	19.0	14.2	16.2	31.9	20.6	13.8	12.9	29.7	8.2	24.5	6.0	20.4	10.0	12.0	15.6	8.7	35.4	12.5	5.2	16.8	22.1	32.8	14.2	11.9	14.1	13.1	17.7	21.8	32.9	38.3	14.7	20.7	20.4	17.5	19.2	23.7	20.3	13.5	15.3	11.7	17.3	10.7	68.2	4.9	12.1	7.3	7.5	13.1	5.9	9.9	6.5	6.0	11.1	7.0	5.9	6.9	2.6	7.3	10.3	49.1	7.2	9.1	51.4	72.8	13.4	93.8	78.4	40.7	86.7	49.0	66.7	63.5
DCLK1	"DCAMKL1, DCDC3A, DCLK, KIAA0369"	ENSG00000133083	"Doublecortin like kinase 1"	O15075	13	35768652-36131306	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 76.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 17.3;ASC TERT1: 16.4;fHDF/TERT166: 13.3;HAP1: 10.3;HSkMC: 15.1;NTERA-2: 21.4"	"Cancer enhanced"	"Detected in many"		"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012405, HPA015040, HPA015655"	Enhanced		Approved	Nucleoplasm,Cytosol			11000	Nucleoplasm	Cytosol	"CAB012405: , HPA015040: , HPA015655: "	"unprognostic (2.29e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (4.42e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-4)"	13.9	3.3	14.3	4.2	25.0	1.1	8.6	8.6	76.5	12.2	3.5	8.6	0.5	2.0	6.4	5.8	5.8	3.3	7.1	5.8	21.9	21.9	1.9	1.2	3.0	4.3	11.9	22.5	6.4	2.1	1.5	7.4	1.1	13.9	4.7	4.4	0.5	2.5	4.7	1.9	4.7	2.7	17.0	10.4	4.6	2.5	2.2	8.5	0.0	2.1	1.4	2.9	5.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	17.3	16.4	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	13.3	0.0	10.3	0.2	0.0	0.0	0.6	0.0	0.4	0.0	0.6	0.0	0.0	15.1	7.5	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	21.4	0.2	0.0	1.2	0.0	0.6	0.0	4.3	2.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.5	4.4	0.7	0.1	0.0	0.0	1.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	25.0	8.6	45.8	21.9	21.9	11.9	22.5	13.9	8.5
DCLK2	"DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428"	ENSG00000170390	"Doublecortin like kinase 2"	Q8N568	4	150078274-150257457	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 60.5"	"Cell line enhanced"	"Detected in many"		"AF22: 18.2;BJ hTERT+: 19.0;fHDF/TERT166: 8.3"	"Cancer enriched"	"Detected in many"	17	"glioma: 53.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.5;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015770	Enhanced									"HPA015770: AB_1847509"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.38e-3)"	"unprognostic (2.18e-1)"	"prognostic favourable (3.25e-4)"	"prognostic favourable (2.48e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.74e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-2)"	2.9	3.9	23.3	2.1	23.5	1.6	2.0	9.3	60.5	3.1	2.8	16.5	0.8	2.8	4.3	3.5	3.0	2.8	4.0	14.4	23.5	17.5	2.9	1.8	2.7	1.6	14.9	14.5	4.3	3.5	1.4	4.7	2.9	20.2	3.9	3.5	2.1	2.0	3.6	2.3	2.1	2.7	6.4	23.4	2.1	2.2	4.2	15.9	0.0	4.1	0.0	1.5	3.3	2.0	2.5	1.5	0.0	0.5	0.0	0.0	0.0	0.8	3.2	18.2	2.8	0.0	0.9	0.3	8.2	19.0	2.7	0.6	0.1	0.0	0.0	0.3	8.3	0.0	2.6	0.0	3.4	3.7	1.6	0.0	4.7	0.0	3.9	0.5	0.5	0.5	0.0	1.6	0.2	0.9	0.0	0.0	1.9	0.1	0.3	0.0	0.3	1.0	0.0	2.1	0.7	0.0	0.8	7.0	6.6	3.4	2.5	0.8	0.0	0.0	1.6	2.5	1.0	1.6	0.9	0.8	0.0	0.0	2.4	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	23.3	23.5	9.3	19.3	23.5	17.5	14.9	14.5	20.2	15.9
DLEU7	FLJ44882	ENSG00000186047	"Deleted in lymphocytic leukemia, 7"	Q6UYE1	13	50711008-50843939	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 13.2"	"Group enriched"	"Detected in some"	8	"NTERA-2: 15.1;U-698: 6.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 1.5;naive B-cell: 1.3;neutrophil: 1.2;T-reg: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA053750	Uncertain									"HPA053750: "	"unprognostic (3.97e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.03e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.75e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	0.7	1.0	4.8	0.8	7.8	0.5	0.5	5.8	13.2	0.6	0.7	0.5	0.0	0.6	0.8	3.0	0.5	0.5	0.4	0.5	4.6	5.7	1.4	0.5	0.5	0.4	3.7	4.2	0.6	0.7	0.4	0.1	0.5	4.1	0.7	0.8	0.0	0.4	0.5	0.5	1.0	0.8	0.5	1.2	0.8	0.5	0.9	0.8	1.3	1.9	0.0	0.5	0.4	0.1	1.3	0.0	1.2	1.5	0.0	1.4	0.7	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	15.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.3	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	1.3	0.1	0.0	1.2	0.0	0.0	0.0	1.4	0.7	4.8	7.8	5.8	9.9	4.6	5.7	3.7	4.2	4.1	0.8
DLGAP3	"DAP3, SAPAP3"	ENSG00000116544	"DLG associated protein 3"	O95886	1	34865436-34929585	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 28.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 9.3;NTERA-2: 5.1;SCLC-21H: 15.2"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 1.0;glioma: 1.5;ovarian cancer: 1.9;testis cancer: 5.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 128.4;basal ganglia: 124.0;cerebral cortex: 122.6;hippocampal formation: 84.0;thalamus: 55.9"	"Low region specificity"	"Detected in all"			HPA026445	Enhanced									"HPA026445: AB_1847733"	"unprognostic (8.63e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.77e-7)"	"unprognostic (4.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.27e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.21e-1)"	1.3	1.5	17.4	1.8	20.0	2.8	1.1	14.6	28.7	0.9	1.2	3.3	0.0	1.4	1.0	1.0	0.9	1.0	1.1	1.0	17.7	5.5	1.3	1.0	1.1	1.4	5.4	9.6	1.0	2.2	1.0	1.9	1.0	2.3	1.0	1.0	0.7	1.1	1.5	1.0	1.1	1.3	1.0	1.1	2.5	1.3	6.7	5.0	0.0	1.0	0.0	1.2	1.0	0.0	0.3	3.2	0.4	2.3	0.1	0.8	0.9	0.0	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	9.3	0.2	0.0	0.0	1.5	0.0	0.0	0.2	0.2	0.7	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.5	0.0	0.0	5.1	0.0	0.5	0.0	0.2	0.0	0.5	15.2	3.0	0.1	0.1	0.0	0.3	0.1	0.1	0.1	1.6	0.0	0.0	0.2	0.3	1.9	0.1	0.1	0.1	0.4	2.3	0.0	0.2	1.4	0.8	0.3	0.5	0.5	3.2	0.3	0.2	0.8	0.0	0.1	0.1	0.9	0.7	0.9	17.4	20.0	14.6	22.4	17.7	5.5	5.4	9.6	2.3	5.0
EGR4	"NGFI-C, PAT133"	ENSG00000135625	"Early growth response 4"	Q05215	2	73290929-73293705	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 20.0"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA028983	Enhanced									"HPA028983: AB_10603665"	"unprognostic (7.75e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.39e-4)"	"unprognostic (2.43e-3)"	"unprognostic (2.68e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.29e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.07e-3)"	1.1	0.8	4.9	1.0	15.9	0.9	0.6	17.2	20.0	0.6	0.6	1.2	0.0	0.5	0.6	0.5	0.6	0.6	0.6	0.6	8.8	1.9	0.6	0.6	0.6	0.6	0.3	4.4	0.6	0.5	0.6	2.3	0.6	0.0	0.7	0.6	0.0	0.5	0.5	0.6	0.6	0.6	0.6	0.3	0.6	0.7	4.9	2.6	0.0	0.5	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	15.9	17.2	20.0	8.8	1.9	0.3	4.4	0.0	2.6
ENHO	"C9orf165, UNQ470"	ENSG00000168913	"Energy homeostasis associated"	Q6UWT2	9	34521040-34523041	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 79.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 13.2;NTERA-2: 18.2;SCLC-21H: 9.3;SH-SY5Y: 8.8"	"Cancer enhanced"	"Detected in many"		"glioma: 44.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"myeloid DC: 19.4"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042575	Approved				"Secreted to blood"	4236667				"HPA042575: AB_10794914"	"unprognostic (2.63e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (3.71e-4)"	"unprognostic (1.30e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.78e-4)"	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.76e-2)"	1.5	1.9	58.0	1.9	59.3	1.7	3.7	15.5	79.6	2.9	3.9	13.9	0.0	3.0	1.4	1.4	1.5	3.6	1.8	1.8	36.3	37.5	1.5	12.0	2.0	1.4	52.0	27.1	1.5	2.6	1.2	1.0	1.3	13.7	5.2	3.2	0.1	1.8	1.7	1.6	3.8	3.6	1.3	17.1	1.6	5.3	6.4	13.4	0.0	1.4	0.0	1.4	1.5	0.0	0.0	19.4	0.0	2.5	2.7	0.0	0.4	0.1	0.9	5.2	13.2	0.1	0.0	0.3	0.0	0.0	2.1	2.1	0.5	0.2	2.2	3.6	0.0	0.2	6.0	0.4	0.4	0.3	5.8	0.0	0.1	1.2	0.1	0.0	2.9	0.0	0.1	0.0	0.2	0.0	0.0	1.9	0.4	0.3	0.0	0.0	18.2	3.7	0.1	0.0	0.3	0.5	0.0	9.3	8.8	0.7	4.1	0.4	0.3	1.7	0.0	0.4	2.0	0.1	0.1	1.1	1.2	0.1	0.4	0.0	3.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	2.7	0.7	1.0	0.0	0.4	58.0	59.3	15.5	37.0	36.3	37.5	52.0	27.1	13.7	13.4
ENO2		ENSG00000111674	"Enolase 2"	P09104	12	6913745-6923698	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 119.2"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 8.2;MAIT T-cell: 9.7;memory B-cell: 5.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 9.6;naive B-cell: 3.3;naive CD4 T-cell: 7.1;naive CD8 T-cell: 7.4;neutrophil: 6.2;T-reg: 5.5"	"Group enriched"	"Detected in many"	7	"B-cells: 5.6;granulocytes: 6.2;T-cells: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000063, HPA068284, HPA068721, CAB073539, CAB079023"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"			89000000	"Plasma membrane, Cytosol"		"CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: "	"unprognostic (8.96e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavourable (6.96e-4)"	"unprognostic (1.28e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (5.15e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (7.89e-11)"	"unprognostic (7.61e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.24e-1)"	4.2	20.7	31.2	8.3	48.0	4.0	4.9	115.2	119.2	7.6	7.9	10.9	2.6	4.9	11.7	6.3	5.9	9.4	8.0	10.3	30.2	39.2	3.5	2.0	10.1	10.5	29.6	47.4	3.7	4.1	19.1	15.5	4.8	47.7	8.0	7.4	28.6	3.1	15.3	2.1	5.8	6.0	15.2	15.7	5.8	6.4	3.2	13.3	1.7	14.2	0.3	10.3	7.1	5.0	5.6	1.0	6.2	0.2	0.4	10.8	4.5	14.0	8.9	3.2	0.1	4.8	5.2	0.2	10.9	7.0	16.2	25.0	1.7	1.1	19.8	1.8	4.7	2.1	33.7	3.0	24.6	39.6	3.1	27.3	9.1	11.8	3.5	1.6	32.9	2.6	0.1	11.9	2.4	3.4	1.8	0.2	10.8	1.9	12.8	1.7	17.1	5.0	14.2	2.7	4.3	7.9	1.9	25.9	18.2	2.8	0.2	18.6	0.9	0.8	4.3	14.2	15.0	19.1	14.1	14.5	14.5	2.9	81.3	0.0	2.9	1.3	0.0	0.1	8.2	0.0	9.7	5.6	10.8	9.6	0.0	3.3	7.1	7.4	6.2	0.4	0.2	1.0	5.5	4.5	31.2	48.0	115.2	91.3	30.2	39.2	29.6	47.4	47.7	13.3
EPHB1	"EPHT2, Hek6"	ENSG00000154928	"EPH receptor B1"	P54762	3	134597801-135260467	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 74.7"	"Group enriched"	"Detected in some"	4	"HDLM-2: 33.9;HMC-1: 20.1;RPTEC TERT1: 9.2"	"Cancer enriched"	"Detected in many"	6	"glioma: 7.0"	"Region enhanced"	"Detected in all"		"cerebellum: 74.7"	"Group enriched"	"Detected in some"	33	"neutrophil: 15.9;plasmacytoid DC: 15.4"	"Group enriched"	"Detected in many"	33	"dendritic cells: 15.4;granulocytes: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067740	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Cytosol"				"Endoplasmic reticulum, Plasma membrane, Cytosol"		"HPA067740: "	"unprognostic (1.99e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.41e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.88e-4)"	2.0	1.5	9.0	1.8	16.6	1.5	5.5	74.7	23.6	3.6	3.4	3.4	3.1	2.8	4.1	2.0	3.8	2.8	3.3	1.1	9.4	5.3	2.3	2.9	1.0	3.3	2.8	7.0	1.7	1.1	0.6	3.8	0.9	7.1	3.3	1.4	1.9	3.9	5.1	7.4	6.0	1.7	1.7	6.0	3.4	1.3	16.7	6.0	0.0	11.6	2.9	3.3	4.5	2.6	0.0	15.4	15.9	0.0	0.0	0.4	0.1	0.0	0.0	4.7	0.0	0.1	0.0	0.1	3.5	0.0	0.2	0.0	0.0	0.0	0.6	1.0	1.8	0.0	3.1	0.0	0.6	33.9	0.4	2.5	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.5	0.1	0.1	0.1	1.3	0.0	0.0	0.5	0.1	9.2	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.6	2.0	0.3	4.2	0.1	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	15.4	0.0	0.1	9.0	16.6	74.7	19.0	9.4	5.3	2.8	7.0	7.1	6.0
ERC2	"CAST, CAST1, ELKSL, KIAA0378, SPBC110, Spc110"	ENSG00000187672	"ELKS/RAB6-interacting/CAST family member 2"	O15083	3	55508308-56468363	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 30.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.7;HUVEC TERT2: 3.6;Karpas-707: 12.0;SH-SY5Y: 3.0;U-266/70: 8.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073739	Enhanced									"HPA073739: "	"unprognostic (2.13e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.09e-2)"	0.9	1.6	13.4	1.0	9.5	0.9	1.1	11.5	30.5	1.0	1.0	0.7	1.3	1.0	1.2	0.9	1.0	1.0	1.1	2.2	9.4	5.3	1.4	0.9	1.1	0.9	3.8	12.6	2.9	1.3	0.9	7.4	1.3	8.8	1.5	1.0	1.1	1.0	3.1	0.9	0.9	1.1	1.1	2.3	0.9	1.2	1.5	1.5	0.0	1.3	0.0	0.9	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.6	0.0	12.0	0.0	1.5	0.0	0.0	2.6	0.3	0.0	0.2	0.0	2.7	0.0	1.4	3.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.3	8.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	13.4	9.5	11.5	16.8	9.4	5.3	3.8	12.6	8.8	1.5
FEZ1	UNC-76	ENSG00000149557	"Fasciculation and elongation protein zeta 1"	Q99689	11	125445745-125496317	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 123.4"	"Cell line enhanced"	"Detected in many"		"AF22: 39.9;HBEC3-KT: 38.6;NTERA-2: 36.5;SCLC-21H: 39.0"	"Cancer enriched"	"Detected in all"	10	"glioma: 68.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 30.8;MAIT T-cell: 18.0;memory CD8 T-cell: 8.9;naive CD8 T-cell: 7.7"	"Lineage enriched"	"Detected in many"	14	"T-cells: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038490, HPA076844"	Approved		Supported	Microtubules,Cytosol				Microtubules	Cytosol	"HPA038490: AB_10672647, HPA076844: "	"unprognostic (5.68e-2)"	"prognostic unfavourable (9.06e-5)"	"unprognostic (7.40e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (2.16e-6)"	"unprognostic (2.14e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.02e-1)"	6.6	5.6	48.3	4.4	50.1	1.3	4.3	28.2	121.4	6.4	5.1	58.8	0.2	2.9	6.9	4.0	5.9	4.1	9.4	12.4	54.2	38.2	2.7	7.4	10.0	3.5	68.2	29.8	6.0	1.4	5.0	2.3	6.0	43.4	6.6	5.3	1.4	2.4	12.9	1.7	3.5	3.5	13.0	123.4	3.9	2.5	7.2	51.4	0.0	2.2	0.0	2.9	16.8	2.1	0.0	0.4	2.1	0.5	1.0	30.8	5.0	0.0	0.0	39.9	0.0	26.3	24.0	0.0	6.2	8.0	1.5	0.3	0.0	0.0	0.0	7.3	11.7	0.1	18.1	38.6	0.8	3.2	0.2	18.3	0.0	0.0	22.2	0.0	0.1	19.6	8.9	7.2	19.1	17.6	2.4	0.2	1.9	0.9	0.1	0.0	36.5	0.4	0.0	0.0	0.0	0.0	14.0	39.0	4.1	0.1	0.0	0.6	2.9	17.9	15.8	0.1	1.0	0.0	5.2	0.4	0.1	0.0	4.3	0.0	16.8	2.1	0.5	0.0	30.8	0.1	18.0	0.0	1.1	8.9	0.4	0.0	0.4	7.7	0.6	1.0	0.0	0.0	0.0	5.0	48.3	50.1	28.2	97.4	54.2	38.2	68.2	29.8	43.4	51.4
FGF5		ENSG00000138675	"Fibroblast growth factor 5"	P12034	4	80266599-80336680	"Disease related genes, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 38.2"	"Cell line enhanced"	"Detected in some"		"BJ: 19.7;BJ hTERT+: 37.4;fHDF/TERT166: 26.9;HBF TERT88: 28.1;LHCN-M2: 25.2;U-138 MG: 34.9;U-251 MG: 16.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	9	"cerebellum: 38.2"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB010313, HPA042442"			Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"	"Secreted in brain"			"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010313: AB_2102677, HPA042442: "	"unprognostic (6.44e-2)"	"unprognostic (6.24e-3)"	"unprognostic (8.49e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.80e-3)"		"unprognostic (6.87e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.33e-16)"	"unprognostic (3.02e-3)"	"unprognostic (3.14e-1)"		"unprognostic (2.83e-2)"	0.1	0.1	0.1	1.7	0.1	0.5	0.1	38.2	1.3	0.1	3.1	0.0	0.0	0.4	0.4	0.1	1.3	0.1	9.2	0.3	1.6	0.2	2.3	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.0	1.3	0.1	4.1	0.2	0.1	0.0	0.1	0.0	0.5	0.4	2.8	2.4	0.3	0.1	0.8	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.7	1.7	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	1.9	7.1	0.0	19.7	37.4	5.2	3.8	0.0	0.0	0.0	0.0	26.9	0.0	0.0	6.9	28.1	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	2.0	0.0	15.3	7.3	1.7	0.0	0.1	25.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	6.4	34.9	1.4	1.7	16.7	0.0	0.0	0.0	2.0	0.0	0.7	1.7	0.3	0.3	0.4	0.2	0.5	0.2	0.3	0.4	0.2	0.7	0.5	0.5	0.9	0.2	0.2	0.7	0.2	0.0	0.1	0.1	38.2	1.3	1.6	0.2	0.2	0.2	4.1	0.1
FOXB1	"FKH5, HFKH-5"	ENSG00000171956	"Forkhead box B1"	Q99853	15	60004222-60061730	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 16.7"	"Group enriched"	"Detected in some"	4	"AF22: 7.0;HDLM-2: 15.2;HEK 293: 11.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.2"	"Region enhanced"	"Detected in many"		"pons and medulla: 16.7"	"Cell type enriched"	"Detected in single"	4	"T-reg: 3.8"	"Lineage enriched"	"Detected in single"	38	"T-cells: 3.8"	"Region enhanced"	"Detected in some"		"hypothalamus: 7.7"	"Low region specificity"	"Detected in many"			HPA073369			Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA073369: "	"unprognostic (1.69e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-2)"		"unprognostic (1.47e-2)"	"unprognostic (5.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.12e-9)"	"unprognostic (8.74e-2)"	"unprognostic (1.74e-1)"		"unprognostic (9.38e-2)"	0.0	0.0	0.3	0.5	4.1	0.2	0.2	0.6	0.0	0.1	0.1	0.6	0.0	0.0	0.6	0.0	0.2	0.9	0.1	0.2	0.1	6.2	0.0	0.1	0.1	1.8	6.5	0.0	0.0	0.4	0.0	0.0	1.9	16.7	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	8.4	0.1	1.8	2.6	3.7	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	2.6	0.0	7.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.2	11.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.3	4.1	0.6	0.0	0.1	6.2	6.5	0.0	16.7	3.7
GABRA2		ENSG00000151834	"Gamma-aminobutyric acid type A receptor alpha2 subunit"	P47869	4	46248427-46475230	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 52.6"	"Cell line enhanced"	"Detected in some"		"U-2 OS: 9.4;U-87 MG: 4.4;WM-115: 5.0"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB079061		Supported			"Intracellular and membrane"					"CAB079061: "	"unprognostic (2.03e-2)"		"unprognostic (2.77e-1)"	"unprognostic (2.45e-4)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-1)"		"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.22e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.04e-2)"	2.2	1.3	38.5	1.4	34.4	1.2	1.9	10.4	52.6	1.7	4.5	4.9	0.0	2.0	1.4	11.7	1.7	1.0	1.6	1.0	38.9	7.7	8.8	1.4	1.0	1.4	3.7	31.0	1.9	1.0	0.9	0.6	1.5	10.5	1.0	3.5	0.0	1.2	1.9	1.0	1.3	7.7	1.3	6.9	2.3	1.6	1.5	7.1	0.0	1.1	0.0	1.4	1.2	0.8	0.2	0.3	1.0	0.1	0.1	0.1	0.0	0.5	0.5	0.1	0.6	0.0	0.0	0.5	0.3	0.0	0.0	0.0	2.1	0.6	0.2	0.5	0.0	0.8	0.0	0.0	0.1	0.5	0.5	0.1	0.7	0.2	0.8	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.8	0.2	0.0	0.4	0.0	0.3	0.9	0.1	0.0	0.6	0.4	0.1	0.6	0.2	0.0	0.1	0.3	0.0	0.3	0.4	0.1	0.5	9.4	0.5	0.1	0.7	1.2	0.2	4.4	0.4	5.0	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.1	0.3	0.0	0.0	38.5	34.4	10.4	31.4	38.9	7.7	3.7	31.0	10.5	7.1
GABRA4		ENSG00000109158	"Gamma-aminobutyric acid type A receptor alpha4 subunit"	P48169	4	46918900-46994407	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 16.1"	"Cell line enriched"	"Detected in single"	173	"REH: 17.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																"unprognostic (2.78e-2)"		"unprognostic (6.57e-3)"	"unprognostic (2.46e-1)"			"unprognostic (2.23e-1)"		"unprognostic (3.17e-1)"			"unprognostic (1.11e-1)"	"unprognostic (6.91e-2)"			0.0	0.1	2.7	0.1	8.9	0.0	0.0	0.3	16.1	0.1	0.1			0.6	0.0	0.0	0.2	0.0	0.1	4.0	1.9	1.4	0.1	0.0	0.0	0.0	1.0		0.0	0.0	0.0	0.2	0.3		0.0	0.1		0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0										
GDI1	"FLJ41411, GDIL, MRX41, MRX48, OPHN2, RABGDIA, XAP-4"	ENSG00000203879	"GDP dissociation inhibitor 1"	P31150	X	154436913-154443467	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 122.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012979, HPA049290, HPA057668"	Enhanced		Approved	Vesicles			70000000	Vesicles		"CAB012979: AB_2533970, HPA049290: , HPA057668: "	"prognostic unfavourable (6.84e-4)"	"unprognostic (1.13e-2)"	"prognostic unfavourable (3.83e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.98e-3)"	"unprognostic (3.86e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.72e-1)"	19.8	27.1	51.7	16.2	65.3	10.5	12.0	61.3	122.3	16.7	13.6	46.2	6.5	11.5	20.1	15.7	14.4	23.0	15.2	25.7	53.7	54.3	13.7	10.3	16.9	15.1	45.1	49.6	27.7	16.2	18.8	26.9	19.0	65.3	19.6	13.9	13.8	13.6	24.0	14.3	17.2	13.1	25.6	46.4	17.1	13.5	12.9	31.3	6.8	12.7	6.2	15.7	13.9	11.8	7.6	8.3	20.6	13.4	5.6	13.0	4.9	20.3	18.9	42.7	35.2	17.5	20.7	13.4	29.5	19.8	31.1	32.5	11.0	10.8	16.3	30.9	29.9	16.1	37.4	18.0	21.6	29.4	18.4	5.1	27.7	7.3	25.8	4.9	18.6	21.2	22.3	36.0	22.1	20.0	6.2	25.9	36.9	20.6	15.6	12.4	11.3	34.5	15.6	11.1	9.3	21.7	9.6	59.1	45.7	14.2	18.5	22.4	11.0	8.9	22.6	28.7	24.9	29.7	43.1	36.7	38.9	25.9	31.2	11.1	35.2	14.9	5.7	17.2	8.9	8.6	13.0	7.3	9.6	8.6	4.7	7.6	7.6	7.5	20.6	5.6	13.4	8.3	10.8	4.9	51.7	65.3	61.3	96.6	53.7	54.3	45.1	49.6	65.3	31.3
GPR37	"EDNRBL, hET(B)R-LP, PAELR"	ENSG00000170775	"G protein-coupled receptor 37"	O15354	7	124745997-124765627	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 62.4"	"Cell line enhanced"	"Detected in many"		"AF22: 9.4;fHDF/TERT166: 21.9;hTCEpi: 9.7;SK-BR-3: 8.5;TIME: 15.3"	"Cancer enhanced"	"Detected in many"		"glioma: 19.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042903, HPA068009"	Approved		Approved	"Nuclear membrane,Cytosol"			48000	"Nuclear membrane, Cytosol"		"HPA042903: , HPA068009: "	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (6.00e-5)"	"unprognostic (6.19e-2)"	"prognostic favourable (7.26e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-4)"	1.6	1.0	14.5	1.1	19.6	0.9	1.7	2.3	52.6	1.5	1.4	62.4	0.0	1.0	2.1	1.4	7.8	2.1	1.4	0.9	23.9	11.3	1.2	8.8	1.3	1.1	33.5	12.3	1.0	3.0	0.8	0.3	10.0	23.3	1.8	1.5	3.5	1.6	1.8	1.1	4.1	1.3	3.0	49.4	4.3	1.2	15.5	26.5	0.0	0.9	0.0	0.9	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	9.4	0.0	0.0	0.0	2.7	0.5	2.5	2.4	0.6	0.4	0.8	0.0	0.0	21.9	0.2	2.7	0.0	0.5	0.4	1.2	0.1	5.9	0.0	2.8	0.0	0.4	0.0	9.7	0.0	0.1	4.5	0.0	4.3	0.0	0.5	0.0	0.0	1.4	4.5	0.0	0.0	0.0	0.0	0.1	2.2	3.3	0.0	8.5	3.2	2.2	0.0	15.3	2.0	0.7	0.0	0.0	1.3	0.0	0.0	1.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	19.6	2.3	19.6	23.9	11.3	33.5	12.3	23.3	26.5
GPR45	"PSP24, PSP24A"	ENSG00000135973	"G protein-coupled receptor 45"	Q9Y5Y3	2	105241743-105243049	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 5.7"	"Group enriched"	"Detected in some"	11	"BEWO: 3.1;U-2 OS: 9.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055940	Uncertain									"HPA055940: "	"unprognostic (3.80e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.13e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.99e-2)"	0.1	0.1	1.4	0.1	2.3	0.0	0.1	0.0	5.7	0.0	0.1			0.2	0.0	0.0	0.2	0.0	0.1	0.1	1.4	3.1	0.1	0.0	0.0	0.3	1.2		0.1	0.0	0.0	0.0	0.2		0.2	0.0		0.4	0.1	0.2	0.4	0.4	0.0	0.4	0.2	0.2	1.2			0.3		0.0	0.1	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	9.6	0.0	0.1	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GPRIN1	"GRIN1, KIAA1893"	ENSG00000169258	"G protein regulated inducer of neurite outgrowth 1"	Q7Z2K8	5	176595802-176610133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 28.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.3;SCLC-21H: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA036478, HPA070892"	Enhanced		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"HPA036478: , HPA070892: "	"unprognostic (1.70e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.06e-1)"	"unprognostic (4.76e-6)"	"prognostic unfavourable (6.83e-6)"	"unprognostic (1.11e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-3)"	"prognostic unfavourable (2.79e-7)"	"unprognostic (4.24e-3)"	"unprognostic (5.60e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.32e-3)"	1.3	3.2	16.9	1.8	6.4	0.9	0.9	16.9	28.2	1.1	1.6	0.2	0.0	6.4	1.3	0.6	1.1	0.7	1.1	0.7	11.1	11.1	0.7	0.7	1.1	1.7	3.6	11.4	0.5	1.5	0.7	5.8	1.0	4.4	0.7	1.3	0.7	0.7	0.6	0.7	1.5	4.0	1.7	1.9	0.9	1.9	2.2	0.7	0.0	0.8	0.0	2.3	0.9	0.1	0.9	0.0	0.0	0.0	0.5	0.3	0.0	3.6	3.9	4.9	7.1	1.1	2.4	4.2	4.9	2.5	3.8	4.9	4.7	2.4	8.3	10.0	2.6	3.2	3.1	3.4	3.3	27.3	2.1	0.1	2.1	1.6	0.4	0.2	2.1	1.1	2.6	4.1	0.6	2.7	4.3	12.1	3.1	9.5	0.8	0.0	5.0	7.7	15.4	5.5	4.9	4.3	3.8	30.3	17.4	5.6	1.6	8.5	3.7	3.1	3.3	7.1	8.2	2.7	7.1	0.2	1.0	2.3	6.1	0.4	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	16.9	6.4	16.9	14.3	11.1	11.1	3.6	11.4	4.4	0.7
GRIN3A	GluN3A	ENSG00000198785	"Glutamate ionotropic receptor NMDA type subunit 3A"	Q8TCU5	9	101569353-101738580	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 17.3"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 6.3"	"Cancer enriched"	"Detected in single"	7	"prostate cancer: 3.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 3.3;non-classical monocyte: 2.5"	"Lineage enriched"	"Detected in single"	7	"monocytes: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.29e-1)"	"unprognostic (7.10e-3)"	"unprognostic (3.01e-5)"	"unprognostic (3.39e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.06e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.56e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.87e-1)"	"unprognostic (9.41e-2)"	0.6	0.6	7.4	0.8	4.2	0.5	0.7	0.4	17.3	4.1	1.0	2.6	0.0	0.6	1.0	1.0	0.5	0.6	0.5	1.2	6.8	6.4	0.6	0.6	0.7	1.1	3.8	12.4	2.4	0.5	0.4	0.4	0.4	4.6	1.8	0.8	2.7	0.6	2.6	0.7	1.0	0.7	0.7	3.0	1.8	0.6	1.0	2.3	0.0	0.5	0.0	0.8	0.5	0.6	0.0	0.4	0.1	3.3	0.0	0.4	0.2	0.0	0.2	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.2	0.0	0.2	0.5	0.0	0.0	0.6	0.1	0.0	0.1	0.2	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.3	0.7	0.5	0.3	0.4	0.1	0.0	0.3	6.3	0.6	0.2	0.2	0.2	0.2	0.3	0.3	0.4	0.1	0.7	0.2	0.6	1.0	0.3	0.7	0.3	1.2	0.0	0.6	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	2.5	0.0	0.4	0.2	7.4	4.2	0.4	13.4	6.8	6.4	3.8	12.4	4.6	2.3
HMSD	"ACC-6, ACC6, C18orf53"	ENSG00000221887	"Histocompatibility minor serpin domain containing"	"A8MTL9, P0C7T4"	18	63949301-63981774	"Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"brain: 26.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 7.7;HDLM-2: 18.1;Karpas-707: 7.1"	"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	18	"plasmacytoid DC: 5.0"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 5.0"														"Secreted to blood"						"unprognostic (5.83e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.42e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.19e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.14e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-3)"	"unprognostic (3.55e-1)"	1.7	1.9	3.9	3.4	8.4	0.5	1.5	0.6	4.8	0.4	0.8	11.3	0.0	0.7	0.3	0.2	1.3	0.8	0.4	1.0	5.8	4.2	0.3	1.9	3.0	5.9	15.1	1.0	1.2	0.9	0.2	0.3	0.3	12.1	0.3	2.1	0.0	0.6	0.5	0.5	2.9	1.0	0.4	26.1	2.1	1.5	2.1	11.2	1.4	0.8	0.2	4.9	0.5	1.3	0.2	5.0	0.0	0.0	0.0	0.0	0.2	3.2	0.0	0.0	0.0	3.3	7.7	0.0	0.6	2.1	0.3	4.1	0.0	0.8	0.0	0.0	0.9	3.3	1.3	0.2	2.6	18.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	4.2	0.0	2.8	0.1	0.0	0.0	7.1	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.0	0.2	1.3	0.0	0.0	3.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.2	3.9	8.4	0.6	3.7	5.8	4.2	15.1	1.0	12.1	11.2
INA	"NEF5, NF-66"	ENSG00000148798	"Internexin neuronal intermediate filament protein alpha"	Q16352	10	103277163-103290351	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 65.4"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 20.6;SCLC-21H: 40.5;SH-SY5Y: 23.0;SiHa: 27.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 18.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002059, HPA007572, HPA008057"	Enhanced	Supported	Approved	"Intermediate filaments"				"Intermediate filaments"		"CAB002059: AB_442031, HPA007572: , HPA008057: AB_1851833"	"unprognostic (1.77e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.49e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-1)"	1.5	15.7	16.6	2.6	21.3	1.3	1.3	26.9	65.2	1.3	2.7	2.3	0.0	2.0	1.3	1.4	1.9	1.3	1.5	1.3	13.2	34.0	1.3	1.4	1.5	1.4	27.2	17.7	1.3	3.6	1.3	12.8	1.5	65.4	1.5	2.8	5.5	1.3	1.4	1.3	2.2	2.5	2.2	7.9	1.3	2.6	4.1	3.3	0.0	1.5	0.0	1.5	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	4.6	0.0	0.0	0.0	7.5	5.1	1.2	1.2	0.1	0.0	0.0	0.0	2.1	0.3	0.7	4.2	0.0	0.3	9.2	1.9	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	5.0	0.0	20.6	0.0	0.0	0.0	0.0	3.2	0.0	40.5	23.0	27.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	21.3	26.9	42.0	13.2	34.0	27.2	17.7	65.4	3.3
IQCJ		ENSG00000214216	"IQ motif containing J"	Q1A5X6	3	158962928-159266307	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 19.5"	"Cell line enriched"	"Detected in single"	21	"Daudi: 10.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA052835	Uncertain									"HPA052835: "	"unprognostic (1.99e-2)"																	0.5	0.5	19.5	0.5	10.0	0.5	1.6	0.4	14.5	0.5	0.5	0.1	0.0	0.5	0.5	0.5	0.8	0.5	0.7	1.0	9.4	0.6	0.6	0.5	0.5	0.9	0.9	7.4	0.6	0.5	0.5	3.6	0.5	6.8	0.5	0.5	0.0	0.5	0.9	0.5	0.5	0.5	0.5	0.5	0.5	0.5	4.8	1.5	0.0	0.5	0.0	0.6	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	10.0	0.4	14.5	9.4	0.6	0.9	7.4	6.8	1.5
KCNG2	"KCNF2, Kv6.2"	ENSG00000178342	"Potassium voltage-gated channel modifier subfamily G member 2"	Q9UJ96	18	79863668-79900184	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 5.3"	"Cell line enhanced"	"Detected in some"		"NB-4: 3.5;U-2 OS: 1.1;U-937: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 31.7"	HPA048628	Enhanced									"HPA048628: "	"unprognostic (1.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.39e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.78e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.18e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.63e-2)"	0.2	0.1	1.5	0.8	2.2	0.6	0.0	0.1	2.4	0.0	0.3			1.1	0.3	0.0	0.1	0.0	0.0	0.0	5.3	1.0	0.9	0.1	0.2	0.4	0.0		0.2	0.0	0.0	0.1	0.6		0.0	0.0		0.3	0.0	0.0	0.1	1.1	0.0	0.2	0.3	0.3	1.2			0.0		0.0	0.5	0.0	0.6	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.5	0.0	0.7	0.3	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.7	0.1	0.1	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0										
KCNK12	"K2p12.1, THIK-2, THIK2"	ENSG00000184261	"Potassium two pore domain channel subfamily K member 12"	Q9HB15	2	47516581-47570939	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"brain: 22.7"	"Group enriched"	"Detected in some"	6	"REH: 21.6;SCLC-21H: 8.5"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 2.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (6.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.02e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.12e-6)"	"unprognostic (1.36e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.25e-1)"	1.1	1.7	9.8	5.1	4.6	1.0	0.9	22.7	16.1	0.8	1.1	2.4	0.0	1.0	1.0	1.0	1.0	0.9	0.9	0.9	5.6	3.4	1.0	0.8	1.0	1.6	7.2	4.0	1.2	0.8	0.9	5.5	1.7	8.1	1.0	0.9	0.6	0.9	0.8	1.2	1.0	0.9	0.9	10.1	1.1	1.2	1.5	2.1	0.0	1.0	0.0	1.5	1.0	0.3	0.7	0.1	0.2	0.0	0.4	1.8	0.2	0.0	0.1	0.7	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	1.2	0.5	21.6	0.0	1.6	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.7	1.0	1.8	0.1	0.2	1.1	1.0	0.2	0.4	0.0	0.0	1.1	0.2	9.8	4.6	22.7	16.1	5.6	3.4	7.2	4.0	8.1	2.1
KIF5C		ENSG00000168280	"Kinesin family member 5C"	O60282	2	148875250-149026759	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Transport	"Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 95.8"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 65.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 5.9"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035210, HPA062272"	Enhanced		Approved	Vesicles				Vesicles		"HPA035210: AB_10671931, HPA062272: "	"unprognostic (1.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.70e-4)"	"unprognostic (1.89e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.56e-1)"	"unprognostic (6.55e-6)"	"unprognostic (8.34e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.46e-2)"	1.8	10.5	32.0	2.3	31.8	1.3	1.6	33.8	95.8	2.2	2.5	21.7	0.0	1.6	1.8	11.0	1.4	1.6	1.7	1.6	25.4	13.7	1.6	1.2	1.5	1.8	15.8	25.5	3.3	2.5	1.5	12.6	1.3	27.1	21.9	3.2	0.4	1.4	7.5	1.3	1.4	2.3	2.0	20.1	1.6	2.4	13.5	18.3	0.0	3.6	0.0	1.7	2.4	1.0	0.8	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	12.6	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.6	0.0	0.1	0.0	7.3	0.0	1.4	3.7	1.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	12.7	3.9	0.0	0.1	0.0	0.0	2.7	65.3	15.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	1.1	0.0	1.8	1.2	0.2	0.0	4.6	0.2	0.4	0.0	0.0	0.0	0.3	0.0	5.9	0.5	1.1	1.4	0.0	0.8	0.2	0.3	0.0	0.0	0.0	0.0	0.7	0.0	32.0	31.8	33.8	40.3	25.4	13.7	15.8	25.5	27.1	18.3
KLC1	"hKLC1B, hKLC1G, hKLC1J, hKLC1N, hKLC1P, hKLC1R, hKLC1S, KLC, KNS2, KNS2A"	ENSG00000126214	"Kinesin light chain 1"	Q07866	14	103561896-103714249	"Predicted intracellular proteins"	"Host-virus interaction"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 117.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB009798, HPA044617, HPA052450"	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB009798: AB_2280879, HPA044617: , HPA052450: "	"unprognostic (6.93e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.67e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.62e-2)"	"prognostic favourable (6.75e-4)"	"unprognostic (6.84e-3)"	"prognostic unfavourable (7.17e-4)"	"unprognostic (6.58e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.49e-1)"	19.5	20.4	61.3	15.7	45.6	17.6	16.6	103.0	117.9	15.2	14.8	22.4	11.5	10.5	21.1	18.7	19.7	16.0	15.7	27.1	61.0	65.1	8.6	8.9	20.0	15.9	66.2	47.9	19.8	14.8	25.2	17.0	17.9	50.7	16.3	14.1	14.1	16.9	19.7	28.2	22.4	12.8	23.1	56.0	18.3	13.8	14.3	23.2	7.9	13.8	13.0	18.1	15.7	14.9	7.3	10.4	12.4	8.6	4.1	10.9	3.1	16.3	22.0	42.5	23.1	28.7	31.4	19.5	38.5	31.6	36.2	24.8	18.8	17.9	21.7	20.1	41.5	27.3	25.9	20.3	34.4	26.1	13.0	12.1	26.0	19.0	32.7	23.7	24.1	22.8	33.1	27.3	33.3	31.1	18.0	24.9	31.5	27.5	15.9	20.9	13.6	40.6	15.3	17.8	10.7	22.5	36.3	50.1	28.0	31.3	15.9	25.4	14.0	11.7	45.2	26.9	13.3	36.8	21.3	20.0	13.9	24.1	30.8	13.7	28.8	7.6	5.8	12.4	10.3	6.0	9.5	6.4	9.3	10.9	6.8	7.3	7.9	7.2	7.0	4.1	8.6	10.4	8.4	3.1	61.3	45.6	103.0	90.3	61.0	65.1	66.2	47.9	50.7	23.2
KLHL3	KIAA1129	ENSG00000146021	"Kelch like family member 3"	Q9UH77	5	137617500-137736090	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 64.2"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 6.3;RT4: 6.6;TIME: 14.6;U-266/70: 8.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 64.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051291	Approved									"HPA051291: "	"unprognostic (4.31e-2)"	"unprognostic (5.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.39e-3)"	"unprognostic (3.28e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.50e-4)"	4.1	5.8	9.1	3.2	11.9	1.2	2.7	64.2	12.0	5.3	2.1	0.8	1.7	2.6	5.0	2.7	2.2	5.1	5.8	14.7	6.2	4.2	10.2	1.8	2.8	5.2	4.7	9.3	9.0	2.2	1.3	5.9	3.3	5.0	2.3	2.4	10.4	1.6	2.2	2.2	3.1	1.9	3.6	4.2	3.5	5.1	5.5	1.7	3.7	12.1	1.3	4.0	3.0	3.4	0.1	1.2	1.6	0.0	2.2	3.2	0.6	0.4	0.3	1.5	0.0	0.9	1.2	1.0	0.3	0.4	0.2	0.2	0.5	5.8	1.4	3.1	0.0	0.2	0.3	2.6	0.2	1.4	0.7	0.6	1.0	0.0	0.3	0.0	1.1	1.1	0.2	0.7	0.0	6.3	0.3	1.2	0.2	0.0	3.1	0.9	2.7	0.9	2.5	0.0	0.0	1.0	6.6	1.8	1.0	0.4	0.0	0.5	0.0	0.5	14.6	0.4	0.4	0.0	0.4	8.8	4.9	0.0	5.6	0.1	0.7	0.0	0.0	1.6	0.7	0.0	0.8	0.0	3.0	1.1	0.1	0.1	3.2	1.8	0.0	2.2	0.0	1.2	1.3	0.6	9.1	11.9	64.2	12.0	6.2	4.2	4.7	9.3	5.0	1.7
LGI1	"EPITEMPIN, EPT, ETL1, IB1099"	ENSG00000108231	"Leucine rich glioma inactivated 1"	O95970	10	93757809-93806272	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 45.1"	"Group enriched"	"Detected in some"	5	"AF22: 13.2;NTERA-2: 8.9"	"Group enriched"	"Detected in some"	7	"glioma: 1.8;testis cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"						"unprognostic (1.26e-1)"			"unprognostic (4.68e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.20e-2)"		"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.07e-3)"	"unprognostic (8.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.93e-2)"	"unprognostic (4.65e-1)"	1.4	4.5	15.3	1.4	30.6	1.1	1.5	18.1	45.1	1.4	4.4	7.3	0.0	1.3	1.3	1.2	7.2	1.2	2.6	1.5	16.3	10.1	1.2	5.4	1.2	1.2	9.6	17.3	1.3	1.5	1.1	6.5	1.1	35.6	2.2	5.2	10.9	1.1	1.9	9.2	1.2	2.3	2.1	7.3	1.1	2.4	1.5	10.4	0.0	1.2	0.0	1.3	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	30.6	18.1	20.7	16.3	10.1	9.6	17.3	35.6	10.4
LINC00672		ENSG00000263874	"Long intergenic non-protein coding RNA 672"		17	38925168-38929384	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	4	"brain: 16.8"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																						"unprognostic (3.28e-1)"	"unprognostic (9.28e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.15e-2)"	"unprognostic (8.81e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.68e-6)"	"unprognostic (7.29e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.59e-4)"	0.7	2.5	4.6	1.0	9.6	3.5	0.9	5.1	16.8	0.4	1.1	4.0	0.0	1.0	2.5	3.1	0.7	1.5	1.8	1.1	5.0		0.3	0.2	1.4	1.4	2.8	7.5	2.7	0.3	0.4	0.4	1.0	7.1	1.5	1.7	2.1	0.6	3.1	0.6	2.3	1.8	2.3	3.5	1.9	1.6	0.3	3.7	0.0	0.2	0.0	0.9	0.8	0.0	1.3	1.0	4.0	1.2	1.4	2.8	0.5	0.7	1.0	2.1	1.4	1.2	1.5	0.3	0.9	0.7	0.2	0.6	0.4	3.8	0.7	0.7	1.3	2.0	0.0	0.5	0.7	0.4	0.6	1.1	1.1	0.1	0.7	1.4	2.6	1.5	0.8	0.7	0.3	0.3	0.2	0.8	0.5	0.7	0.7	1.5	11.5	0.0	3.2	0.2	1.0	1.2	0.9	0.2	4.4	1.2	1.2	0.7	1.4	1.3	2.2	0.6	0.9	0.8	0.4	1.1	1.6	0.8	1.1	1.5	0.4	1.6	1.2	1.9	1.1	0.5	0.5	0.7	0.8	0.8	0.5	1.3	0.9	2.8	4.0	1.4	0.7	1.0	0.7	0.5										
LIX1	"C5orf11, Lft"	ENSG00000145721	"Limb and CNS expressed 1"	Q8N485	5	97091867-97142872	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 35.9"	"Cell line enriched"	"Detected in some"	12	"RPTEC TERT1: 26.8"	"Cancer enhanced"	"Detected in many"		"glioma: 13.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"naive B-cell: 5.9"	"Lineage enriched"	"Detected in single"	9	"B-cells: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058426	Uncertain		Approved	"Vesicles,Cytokinetic bridge,Cytosol"				Cytosol	"Vesicles, Cytokinetic bridge"	"HPA058426: "	"unprognostic (3.18e-1)"	"unprognostic (4.53e-2)"	"unprognostic (9.46e-2)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (8.96e-2)"	"unprognostic (6.60e-2)"		"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.61e-2)"	1.0	1.2	14.9	1.3	16.9	1.4	1.1	6.1	35.9	1.0	1.3	19.2	1.0	1.2	1.2	1.2	1.0	1.2	1.1	1.1	24.6	10.7	4.9	1.0	1.1	1.6	11.7	13.2	1.0	1.0	1.0	1.2	1.4	12.4	3.0	1.4	3.3	1.1	8.3	1.1	1.1	1.2	1.2	10.1	1.2	1.2	1.1	13.0	0.0	6.5	0.0	1.0	1.0	0.2	5.9	0.1	0.6	0.1	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.2	1.2	0.1	0.0	0.0	5.9	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	14.9	16.9	6.1	11.9	24.6	10.7	11.7	13.2	12.4	13.0
LMTK3	"KIAA1883, LMR3, PPP1R101, TYKLM3"	ENSG00000142235	"Lemur tyrosine kinase 3"	Q96Q04	19	48485271-48513189	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 38.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 8.4;SK-BR-3: 10.0;U-266/70: 9.3;U-266/84: 7.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040203, HPA077070"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA040203: AB_10671690, HPA077070: "	"unprognostic (2.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.47e-1)"	"prognostic favourable (3.18e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.11e-2)"	1.3	4.4	19.8	2.3	28.6	2.0	2.0	20.0	38.1	2.0	1.5	6.0	0.2	6.2	1.4	1.5	2.3	1.6	1.9	1.7	17.2	11.1	2.5	1.3	3.2	2.2	6.5	23.8	1.3	2.1	8.5	6.1	2.1	12.5	3.5	1.2	1.6	5.2	3.1	1.2	2.4	4.0	1.2	6.6	1.8	2.9	1.5	10.3	0.0	2.3	0.0	2.2	1.6	1.2	0.0	0.0	0.0	0.2	0.0	0.4	0.1	4.5	3.0	0.3	0.0	0.0	0.0	4.4	0.0	0.2	0.0	0.1	2.2	3.6	1.6	1.2	0.0	2.1	0.3	1.6	0.0	0.0	1.2	0.2	0.3	0.7	0.0	0.0	8.4	0.2	0.9	0.0	0.0	0.1	1.4	2.8	0.0	3.0	0.6	0.8	1.1	0.9	3.8	0.0	1.3	1.1	0.7	0.7	2.8	0.1	10.0	0.0	3.8	0.2	0.1	0.0	0.8	0.1	0.0	9.3	7.5	0.4	0.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	19.8	28.6	20.0	38.1	17.2	11.1	6.5	23.8	12.5	10.3
LRRC7	"densin-180, KIAA1365"	ENSG00000033122	"Leucine rich repeat containing 7"	Q96NW7	1	69568398-70151945	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 29.1"	"Group enriched"	"Detected in some"	6	"HaCaT: 10.3;HEL: 30.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"eosinophil: 1.4;naive CD4 T-cell: 1.7;naive CD8 T-cell: 1.3"	"Group enriched"	"Detected in many"	14	"granulocytes: 1.4;T-cells: 1.7"	"Low region specificity"	"Detected in many"							HPA005625			Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Nucleoplasm, Centrosome"	"HPA005625: AB_1853340"	"unprognostic (2.81e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.84e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.64e-6)"	"unprognostic (1.31e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.08e-3)"	1.0	1.3	20.2	1.0	29.1	1.0	0.8	0.5	21.9	1.2	1.9	5.0	0.0	1.0	1.2	1.0	1.3	0.8	3.2	2.8	15.4	5.8	2.8	1.2	0.8	0.9	4.4	17.6	1.0	2.7	0.7	0.4	1.2	2.4	1.5	2.4	0.2	0.9	1.1	2.8	1.1	1.3	1.2	2.5	0.8	0.8	5.8	7.6	0.0	6.7	0.0	0.8	0.9	0.5	0.0	0.1	1.4	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	3.3	0.0	10.3	0.2	0.0	0.0	0.0	0.5	30.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	3.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.7	1.3	0.0	0.0	0.0	0.0	0.0	0.1	20.2	29.1	0.5	19.2	15.4	5.8	4.4	17.6	2.4	7.6
MAP1B	"MAP5, PPP1R102"	ENSG00000131711	"Microtubule associated protein 1B"	P46821	5	72107234-72209570	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 102.5"	"Cell line enhanced"	"Detected in many"		"TIME: 64.1"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009792, HPA022275"	Enhanced	Supported	Enhanced	Cytosol			140000	Cytosol		"CAB009792: AB_2137420, HPA022275: AB_1853944"	"unprognostic (9.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-2)"	"prognostic unfavourable (8.22e-5)"	20.3	18.1	27.5	10.2	39.6	1.6	9.3	52.3	101.9	15.3	6.1	21.6	3.5	3.2	9.2	9.8	12.8	7.7	10.7	17.1	37.6	40.7	4.4	3.3	3.7	3.2	42.4	42.5	7.8	4.5	3.0	7.0	9.5	102.5	19.0	6.2	9.4	7.6	24.0	3.6	10.2	3.9	22.9	45.7	2.4	7.2	11.0	11.3	0.0	5.7	0.1	2.6	13.4	5.9	0.2	0.4	0.6	0.0	0.0	0.3	2.1	0.3	12.1	30.5	11.0	19.0	33.3	0.0	6.5	5.0	6.6	7.9	0.1	0.4	0.0	15.7	24.1	0.1	16.6	0.6	10.0	0.0	2.4	1.3	4.3	3.9	10.1	0.0	1.0	33.4	2.1	26.6	9.9	20.6	1.9	0.0	11.2	0.1	0.0	0.0	8.2	3.9	0.1	3.6	0.0	0.5	0.0	19.7	13.6	6.4	0.0	3.3	0.0	1.2	64.1	21.0	9.9	15.3	29.4	1.4	0.0	0.0	22.7	0.0	16.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.1	0.2	0.6	0.0	0.0	0.4	0.2	2.1	27.5	39.6	52.3	59.1	37.6	40.7	42.4	42.5	102.5	11.3
MMP24	MT5-MMP	ENSG00000125966	"Matrix metallopeptidase 24"	Q9Y5R2	20	35226654-35277000	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 38.5"	"Cell line enhanced"	"Detected in some"		"A549: 19.6;CACO-2: 29.9;EFO-21: 8.8;RPTEC TERT1: 13.5;U-2 OS: 10.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 38.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 91.3"	"HPA049280, HPA078816"	Approved		Approved	"Nucleoli,Plasma membrane"	"Secreted to extracellular matrix"			"Nucleoli, Plasma membrane"		"HPA049280: , HPA078816: "	"unprognostic (1.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.51e-4)"	"unprognostic (2.47e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.12e-2)"	"prognostic favourable (8.17e-11)"	"unprognostic (3.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.90e-4)"	1.6	1.3	4.0	0.4	7.8	0.6	0.4	38.5	8.9	0.7	0.3	1.3	0.2	2.8	1.6	0.9	0.2	2.8	0.6	1.0	2.7	3.2	8.6	0.9	6.1	0.3	1.8	1.5	0.9	8.0	0.0	3.8	0.6	1.7	2.2	0.1	0.5	0.4	6.0	0.2	1.5	1.7	2.5	0.9	0.6	0.7	0.4	1.4	0.2	0.8	0.2	0.2	0.5	0.2	0.8	0.4	2.2	0.8	0.6	1.2	0.3	0.3	19.6	0.0	0.1	0.1	0.0	0.6	1.1	1.2	2.1	1.1	29.9	5.3	0.0	8.8	1.3	0.3	4.6	0.0	0.9	0.1	0.2	1.0	0.5	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.1	0.1	7.5	1.3	0.0	0.1	0.0	13.5	0.1	7.8	5.4	1.4	0.5	0.2	0.3	0.1	0.3	4.2	10.1	1.0	0.4	0.1	0.1	0.0	0.9	0.1	0.6	1.0	0.6	0.1	1.0	0.7	1.2	0.6	0.7	0.8	0.4	0.8	0.6	0.6	2.2	0.6	0.8	0.2	0.0	0.3	4.0	7.8	38.5	5.3	2.7	3.2	1.8	1.5	1.7	1.4
MTURN	"C7orf41, Ells1, FLJ25903"	ENSG00000180354	"Maturin, neural progenitor differentiation regulator homolog"	Q8N3F0	7	30134810-30162762	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 189.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 22.6;HEL: 39.3;SCLC-21H: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 9.9"	"Group enriched"	"Detected in many"	4	"granulocytes: 9.9;NK-cells: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029507	Enhanced		Approved	Cytosol				Cytosol		"HPA029507: AB_10601149"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-3)"	"unprognostic (9.80e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.11e-3)"	"prognostic favourable (7.64e-13)"	"unprognostic (9.50e-2)"	"unprognostic (7.64e-2)"	"unprognostic (4.64e-1)"	"unprognostic (3.26e-1)"	35.9	5.7	113.5	4.8	86.7	9.3	14.2	21.7	100.8	12.9	5.2	97.0	3.3	3.0	7.9	45.6	9.6	8.2	5.3	11.2	122.8	79.5	24.7	2.3	10.1	2.8	162.4	26.2	16.5	6.2	9.7	2.7	4.0	54.2	9.2	5.3	2.9	14.9	12.0	14.3	7.8	3.4	8.5	189.2	4.1	10.0	4.5	49.4	0.0	6.7	2.4	3.0	6.0	6.5	0.7	1.4	9.9	0.4	3.0	0.8	2.4	5.0	0.9	3.0	3.1	22.6	15.4	2.7	2.5	2.9	0.8	1.2	0.4	2.0	0.3	2.0	5.4	0.9	6.7	9.6	2.7	2.1	5.4	39.3	6.2	2.7	1.7	1.9	13.0	7.6	4.5	2.5	4.6	1.3	2.4	2.1	5.7	1.9	2.2	0.9	2.0	3.1	0.2	6.9	8.4	10.1	2.0	29.0	7.7	1.5	7.9	7.9	5.6	3.0	6.3	3.3	3.6	6.9	3.4	3.5	5.0	0.4	4.4	4.2	1.6	9.9	0.4	4.8	0.5	0.2	0.1	0.7	0.3	0.2	0.6	0.5	0.2	0.5	3.1	3.0	0.0	1.4	0.8	2.4	113.5	86.7	21.7	51.7	122.8	79.5	162.4	26.2	54.2	49.4
NRIP2	DKFZP761G1913	ENSG00000053702	"Nuclear receptor interacting protein 2"	Q9BQI9	12	2825348-2835544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 48.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.9"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA039197, HPA039860"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039197: AB_10673416, HPA039860: AB_10794203"	"unprognostic (3.28e-3)"	"unprognostic (3.83e-1)"	"prognostic unfavourable (8.05e-4)"	"unprognostic (2.10e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.26e-3)"	"unprognostic (5.66e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.39e-2)"	"prognostic favourable (8.69e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (7.55e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.97e-2)"	5.4	5.1	5.8	3.9	20.1	4.3	3.9	48.5	20.9	6.0	4.2	13.5	1.1	2.9	9.8	9.9	3.0	5.9	7.4	6.2	9.7	7.3	9.2	1.6	2.0	4.6	27.6	5.6	11.7	2.5	0.5	2.6	3.3	11.9	3.2	3.8	4.6	4.3	6.6	5.4	3.2	4.1	6.4	7.2	8.0	3.3	2.6	27.7	0.7	5.9	3.0	3.0	3.8	6.3	2.1	0.8	5.9	1.1	1.1	2.3	0.3	0.8	1.7	2.9	1.7	0.0	0.0	3.7	2.1	0.0	0.0	0.0	4.4	2.2	2.3	0.6	0.0	1.7	0.0	0.0	0.0	1.6	2.6	3.7	4.6	0.5	0.0	4.5	2.8	0.1	0.0	0.0	0.0	0.0	2.1	5.4	0.0	1.8	2.8	2.4	3.0	0.8	1.7	3.1	1.4	0.0	3.0	2.3	3.4	1.6	2.4	0.5	1.7	0.8	2.3	1.2	1.5	1.8	3.1	0.9	0.2	3.5	3.0	2.2	1.5	5.9	1.1	0.4	1.7	0.7	0.9	2.1	1.3	1.5	0.7	2.0	2.3	1.0	0.5	1.1	0.4	0.8	0.5	0.3	5.8	20.1	48.5	20.9	9.7	7.3	27.6	5.6	11.9	27.7
OLIG1	"BHLHB6, bHLHe21"	ENSG00000184221	"Oligodendrocyte transcription factor 1"	Q8TAK6	21	33070144-33072420	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 95.6"	"Group enriched"	"Detected in some"	6	"NB-4: 23.8;RPMI-8226: 12.4;THP-1: 15.6;U-937: 17.8"	"Cancer enriched"	"Detected in some"	18	"glioma: 116.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 6.3;eosinophil: 22.0"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 22.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (4.13e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.06e-1)"	"unprognostic (3.58e-1)"	"unprognostic (9.01e-3)"	"unprognostic (2.40e-1)"		"unprognostic (7.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.82e-3)"	"unprognostic (5.19e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.17e-1)"	1.8	1.8	44.6	1.9	51.6	2.5	1.9	7.3	95.6	1.8	1.8	58.3	0.0	1.9	1.8	1.8	1.8	1.8	1.8	1.8	42.7	30.4	3.1	1.8	1.9	1.8	40.7	22.7	1.8	1.9	1.8	0.1	1.8	35.5	1.8	1.8	0.0	1.9	1.8	3.0	1.8	2.0	1.8	41.4	2.3	2.0	2.2	35.7	0.0	1.8	0.0	1.8	1.9	0.0	0.0	0.2	22.0	1.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	1.6	0.4	0.0	0.0	0.0	0.0	1.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	23.8	0.1	0.0	0.0	0.1	12.4	0.0	0.0	0.8	0.0	0.0	0.0	2.9	0.1	15.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	17.8	1.0	6.3	1.6	22.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	1.4	0.1	0.0	0.3	44.6	51.6	7.3	35.2	42.7	30.4	40.7	22.7	35.5	35.7
OLIG2	"BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17"	ENSG00000205927	"Oligodendrocyte transcription factor 2"	Q13516	21	33025845-33029196	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 66.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 29.3;NB-4: 21.2;THP-1: 18.4;WM-115: 6.0"	"Cancer enriched"	"Detected in some"	52	"glioma: 46.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"eosinophil: 15.4"	"Lineage enriched"	"Detected in single"	154	"granulocytes: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003254, CAB019381"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"CAB019381: , HPA003254: AB_1854795"		"unprognostic (5.14e-1)"	"unprognostic (4.56e-1)"		"unprognostic (1.44e-2)"	"unprognostic (8.27e-2)"		"unprognostic (3.24e-2)"	"unprognostic (4.34e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.41e-2)"		"unprognostic (1.39e-1)"	"unprognostic (5.78e-5)"	"unprognostic (2.76e-1)"			1.3	1.3	24.1	1.4	19.1	1.4	1.3	4.2	66.2	1.3	1.3	41.4	0.0	1.7	1.3	1.3	1.3	1.3	1.3	1.3	23.6	15.6	1.3	1.3	1.3	1.3	20.9	15.5	1.3	1.3	1.3	0.0	1.3	17.1	1.3	1.3	0.0	1.3	1.3	1.3	1.3	1.5	1.3	16.8	1.3	1.4	1.3	16.6	0.0	1.3	0.0	1.3	1.4	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.6	4.2	0.0	0.0	0.0	0.8	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	21.2	1.9	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	6.0	1.8	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	19.1	4.2	27.6	23.6	15.6	20.9	15.5	17.1	16.6
OR9A2		ENSG00000179468	"Olfactory receptor family 9 subfamily A member 2"	Q8NGT5	7	143026158-143027195	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	4	"brain: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.6	0.0	0.0			0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.6		0.0	0.0	0.0	0.0	0.2		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.0	2.6	0.0	0.0	0.6			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PCDH19	"EFMR, EIEE9, KIAA1313"	ENSG00000165194	"Protocadherin 19"	Q8TAB3	X	100291644-100410273	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 27.1"	"Cell line enriched"	"Detected in some"	6	"AF22: 19.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027533	Approved		Approved	Cytosol				Cytosol		"HPA027533: AB_10602043"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.77e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.80e-4)"	"unprognostic (1.37e-1)"	4.9	1.1	19.8	1.3	10.5	0.7	3.7	1.0	22.5	5.5	4.0	1.9	0.0	1.2	3.8	1.3	2.9	2.2	2.0	1.6	27.1	12.8	1.4	0.9	1.0	1.3	3.7	14.2	3.6	1.1	1.2	2.1	1.0	7.3	1.4	5.5	6.4	2.1	1.6	2.4	3.3	1.8	3.1	3.7	0.8	2.0	2.3	1.0	0.0	1.1	0.7	0.9	2.3	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	19.6	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	3.4	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	2.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	10.5	1.0	22.5	27.1	12.8	3.7	14.2	7.3	1.0
PDE1B	PDES1B	ENSG00000123360	"Phosphodiesterase 1B"	Q01064	12	54549350-54579239	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 52.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.3;HL-60: 6.3;HMC-1: 12.1;NB-4: 8.0;THP-1: 7.7;U-937: 6.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 52.6"	"Cell type enriched"	"Detected in single"	4	"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.6"	"Region enriched"	"Detected in all"	6	"basal ganglia: 895.2"	"Region enriched"	"Detected in all"	7	"basal ganglia: 253.8"	HPA018492	Enhanced									"HPA018492: AB_1855119"	"unprognostic (2.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.67e-4)"	"unprognostic (5.63e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (4.77e-6)"	"unprognostic (6.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.83e-2)"	12.3	1.4	9.9	4.6	52.6	5.6	2.7	3.1	19.4	2.6	3.7	1.4	0.0	1.2	3.9	2.5	1.7	2.4	2.9	1.9	3.7	3.8	1.3	1.6	2.9	1.6	3.0	9.3	12.5	0.6	11.0	0.5	0.5	5.8	1.0	1.7	0.5	1.3	2.1	0.7	1.0	2.6	4.9	1.2	4.8	2.5	1.1	7.7	0.0	2.7	0.0	1.1	2.8	1.1	0.2	0.3	0.1	0.3	0.1	1.6	0.4	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.1	0.0	0.0	1.8	0.0	0.0	11.3	0.3	4.6	0.0	0.0	0.0	6.3	12.1	0.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.7	8.0	3.3	0.0	2.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.4	0.0	6.4	1.2	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.2	1.6	0.0	0.1	0.1	0.0	0.0	0.0	0.4	9.9	52.6	3.1	19.4	3.7	3.8	3.0	9.3	5.8	7.7
POU4F1	"BRN3A, RDC-1"	ENSG00000152192	"POU class 4 homeobox 1"	Q01851	13	78598362-78603560	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 25.3"	"Cell line enhanced"	"Detected in some"		"HEK 293: 10.9;HEL: 11.5;REH: 8.1;RH-30: 13.9;SCLC-21H: 13.3;U-266/70: 12.5"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	23	"pons and medulla: 25.3"	"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.1"	"Group enriched"	"Detected in some"	14	"midbrain: 3.0;pons and medulla: 2.2;thalamus: 2.4"	"Group enriched"	"Detected in some"	25	"midbrain: 3.1;pons and medulla: 7.4;thalamus: 2.5"	HPA068024	Enhanced	Approved								"HPA068024: "	"unprognostic (6.70e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-3)"		"unprognostic (1.32e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.98e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.53e-1)"		"unprognostic (4.75e-3)"	0.1	0.0	1.1	2.3	1.0	1.2	1.0	0.2	0.4	0.1	0.1	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.2	1.0	1.0	0.0	0.5	0.1	2.3	0.7	0.0	0.0	0.1	0.1	0.0	0.9	25.3	0.0	0.3	6.3	0.2	0.0	1.8	0.4	0.3	0.0	2.5	0.3	0.3	4.4	0.4	2.7	0.0	0.2	3.5	0.3	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	10.9	11.5	0.0	1.4	0.0	5.7	3.4	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.5	0.0	0.8	1.0	0.0	0.0	8.1	13.9	0.0	0.0	0.0	13.3	0.1	0.0	0.0	0.5	0.0	1.1	0.1	0.0	0.0	0.2	0.0	12.5	3.7	0.0	0.0	6.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.1	1.0	0.2	0.4	1.0	1.0	0.7	0.0	25.3	0.4
RFPL1	RNF78	ENSG00000128250	"Ret finger protein like 1"	O75677	22	29438583-29442455	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"brain: 20.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.9;HMC-1: 4.2;Karpas-707: 4.5;SH-SY5Y: 5.7;SiHa: 2.7;THP-1: 5.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA048320, HPA072380"			Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Plasma membrane"	"HPA048320: , HPA072380: "		"unprognostic (4.54e-1)"				"unprognostic (6.63e-8)"						"unprognostic (3.14e-3)"			"unprognostic (1.89e-1)"			0.0	3.3	0.2	0.1	0.7	0.0	0.0	0.4	20.4	0.2	0.0			0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.0	1.9	0.0	0.1	0.4		2.8	0.0	0.0	0.6	0.0		3.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	4.5			0.0		0.0	0.0	0.4	1.6	0.9	0.0	1.8	0.0	1.2	0.5	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.9	0.7	0.0	1.0	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.3	4.5	0.0	0.2	0.1	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	5.7	2.7	0.0	0.0	0.0	5.2	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.2	1.2	0.8	0.0	0.6	1.0	0.9	1.6	0.1	1.1	0.0	0.0	1.8	0.0	1.2	0.5										
RGS20	"RGSZ1, ZGAP1"	ENSG00000147509	"Regulator of G protein signaling 20"	O76081	8	53851808-53959303	"Plasma proteins, Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 20.0"	"Cell line enhanced"	"Detected in many"		"AF22: 12.5;SK-MEL-30: 19.0;U-87 MG: 18.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 12.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070193	Enhanced									"HPA070193: "	"unprognostic (2.14e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.91e-5)"	"unprognostic (5.03e-5)"	"unprognostic (2.15e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.86e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.75e-8)"	"unprognostic (3.71e-3)"	"unprognostic (9.78e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.69e-2)"	0.7	0.6	12.4	0.7	20.0	0.6	1.0	3.8	17.6	0.9	0.6	1.3	0.0	0.6	0.8	0.6	1.8	0.6	0.6	0.6	6.2	2.2	0.6	0.6	0.7	0.6	1.9	5.6	0.8	0.6	0.6	0.0	3.8	1.4	0.6	0.6	4.7	0.7	0.6	0.6	3.1	0.6	0.6	1.5	0.6	0.6	0.9	2.9	0.0	4.1	1.4	1.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	6.4	12.5	0.2	0.4	1.5	0.0	5.0	2.9	4.4	2.6	0.0	5.6	0.0	0.2	1.4	6.7	0.2	8.1	2.9	0.0	0.9	1.5	1.0	1.1	2.0	0.0	0.6	0.3	5.3	3.5	10.5	1.7	0.4	0.0	7.2	0.0	0.0	0.3	0.2	2.5	0.0	0.4	0.0	8.5	0.6	7.8	0.7	0.4	0.0	19.0	0.0	0.0	5.4	1.1	0.0	9.3	3.7	1.5	0.0	0.0	18.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	20.0	3.8	8.2	6.2	2.2	1.9	5.6	1.4	2.9
RGS4	SCZD9	ENSG00000117152	"Regulator of G protein signaling 4"	P49798	1	163068775-163076802	"Disease related genes, Predicted intracellular proteins"		"Signal transduction inhibitor"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 88.0"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 37.4;SH-SY5Y: 74.4;TIME: 151.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030802			Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA030802: AB_10602295"	"unprognostic (1.03e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.02e-2)"	"unprognostic (6.84e-2)"	"prognostic unfavourable (2.62e-4)"	"unprognostic (8.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.47e-2)"	"prognostic unfavourable (3.97e-4)"	"prognostic unfavourable (1.92e-4)"	"unprognostic (1.00e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.30e-2)"	2.9	20.9	9.1	2.1	45.3	0.5	1.4	1.1	88.0	4.0	1.7	1.0	0.0	2.9	4.8	1.4	6.3	4.9	11.2	4.7	13.9	10.1	1.5	2.6	2.1	2.3	12.1	36.2	1.1	2.7	1.2	6.2	1.3	16.0	3.3	1.8	1.0	0.9	3.9	0.7	0.6	1.6	3.0	1.9	1.5	3.7	2.1	2.1	0.0	1.5	0.2	0.7	2.8	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	3.7	19.2	0.0	12.9	14.1	1.9	5.0	0.0	0.0	0.0	5.7	8.3	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	3.1	0.0	20.4	2.5	19.7	0.0	0.0	37.4	0.0	0.0	0.0	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.4	74.4	0.0	0.0	0.0	0.0	0.0	151.8	15.4	0.7	3.0	21.5	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.1	45.3	1.1	78.8	13.9	10.1	12.1	36.2	16.0	2.1
RUNX1T1	"AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2"	ENSG00000079102	"RUNX1 translocation partner 1"	Q06455	8	91954967-92103286	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 57.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 12.9;fHDF/TERT166: 11.0;HEL: 23.7;HSkMC: 9.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	4	"cerebellum: 57.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049852, HPA070951"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA049852: , HPA070951: "	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.37e-4)"	"unprognostic (2.29e-4)"	"unprognostic (5.56e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.70e-4)"	"unprognostic (8.98e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.80e-3)"	9.6	4.6	7.7	4.5	11.5	0.4	6.9	57.8	13.0	14.0	7.8	1.1	2.0	2.0	11.8	5.9	4.1	7.7	7.8	12.3	5.8	4.0	2.5	1.3	6.0	2.0	3.6	9.6	7.7	1.8	1.7	8.6	8.7	4.2	4.2	4.0	5.3	4.7	4.1	5.5	3.6	3.6	10.3	3.0	2.9	4.2	5.6	3.7	0.0	5.2	3.3	1.8	5.7	5.9	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.3	3.5	5.1	0.0	5.1	7.8	3.4	5.3	0.0	0.0	12.9	0.0	11.0	0.0	2.7	0.3	2.3	0.0	2.1	23.7	0.0	0.0	1.4	0.0	0.0	9.5	0.0	5.7	0.2	7.3	0.1	0.0	0.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	7.7	4.1	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.6	0.0	2.6	0.0	4.1	0.5	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	7.7	11.5	57.8	13.0	5.8	4.0	3.6	9.6	4.2	3.7
S100B	S100beta	ENSG00000160307	"S100 calcium binding protein B"	P04271	21	46598962-46605208	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 342.0"	"Group enriched"	"Detected in some"	7	"SK-MEL-30: 81.0;WM-115: 159.2"	"Group enriched"	"Detected in all"	58	"glioma: 463.5;melanoma: 495.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 78.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 78.0"	"Low region specificity"	"Detected in all"							"CAB000073, HPA015768, CAB078196"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol			120000	"Nucleoplasm, Cytosol"	Vesicles	"CAB000073: AB_10013383, CAB078196: , HPA015768: AB_1856538"	"unprognostic (5.67e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.08e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.70e-2)"	"unprognostic (4.41e-7)"	"unprognostic (3.55e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	67.7	14.0	60.9	5.6	51.0	2.0	13.2	39.4	151.2	5.2	9.1	101.0	3.0	4.7	1.5	7.6	8.6	2.1	8.3	6.6	74.6	65.4	1.5	1.6	2.9	9.8	152.0	36.5	2.4	3.0	1.1	3.1	1.4	90.3	3.0	8.3	7.4	10.1	15.3	1.3	5.7	7.5	4.3	342.0	5.7	4.3	1.5	46.4	0.0	1.3	1.8	10.8	8.2	1.6	0.1	3.4	0.7	1.9	11.0	78.0	10.6	0.1	0.0	17.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	81.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.2	1.0	159.2	0.0	0.1	0.0	78.0	1.8	22.4	0.0	0.2	14.5	3.4	0.1	0.6	33.3	0.7	11.0	1.9	0.8	0.0	10.6	60.9	51.0	39.4	37.6	74.6	65.4	152.0	36.5	90.3	46.4
SHF		ENSG00000138606	"Src homology 2 domain containing F"	Q7M4L6	15	45167214-45201175	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 84.3"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 49.5;SH-SY5Y: 22.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 84.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 269.9"					HPA057381			Approved	Nucleoplasm				Nucleoplasm		"HPA057381: "	"unprognostic (4.05e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.50e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.12e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.83e-2)"	2.9	19.3	6.9	3.3	10.4	0.6	3.3	84.3	14.5	7.3	6.3	3.9	2.2	10.5	8.5	4.0	4.1	6.2	5.3	4.5	5.9	7.2	1.8	18.9	2.9	1.8	4.5	6.7	20.5	2.5	2.5	3.5	1.5	7.1	5.3	4.4	6.3	5.3	5.2	2.6	6.5	7.9	6.3	5.2	2.3	2.9	4.1	3.2	1.6	4.9	2.4	1.8	5.8	5.5	3.3	2.6	2.5	1.9	5.1	4.2	1.5	0.0	0.5	9.7	0.3	0.7	0.4	4.6	1.2	0.8	2.7	3.9	1.4	4.6	0.5	3.9	1.6	0.8	3.7	0.3	1.3	0.8	1.7	0.3	0.8	9.6	0.4	0.0	3.2	0.9	0.2	0.3	0.0	2.1	1.9	0.2	3.8	1.6	2.1	0.3	3.8	0.2	5.8	7.7	0.2	0.9	0.2	49.5	22.1	0.3	0.3	0.1	0.4	0.9	0.1	0.3	4.2	0.3	0.1	0.4	0.3	0.4	0.1	0.2	1.5	0.3	1.9	1.2	3.8	1.7	4.2	2.4	1.6	2.4	1.8	3.3	2.2	1.7	2.5	5.1	1.7	2.6	0.3	1.5	6.9	10.4	84.3	12.1	5.9	7.2	4.5	6.7	7.1	3.2
SHISA8	"C22orf17, Orf26"	ENSG00000234965	"Shisa family member 8"	B8ZZ34	22	41909554-41914667	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 42.2"	"Cell line enriched"	"Detected in some"	7	"HEK 293: 20.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	15	"cerebellum: 42.2"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.7"	"Group enriched"	"Detected in some"	5	"cerebellum: 8.7;olfactory region: 19.4"	"Group enriched"	"Detected in all"	4	"cerebellum: 61.4;olfactory region: 45.2"	HPA059173	Uncertain									"HPA059173: "	"unprognostic (8.76e-2)"	"unprognostic (2.98e-4)"	"unprognostic (1.03e-1)"	"prognostic favourable (2.76e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.22e-4)"	"unprognostic (7.84e-2)"	0.1	9.4	0.5	1.6	0.5	0.2	0.1	42.2	2.7	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.4	0.2	0.3	0.3	0.5	0.2	0.2	0.1	0.1	3.0	0.3	1.7	0.1	0.1	0.1	0.8	0.0	2.2	0.2	0.0	1.5	1.8	0.2	0.8	0.5	0.8	0.0	0.3	2.7	0.7	0.2	0.0	0.0	0.1	0.0	3.8	0.4	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.8	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	42.2	2.7	0.5	0.2	0.3	1.7	2.2	0.0
SLC26A5	"DFNB61, PRES"	ENSG00000170615	"Solute carrier family 26 member 5"	P58743	7	103352730-103446177	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell shape, Hearing"	"Motor protein"	"Deafness, Non-syndromic deafness"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 20.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.9;PC-3: 2.5;U-2197: 1.7"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	8	"cerebellum: 20.4"	"Cell type enriched"	"Detected in single"	8	"basophil: 2.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.7"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in some"	8	"basal ganglia: 9.5"												"unprognostic (3.86e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.56e-4)"	"unprognostic (4.21e-3)"	"unprognostic (8.92e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.67e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.69e-3)"	1.3	1.0	0.6	0.3	0.7	2.3	3.1	20.4	0.8	0.6	0.3	0.5	0.0	0.9	0.5	0.0	0.2	0.4	0.2	0.4	0.8	0.4	0.7	0.9	2.2	1.2	1.3	0.4	0.4	0.7	2.5	4.6	0.1	2.6	3.1	0.1	0.9	1.4	1.0	0.6	2.2	0.5	1.2	2.9	0.9	3.2	0.9	0.2	0.0	1.8	0.0	0.2	3.2	0.4	0.2	0.0	2.7	0.1	0.3	0.1	0.0	0.2	0.0	0.3	0.7	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	1.1	0.7	0.4	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.2	0.9	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.3	2.9	0.0	1.1	0.8	0.3	0.1	2.5	0.2	0.1	0.4	0.0	0.8	0.9	1.4	0.3	0.3	0.0	0.7	0.0	0.0	0.6	0.5	1.7	0.4	0.7	0.4	0.4	0.2	0.2	0.3	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.7	20.4	0.8	0.8	0.4	1.3	0.4	2.6	0.2
SLC44A1	"CD92, CDw92, CHTL1, CTL1"	ENSG00000070214	"Solute carrier family 44 member 1"	Q8WWI5	9	105244622-105439171	"CD markers, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 111.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 71.8;ASC TERT1: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064714			Supported	Nucleoplasm,Mitochondria			270000	Mitochondria	Nucleoplasm	"HPA064714: "	"unprognostic (3.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (4.49e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.20e-2)"	"prognostic favourable (1.85e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-2)"	8.7	7.4	40.0	6.4	48.8	5.3	14.6	7.2	37.0	9.9	26.7	69.5	10.2	12.0	8.8	18.4	10.1	8.5	11.0	6.9	50.0	29.6	12.0	20.3	9.8	4.6	64.3	21.3	8.0	8.0	20.5	3.9	12.3	38.2	6.6	26.9	4.6	6.0	14.8	4.8	11.4	14.0	9.5	111.6	4.8	18.9	2.3	59.4	2.3	24.0	5.1	7.9	12.4	7.9	2.4	3.7	2.5	5.4	8.7	1.8	1.6	6.7	5.7	1.5	1.9	71.8	56.8	4.9	5.7	14.9	3.7	5.0	6.0	18.0	9.0	2.9	21.5	13.5	4.6	8.2	6.4	7.8	3.8	11.2	4.0	7.5	4.8	2.2	5.8	31.5	6.8	7.1	6.5	11.7	0.3	18.8	4.2	9.6	8.9	2.5	8.7	5.5	1.8	6.0	6.8	5.1	15.9	7.5	2.9	8.0	8.9	8.0	8.8	6.8	10.0	3.7	3.4	4.0	4.1	14.5	9.5	6.8	7.2	4.9	4.9	2.5	5.4	1.1	1.1	2.1	0.8	2.0	1.2	0.8	3.7	2.4	1.8	0.6	1.0	8.7	1.2	1.3	1.1	1.6	40.0	48.8	7.2	29.8	50.0	29.6	64.3	21.3	38.2	59.4
SLC6A17		ENSG00000197106	"Solute carrier family 6 member 17"	Q9H1V8	1	110150486-110202202	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 53.5"	"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 27.6"	"Cancer enriched"	"Detected in some"	9	"melanoma: 17.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007663, HPA008044"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA007663: AB_1857194, HPA008044: AB_1857192"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-3)"	"unprognostic (5.52e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.68e-3)"	1.4	7.8	9.3	1.2	18.3	1.1	1.3	21.8	53.5	1.0	1.1	2.3	0.0	1.0	1.0	2.1	1.3	1.0	1.1	1.0	11.2	14.9	2.1	0.9	1.0	0.9	6.0	16.2	1.0	2.6	1.0	12.4	1.8	19.5	1.0	1.0	2.6	1.2	1.0	1.0	7.6	1.1	1.1	1.8	1.0	1.8	2.4	0.7	0.0	1.3	0.0	0.9	1.0	0.1	0.3	0.0	0.8	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	4.2	0.4	1.6	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.6	4.7	1.4	27.6	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	5.6	0.0	2.5	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	9.3	18.3	21.8	37.3	11.2	14.9	6.0	16.2	19.5	0.7
SLC6A5	"GLYT2, NET1"	ENSG00000165970	"Solute carrier family 6 member 5"	Q9Y345	11	20599400-20659285	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 21.3"	"Cell line enriched"	"Detected in single"	5	"SCLC-21H: 2.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"pons and medulla: 21.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	9	"pons and medulla: 51.6"	"Region enriched"	"Detected in some"	9	"pons and medulla: 33.2"	CAB079052		Supported								"CAB079052: "					"unprognostic (6.94e-2)"	"unprognostic (2.28e-1)"									"unprognostic (4.75e-2)"			0.0	0.1	0.1	0.1	0.0	0.0	0.0	3.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	5.1	0.1	0.1	0.0	0.0	0.0	0.0	2.2	0.0	21.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	6.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.4	0.3	0.1	0.1	0.0	21.3	0.0
SPTBN4	"KIAA1642, SPTBN3"	ENSG00000160460	"Spectrin beta, non-erythrocytic 4"	Q9H254	19	40466241-40576464	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 36.3"	"Cell line enhanced"	"Detected in some"		"K-562: 3.5;Karpas-707: 5.0;SCLC-21H: 7.9;SH-SY5Y: 4.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054481	Enhanced		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA054481: "	"unprognostic (1.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.65e-4)"	"unprognostic (3.72e-4)"	"unprognostic (7.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.02e-1)"	3.1	5.9	13.4	1.2	15.3	1.2	1.2	36.3	27.1	1.4	1.3	1.8	0.0	1.7	2.3	1.3	1.6	2.0	1.8	3.3	9.8	10.8	1.9	1.3	1.2	1.0	7.5	13.0	4.1	3.0	3.3	8.0	1.0	10.4	2.8	1.1	2.6	2.2	2.0	5.1	1.3	1.5	1.8	2.8	1.3	2.5	3.5	3.7	0.0	1.6	0.0	1.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.5	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.4	2.3	1.9	0.4	0.0	0.0	0.0	0.0	0.4	2.3	0.5	0.0	0.0	0.3	0.0	0.8	0.3	0.0	0.0	0.0	0.0	3.5	5.0	0.0	1.3	0.0	0.0	0.2	0.8	0.5	0.0	1.1	0.0	0.0	7.9	4.8	0.1	0.2	0.0	0.7	0.0	0.0	0.0	1.4	0.8	0.0	0.2	0.3	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	15.3	36.3	22.7	9.8	10.8	7.5	13.0	10.4	3.7
SSTR4		ENSG00000132671	"Somatostatin receptor 4"	P31391	20	23035386-23036812	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	4	"brain: 3.8"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA064252	Uncertain									"HPA064252: "																		0.0	0.0	1.7	0.0	1.1	0.0	0.0	3.0	3.8	0.0	0.0			0.0	0.7	0.0	0.0	0.1	0.0	0.0	1.3	0.4	0.0	0.0	0.8	0.0	0.1		0.0	0.0	0.0	0.0	0.1		0.0	0.1		0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
STMN2	"SCG10, SCGN10"	ENSG00000104435	"Stathmin 2"	Q93045	8	79610814-79666175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 153.3"	"Cell line enriched"	"Detected in some"	9	"SH-SY5Y: 120.5"	"Group enriched"	"Detected in many"	5	"glioma: 26.1;pancreatic cancer: 10.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 5.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026922			Approved	"Endoplasmic reticulum,Vesicles"				Vesicles	"Endoplasmic reticulum"	"HPA026922: AB_1857605"	"unprognostic (4.41e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.20e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.29e-13)"	"unprognostic (1.14e-1)"	"unprognostic (3.86e-1)"	"unprognostic (5.77e-3)"	"unprognostic (9.59e-2)"	1.7	35.4	35.2	5.6	35.0	1.4	2.5	99.8	153.3	5.3	10.7	4.2	0.0	7.7	1.9	1.3	1.8	1.4	3.0	1.3	40.3	71.9	1.4	1.8	1.5	1.6	44.7	60.4	1.4	3.2	1.4	1.5	1.4	102.4	2.5	14.2	2.6	1.7	2.1	1.3	6.4	9.8	4.3	19.0	3.1	2.4	2.2	6.6	0.0	1.3	0.0	1.9	1.5	0.9	0.0	5.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.4	120.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	5.6	0.0	0.0	35.2	35.0	99.8	68.3	40.3	71.9	44.7	60.4	102.4	6.6
STMN3	SCLIP	ENSG00000197457	"Stathmin 3"	Q9NZ72	20	63639705-63657682	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 90.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 31.7;MOLT-4: 34.3;REH: 35.3;SCLC-21H: 49.5;SH-SY5Y: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 3.3;MAIT T-cell: 3.5;memory CD4 T-cell: 6.8;memory CD8 T-cell: 5.8;naive CD4 T-cell: 8.3;naive CD8 T-cell: 6.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012947	Enhanced									"HPA012947: AB_1857606"	"unprognostic (7.59e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.65e-3)"	"unprognostic (7.52e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.73e-2)"	"unprognostic (9.87e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.08e-3)"	9.0	21.0	53.5	13.1	52.7	6.9	7.7	48.8	90.9	10.9	5.3	6.7	1.2	4.2	10.9	4.2	5.9	10.3	7.6	5.0	48.9	47.7	4.6	1.6	6.2	15.2	34.2	63.6	19.8	7.6	6.2	18.6	7.0	45.8	8.2	4.2	6.2	7.5	9.5	3.3	11.6	6.5	10.1	29.5	20.3	6.5	4.1	12.3	11.0	20.9	1.9	8.4	6.6	3.5	1.0	1.3	1.2	0.1	0.0	8.3	2.5	2.5	2.9	19.0	31.7	0.5	1.9	1.3	3.0	0.1	9.2	4.3	18.2	3.4	0.1	9.3	1.1	17.2	13.2	0.3	2.8	1.2	3.5	1.2	4.0	6.7	2.6	0.9	10.8	4.0	0.0	2.9	0.7	0.3	23.8	0.5	2.4	2.8	34.3	4.3	19.5	20.7	35.3	3.1	14.1	15.5	0.5	49.5	37.7	1.4	0.8	3.6	0.5	6.4	0.4	0.2	5.3	0.2	0.6	1.2	2.5	0.8	0.5	3.5	12.3	1.0	0.1	1.2	3.3	0.1	3.5	0.3	6.8	5.8	0.1	1.0	8.3	6.8	0.2	0.0	0.1	1.3	1.1	2.5	53.5	52.7	48.8	74.0	48.9	47.7	34.2	63.6	45.8	12.3
SVOP	DKFZp761H039	ENSG00000166111	"SV2 related protein"	Q8N4V2	12	108907741-109021240	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 30.3"	"Group enriched"	"Detected in some"	13	"Karpas-707: 6.1;RPMI-8226: 6.2;SCLC-21H: 3.4;SH-SY5Y: 3.0;U-266/84: 2.8"	"Group enriched"	"Detected in some"	9	"glioma: 0.6;pancreatic cancer: 1.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016573	Uncertain									"HPA016573: AB_2197027"	"unprognostic (6.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.25e-1)"		"unprognostic (3.38e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.07e-1)"	"unprognostic (4.28e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.26e-2)"		"unprognostic (6.17e-2)"	0.6	2.9	6.9	0.7	14.0	0.7	0.6	8.2	30.3	0.6	0.8	0.5	0.0	1.3	0.6	0.7	0.6	1.1	0.6	1.1	8.9	1.9	0.7	0.6	0.7	0.6	0.7	10.0	0.6	1.7	0.5	6.8	0.6	6.4	0.8	0.8	1.5	0.6	0.7	0.7	0.6	1.0	0.6	0.8	0.6	1.8	1.0	0.7	0.0	0.7	0.0	0.5	0.6	0.7	0.6	0.4	2.0	0.4	0.9	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	6.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.0	3.4	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	2.8	0.1	0.0	0.1	0.0	1.5	0.4	0.4	0.3	0.2	0.2	0.2	0.3	0.2	0.1	0.6	0.3	0.3	2.0	0.9	0.3	0.4	0.2	0.1	6.9	14.0	8.2	21.6	8.9	1.9	0.7	10.0	6.4	0.7
SYNJ2	INPP5H	ENSG00000078269	"Synaptojanin 2"	O15056	6	157981887-158099176	"Enzymes, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 62.0"	"Cell line enhanced"	"Detected in many"		"TIME: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031575	Approved		Approved	Microtubules,Cytosol				Microtubules	Cytosol	"HPA031575: AB_10604101"	"prognostic unfavourable (2.63e-4)"	"unprognostic (1.94e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (4.02e-6)"	"unprognostic (1.66e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.45e-2)"	2.8	3.9	12.2	4.9	25.1	15.3	6.7	3.0	18.7	3.9	8.7	50.5	3.7	5.8	5.2	9.4	6.0	4.6	8.0	8.5	17.8	10.9	3.2	4.0	2.8	4.4	46.8	8.8	2.9	6.6	1.1	2.9	2.6	33.0	5.3	8.9	1.4	13.5	5.1	4.3	3.1	5.6	6.6	62.0	3.3	7.0	6.5	24.4	3.0	4.4	1.4	5.3	5.9	3.0	3.2	1.1	9.3	1.3	2.4	3.8	0.8	5.9	20.9	1.7	2.7	1.3	4.3	9.3	11.0	22.4	13.2	15.6	10.7	5.1	0.2	7.5	21.2	5.7	3.7	6.9	15.4	8.3	3.4	11.6	10.9	11.3	2.5	4.0	12.6	2.2	3.7	20.1	4.7	22.9	8.8	2.6	6.0	2.8	5.0	4.5	2.0	11.7	2.2	7.2	5.3	4.4	6.9	13.3	0.7	8.5	5.4	2.1	4.2	2.5	40.5	10.0	10.3	23.1	13.3	1.1	2.8	0.3	18.8	6.4	6.9	4.5	1.3	1.1	1.9	0.6	3.8	1.9	2.6	1.7	1.1	3.2	2.2	1.7	9.3	2.4	0.8	1.1	2.1	0.8	12.2	25.1	3.0	18.7	17.8	10.9	46.8	8.8	33.0	24.4
SYT5		ENSG00000129990	"Synaptotagmin 5"	O00445	19	55171199-55180441	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 73.0"	"Group enriched"	"Detected in some"	4	"EFO-21: 15.4;HMC-1: 34.1;K-562: 12.0;SCLC-21H: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA078390	Enhanced									"HPA078390: "	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"unprognostic (9.76e-2)"	"unprognostic (4.59e-2)"	"prognostic unfavourable (6.54e-4)"	"unprognostic (9.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.82e-1)"	"prognostic favourable (5.54e-4)"	"unprognostic (1.15e-3)"	"unprognostic (3.71e-7)"	"unprognostic (7.09e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.55e-1)"	1.2	9.8	20.0	2.7	30.9	1.4	1.0	1.3	73.0	1.8	1.7	1.0	0.0	2.2	1.2	1.0	1.2	1.3	1.3	1.1	22.0	18.8	1.1	1.1	1.2	1.2	6.1	19.8	1.1	2.6	1.1	16.3	1.1	8.3	1.1	1.7	0.0	1.1	1.0	1.2	1.4	1.8	1.5	1.9	1.2	2.9	3.5	3.6	0.0	1.2	0.0	1.3	1.1	0.0	1.0	1.8	3.6	0.8	1.1	0.5	0.5	0.1	0.1	0.2	0.2	0.5	0.0	0.2	0.3	0.0	0.0	0.5	0.0	0.6	0.9	15.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.0	34.1	0.4	0.1	0.0	0.0	0.3	12.0	2.1	0.0	0.3	0.3	0.0	0.0	2.1	0.1	0.2	0.2	0.0	0.0	9.0	4.0	0.0	0.5	0.4	0.2	0.0	0.0	0.7	0.7	1.0	0.0	0.1	0.7	0.4	0.3	0.0	0.2	3.6	0.8	1.1	0.4	0.5	0.4	0.7	0.3	0.5	1.8	1.0	0.4	0.5	3.4	1.1	0.4	0.8	0.3	0.5	20.0	30.9	1.3	36.6	22.0	18.8	6.1	19.8	8.3	3.6
TMEM155	FLJ30834	ENSG00000164112	"Transmembrane protein 155"	Q4W5P6	4	121758933-121765427	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 25.6"	"Group enriched"	"Detected in some"	5	"fHDF/TERT166: 7.2;HAP1: 3.3;LHCN-M2: 10.2;MOLT-4: 6.2"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"cerebral cortex: 25.6"	"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.3;T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.3"									HPA077585	Approved				"Secreted in brain"					"HPA077585: "	"unprognostic (9.67e-3)"	"unprognostic (3.25e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.82e-7)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.04e-1)"	0.6	0.3	5.9	0.5	8.3	0.3	0.3	0.3	25.6	0.4	1.3	0.0	0.0	0.4	0.3	0.3	0.5	0.3	0.4	0.4	7.9	1.6	0.3	0.3	0.6	4.0	0.9	8.9	0.3	0.3	0.2	0.2	6.1	0.7	0.5	0.7	0.9	0.5	0.6	0.3	0.3	0.6	0.9	0.3	0.8	0.5	0.7	0.0	0.0	0.3	0.0	0.6	0.5	0.3	0.0	0.0	0.7	0.0	0.0	2.3	0.3	0.0	0.0	0.1	0.0	1.4	0.2	1.0	0.7	0.2	0.3	0.5	0.0	0.0	0.0	0.0	7.2	0.0	3.3	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.2	0.0	0.3	0.0	0.0	10.2	0.0	6.2	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.3	5.9	8.3	0.3	25.6	7.9	1.6	0.9	8.9	0.7	0.0
TUBB2B	"bA506K6.1, DKFZp566F223, MGC8685"	ENSG00000137285	"Tubulin beta 2B class IIb"	Q9BVA1	6	3224261-3231730	"Disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 125.4"	"Cell line enhanced"	"Detected in some"		"AF22: 72.9;CACO-2: 53.5;NTERA-2: 35.7;RPMI-8226: 36.6;SCLC-21H: 109.3;SH-SY5Y: 53.1"	"Cancer enriched"	"Detected in many"	9	"glioma: 216.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"memory B-cell: 2.0"	"Lineage enriched"	"Detected in single"	21	"B-cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Supported									"HPA043640: , HPA046280: "	"unprognostic (2.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.92e-3)"	"prognostic unfavourable (1.94e-4)"	"unprognostic (6.81e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.03e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.24e-3)"	"unprognostic (6.04e-2)"	"unprognostic (3.58e-4)"	"unprognostic (2.30e-3)"	3.8	5.9	53.6	5.9	63.1	1.5	4.4	23.2	125.4	4.7	4.6	22.6	0.0	2.8	4.0	29.7	2.5	2.0	3.6	2.1	34.3	48.6	6.6	1.4	1.6	6.0	56.7	18.6	1.5	2.9	1.4	4.8	3.9	36.1	2.1	3.1	2.3	3.6	4.3	4.5	3.0	4.7	5.5	80.5	1.8	3.3	1.7	16.2	0.0	1.6	0.0	4.6	2.1	0.6	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	72.9	22.0	0.0	0.0	0.0	0.4	0.8	2.7	5.9	53.5	0.2	0.0	0.7	0.5	0.0	28.4	0.0	1.6	0.0	13.0	0.0	0.0	4.1	0.2	0.0	0.8	0.4	0.0	0.3	0.0	0.0	0.8	0.1	0.7	0.0	0.1	0.0	35.7	2.3	0.0	3.5	36.6	0.3	0.0	109.3	53.1	0.0	0.2	0.3	0.4	0.0	0.0	0.0	12.4	0.6	0.0	7.2	0.0	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	53.6	63.1	23.2	39.2	34.3	48.6	56.7	18.6	36.1	16.2
TUBB3	"beta-4, CFEOM3, CFEOM3A, FEOM3"	ENSG00000258947	"Tubulin beta 3 class III"	Q13509	16	89921392-89938761	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 85.1"	"Cell line enhanced"	"Detected in many"		"A549: 65.2;SCLC-21H: 66.4;SH-SY5Y: 67.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"naive B-cell: 5.2"	"Lineage enriched"	"Detected in single"	7	"B-cells: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Approved						250000000			"HPA043640: , HPA046280: "	"unprognostic (7.08e-2)"	"unprognostic (3.37e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.27e-3)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.91e-2)"	5.1	19.4	23.9	8.9	23.3	3.2	1.2	24.1	85.1	2.4	4.1	7.8	0.0	3.6	7.9	1.1	2.2	1.0	7.3	1.8	25.0	66.5	1.1	1.1	1.6	5.7	44.5	15.9	1.1	2.5	1.0	9.9	2.2	60.9	1.6	2.8	5.5	1.9	1.3	1.0	4.1	4.8	9.3	12.9	1.1	2.5	11.2	3.3	0.0	1.0	1.7	4.4	5.3	0.6	5.2	0.7	0.2	0.3	0.0	0.2	0.2	4.5	65.2	24.3	27.6	2.9	28.0	1.0	27.9	4.8	16.9	7.7	8.8	8.4	13.8	14.6	21.1	17.2	23.4	4.1	4.3	3.4	2.3	0.1	5.5	57.7	0.9	0.0	10.8	16.0	1.2	25.8	2.2	13.8	1.4	0.4	19.2	43.4	0.1	4.6	42.6	35.8	0.0	8.5	1.4	20.9	1.3	66.4	67.0	39.2	0.7	19.0	2.1	0.2	17.4	23.1	24.9	30.9	28.2	0.2	2.8	5.2	23.9	1.7	40.8	0.2	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.2	0.0	5.2	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.2	23.9	23.3	24.1	51.0	25.0	66.5	44.5	15.9	60.9	3.3
